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Monoclonal Antibody Production and Purification
Abstract

Monoclonal antibody (mAb) therapy is a form of immunotherapy that uses mAbs to bind mono-specifically
to certain cells or proteins. This may then stimulate the patient's immune system to attack those cells. MAbs
are currently used to treat medical conditions such as cancer, diabetes, arthritis, psoriasis, and Crohn’s Disease,
but have the potential to treat countless diseases and disorders. In 2015, the mAb market was valued at $85.4
billion, and is expected to reach $138.6 billion by 2024.1 In manufacturing, mAbs are typically produced in
suspension in a series of fed-batch bioreactors using genetically engineered cells originally obtained from
Chinese Hamster Ovaries (CHO).2 In this proposal, two upstream bioreactor designs were analyzed for
economic comparison given an annual production goal of 100 kg of mAb, with the first design culminating in
a 20,000 L volume at low mAb titer and the second design culminating with a 2,000 L volume at high mAb
titer. Following upstream mAb production, the protein was purified to meet clinical FDA standards using a
series of downstream purification techniques, including centrifugation, filtration, and chromatography. The
two designs can be modeled for both an on-patent and off-patent mAb in order to ensure long-term economic
viability. In this project, the drug was modeled based on Ocrevus (ocrelizumab), a humanized therapeutic
mAb brought to market in 2017 that targets a CD20-positive B cell to treat the symptoms of both primary
progressive and relapsing Multiple Sclerosis.3 For an off-patent drug, it is recommended that the mAb be
priced at $35,000 per 1200 mg annual treatment in order to earn a 15% Internal Rate of Return (IRR) within
5 years of market uptake. For an on-patent drug, a price of $65,000 per 1200 mg treatment should be used to
recover the R&D costs of developing a new drug and sunk cost of past unsuccessful drugs. After analyzing
both designs, it was concluded that the second, smaller design scheme is more scalable, less risky, and more
cost effective for the production of both the on- and off-patent drugs.
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April 17, 2018
Professor Bruce Vrana
University of Pennsylvania
Department of Chemical and Biomolecular Engineering
220 S. 33rd Street
Philadelphia, PA 19104
Dear Professor Vrana,
Enclosed are detailed process designs and economic analyses comparing two different bioreactor
design schemes for monoclonal antibody (mAb) drug substance production. The project proposal
specified an annual production goal of 100 kg mAb with a 90% process uptime. The goal of our
analysis was to design a process that would meet these requirements and recommend a selling
price that would provide a 15% internal rate of return (IRR). To more accurately model this
production project, we decided to base our design and economic decisions on a mAb that has
recently entered the market, Ocrevus (ocrelizumab). Using these parameters, we evaluated the
economic potential of our design schemes using both an on-patent and off-patent framework.
After careful consideration of the variables affecting drug quality and manufacturing
requirements, we designed two production schemes. The first upstream scheme culminates in a
20,000 L large production bioreactor, resulting in 25 kg of mAb per batch after downstream
purification. The second upstream scheme ends in a 2,000 L small production bioreactor to
produce 6.3 kg mAb per batch after downstream purification. Both designs are capable of
meeting the 100 kg annual production requirement within four to six months of the year. In order
to earn a 15% IRR within 4-6 years of production launch, we recommend pricing the off-patent
drug at $35,000 per 1200 mg annual treatment, and the on-patent drug at $65,000 per 1200 mg.
Considering both the economic and engineering analyses, we recommend implementing the
second, small bioreactor scheme, as it is more flexible, less risky, and more lucrative for the
production of both the on- and off-patent drugs.
Sincerely,

Hope McMahon

Jessica Schwartz

Shritama Ray
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1. Abstract
Monoclonal antibody (mAb) therapy is a form of immunotherapy that uses mAbs to bind
mono-specifically to certain cells or proteins. This may then stimulate the patient's immune
system to attack those cells. MAbs are currently used to treat medical conditions such as cancer,
diabetes, arthritis, psoriasis, and Crohn’s Disease, but have the potential to treat countless
diseases and disorders. In 2015, the mAb market was valued at $85.4 billion, and is expected to
reach $138.6 billion by 2024.1 In manufacturing, mAbs are typically produced in suspension in a
series of fed-batch bioreactors using genetically engineered cells originally obtained from
Chinese Hamster Ovaries (CHO).2 In this proposal, two upstream bioreactor designs were
analyzed for economic comparison given an annual production goal of 100 kg of mAb, with the
first design culminating in a 20,000 L volume at low mAb titer and the second design
culminating with a 2,000 L volume at high mAb titer. Following upstream mAb production, the
protein was purified to meet clinical FDA standards using a series of downstream purification
techniques, including centrifugation, filtration, and chromatography. The two designs can be
modeled for both an on-patent and off-patent mAb in order to ensure long-term economic
viability. In this project, the drug was modeled based on Ocrevus (ocrelizumab), a humanized
therapeutic mAb brought to market in 2017 that targets a CD20-positive B cell to treat the
symptoms of both primary progressive and relapsing Multiple Sclerosis.3 For an off-patent drug,
it is recommended that the mAb be priced at $35,000 per 1200 mg annual treatment in order to
earn a 15% Internal Rate of Return (IRR) within 5 years of market uptake. For an on-patent drug,
a price of $65,000 per 1200 mg treatment should be used to recover the R&D costs of developing
a new drug and sunk cost of past unsuccessful drugs. After analyzing both designs, it was
concluded that the second, smaller design scheme is more scalable, less risky, and more cost
effective for the production of both the on- and off-patent drugs.

1

2. Introduction and Objective Time Chart
2.1 Project Background
Monoclonal antibodies (mAbs) are proteins that bind to specific cellular targets and
activate the body’s immune system for subsequent destruction. MAbs are used in clinical therapy
to treat medical conditions such as cancer, diabetes, arthritis, psoriasis, and Crohn’s Disease, and
have been the focus of the biopharmaceutical industry in recent years. The mAb proteins are
derived from a single immune cell and can target a specific cell surface receptor for destruction.
The antibody derived from this immune cell can be isolated and engineered to be secreted by a
host cell line for clinical treatment. MAbs are often have a high degree of similarity, allowing a
given manufacturing scheme to be used for several mAb therapies with minimal alterations to
process design.4 During bioreaction steps, mAbs are secreted by the cells into the liquid growth
medium. Following production, the cell suspension undergoes a series of downstream process
steps to purify, concentrate, stabilize, and package the mAbs using methods that preserve
medicinal efficacy and ensure a virus-free product.2 An overview of a typical production scheme
is shown in Figure 2.1.

Figure 2.1 A typical mAb production process. The upstream steps grow the cells and express the protein,
while the downstream steps isolate and purify the protein product.

At the industrial scale, biopharmaceutical companies such as Genentech produce upwards
of 100 kg of a given product every year, and must have the capacity to scale up or down as
needed. To model typical production practices at companies with larger operations, this project
process has been designed to achieve a 100 kg production goal of a mAb in a four to six month
2

span. Other recent trends in mAb production, such as the use of single-use disposable bioreactors
and the implementation of high-throughput systems, are being implemented to reduce overall
capital investment and labor costs.
2.2 Design Schemes
The growing demand for mAb therapies has given rise to the rapid development of highyielding and robust manufacturing processes. Production bioreactors can be as large as 25,000 L
in many traditional scenarios. However, there are several risks and limitations associated with
producing such large batch volumes. When scaling up to such large culture volumes, oxygen
transfer decreases, aggregation of cells and mAb is more prevalent, and CO2 stripping becomes
difficult to control without exceeding gas sparging flow rate limitations. This results in decreased
cell viability, specific mAb productivity by the cells, and product quality.5 Also, there is a higher
risk associated with each batch in the case of malfunction or contamination, in which case the
entire batch would be void. To mitigate these outcomes, large upstream batch volumes must
produce protein in low titers below 4 g/L. To eliminate these concerns, advances in mammalian
cell culture techniques have increased mAb productivity of engineered host cell lines, which
allow for higher protein titers well beyond 5 g/L to be produced in smaller batch volumes.6 For
the same reasons outlined above, smaller batch volumes have lower risk, higher cell viability,
and higher product quality.
To compare these upstream production scenarios, two upstreams schemes have been
designed with corresponding downstream designs. The first scheme is a large production
bioreactor process with a low protein titer (2.97 g/L), and the second scheme is a small
production bioreactor process with a higher protein titer (6.41 g/L). Both schemes make
extensive use of disposable, single-use technologies. The recent industry uptake of single-use
equipment has been robust, due to its increased efficiency and cost reduction potential.7 The
design of these schemes is described in more detail in Section 10.
2.3 Ocrevus ™
In order to evaluate this project under real-world constraints, a specific mAb product,
Ocrevus, was selected. Ocrevus (ocrelizumab) is a humanized therapeutic mAb that targets a
CD20-positive B cell. On March 28, 2017, Ocrevus was approved by the FDA for the treatment
of relapsing and primary progressive forms of multiple sclerosis (MS). Ocrevus was discovered,
developed, and now marketed by the Roche subsidiary, Genentech.3
3

MS is a chronic neurological disease without a cure, affecting over 400,000 people in the United
States. In MS patients, the immune system attacks the insulation around nerve cells in the brain,
spinal cord and/or optic nerves, resulting in inflammation and often debilitating symptoms. The
majority of people living with MS either have a relapsing form (RMS) or primary progressive
multiple sclerosis (PPMS) at the time of diagnosis. RMS is characterized by episodes of new or
worsening symptoms, defined as relapses, followed by periods of recovery. PPMS is a highly
disabling form of MS characterized by steadily worsening symptoms, usually without periods of
improvement or remission.8
Ocrevus is the first drug on the market to be approved for the PPMS in addition to RMS.
In clinical studies, it was shown to reduce relapses per year by nearly half and reduce disability
in RMS patients. It was also shown to be the first treatment to significantly slow disability
progression in PPMS patients. Ocrevus is administered intravenously in 600 mg doses every six
months. The first dose is a 300 mg intravenous infusion, followed by a second 300 mg infusion
two weeks later. Going forward, patients receive 600 mg infusions every 6 months. The price for
the first annual treatment of 1200 mg is $65,000. The market performance and attributes of this
drug have been used for the design decisions and economic evaluation.
2.4 Objective Time Chart
N/A
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2.5 Project Charter
Project Name:
Monoclonal Antibody Production, Purification, and Packaging
Project Leaders:
Hope McMahon, Shritama Ray, Jessica Schwartz
Specific Goals:
Design a process for producing mAbs within an existing
biopharmaceutical company to obtain a sales price for an internal rate of return (IRR) of 15%
based upon two schemes, one considering only capital investment and the other considering
capital investment, research and development (R&D) costs, and risk adjustment.
Project Scope
In Scope:
 Upstream manufacturing process for mAb including growing CHO cells from frozen
inoculum of cells to final growth step and mAb production
 Design process to include large production bioreactor (20,000L)
 Design process to include multiple small production bioreactors (2,000L)
 Downstream purification process starting with centrifugation to final sterile filtration
and bulk drug substance storage.
 Maintain process integrity and compliance by adhering to good manufacturing
practices (GMP)
 Compare both process designs including and excluding R&D costs to generate a sales
price per gram to ensure a 15% IRR.
 Determine which process design is optimal by evaluating cost, risk, and product
quality
Out of Scope:
 Research and development of monoclonal antibody
 Cell line development
 Packaging and distribution of drugs
 Clinical Trials
 FDA approval of process
Deliverables
Business Opportunity Assessment
 What is the current market for monoclonal antibodies?
Technical Feasibility Assessment
 Is it feasible to produce 100 kg of mAb in 4-6 months using both design scenarios?
Manufacturing Capability Assessment
 What is the capital investment for the manufacturing facility?
 Will the process satisfy the FDA for a pure, consistent product?
Timeline
Facility and process design along with 10 years of production & sales

5

3. Innovation Map
N/A
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4. Market and Competitive Analyses
4.1 Competitive Landscape
The motivation for this project stems from the increasing demand for mAb therapies and
the rapidly evolving production platforms. The mAb market was valued at $85.4 billion in 2015
and is expected to reach $138.6 billion by 2024.1 This growth will be driven by increasing R&D
for mAbs and supportive government initiatives, which can be attributed to growing demands for
personalized medicine in addition to specific benefits associated with mAb therapy such as fewer
adverse effects, homogeneity, specificity, and large-scale production.
Additionally, the MS treatment market was valued at an estimated $17.2 billion in 2015
and is expected to grow at a 1.5% compound-annual growth rate (CAGR) to reach $20 billion by
2024.9 Since Ocrevus is the first drug approved to treat multiple forms of MS, it is expected to be
a blockbuster drug and the specialist community is certain that it will assume a dominant
position in the MS market over the next 3 to 5 years. The drug has shown high efficacy in both
forms of the disease, has a reasonable safety profile, and has a price tag of $65,000 per 1200 mg
treatment, which is a 20% discount from the average list prices of its competitors.10
Other MS treatments on the market include Biogen’s Tysabri and Tecfidera, Novartis’
Gilenya, and Teva’s Copaxone. Copaxone was previously a market leader, being the first noninterferon to enter the market, while Tecfidera had the fastest market uptake in the field.
Analysts expect 40%-50% erosion of Tysabri, and 30%-40% erosion of Tecfidera and Gilenya
sales once Ocrevus is taken up by the market. Ocrevus is also anticipated to surpass historical
performances due to its novel indication of use, high efficacy, convenient dosing, reasonable
safety, and modest pricing.10
4.2 Sales Forecast
Since its approval in March 2017, Ocrevus saw 12-month sales of $1.4 billion from Q2
2017 to Q1 2018.11 At $65,000 per treatment, it is estimated that 20,000 treatments were
administered. The revenues are projected to grow rapidly and soon dominate the MS market.
These metrics and predictions have been used to create sales forecasts in order to evaluate the
economic viability of the two designs presented in this project.
In order to build the forecast, 10-year sales for an Ocrevus competitor, Gilenya, were extracted
from Novartis’ annual reports.12 The annual year-over-year (YOY) growth rates were calculated
to build a model representative of the anticipated market uptake for an MS mAb drug. This
7

growth model was then applied to the known Year 1 Ocrevus sales to build an 8-year forecast,
which is depicted in Table 4.1. The growth is rapid in the first few years during initial market
uptake, but slows significantly after Year 4. This trend is illustrated in Figure 4.1. These
forecasts are indicators of market demand and were used to design the annual production
schedule. They also dictate the forecasted annual revenue, which is built into the profitability
analysis in Section 21.
Table 4.1. Sales Forecast Construction of Ocrevus. Gilenya YOY growth rates were applied to Year 1
sales of Ocrevus to build a representative 8-year sales model.

YEAR
1
2
3
4
5
6
7
8

Gilenya Sales
($MM)
494
1,195
1,934
2,477
2,776
3,109
3,185
N/A

YOY % Growth
N/A
142%
62%
28%
12%
12%
2%
2%

Forecasted Ocrevus
Sales ($MM)
1,377
3,331
5,397
6,908
7,737
8,666
8,839
9,016

Figure 4.1. Projected Ocrevus sales based on historical Gilenya sales data. The growth
rate is plateaus around 2022 (Year 4).

5. Customer Requirements
N/A
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6. Critical-to-Quality Variables
Because therapeutic protein products impact human life, quality is an essential
consideration in the highly regulated biopharmaceutical industry. The U.S. Food & Drug
Administration (FDA) dictates and enforces Quality by Design (QbD), a systematic approach to
development based on quality and risk-management. It begins with predefined objectives and
emphasizes science-driven product and process understanding and control.13 This involves
defining the Quality Target Product Profile (QTPP), a summary of the quality characteristics of
the drug product that will ideally be achieved to ensure the desired quality while accounting for
safety and efficacy. QTPP elements include dosage form & design, route of administration,
dosage strength, pharmacokinetics, stability, and drug product quality attributes.
Ocrevus is administered by intravenous (IV) infusion, and is supplied in single dose 15
mL vials containing 300 mg of ocrelizumab at a nominal fill volume of 10.0 mL. The final
formulation includes sodium acetate, trehalose dihydrate, and 0.02% (w/v) polysorbate 20, pH
5.3. Prior to administration, it is diluted with 0.09% sodium chloride solution to reach a protein
concentration of approximately 1.2 mg/mL.14
As the scope of this project excludes drug product filling and packaging processes, the
quality standards for the bulk drug substance are most relevant. The Critical Quality Attributes
(CQA’s) of the Drug Substance are shown in Table 6.1. These attributes and requirements have
guided the design of the operating parameters, equipment selection, and control strategy.

9

Table 6.1 Critical to Quality Attributes of the Drug Substance

CQA
Host Cell Protein (HCP)
Host Cell DNA
Adventitious Viral
Agents
Bioburden

Endotoxins

Risk
Safety & immunogenicity
Safety
Safety
Safety, Purity, and Efficacy;
Degradation or modification
of product by contaminating
microorganisms
Safety and Purity

Mycoplasma
Appearance (color,
clarity, and opalescence)
Leachables/extractables

Safety
Safety and Efficacy

Osmolality

Safety

Polysorbate 20

Safety

Safety

Origin
Process-related impurities
Process-related impurities
Likely introduce during cellculture operations
Bioburden can be introduced by
raw materials and throughout the
manufacturing process
Endotoxins can be introduced by
raw materials and throughout the
manufacturing process
N/A
Leachables and extractables
could be introduced by any
product contact equipment,
containers, and consumables
Osmolality is impacted by
formulation. No change is
expected during storage.
Polysorbate 20 is added during
DS formulation.
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7. Product Concepts
N/A
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8. Superior Product Concepts
N/A
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9. Competitive Patent Analysis
Many pharmaceutical companies file patents on their drug discoveries to claim rights to a
formulation and ensure exclusivity in the marketplace. Currently, the term of a new patent is 20
years from the date on which the application for the patent was filed in the U.S. During the 20
year patent term, this company claims the sole rights to manufacture and distribute the drug.15
Roche’s patent on Ocrevus was filed on September 24, 2007, and will thus expire in 2027. For
the duration of the patent, only Roche is allowed to legally manufacture, sell, and administer
Ocrevus.
Once a patent term expires, other competitors are able to enter the market and administer
the formulation as a generic, off-patent product. When this happens, the price of the drug almost
always drops in order for companies to stay competitive. The typical price drop for a physicianadministered biopharmaceutical product is 38 - 48%.16 For example, when Ocrevus goes offpatent in 2027, it can be expected that the price of a 1200 mg treatment will drop from $65,000
to between $33,800 and $40,300.
This pricing difference plays a key role in evaluating the economic viability of a drug
manufacturing project. For this reason, two economic frameworks have been considered in this
design. The first is an off-patent framework, in which only capital investment and annual
operating costs will be considered in the profitability analysis. The second framework is
designed for an on-patent drug, which will require all R&D expenditures, clinical trial
operations, and drug success probabilities to be factored into the evaluation in addition to the
capital investment and annual operating costs. Further details for these two evaluations are
presented in Section 21.
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10. Preliminary Process Synthesis
The overall process flow of mAb production and processing is standardized across the
industry.2 Figure 2.1 illustrates a general block flow diagram for this process, with each step
representing opportunities for design decisions.The overall process is split into three upstream
sections and three downstream sections. Because the upstream bioreaction and downstream
purification steps are largely independent, design considerations for upstream and downstream
steps were evaluated separately. Design decisions were made to determine the number, type, and
capacity of seed and production bioreactors, the production capacity of the downstream process,
and the types of chromatography used in later downstream purification steps. Since the
downstream process uses smaller equipment in series, it can be scaled for several possible
upstream combinations.
When designing the upstream processes, the amount of mAb produced for the same
liquid volume can be increased without significantly raising costs because the equipment and
raw materials required for operation will not change. On the other hand, if the amount of mAb
produced is kept constant, the cost of a given upstream design will scale with volume because
the volume of media and bioreactor largely affect the cost. However, downstream unit capacity
always scales with the amount of mAb product per batch, since its cost is based on productspecific separation processes. Therefore, as product titer increases, the cost becomes increasingly
dependent on downstream processes as compared to upstream processes.2
Two designs were created for this project to compare a large volume, low titer and a
small volume, high titer production scenario. The first design scheme, referred to as the Large
Production Bioreactor Design, is illustrated in Figure 10.1. It illustrates a more traditional
upstream process, in which the bioreaction steps culminate in a 20,000 L, stainless steel
bioreactor. Selection of smaller volume bioreactors in inoculum preparation and cell seeding
bioreactions was based on cell growth kinetics and production formation requirements as
discussed in Section 11.2. The resulting product titer of this upstream design was 2.97 g/L,
which is a typical low titer in mAb manufacturing processes.
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Figure 10.1 Overall block flow diagram of the Large Production Bioreactor Design for mAb production
and purification. This design represents a low volume, high titer manufacturing scenario.

The second design scheme, referred to as the Small Production Bioreactor Design,
represents a more modern upstream process, incorporating a production bioreactor that has a
smaller volume capacity, but handles higher product titers with greater ease. The bioreaction
steps in this scheme culminate in a 2,000 L single-use bioreactor, with a product titer of 6.41 g/L,
which is approximately double that of the Large Production Bioreactor Design. Due to the
smaller final upstream volume, less inoculum preparation and cell seeding steps were required.
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Figure 10.2 Overall block flow diagram of the Small Production Bioreactor Design for mAb production
and purification. This design represents a high volume, low titer manufacturing scenario.

For both schemes, the downstream purification process was scaled to match the amount
of product produced at the end of the upstream process. Based on this mass, the number of
chromatography cycles needed per batch was calculated. Since mAb product is lost in separation
and purification steps, an overall yield of 63% was calculated for the downstream process. The
upstream processes for both schemes were then adjusted to meet the specified annual production
goal of 100 kg of mAb.
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11. Assembly of Database
11.1 Chemical Components and Thermophysical properties
Water was used as the main reference component for all thermophysical calculations of
the mAb product and growth media. Air was also used in bioreaction steps. Other components
present were considered negligible in a thermophysical context. Properties of water and air are
listed in Table 11.1
Table 11.1 Properties of relevant chemical components in mAb production and purification processes

Chemical
Component
Water (WFI)
Air

Molecular
Weight (g/mol)
18.02
28.96

Heat Capacity
(J/g°C)
4.184
1.006

Density 36.5°C,
1 atm (kg/m3)
1000
1.14

Viscosity
(kg/m s)
4.8x10-9
--

Cost
($/kg)
0.0047
--

11.2 Cell Growth Kinetics and mAb Production Rate
Cell growth and mAb production occur in two phases. First, the cells must be grown to a
specified peak viable cell density of 9x106 cells/mL, with at least 90% cell viability, as stated by
the project charter. Then, the cells reach a growth plateau and product formation occurs linearly
given a specific productivity of 3.3x10-10 g mAb per viable cell. From Equation 1 below, the
final density of cells in a given bioreactor can be calculated based on the growth rate and growth
time spent in the vessel. In the final process design and scheduling, one day was added to the
specified growth time to account for the lag phase of the cells upon initial re-seeding. During the
lag phase, the cells are adjusting to their new environment and adhering to the cell surface before
entering the exponential log growth phase.
𝑁

𝑙𝑛 (𝑁2 ) = 𝜇(𝛥𝑡)
1

(1)

where, N1 = initial cell density (cells/mL)
N2= final cell density (cells/mL)
μ = growth rate (day-1)
Δt = duration of cell growth (day)
In the inoculum preparation steps of the upstream process, which occur within the first 7
days of the overall process, an average growth rate of 0.63 day-1 was used. This value was
obtained in a feed study utilizing the same CHO DG44 cell line and ActiPro, 7a, 7b feeding
regime as will be used in this process.17 When cells are initially thawed from their cryogenic
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state, it can require a few passages, or cell division cycles, to reach full potency. For the
remaining duration of the upstream process, the growth rate was calculated from the projectspecified peak doubling time of 20 hours. From Equation 2 below, the growth rate was found to
be 0.83 day-1.
𝑡𝐷 =

𝑙𝑛(2)
𝜇

(2)

In order to maintain cell viability higher than 90%, which is a requirement for adequate
product formation and quality for the given CHO DG44 cell line, cell dilution and scale-up factor
are critical parameters to consider. In culture, cells cannot be diluted by more than a factor of 4
or scaled by more than a factor of 10. If the cells are too dilute in the culture media, the cells will
swell and will not take up the required nutrients for growth in order to maintain the osmotic
pressure across the membrane and prevent bursting. If the cells are scaled up by more than a
factor of 10, the number of cells dying as result of the natural cell cycle will become toxic to cell
growth. In addition, the cells will become too crowded and begin to aggregate, which inhibits
cell growth and promotes accelerated cell death. As a result, upstream design decisions were
made to dilute cells by less than or equal to 4 and scale them up by less than or equal to 10 in
equivalent volumes. Both bioreactor volumes and fed-batch strategies were based on these
parameters.43 For culture volumes that are 250L or greater, the bioreactors are only filled to half
of the intended final volume initially. The remaining half of the final bioreactor culture volume is
fed to the cells in a daily bolus of culture media and feed supplements. These feed supplements
provide additional nutrients and can be scaled based on manual daily samples to maintain
optimal glucose and amino acid levels. This fed-batch feeding strategy increases the culture
volume incrementally, prevents the cells from being too dilute while allowing scale up of factors
greater than 10, especially in larger cell seeding steps and in the product formation step.2, 6
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12. Process Flow Diagram and Material Balances
The process flow diagrams (PFD) and mass balances listed below visualize and
characterize the two main process designs. The upstream and downstream PFD’s are illustrated
separately for both the Large and Small Production Bioreactor Designs. The two downstream
processes have the same design, but were scaled for the appropriate volumes. Media preparation
schemes are depicted below each of the upstream flowsheets.
12.1 Upstream Process for Large Production Bioreactor Design
The flowsheet in Figure 12.1 portrays the upstream portion of the Large Production
Bioreactor design, which concludes in a 20,000 L stainless steel production bioreactor. The
solution of media, cells, and mAb in this production bioreactor are then passed onto to the
primary recovery step of downstream purification. Streams labeled “Media Prep” refer to the
media preparation schemes illustrated in Section 12.1.1. The flowsheet for the corresponding
downstream purification process are illustrated in Section 12.2.
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12.1.1 Upstream PFD for Large Production Bioreactor Design (PFD 01)

Figure 12.1 Upstream PFD for mAb production for the Large Production Bioreactor Design.

20

12.1.2 Media Preparation Scheme for PFD 01

Figure 12.2 A detailed flow diagram of “Media Prep” streams in PFD 01 for mAb production in the Large
Production Bioreactor scheme.
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12.1.3 Overall Mass Balance for PFD 01
Components (Name)
Cells
mAB Product
Water (H2O)
Glucose (C6H12O6)
Glutamine (C5H10O3N2)
Oxygen
Carbon Dioxide (CO2)
Ammonia (NH3)
Lactate (C3H6O3)
TOTAL

IN (kg/batch)
0.0000047
0
0.03
721
70
2983
0
0
0
3493

OUT (kg/batch)
75.4
40.1
13500
0
0
0
463
7.4
136.6
14223
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12.2 Downstream Process for Large Production Bioreactor Design
12.2.1 Downstream PFD for Large Production Bioreactor Design

Figure 12.3 Downstream PFD for for mAb purification in the large production bioreactor design. The
downstream will be run 1 time per batch.

12.2.2 Overall Mass Balance for PFD 02
Components (Name)
Cells
Water (H2O)
mAb Product

IN (kg/batch)
75.4
13500
40.1

OUT (kg/batch)
0
700
25.2
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12.3 Upstream Process for Small Production Bioreactor Design (PFD 03)
The flowsheet in Figure 12.3 portrays the upstream portion of the Small Production Bioreactor
design, which concludes in a 2,000L stainless steel production bioreactor. The solution of media,
cells, and mAb in this production bioreactor are then passed onto to the primary recovery step of
downstream purification. Streams labeled “Media Prep” refer to the media preparation schemes
illustrated in Section 12.3.1. The flowsheet for the corresponding downstream purification
process are illustrated in Section 12.4.
12.3.1 Upstream PFD for Small Production Bioreactor Design

Figure 12.4 Upstream PFD for mAb production in the Small Production Bioreactor scheme. The upstream
will be run 1 time per batch.
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12.3.2 Media Preparation Scheme for PFD 03

Figure 12.5 A detailed flow diagram of “Media Prep” streams in PFD 03 for mAb production in the Small
Production Bioreactor scheme.

12.3.3 Overall Mass Balance for PFD 03
Components (Name)
Cells
mAB Product
Water (H2O)
Glucose (C6H12O6)
Glutamine (C5H10O3N2)
Oxygen
Carbon Dioxide (CO2)
Ammonia (NH3)
Lactate (C3H6O3)
TOTAL

IN (kg/batch)
0.0000047
0
0.03
333
32
2465
0
0
0
2830

OUT (kg/batch)
29.4
40.1
13500
0
0
0
214
3.4
63
6590
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12.4 Downstream Process for Small Production Bioreactor (PFD 04)

Figure 12.6 Downstream PFD for for mAb purification in the small production bioreactor design. The
design is the same as PFD 02, but the units are scaled appropriately. The downstream will be run 4 times
per batch, with one cycle being run for each upstream 2,000L production bioreactor.

12.4.2 Overall Mass Balance for PFD 04
Components (Name)
Cells
Water (H2O)
mAb Product

IN (kg/batch)
29.4
1560
10.0

OUT (kg/batch)
0
420
6.30
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13. Process Description
MAb production and purification is divided into upstream and downstream processes.
The upstream process objective is to grow the CHO cells up to peak viable cell density such that
they secrete mAb into the surrounding growth media. Then, the downstream processes harvest
the product from the cell culture solution and purify the remaining protein according to FDA
quality standards for commercial use.
13.1 Upstream Production Process Description
In the upstream production of mAbs, there are two phases of growth: cell growth and
mAb formation. The inoculum preparation and seed bioreaction steps achieve the first cell
growth step, while the final production bioreaction step achieves the second step of mAb
formation. The engineered CHO cell line selected for this process was CHO DG44, which was
analyzed for nutrient requirements, initial average growth rate, and media formulations in a
previous study that was discussed in Section 11.2 17. Section 11.2 also outlines how cell density
and culture durations were calculated for all upstream processes. Proper preparation of cell
culture media formulations in addition to precise control of operational parameters are detailed in
the following sections as they are vital for optimal cell growth and product formation. Execution
of inoculum preparation, seed bioreaction, and production bioreaction steps are then described
for the Large and Small Production Bioreactor Processes. These steps are shown in the process
flow diagrams in Sections 12.1 and 12.3.
13.1.1 Media Preparation - Large & Small Production Bioreactor Designs
For both processes, pre-formulated HyClone™ ActiPro™ cell culture medium
from GE Healthcare Life Sciences will be used. The media has been designed for highyield recombinant protein production via CHO cells in a batch or fed-batch process, and
is chemically defined and animal-derived-component-free. This provides consistency
across batches as there are known concentrations of all chemical components and no
complex contaminants.
13.1.1.1 Growth Media
For all inoculum steps and bioreactor, dry powder growth medium
medium will be mixed with water-for-injection (WFI) at 25°C. The complete
protocol for reconstituting dry powder ActiPro™ medium can be found in
Appendix B. The final pH of the mixture should be in the neutral range with
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osmolality ranging 270 to 330 mOsmol/kg. The prepared growth media will then
flow perpendicularly through a sterile 0.2 µm, hydrophilic polyethersulfone (PES)
membrane filter with a filtration area of 0.57 m2 to remove large contaminants.
This is followed by transfer to a storage tank for storage at 4°C until further use.
Transfer steps will occur via peristaltic pump at flow rates corresponding to the
volume of media being prepared.
13.1.1.2 Feed Supplement Media
Feed supplements HyClone™ CellBoost™ 7a and CellBoost™ 7b will be
used in production steps for both processes, which are also chemically defined
and animal-derived-component-free for recombinant protein production. The
feeds are concentrated nutrients that are complementary used in conjunction to
maintain nutrient concentrations at appropriate values for growth. CellBoost 7a
contains amino acids, vitamins, salts, glucose, and other trace elements. CellBoost
7b contains concentrated amino acids. For preparation, each dry powder medium
will be mixed with water-for-injection (WFI) at 25°C. The complete protocol for
reconstituting the dry powder CellBoost™ media can also be found in Appendix
B. The mixed CellBoost 7a should have a neutral pH, while the CellBoost 7b
should have a basic pH. The prepared medias will each be filtered by a sterile 0.2
µm, hydrophilic polyethersulfone (PES) membrane to remove large contaminants
followed by transfer to respective storage tanks for storage at 4°C until further
use. Transfer steps will occur via peristaltic pump at flow rates corresponding to
the volume of media being prepared.
13.1.2 Operation Set Points and Controls
Both cell culture and mAb production are very sensitive processes that require
careful monitoring of conditions and tight control. Main conditions of interest are
temperature, dissolved oxygen (dO2), dissolved carbon dioxide (dCO2), pH, and
osmolality, which are all closely linked to metabolite levels, cell growth, cell viability,
cell productivity, and product quality. The relationships between various controlled
variables and cell and product variables is illustrated in Figure 13.1.18 Offline
measurements will be performed for cell counting and cell viability, pH verification,
osmolality, and metabolite concentrations. Cell counting and viability will be measured
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using a hemocytometer assay, while metabolites will be monitored by taking samples
from the cell culture. Metabolites of interest are: glucose, glutamine, glutamate, lactate,
and ammonia. Glucose, glutamine, and glutamate are consumed by the cells while lactate
and ammonia are produced by the cells. However, the cells can also use lactate as a
source of potential energy over glucose. Osmolality levels of the culture medium should
remain in the range of 270-330 mOsm/kg set during media preparation. Osmolality is
measured daily using freezing-point depression osmometry, a technique based on the
property that the freezing point of a known solvent decreases when solute is added. The

Figure 13.1. Relationship between upstream operation parameters and their effect on both CHO cells and
the secreted mAb product.

freezing point is directly related to the number of solute particles present, therefore
concentration can be measured with this method. It is preferred to keep osmolality values
on the lower end of the acceptable range. In higher cell densities, high osmolality and
high dCO2 levels can lead to growth inhibition and decreased cell productivity relating to
mAb formation.
Real-time measurements of temperature, dO2, dCO2, and pH will also be
performed. For the disposable bioreactors and cell incubator, temperature measurement
and control is automated and comes with the devices. The temperature of the 20,000L
stainless steel bioreactor in the Large Production Bioreactor scheme will be measured
with a temperature probe connected to the heating and cooling jacket of the bioreactor for
29

control. An acceptable temperature range is between 36 and 37°C, with the ideal setpoint
being at 36.5°C.
Another parameter in the disposable bioreactors that has built in probes and controls is
dO2. The setpoint for dO2 in these processes is 40% of air saturation, however an
acceptable range is 20-50%. It is important to prevent low dO2 levels, as this will lead to
excessive lactate synthesis by the cells and lower product yields. Similarly if the dO2 is
too high, the cells will become toxic and likely die. In the 20,000L stainless steel
production bioreactor, a Clark type electrode will measure dO2. To increase dO2, the
agitation and air sparging rate should be increased. For rocking disposable bioreactors,
the rocking speed should be increased along with an increase in air sparging. However, it
is important that agitation and air sparging rates do not become too high. If rocking or
impelled speeds are too high this could result in damaging levels of shear stress on the
cells and could lead to excessive bubble formation and foaming. When bubbles are
introduced in the culture, they rise to the top and burst, releasing high and harmful energy
on the cells below. If these methods do not appropriately correct dO2 levels, then pure O2
will be sparged in separately instead of adding more air and creating too many big
bubbles. Anti-foaming agent like a pluronic can also be added to reduce foaming and
bubbles.
In addition, dCO2 levels are also extremely important, because CO2 can inhibit
cell growth and product quality. If the dCO2 is too high, cell growth will be inhibited as
CO2 displaces O2 in culture and results in an O2 limiting situation. If it is too low, the
solution will become too basic and affect both glucose consumption and lactate
production of the cells. Further, CO2 has a profound effect on the pH of the culture
medium as increasing dCO2 increases the acidity of the solution and vice versa. This very
careful balance is made more challenging by the fact that the cells produce 1 mole of CO2
for every mole of O2 consumed. dCO2 will be measured by CO2 sensors and an offline
blood-gas analyzer. An acceptable range for dCO2 is between 120 and 150 mmHg, with
the ideal setpoint being 130 mmHg. If CO2 is too low, sodium carbonate (Na2CO3) will
be added and dissociated into CO2 and H2O in culture. Also, CO2 gas can be sparged into
the culture. Using Na2CO3 is more ideal because it eliminates issues with sparging rates
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like shear stress. It can also form an ionic bond with lactic acid in solution to form
sodium lactate (NaC3H5O3), as seen by the chemical reaction below.
Na2CO3 (s) + HC3H5O3 (aq.) → NaC3H5O3 (aq.) + CO2 (g) + H2O (l)
This helps remove lactate as a potential energy source over glucose for the cells. If the
CO2 is too high, either sterile air or pure O2 will be sparged in more to strip the CO2 from
the medium.
pH levels are very heavily tied to dCO2 and lactate levels, and cell growth is very
sensitive to pH. Even a 0.1 deviation from the optimum value of 7.1 can affect glucose
consumption and lactate synthesis. The culture medium in itself has sodium bicarbonate
(NaHCO3) to act as a buffering agent, however this alone is usually not enough to
maintain tight control. The ideal pH setpoint is 7.1, although higher values are preferred
during initial growth phase. This is because the initial cell growth phases produce a lot of
lactate. pH probes will be used in the bioreactors for real-time measurements, however
off-line measurements will also be performed since prolonged use of pH probes can
result in reduced sensitivity. As lactate concentrations exceed the buffering capacity of
the already present NaHCO3, the pH becomes more acidic. To increase the alkalinity of
the culture medium, a base such as NaOH is added, which subsequently also increases
osmolality of the medium. It is important to tightly control addition of base, as the
additive effects of high pH, high lactate concentrations, and high osmolality lead to an
acceleration of cell death and slowing of growth. To counteract medium that is too
alkaline, Na2CO3 will be added to dissociate into CO2 and H2O with a bonus effect of
forming NaC3H5O3, removing lactate as potential source of toxicity, delayed cell growth,
and decreased product quality.
13.1.3 Inoculum Preparation - Large & Small Production Bioreactor Designs
Following recovery from cryogenic storage conditions, the CHO cells must be
revived and acclimated to optimal culture conditions inoculation into seed and production
bioreactors. Although cryogenic freezing maintains cell potential, the process of recovery
is very harsh and the cells must undergo several cycles of replication before reaching a
viable biomass that is compatible with aggressive volume scale-up strategies. Therefore,
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the inoculum preparation steps are designed for small volumes and gentle culture
conditions with ample nutrients and highly controlled atmospheric conditions.
13.1.3.1 250 mL Shaker Flask
To prepare the inoculum for cell seeding and growth, a 250mL Pyrex™
shaker flask with 125mL working volume will be filled with 95 mL of prewarmed growth media via a serological pipette in a HEPA filtered hood on site.
Fifty percent working volume allows for adequate agitation, aeration, and room
for cell growth. Recombinant CHO DG44 cells will be recovered from cryogenic
storage in a lab on site to a volume of 30 mL at a density of 3.00 x 105 cells/mL.
The recovery procedure can be found in Appendix A. The 30mL of cells will be
added via serological pipette to the pre-filled shaker flask to an initial density of
7.20x104 cells/mL. The flask will then be clamped to a flat, low speed orbital
shaker at 60 rpm for agitation. The flask and shaker will be placed in a cell
incubator at 36.5°C temperature and 5.0% CO2 with built-in controls for 3 days to
reach a desired cell concentration of 2.54x105 cells/mL. The culture will be
sampled once daily to ensure control setpoints are being met. Media or feed
supplement boluses will be injected to correct for any nutrient deficiencies. Since
the flasks are in a CO2 incubator, culture conditions will be altered accordingly if
set point values are outside the desired ranges.
13.1.3.2 25 L Single-Use Bioreactor
To prepare for the next inoculation step, a 25L single-use, bag bioreactor
with 12.5L working volume will be filled with sterile air and heated to 36.5°C
with built-in controls. 12.4L of growth media will be transferred from a growth
media storage tank to the bioreactor through jacketed pipe that contains 10%
propylene glycol in water at 60°C in the outer annulus for heating. The transfer
step will occur via peristaltic pump at a flow rate of 0.006 L/min. The rocking
speed of the bioreactor will be initially set to 10 rpm at an angle of 6° and
increased to 15 rpm and a 7°angle as media is added. After 1 hour of acclimating
the media to the bioreactor, the cell culture from the shaker flask will be
transferred via a peristaltic pump to the 25L bag bioreactor at a flow rate of 0.008
L/min.
32

The cell culture will be grown for 3 days. The culture will be sampled once daily
to ensure control setpoints are being met and that nutrient levels are within the
acceptable ranges. Media or feed supplement boluses will be injected to correct
for any nutrient deficiencies. To correct for offsets in set points, the bag
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired
final cell density after 3 days is 8.95 x 103 cells/mL.
13.1.3 Bioreaction Processes - Large Production Bioreactor Design
The following sections outline the remaining upstream processes after
inoculum preparation for the Large Production Bioreactor Process Scheme,
ending in a 20,000 L stainless steel production bioreactor. The seed bioreaction
steps grow the cells to a peak viable cell density, while the production bioreaction
step maximizes mAb product formation at a consistent cell density.
13.1.3.1 100 L Single-Use Seed Bioreactor
For cell seeding, a 100L single-use, bag bioreactor with 50L working
volume will be filled with sterile air and heated to 36.5°C with built-in controls.
37.5L of growth media will be transferred from a growth media storage tank to
the bioreactor through jacketed pipe that contains 10% propylene glycol in water
at 60°C in the outer annulus for heating. The transfer step will occur via peristaltic
pump at a flow rate of 2.5 L/min. The rocking speed of the bioreactor will be
initially set to 15 rpm at an angle of 6° and increased to 25 rpm and an 8° angle as
media is added. After 1 hour of acclimating the media to the atmosphere of the
bag, the 12.5L of cell culture from the 25L bioreactor will be transferred via a
peristaltic pump to the 100L bag bioreactor at a flow rate of 0.83 L/min.
The cell culture will be grown for a total of 3 days. The culture will be sampled
once daily to ensure control setpoints are being met and that nutrient levels are
within the acceptable ranges. To correct for offsets in set points, the bag
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired
final cell density after 3 days is 1.18x104 cells/mL.
13.1.3.2 500 L Single-Use Seed Bioreactor - Two in Parallel
To continue cell growth, two 500L single-use, bag bioreactors with 250L
working volumes will be filled with sterile air and heated to 36.5°C with built-in
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controls. Initially, the bioreactors will be filled to half of their working volume.
100L of growth media will be transferred from a growth media storage tank to
each bioreactor through jacketed pipe that contains 10% propylene glycol in water
at 60°C in the outer annulus for heating. The transfer step will occur via a
diaphragm pump at a flow rate of 6.7 L/min. The rocking speed of the bioreactor
will be initially set to 5 rpm at an angle of 3° and increased to 15 rpm and a 4°
angle as media is added. After 2 hours of acclimating the media to the bag, 25L of
cell culture from the 100L bioreactor will be transferred via a peristaltic pump to
each 500L bag bioreactor at a flow rate of 1.67 L/min.
The cell culture will be grown for a total of 3 days. Each day after the first
day, a media bolus of 62.5L containing 3.00% by volume of CellBoost™ 7a and
0.30% by volume of CellBoost™ 7b will be added to each bioreactor. This helps
maintain nutrient levels and prevent overcrowding. The culture will be sampled
once daily to ensure control setpoints are being met and that nutrient levels are
within the acceptable ranges. Media or feed supplement boluses will be injected
to correct for any nutrient deficiencies. To correct for offsets in set points, the bag
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired
final cell density in each bioreactor after 3 days is 6.21 x 103 cells/mL.
13.1.3.3 2,000 L Single-Use Seed Bioreactor - Two in Parallel
After 3 days of culture, two single-use, 2,000 L bag bioreactors with
1,600L working volumes will be filled with sterile air and heated to 36.5°C with
built-in controls. Initially, the bioreactors will be filled to only half of the final
volume. 550L of growth media will be transferred from a growth media storage
tank to each bioreactor through jacketed pipe that contains 10% propylene glycol
in water at 60°C in the outer annulus for heating. The transfer step will occur via a
diaphragm pump at a flow rate of 19.0 L/min. The agitation speed of the
bioreactor will be initially set to 100 rpm and increased to 110 rpm as media is
added. After 2 hours of acclimating the media to the atmosphere of the bag, 250L
of cell culture from each 500L bioreactor will be transferred via a peristaltic pump
to each 2,000L bag bioreactor at a flow rate of 16.7 L/min.
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The cell culture will be grown for a total of 3 days. Each day after the first day, a
media bolus of 400L containing 3.00% by volume of CellBoost 7a and 0.30% by
volume of CellBoost 7b will be added to each bioreactor. This helps maintain
nutrient levels and prevent overcrowding. The culture will be sampled once daily
to ensure control setpoints are being met and that nutrient levels are within the
acceptable ranges. Media or feed supplement boluses will be injected to correct
for any nutrient deficiencies. To correct for offsets in set points, the bag
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired
final cell density in each bioreactor after 3 days is 5.12 x 103 cells/mL.
13.1.3.4 20,000 L Stainless Steel Stirred Tank Production Bioreactor
After cell seeding is complete, the final production bioreactor will grow
the culture up to peak density and then maximize production formation and
secretion from the cells. A 20,000L stainless steel, cylindrical bioreactor with
pitch-blade impellers, a heating jacket, and sparging apparatuses for sterile air and
sterile O2 will be will be filled with sterile air and heated to 36.5°C using
proportional–integral–derivative (PID) controllers. The agitation speed of the
bioreactor’s impeller power will be set to 0.055 W/kg and then adjusted as
needed. Air will be sparged in at a rate of 0.019 volume of air per volume of
liquid per minute (vvm), which assumes that only 30% of the sparged air is taken
up by the cells. This calculation can be found in Appendix D. Initially, the
bioreactor will be filled with media to only half of the final volume. 3,550L of
growth media will be transferred from a growth media storage tank to each
bioreactor through jacketed pipe that contains 10% propylene glycol in water at
60°C in the outer annulus for heating. The transfer step will occur via a peristaltic
pump at a flow rate of 29.6 L/min. After 4 hours of acclimating the media to the
tank conditions, 3,200L of cell culture from both 2,000L bioreactor bags will be
transferred via a diaphragm pump to the production bioreactor at a flow rate of
26.7 L/min.
The total production duration is 19 days, over which growth media and feed
supplements will be added each day to maintain nutrient levels and prevent
overcrowding. Each subsequent day of production, a media bolus of 375L
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containing 3.00% by volume of CellBoost 7a and 0.30% by volume of CellBoost
7b will be added to the bioreactor. The culture will be sampled once daily to
ensure control setpoints are being met, that nutrient levels are within the
acceptable ranges, and that mAb production is occurring at an acceptable rate.
Media or feed supplement boluses will be injected to correct for any nutrient
deficiencies. The bioreactor conditions will be controlled via PID control to keep
pH, osmolality, sparging rates, mixing rates, dO2, dCO2, and venting within
setpoints outlined in Section 13.1.2. The desired final cell density in the
bioreactor after the first 12 days is 9.00 x 106 cells/mL, which is the specified
peak viable cell density. For the remaining 7 days, mAb production will be
maximized at a constant cell density to reach a final mass of 40.1 kg in a volume
of 13,500L for a final titer of 2.97 g/L. At the end of the production period, the
culture is transferred to a centrifuge for downstream primary recovery.
13.1.4 Bioreaction Processes - Small Production Bioreactor Design
The following sections outline the remaining upstream processes after inoculum
preparation for the Small Production Bioreactor Scheme, ending in a 2,000 L single-use
production bioreactor. As compared to the Large Production Bioreactor Design, this
design only contains one seed bioreactor, because the final bioreactor volume is smaller.
However, to ensure proper dilution ratio and scale up conditions, the cells are held for a
longer time in this seed bioreactor. The seed bioreaction steps grow the cells to a peak
viable cell density, while the production bioreaction step maximizes mAb product
formation at a consistent cell density. The two designs use the same equipment for the
inoculum stages, but this design only has two additional bioreactors after this: a 500L
bioreactor which feeds the final 2,000L production bioreactor.
The following sections outline the remaining upstream processes after inoculum
preparation for the Small Production Bioreactor Process Scheme, ending in a 2,000 L
single-use bag production bioreactor.
13.1.4.1 500 L Single-Use Seed Bioreactor
This seed bioreaction step utilizes the same 500L single-use, bag
bioreactor as described in Section 13.1.3.2, but the following changes will be
made. 112.5 L of fresh cell culture media will be transferred from a media storage
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tank to the bioreactor via peristaltic pump at a flow rate of 7.50 L/min. After 2
hours of acclimating the media to the bioreactor environment, 12.5 L of cells from
the previous bioreactor will be transferred to the 500 L bioreactor via a peristaltic
pump at a flow rate of 0.83 L/min. After the initial transfer step, a media bolus of
59.4 L containing regular growth media, CellBoost 7a, and 7b will be fed to the
bioreactor daily for the remaining bioreaction period. The cell culture will be
grown for 6 days to a final cell density of 3.09x104. All other conditions and
process steps including culture sampling and set point correction, are the same as
described in Section 13.1.3.2.
13.1.4.2 2,000 L Single-Use Production Bioreactor
The production bioreactor process for optimal product formation utilizes
the same 2000L bag bioreactor described in Section 13.1.3.3 with the following
changes. Upon the start of the production period, the bioreactors will be filled to
half of the total final volume with 580L of growth media. This volume will be
transferred from a media storage tank to the bioreactor via a peristaltic pump at a
flow rate of 18.4 L/min. After 2 hours of acclimating the media to the atmosphere
of the bag, 250L of cell culture from the previous bioreactor will be transferred
via a peristaltic pump to the 2,000L bag bioreactor at a flow rate of 13.3 L/min. A
media bolus of 43.3 L containing regular growth media, CellBoost 7a, and 7b will
be fed to the bioreactor daily for the remainder of the production period, which is
19 days. The desired final cell density after the first 12 days is 9.00x106 cells/mL,
which is the specified peak viable cell density. For the remaining 7 days, mAb
production will be maximized at a constant cell density to reach a final mass of
approximately 10.0 kg of mAb, with a final titer of 6.41 g/L. All other conditions
and process steps including culture sampling and set point correction, are the
same as described in Section 13.1.3.3. At the end of the production period of each
bioreactor, the culture is transferred to a centrifuge for downstream primary
recovery.
13.2 Downstream Purification Process Description
The mAbs are secreted from the cells grown in the upstream process. After this process is
complete, the product must be separated from the cell mass and purified according to FDA
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standards. The purification process is needed to remove process impurities such as host cell
proteins, nucleic acids, and lipids. At the end of the upstream process, the protein titers are 2.97
g/L and 6.41 g/L for the Large and Small Production Bioreactor Designs, respectively. During
the purification process, there are several volume reduction steps that will increase the protein
titer. However, there is an upper limit for protein titer of 150g/L because at high titers, the
protein aggregates solution becomes too viscous. The downstream process consists of three
major parts: primary recovery, purification, and polishing steps. These steps are shown in the
process flow diagrams in Sections 12.2 and 12.4.
13.2.1 Primary Recovery
The primary recovery steps consist of both centrifugation and depth filtration,
which is used for the removal of cells and cell debris from the culture broth and
clarification of the cell culture supernatant that contains the antibody product.
13.2.1.1 Centrifugation
Contents of the final production bioreactor are transferred into the
centrifuge via a peristaltic pump. The centrifuge separates the extracellular
product from the cells and other solid waste. Because the product is secreted, the
cells are no longer needed for the process and they will be disposed of.
Centrifugation operating conditions will be chosen to ensure the cells are not
lysed because this would release additional contaminants in the product solution.
It is assumed that the cells take up a negligible volume in the bioreactors, so the
protein titer is constant for this step, with the large production bioreactor design
having a protein titer of 2.97 g/L of solution and the small production bioreactor
design having a protein titer of 6.41 g/L of solution.
The centrifuge operates in a continuous manner, processing 4,000 L/hr for
the large production bioreactor design and 780 L/hr for the small production
bioreactor design. It is operated at 25°C and has a product yield of 96% with
about 4% of desired product being discarded in the solid waste stream.
Centrifugation for the Large Production Bioreactor Design will require a time of 4
hours and an additional 2 hours for CIP and SIP. Centrifugation for the Small
Production Bioreactor Design will require a time of 2 hours and an additional 2
hours for CIP and SIP.
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13.2.1.2 Depth Microfiltration
In addition to centrifugation, depth filtration will be used as a second
recovery step to eliminate large solid particles from the media. A depth filter is
used because there is a limit to the particle size that can be removed by
centrifugation. Similar to centrifugation, it will be assumed that the volume
reduction from this step is negligible, keeping the protein titer constant. The
supernatant from the centrifuge is applied to the filters. The feed will be filtered at
a speed of 21 L/min/m2 with a yield of 97%. For the Large Production Bioreactor
Design, it will take 9 hours and for the Small Production Bioreactor Design, it
will take 1.5 hours.
13.2.2 Initial Purification
The purification steps include the Protein A chromatography and cation exchange
chromatography, with a diafiltration unit separating them. These units are used as a
capture step in separating the product from smaller impurities and as a concentration step
in reducing the overall volume.
13.2.2.1 Buffer Preparation
Many downstream unit operations, including the chromatography
columns, will require various buffers to be prepared for each batch. Buffers will
be purchased from Millipore Sigma and mixed with WFI in single-use storage
containers. Single use containers will help minimize cleaning and sterilization
procedures and reduce contamination. Once prepared, the pH and conductivities
of the buffers will be checked and controlled until the buffers are used.
13.2.2.2 Protein A Chromatography
Protein A Chromatography is the first of three chromatography steps in
the downstream process. It aims to isolate the mAb product by using a resin that
selectively binds the IgG molecule. Protein A is Staphylococcus aureus cell wall
protein that binds selectively to the Fc region of IgG. Protein A contains five
regions that bind to the Fc region of IgG and one molecule of protein A (on a
resin matrix) can bind at least two molecules of IgG. It is a naturally occuring on
the gram-positive bacterium, and it has been engineered for protein purification
applications19. This step is used to remove process-related impurities such as host
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cell proteins, DNA, cell culture media components, and endogenous and
adventitious virus particles with a high purity and yield. The MabSelect SuRe LX
media resin chosen for this process consists of an alkali- and protease stabilized,
recombinant protein A ligand coupled to a rigid, agarose matrix. The stability of
the protein A ligand minimizes ligand leakage and allows for cleaning procedures
based on NaOH. In addition, the highly cross-linked agarose matrix of the resin
enables the use of high flow velocities at production scale.20
This operation is the first volume reduction step in the downstream process. Once
the protein has been loaded onto the column, it will be eluted with a smaller
volume in order to concentrate the product. For the Large Production Bioreactor
Design, the working volume will be reduced from 13,500L to 3,200L. For the
Small Production Bioreactor Design, the working volume will be reduced from
1,560L to 750L. This increases the protein titer to 10.7 g/L and 11.5 g/L,
respectively.
Before the harvest cell culture fluid is passed over the column, the column
is equilibrated with 5 column volumes (CV) of equilibration buffer (20 mM
sodium phosphate, 150 mM NaCl at a pH of 7.4). After this step, the filtrate from
the depth filtration is loaded onto the column. Then, there are two wash steps that
wash away any impurities that are not bound to the resin. The first wash step uses
3.5 CVs of an equilibration buffer and the second wash step uses 1 CV of a wash
buffer (50 mM acetate at a pH of 6). The mAbs are then washed from the column
using 4 CVs of an elution buffer (50 mM acetate at a pH of 3.5). The low pH
allows for the removal of the product as well as inactivation of viruses present in
the solution. The elution stream is collected and transferred to a storage tank. The
column is regenerated using 3 CV of buffer (100 mM sodium acetate, pH 2.9) and
CIP uses 4 CVs of 100 mM NaOH. Following CIP, the SIP will be performed
after each batch.21 The column is expected to produce a 92% yield with a 98%
purity. For the Large Production Bioreactor Design, it will require 19 hours to
process all of the input, which will be processed in 4 cycles. For the Small
Production Bioreactor Design, it will require 4 hours to process each input, which
will require one cycle.
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13.2.2.3 Virus Inactivation
CHO cells used to manufacture the mAbs produce endogenous
retroviruses and are occasionally infected with adventitious viruses during
processing. The best approach to ensure adequate viral clearance is to have
multiple, orthogonal virus-removal steps and at least one virus inactivation steps.
Virus inactivation methods include low pH, heat, irradiation, and chemical agents.
For this process, the method for inactivating the viruses will be holding the
solution in a low pH buffer. This method was chosen because it can be combined
with the elution step from the Protein A chromatography column to create a more
integrated process. The product will be eluted from the column with an low pH
buffer and once all of the eluent has been collected, the solution will be held for 2
hours before starting diafiltration. This time will allow the viruses to be
inactivated in the acidic conditions.22
13.2.2.4 Ultrafiltration / Diafiltration (UF/DF)
Ultrafiltration and diafiltration are size-exclusion, pressure-driven
membrane processes used for protein concentration and buffer exchange. The
desired separation is created by the different filtration rates of the various species
and the applied pressure driving force. Solvent, buffer salts, and other small
molecules migrate through the membrane while the protein is retained. The
ultrafiltration will be carried out in the tangential flow filtration (TFF) mode.
Tromethamine (Tris base) (pKa = 8.1) will be added to the retentate system at the
same rate that filtrate is removed. This will ensure the protein is in a new buffer to
prime the product for the next chromatography step.
The UF/DF process will be run continuously using membrane cassettes totaling
2.5 m2 in area and with a pore size of 30 kDa. The product in the large production
bioreactor design will be concentrated from 10.7 g/L to 52.1 g/L. The product in
the small production bioreactor design will be concentrated from 11.5 g/L to 55.4
g/L. The total processing time for the Large Production Bioreactor Design will be
4 hours and 1.5 hours for the Small Production Bioreactor Design.
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13.2.2.5 Cation Exchange Chromatography
Cation exchange chromatography uses a resin modified with negatively
charged functional groups to bind positively charged proteins. For this process,
Capto S resin will be used, which has a -SO3 functional group. It is typically used
for mAbs with neutral to basic pI values. Because the pI of the protein is 9.2, it
will be positively charged at its working pH of 5.5. The antibody is bound onto
the resin during the loading step and eluted with a increasing salt buffer, while
keeping pH constant. The increased salt concentration causes the sodium cations
to exchange with mAb. The most negatively charged impurities are removed
during the load and wash steps. These impurities include DNA, some host cell
protein, and leached protein A.23
First, the column is packed with the resin and equilibrated using 5 CV of
20 mM sodium acetate buffer. Then, the sample is loaded with the filtrate from
the previous diafiltration step. The wash step uses 5 CV of 20 mM sodium acetate
buffer. The product is then eluted with 2 CV of a buffer consisting of 20 mM
sodium acetate with 0.5M sodium chloride and collected for additional
purification. The column is regenerated using 2 CVs of 20 mM sodium acetate
with 1M sodium chloride and CIP is performed with 3 CV of 0.5 M NaOH. The
column is expected to have a 92% yield. For the Large Production Bioreactor
Design, it will require 16 hours to process all of the input, which will be
processed in 4 cycles. For the Small Production Bioreactor Design, it will require
4 hours to process each input, which will require one cycle. Similar to the Protein
A chromatography column, the volume of the product solution is determined by
the elution step. However, for this column, there will be an increase in the volume
because of the volume required to remove the protein from the resin. The Large
Production Bioreactor Design will have a volume increase from 640 L to 1290 L
and the Small Production Bioreactor Design will have an increase from 150 L to
320 L. At this point, the protein titers for the two designs are 30.7 g/L and
24.0g/L, respectively.
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13.2.3 Polishing Steps
The polishing steps consist of virus filtration, hydrophobic interaction
chromatography, and two final filtration steps (ultrafiltration/diafiltration and sterile
filtration). These steps are used to remove viruses, aggregated protein, and any other
impurities before storing the proteins.28 The same processes will be used in the
downstream process for both upstream schemes, but they will be adjusted in capacity. At
various points in the downstream purification process, the product will be checked to
ensure quality standards are met.24
13.2.3.1 Virus Filtration
The virus filtration step is used to remove the virus particles that were
previously inactivated. For safety requirements, the product must contain less than
one virus particle per million doses, which translates to 12-18 log10 clearance of
endogenous retroviruses and 6 log10 clearance for adventitious viruses. The US
Food and Drug Administration (FDA) requires that manufacturers of biotech
products that use murine cell lines (including CHO cells) are to demonstrate the
clearance capability of their manufacturing processes with one relevant retrovirus.
Because the virus particles have a diameter of 18–26 nm, but a typical
monoclonal IgG antibody has a hydrodynamic diameter of 8–12 nm, filters are
required to have a very narrow pore size distribution to achieve a high clearance
and yield.25
Four filters will be used and the filtration unit can be run continuously in four
cycles during which the hollow-fiber membrane will retain the virus waste. This
will take 10 hours for the Large Production Bioreactor Design and 6 hours for the
Small Production Bioreactor Design.
13.2.3.2 Hydrophobic Interaction Chromatography
Hydrophobic interaction chromatography (HIC) is commonly used as a
polishing step in mAb purification processes. It is an effective step for removing
trace product and process-related impurities such as aggregates. It is important to
remove protein aggregates because they may lead to an immunogenic reaction
when administered to the patient.26 HIC is a tool used to separate proteins based
on their hydrophobicity. For this process, it will be run in flow through mode,
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meaning the product will flow through while the impurities bind to the resin.
These impurities have chemical properties very similar to the target but they will
be more hydrophobic than the target protein. They will bind at relatively low salt
concentrations to the resin, while the mAb will not bind unless there is a high salt
concentration.27 Depending on the mAb product, HIC may not be required if
cation exchange can adequately purify the product. If only two chromatography
steps are required, this step can be easily eliminated.
The column is equilibrated with 5 CVs of 1.3 M ammonium sulfate, 50
mM sodium phosphate, adjusted to pH 7 using 1M tris base and conductivity
adjusted to 110mS/cm using ammonium sulfate. The filtrate from the virus
filtration unit is loaded onto the column. The product pool is then collected, with a
pH of 7 upon elution, and is quenched with 1M acetic acid to a final pH of 5.5
prior to analysis. The column is then washed with 5 CV of equilibration buffer.
The resin is cleaned with 5 CVs of WFI followed by 5 CVs of 1 M NaOH. The
column is expected to have a 92% yield. For the Large Production Bioreactor
Design, it will require 13 hours to process all of the input, which will be
processed in 4 cycles. For the Small Production Bioreactor Design, it will require
7 hours to process each input, which will require one cycle. This chromatography
step will result in an increase in the working volume so the protein titer will
decrease from 22.6 g/L to 7.7 g/L for the large production bioreactor design and
from 22.8 g/L to 3.2 g/L for the small production bioreactor design.
13.2.3.3 Ultrafiltration / Diafiltration (UF/DF)
A second UF/DF process will be run to achieve the final desired protein
concentration and resuspend the protein in sterile PBS.28 Similar to the first
UF/DF, the filtration will be performed in the tangential flow mode and will
concentrate the product from 7.7 g/L to 37.0 g/L and suspend the product protein
in PBS in preparation for the final product sterilization.
13.2.3.4 Sterile Filtration
Sterile filtration serves as the last purification step to remove any final
contaminants. The product will be directly filtered into the final storage containers
using a 0.2 um membrane cartridges to ensure sterility. For the Large Production
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Bioreactor Design, 70 filters will be run in parallel, one for each of the final
storage containers, and it will take 3 hours to process all input. For the Small
Production Bioreactor Design, 42 filters will be run in parallel and it will also take
3 hours to process all input. The filters are expected to recover 97% of the
product.
13.2.3.5 Final Storage
The purified product will be stored in 10 L polycarbonate Nalgene
biotainers at -80°C. The product will be stored in bulk current market. Depending
on the demand, the product will be sent to the formulation group who will
package the mAbs for patient use in the correct dosage. 70 bottles will be used for
the Large Production Bioreactor Design and 42 will be used for the Small
Production Bioreactor Design. The product will be stored at a titer of 36 g/L and
15 g/L for the two designs.
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14. Energy Balance and Utility Requirements
The major utility requirements for this process are electricity and steam. It is assumed
that since this plant is part of a larger operation, utility supply systems are already installed. The
utility consumption is the only cost consideration.
The Large Production Bioreactor scheme requires 79,300 kWh of electricity. At the PECO
(Philadelphia Electric Company) rate of $0.085/kWh, this results in a per batch cost of $6,740 28.
Steam is another heavily used utility, at $0.02/kg resulting in a $5,007 expenditure. A large
portion of these utilities will be used for operating the large 20,000 L bioreactor, as well as for
CIP and SIP processes. The Small Production Bioreactor scheme, therefore, requires much less
electricity and steam in the upstream process, since the maximum bioreactor size is 2,000 L and
no CIP/SIP is required since all units are disposable. The total utility cost for the small bioreactor
scheme is $6,600 which is less than half that of the large bioreactor scheme.
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15. Equipment List and Unit Descriptions
15.1 Upstream Production Process Units
The equipment used in the two designs (Large and Small Production Bioreactor) are
described in the following sections. Each section references the unit in the process flow sheets
from Section 12. The equipment used for the two designs will be similar, but will be adjusted
based on volumes.
15.1.1 Large Production Bioreactor Design
15.1.1.1 Blending Tank (PFD 01/P-1)
This blending tank is used to mix ActiPro dry powder media with WFI
before being filtered and then transferred to a storage tank until further use. The
tank will be manufactured from polyethylene with a volume of 75L, a working
capacity of 80%, and a height to diameter ratio of 2 to 1. Clean-in-place (CIP) and
Steam-in-place (SIP) will be conducted after each batch, the procedures for which
can be found in Appendix C. The tank operates at room temperature and 1 bar.
The tank is manufactured by White Mountain Process and costs $12,500.
15.1.1.2 Dead-End Filter (PFD 01/P-3)
This dead-end filter is used to filter and remove large contaminants from
blended media before being transferred to storage until further use. The filter pore
size is 0.2 µm and the filtration area is 0.57 m2. The membrane filter material is
polyethersulfone (PES) with a polyethylene film edge and polyester supports. The
maximum differential pressure at room temperature is 6.9 bar with a throughput
of 2000 L/m2/h. The filters are sterile, disposable, and come in disposable housing
units, which are replaced after every batch. Filter P-19 is connected to blending
tank P-1 for filtration of ActiPro media. The capsules are manufactured by
Millipore Sigma and cost $400.
15.1.1.3 Storage/Blending Tank (PFD 01/P-5)
This storage tank is used to store blended and filtered ActiPro culture
media at 4°C until being transferred to the 250mL Shaker Flask, 25L Single-Use
Bioreactor, and 100L Single-Use Seed Bioreactor. The tank will be manufactured
from polyethylene with a volume of 75L, a working capacity of 80%, and a height
to diameter ratio of 2 to 1. Clean-in-place (CIP) and Steam-in-place (SIP) will be
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conducted after each batch, the procedures for which can be found in Appendix C.
The tank operates at 4°C via electric cooling and 1 bar. The estimated cost of the
storage tank is $12,500.
15.1.1.4 250 mL Shaker Flask with Orbital Shaker & Incubator (PFD 01/P-7)
A baffled 250 mL shaker flask manufactured by Corning is used for the
first inoculum preparation step after cryogenic recovery of the cells (Appendix
A). The flask is made from Pyrex and must be autoclaved at 121°C for 60 minutes
before use. The flask will be placed on a low speed orbital shaker with a flat
platform manufactured by Corning LSE. The orbital shaker is 25.5 cm long, 32.0
cm wide, and 16.0 cm in height, with maximum speed of 60 rpm. The flask and
shaker apparatus will be placed inside an Thermo Scientific Forma Series 3 Water
Jacketed CO2 Incubator. The incubator comes equipped with temperature, CO2,
O2, and humidity controls. The incubator is manufactured from stainless steel
with inner dimensions 54.1 cm in length, 68.1 cm in width, and 50.8 cm in height.
The incubator will be set to 36.5°C, 1 bar, a pH of 7.1, 5.0% CO2, and 40% dO2.
The process time for the shaker flask, orbital shaker, and incubator is 3 days. The
shaker flasks are purchased in quantities of six for $157.80 from Corning. The
orbital shaker is a one-time purchase from Corning for $900.00. The incubator is
also a one-time purchase from Thermo Fisher Scientific for $7,900.
15.1.1.5 25 L Single-Use Bioreactor (PFD 01/P-9)
The second inoculum preparation step uses the single-use ReadyToProcess
WAVE™ 25 L rocking bioreactor system from GE Healthcare Life Sciences. The
system consists of a rocker, CBCU gas mixers, pumps, and disposable, presterilized, 22L Cellbags for cell expansion and growth in suspension. It is also
equipped with high level sensors and stable, automated control for temperature,
liquid transfer, dO2, and pH. Cellbags are easily attachable and all operations are
managed with the accompanying UNICORN software installed on a computer.
The base unit dimensions are 0.40 m long, 0.21 m wide, and 0.56 m high. The
tray dimensions to hold the Cellbag are 0.8 m long, 0.07 m wide, and 0.61 m high.
The rocker allows for temperature control integrated into the base unit, stable
mixing, and real-time load measurements. Rocking also helps maintain dissolved
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oxygen levels. The CBCU delivers gases to the culture and is connected to optical
sensors in the cell bag bioreactor for online pH and dO2 control. A maximum of
two CBCU gas mixers and three pump units can be connected to the main rocker.
Because the cell bags are pre-sterilized and disposable, there are no CIP or SIP
steps required and there is minimal cross-contamination between batches. The cell
bags are manufactured from clear, multilayer, laminated USP Class VI plastics
and are replaced between each batch. The unit is kept at 36.5°C, 21 bar, pH at 7.1,
and 40% dO2. The rocker is set to a final agitation speed of 15 rpm at a 7° angle.
The process time for the unit is 3 days. The rocker and CBCU gas mixer are
purchased from GE Healthcare Life Sciences for $60,000 and $1,000,
respectively. The disposable 22L Cellbag is purchased for $500.00.
15.1.1.6 100 L Single-Use Seed Bioreactor (PFD 01/P-29)
Cell seeding and scale-up uses the single-use ReadyToProcess WAVE
Bioreactor 200 system. The system consists of a rocker base unit and a
disposable, pre-sterilized 100L Cellbag. It is also equipped with high level sensors
and PID control for aeration, temperature, dO2, and pH. All operations are
managed with the accompanying UNICORN software installed on a computer.
The unit dimensions including the Cellbag are 1.85 m long, 1.10 m wide, and 1.12
m high. The rocker produces a wave-like motion that mixes the culture, suspends
the cells, and helps provide effective oxygen transfer from the bioreactor
headspace. The degree of mixing and oxygen transfer will be controlled by
adjusting the rocking speed and angle. Oxygen transfer is also supplied by an
internal air pump that passes air through the headspace to continuously supply
oxygen and strip waste gases. O2 is also connected to a separate port to mix air
with O2 if necessary. dO2 levels are controlled either by altering the concentration
of O2 in air pumped into the headspace or by altering rocking speed or angle. A
configured dO2 system with a sensor provides control for both of these options.
On the underside of the rocker is a heating plate that controls temperature along
with a temperature sensor inserted into the Cellbag. An electrochemical pH probe
measures online pH and is connected to pumps for addition of Na2CO3 in H2O for
acid or NaOH in H2O for base. Because the cell bags are pre-sterilized and
49

disposable, there are no CIP or SIP steps required and there is minimal crosscontamination between batches. The cell bags have a 50% working volume, are
manufactured from clear, multilayer, laminated USP Class VI plastics, and are
replaced between each batch. The maximum operating pressure is 0.1 bar, and the
recommended operating pressure is 5 to 7.5 mbar. The unit is kept at 36.5°C,
0.007 bar, pH at 7.1, and 40% dO2. The final rocking speed is set to 25 rpm at an
8° angle. The process time for the unit is 3 days. The rocker and 100L CellBag
are purchased from GE Healthcare Life Sciences for $90,000 and $800,
respectively.
15.1.1.7 Blending Tanks (PFD 01/P-11; P-17; P-23)
Blending tank P-22 is identical to the unit described in 15.1.1.1, but has a
volume of 4,000L and costs $51,000.
Blending tank P-17 is identical to the unit described in 15.1.1.1, but it is
used to mix feed supplement CellBoost™ 7a dry powder media with WFI before
being filtered and transferred to a storage tank until further use. The tank will
have a volume of 7,000L and cost $63,200.
Blending tank P-23 is is identical to the unit described in 15.1.1.1, but it is
used to mix feed supplement CellBoost™ 7b dry powder media with WFI before
being filtered and transferred to a storage tank until further use. The tank will
have a volume of 700L and cost $24,300.
15.1.1.8 Dead-End Filters (PFD 01/P-13; P-19; P-25)
These dead-end filters are the same as previously described in Section
15.1.1.2, connected to blending tanks P-11, P-17, and P-23, respectively.
15.1.1.9 Storage/Blending Tanks (PFD 01/P-15; P-21; P-27)
Storage tank P-15 is identical to the unit described in 15.1.1.3, but has a
volume of 4,000L and is used to store blended and filtered ActiPro culture media
at 4°C until being transferred to the 500L and 2,000L Single-Use Seed
Bioreactors. The tank costs $51,000.
Storage tank P-21 is identical to tank P-15, but stores blended and filtered
feed supplement CellBoost 7a media and has a volume of 250L. The storage tank
costs $18,000.
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Storage tank P-27 is identical to P-21 is but stores blended and filtered
feed supplement CellBoost 7b media and has a volume of 25L. The storage tank
costs $9,200.
15.1.1.10 500 L Single-Use Seed Bioreactors (PFD 01/P-32,33)
Cell seeding continues with use of another single-use ReadyToProcess
WAVE Bioreactor 500/1000 system. The system consists of a rocker base unit,
and a disposable, pre-sterilized 500L Cellbag. It is also equipped with high level
sensors and PID control for aeration, temperature, dO2, and pH. All operations are
managed with the accompanying UNICORN software installed on a computer.
The unit dimensions including the Cellbag are 2.26 m long, 1.24 m wide, and 1.60
m high. The rocker produces a wave-like motion that mixes the culture, suspends
the cells, and helps provide effective oxygen transfer from the bioreactor
headspace. The degree of mixing and oxygen transfer will be controlled by
adjusting the rocking speed and angle. Oxygen transfer is also supplied by an
internal air pump that passes air through the headspace to continuously supply
oxygen and strip waste gases. O2 is also connected to a separate port to mix air
with O2 if necessary. dO2 levels are controlled either by altering the concentration
of O2 in air pumped into the headspace or by altering rocking speed or angle. A
configured dO2 system with a sensor provides control for both of these options.
On the underside of the rocker is a heating plate that controls temperature along
with a temperature sensor inserted into the Cellbag. An electrochemical pH probe
measures online pH and is connected to pumps for addition of Na2CO3 in H2O for
acid or NaOH in H2O for base. Because the cell bags are pre-sterilized and
disposable, there are no CIP or SIP steps required and there is minimal crosscontamination between batches. The cell bags have a 50% working volume, are
manufactured from clear, multilayer, laminated USP Class VI plastics, and are
replaced between each batch. The maximum operating pressure is 0.1 bar, and the
recommended operating pressure is 5 to 7.5 mbar. Each unit is kept at 36.5°C,
0.007 bar, pH at 7.1, and 40% dO2. The final rocking speed is set to 15 rpm at an
4° angle. The process time for the unit is 3 days. Each rocker and 500L CellBag

51

are purchased from GE Healthcare Life Sciences for $150,000 and $1,000,
respectively. Two rockers and CellBags are required per batch.
15.1.1.11 2,000 L Single-Use Seed Bioreactors (PFD 01/P-36,37)
The last cell seeding step is performed with use of another single-use
system, the Xcellerex XDR-2000 cell culture bioreactor systems from GE
Healthcare Life Sciences. The system consists of a jacketed bioreactor vessel, an
I/O and gas mixing cabinet, a control console, and a bioreactor bag assembly,.
The jacketed vessel, manufactured from 304 grade stainless steel, provides
temperature control via an external temperature control (PID) unit. It has a height
to diameter aspect ratio of 1.5 to 1. The vessel also has built in load cells for
weight measurement, inlet and exhaust filter holders, and sidewall ports. The
sidewall ports allow for sterile sampling and sterile probe insertion for pH, dO2,
dCO2 and temperature measurements. The I/O cabinet houses probe transmitters
and peristaltic pumps, while the gas management cabinet houses mass flow
controllers for delivery of gases to the bag sparger or headspace. The control
console visualizes all measurements and manages controls of the Xcellerex XDR
system. The bag assembly consists of a bioreactor bag incorporated with an
impeller/sparger assembly mounted on the bottom for efficient mixing and
oxygen transfer. The impeller is magnetically coupled, has 4 blades at a pitch of
40°, and the impeller diameter to bag diameter aspect ratio is 0.34. The assembly
is also comprised of tubing, complete with weldable and aseptic connectors for
liquid transfer, a disposable pressure sensor, and filters for inlet, exhaust, and
headspace gas transfer. The bag itself has a 100% working volume of 2,000L, is
manufactured from clear, multilayer, laminated USP Class VI plastics, and is
replaced between each batch. Because the bags are pre-sterilized and disposable,
there are no CIP or SIP steps required and there is minimal cross-contamination
between batches. The maximum operating pressure is 0.05 bar. Each unit is kept
at 36.5°C, 0.007 bar, pH at 7.1, and 40% dO2. The agitation speed is set to 110
rpm. The process time for the unit is 3 days. Each Xcellerex XDR vessel and
2,000L Probag are purchased from GE Healthcare Life Sciences for $250,000 and
$5,000, respectively. Two vessels and Probags are required per batch.
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15.1.1.12 Blending Tank (PFD 01/P-46)
Blending tank P-46 is identical to the first unit described in 15.1.1.1 for
mixing regular ActiPro growth media, but has a volume of 6,000L and costs
$59,400.
15.1.1.13 Dead-End Filters (PFD 01/P-48)
These dead-end filters are the same as previously described in Section
15.1.1.2, connected to blending tank P-48.
15.1.1.14 Storage/Blending Tanks (PFD 01/P-50; P-41; P-44)
Storage tank P-50 is identical to the first unit described in 15.1.1.9, but has
a volume of 6,000L and costs $59,400.
Storage tank P-41 is identical to the second unit described in 15.1.1.9, but
has a volume of 7,500L and costs $69,400.
Storage tank P-44 is identical to the third unit described in 15.1.1.9, but
has a volume of 750L and costs $25,500.
15.1.1.15 20,000 L Stainless Steel Production Bioreactor (PFD 01/P-52)
The mAb production step is performed with a traditional stainless-steel,
custom, jacketed bioreactor with a 20,000 L volume and a 16,000 L working
volume. The tank is cylindrical, with a height to diameter ratio is 2 to 1. The
bioreactor is equipped with an impeller, which has a total diameter that is 1/3 the
diameter of the tank. Each impeller blade is 1/5 the diameter of the impeller in
height, and 1/4 the diameter of the impeller in width. There are 4 blades on the
impeller at an angle of 40°. The bioreactor is also equipped with gas sparging
elements and filter ports for sterile air and O2, along with mass flow ports and
filters for fed-batch media and feed supplement transfers, anti-foaming agent,
aqueous Na2CO3, and aqueous NaOH. The vessel will be heated by a waterjacket. There will also be aseptic vessel ports for pH, dO2, dCO2, and temperature
probes, in addition to sampling ports for daily cell density and viability
measurements. The exhaust port will contain a filter and heater to prevent
condensation. All set points will be controlled with PID controls. Following each
batch, CIP and SIP will be conducted to sterilize the vessel. The vessel is operated
at 36.5°C, 2 bar, pH at 7.1, and 40% dO2. The specific agitation power is 0.055
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W/kg, and air is sparged at 0.00981 vvm assuming that 30% of all sparged air is
taken up by the cells. This calculation can be found in Appendix D. The process
time for the unit is 19 days. The estimated total purchase cost of the vessel is
$1,500,000.
15.1.2 Small Production Bioreactor Design
15.1.2.1 Blending Tank (PFD 03/P-1)
This blending tank is identical to the unit described in 15.1.1.1 for mixing
regular ActiPro growth media, but has a volume of 300L and costs $18,100.
15.1.2.2 Dead-End Filter (PFD 03/P-3)
This dead-end filter is identical to the unit described in 15.1.1.2 and is
connected to blending tank P-1.
15.1.2.3 Storage/Blending Tank (PFD 03/P-5)
This storage tank is identical to the unit described in 15.1.1.3, but has a
volume of 300L and costs $18,100.
15.1.2.4 250 mL Shaker Flask with Orbital Shaker & Incubator (PFD 03/P-7)
This shaker flask is identical to the unit described in 15.1.1.4.
15.1.2.5 25 L Single-Use Bioreactor (PFD 03/P-9)
This 25L Single-Use WAVE Bioreactor from GE Healthcare Life Science
is identical to the unit described in 15.1.1.5.
15.1.2.6 Blending Tanks (PFD 03/P-11; P-17)
Blending tank P-11 is identical to the second unit described in 15.1.1.7 for
mixing CellBoost 7a media, but has a volume of 900L and costs $26,000.
Blending tank P-17 is identical to the third unit described in 15.1.1.7 for
mixing CellBoost 7b media, but has a volume of 90L and costs $12,700
15.1.2.7 Dead-End Filters (PFD 03/P-13; P-19)
These dead-end filters are identical to the unit described in 15.1.1.2 and
are connected to blending tanks P-11 and P-17, respectively.
15.1.2.8 Storage/Blending Tanks (PFD 03/P-15; P-21)
Storage tank P-15 is identical to the second unit described in 15.1.1.7 for
CellBoost 7a storage, but has a volume of 50L and costs $10,700.
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Storage tank P-21 is identical to the third unit described in 15.1.1.7 for
CellBoost 7b storage, but has a volume of 25L and costs $9,100.
15.1.2.9 500 L Single-Use Seed Bioreactor (PFD 03/P-23)
This 500L Single-Use WAVE Bioreactor from GE Healthcare Life
Sciences is identical to the unit described in 15.1.1.6. The operating time for this
unit is 6 days. Only one rocker and 500L CellBag will be purchased for $150,000
and $1,000.
15.1.2.10 Blending Tank (PFD 03/P-31)
Blending tank P-31 is identical to the unit described in 15.1.1.1 for mixing
regular ActiPro growth media, but has a volume of 1,100L and costs $28,200.
15.1.2.11 Dead-End Filter (PFD 03/P-33)
This dead-end filter is identical to the unit described in 15.1.1.2 and
isconnected to blending tanks P-31.
15.1.2.12 Storage/Blending Tanks (PFD 03/P-35; P-26; P-29)
Storage tank P-35 is identical to the 15.1.1.3 for ActiPro growth media
storage, but has a volume of 1,100L and costs $28,200.
Storage tank P-26 is identical to the first unit described in 15.1.2.8 for
CellBoost 7a storage, but has a volume of 850L and costs $25,600.
Storage tank P-26 is identical to the first unit described in 15.1.2.8 for
CellBoost 7b storage, but has a volume of 90L and costs $12,700.
15.1.2.13 2,000 L Single-Use Production Bioreactors (PFD 03/P-37)
This 2000L single-use Xcellerex XDR-2000 cell culture bioreactor system
from GE Healthcare Life Sciences is identical to the unit described in 15.1.1.11.
Only one rocker and 2,000L Probag will be purchased for $250,000 and
$2,500.00, respectively.
15.2 Downstream Purification Process Units
The equipment used in for the downstream operations are described in the following
sections. Each section references the unit in the process flow sheets from Section 12. The
equipment used will be based on the corresponding upstream design and the differences are
noted below.
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15.2.1 Primary Recovery
15.2.1.1 Centrifuge (PFD 02/P-54, PFD 04/P-39)
The contents of the production bioreactor must be separated into a solid
waste stream and liquid stream containing the desired product. A disc-stack
centrifuge produced by GEA is used. The CSE 170 model, constructed with
Stainless Steel 316, will be used for the large production bioreactor design and
can be purchased for $1,500,000. It can process throughputs of 3,000-6,000 L/h.
For the small production bioreactor scheme, a smaller centrifuge (CSC 20) will be
used, which can process 500-1000L/hr. It will be purchased from GEA for
$1,200,000. The unit operates in a continuous manner and will process all the
contents of the production bioreactor immediately following its completion. After
each batch, the unit will be sterilized with CIP and SIP. The unit operates at 25°C.
15.2.1.2 Storage Tank 6 (PFD 02/P-56, PFD 04/P-41)
This storage tank will be used to collect the liquid contents of the
centrifuge and store it so that batches can be sent for further purification. It will be
sized to match the size of the production bioreactor. For the large production
bioreactor, the storage tank will have a volume of 20,000 L and for the small
production bioreactor, will be 2,000 L. The maximum working capacity will be
80%. CIP and SIP will be conducted after each upstream batch is processed. The
20,000L tank will be purchased for $104,700 and the 2,000L tank for $36,000
15.2.1.3 Depth Filtration Unit (PFD 02/P-58, PFD 04/P-43)
Depth filtration is used to further clarify the solution containing the mAbs
after centrifugation. The unit housing can hold up to 30 filters at once. For the
large production bioreactor, the three rack housing will be used with 30 filters
running per cycle. For the small production bioreactor, 10 filters will be used per
cycle. The unit is purchased from Millipore Sigma and each filter costs $750. The
housing unit for the 30 filter costs unit costs $67,300 and the housing unit for the
10 filters costs $29,200. The model is the Millistak+® Multilayer Process Scale
Pod Filter with X0HC media. This filter media is meant for secondary
clarification (post-centrifugation) and was chosen based on the specifications of
the mAb product. The Pod filter system was chosen because it can easily scale
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depending on the batch size by adding more or less filters. In addition, the filters
are disposable, which eliminates the need for CIP. It has a maximum operating
pressure of 3.5 bar at 25 °C and has a recommended feed flow rate of 21
L/min/m2.
15.2.1.4 Storage Tank 7 (PFD 02/P-60, PFD 04/P-45)
This storage tank will collect the filtrate from the depth filtration unit and
store it until it needs to be passed to the Protein A chromatography column in the
correct. The unit has a capacity of 80% and is 20,000L for the large production
bioreactor and 2,000L for the small production bioreactor design. The 20,000L
tank will be purchased for $104,700 and the 2,000L tank for $35,900.
15.2.2 Initial Purification
15.2.2.1 Protein A Chromatography Column (PFD 02/P-62 PFD 04/P-47)
The Protein A affinity chromatography column is used to further purify
the filtrate and isolates the product by selectively binding the mAbs. The
Chromaflow 1000/100-300 column will be purchased from GE Healthcare for
$250,000. The column is made with 316 Stainless Steel and is packed with
MabSelect Sure LX resin, which can be be purchased from GE Healthcare Life
Sciences for $8,000 per liter. The column operates as a packed bed, which will
have a bed height of 0.25m and diameter of 1 m. The bed volume is 200 L and the
resin has a binding capacity of 50 g mAb/L. The amount of resin required is
determined by the binding capacity of the resin. For this process, 9.8 kg mAb are
purified per Protein A chromatography cycle and this value is determined by
(50g/L)*(200L bed volume) to get a maximum value of 10 kg mAb. The binding
capacity of the resin decreases slightly after each run, but it was determined that
50 g/L is an accurate estimate of the average binding capacity. The resin can be
used for 150-200 cycles and will be re-purchased every five years. The operating
linear velocity used will be 250-400 cm/hr, depending on the buffer being used.
For the large production bioreactor design, four cycles of Protein A
chromatography are required. For the small production bioreactor, one cycle of
Protein A chromatography is required for each 2,000 L bioreactor.

57

15.2.2.2 Storage Tank 8 (Virus Inactivation) (PFD 02/P-64, PFD 04/P-49)
This storage tank will be used to store the output from the Protein A
column and is the mixing tank where the virus inactivation occurs. The unit will
have a volume of 5,000L for the large production bioreactor design and 1,000L
for the small production bioreactor scheme, both with 80% capacity. For
sterilization, CIP and SIP will be conducted after each batch. The 5,000L tank
will be purchased for $55,100 and the 1,000L tank for $26,600.
15.2.2.3 Ultrafiltration/Diafiltration (PFD 02/P-66, PFD 04/P-51)
This unit is used to concentrate the protein product as well as perform a
buffer exchange. The system used is a Cogent Process Scale TFF system with a
100 L tank. The filtration membrane is provided by a Pellicon 2 cassette with a
2.5 m2 membrane area. The product is retained by the filter, while smaller
particles are passed through it. Then, it washed away using the new buffer that is
required to bring the pH of the solution up. Two filters will be needed for each
batch for the large production bioreactor design and one filter will be needed for
each batch in the small production bioreactor design. The cost of the system is
$500,000 while the disposable membrane cassette is $3,600 per unit.
15.2.2.4 Storage Tank 9 (PFD 02/P-68, PFD 04/P-53)
This storage tank is used to collect the retentate from the diafiltration
column. For the large production bioreactor design, it will be a 2,000L tank and
for the small production bioreactor design, it will be a 500L tank, both with a
maximum of 80% capacity. For sterilization, CIP and SIP will be conducted after
each batch. The 2,000 L tank will be purchased for $35,900 and the 500L tank
will be purchased for $22,550.
15.2.2.5 Cation Exchange Chromatography Column (PFD 02/P-70, PFD
04/P-55)
The cation exchange chromatography column is used to further purify the
solution and removed impurities. The Chromaflow 1000 column will be used with
the Capto S resin and both will be purchased from GE Healthcare Life Sciences.
The column is made of Stainless Steel 316. The column has a bed height of 0.2m
and diameter of 1.0m with a volume of 160 L. The resin has a binding capacity of
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60 g mAb/L and a working linear velocity of up to 600 cm/hr. Similar to the
Protein A chromatography column, the amount of mAb processed per cycle is
determined by the volume of the bed and the binding capacity of the resin. For
this column, 9.4 kg mAb will be processed per cycle which was determined by 60
g mAb/L*160 L. The column is operated at 25°C, at 1 bar. The cost of the column
is $250,000 and the resin is $1500 per liter. For the large production bioreactor
design, four cycles of cation exchange chromatography are required. For the small
production bioreactor design, one cycle of cation exchange chromatography is
required for each 2,000 L bioreactor.
15.2.2.6 Storage Tank 10 (PFD 02/P-72, PFD 04/P-57)
This storage tank is used to collect the effluent from the cation exchange
chromatography column. For the large production bioreactor design, it will be a
2,000L tank and for the small production bioreactor design, it will be a 500L tank,
both with a maximum of 80% capacity. For sterilization, CIP and SIP will be
conducted after each batch. The 2,000 L tank will be purchased for $35,900 and
the 500L tank will be purchased for $22,600.
15.2.3 Polishing Steps
15.2.3.1 Virus Filtration Unit (PFD 02/P-74, PFD 04/P-59)
This unit will remove the virus particles that were previously inactivated.
For safety requirements, the product must contain less than one virus particle per
million doses, which translates to 12-18 log10 clearance of endogenous
retroviruses and 6 log10 clearance for adventitious viruses. This unit is placed at
towards the end of the purification process because the risk of blockage is the
lowest. The membrane used will be a Virosart HF Process Module with a 0.8 m2
area, priced at $10,084 per filter. The Virosart CPV system targets the removal of
both small non-enveloped viruses (20 nm) and larger enveloped viruses (>50 nm).
Each membrane is housed in a Sartopore 2 XLG MaxiCap. Four filtration units
will be used per batch for the large production bioreactor design and one unit will
be used for the small production bioreactor design batch. These virus filtration
units cost $10,000 each.
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15.2.3.2 Hydrophobic Interaction Chromatography Column (PFD 02/P-76,
PFD 04/P-61)
The hydrophobic interaction chromatography column is used as a
polishing step and to remove any aggregates that may have formed due to the pH
changes. The Chromaflow 1000 column from GE Healthcare Life Sciences will
be used with the POROS Benzyl Ultra resin from Thermo Fisher Scientific. The
column is made of Stainless Steel 316. The column has a bed height of 0.25m and
diameter of 1.0m, with a volume of 200L. The resin can used with a working
linear velocity of up to 600 cm/hr. The column is operated at 25°C, with a
pressure of 1 bar. The cost of the column is $250,000 and the resin is $380 per
liter. For the large production bioreactor, four cycles of HIC are required. For the
small production bioreactor, one cycle of HIC is required for each 2,000 L
bioreactor.
15.2.3.3 Storage Tank 11 (PFD 02/P-78, PFD 04/P-63)
This storage tank is used to collect the product flow through from the
hydrophobic interaction chromatography column. For the large production
bioreactor design, it will be a 5,000L tank and for the small production bioreactor
design, it will be a 2,500L tank, both with a maximum of 80% capacity. For
sterilization, CIP and SIP will be conducted after each batch.The 5,000 L tank
will be purchased for $55,100 and the 2,500L tank will be purchased for $38,700.
15.2.3.4 Ultrafiltration / Diafiltration Unit (PFD 02/P-80, PFD 04/P-65)
Similar to the previous UF/DF operation, the Cogent Process Scale TFF
System will be used to concentrate the product to its final titer and ensure sterility
of the buffer. As before, Pellicon 2 cassettes will provide 2.5 m2 of membrane
area.
15.2.3.5 Sterile Filtration (PFD 02/P-82, PFD 04/P-67)
Sterile filtration is used as a final step and the product is filtered directly
into the storage containers. This is an important step to ensure sterility before the
product is frozen and stored. The filters have pore sizes of 0.2 µm and are
Sartopore 2 filters from Sartorius. They can be purchased for $650 per filter.
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15.2.3.6 Final Storage (PFD 02/P-84, PFD 04/P-69)
The final product from the purification process will be stored in 10L
Nalgene Biotainers. These biotainers are polycarbonate and will be stored at 80°C. For the large production bioreactor design, 70 bottles will be used and 42
bottles will be used for the small production bioreactor design. The containers
will be purchased for $100 from Thermo Fisher Scientific.
15.3 Additional Units
15.3.1 Pumps and Tubing
Peristaltic or diaphragm pumps will be used to transfer contents between each unit
in the upstream operations. The peristaltic pump model that will be used in upstream
processes is the 800 series Watson-Marlow Bredel, specifically the 825 series hygienic
pump model. This model is made for shear sensitive products and has CIP and SIP in-line
capability. It has a maximum operable flow rate of 33 L/min, maximum pressure of 3.5
bar, and maximum motor speed of 101 rpm. Each pump costs approximately $3,000. The
two diaphragm pump models that will be used are quaternary diaphragm pumps QF150S
and QF1200S from Quattroflow for bio-pharma application. These pumps have four
possible flow directions, operate in the laminar flow regime with minimal shear, with
maximum motor speeds of 50 Hz. The 150S model will be operated at 4 bar at varying
flow rates between its minimum flow rate of 0.017 L/min and maximum flow rate of 3
L/min. The 1200S 5° Eccentric Shaft model that will be used will be operated at 3 bar at
varying flow rates between its minimum flow rate of 0.17 L/min and its maximum flow
rate of 20 L/min. Both the 150S and 1200S pump models are CIP and SIP sterilizable and
cost $3,000 and $4,000, respectively.
In the downstream processes, only peristaltic pumps will be used. The 800 series
Watson-Marlow Pump used will be the 840 model. The pump has a maximum flow rate
of 8,140 L/hr, maximum pressure of 3.5 bar, and maximum motor speed of 102 rpm.
Each pump costs approximately $3,000.
The tubing used between pump-heads for both upstream and downstream
operations is Cole-Parmer MasterFlex BioPharm Plus Tubing. The tubing is made of
platinum silicone, which provides a smooth, sterile, biocompatible surface for sensitive
biopharmaceutical applications. It can be autoclaved and meets FDA standards. It can
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also withstand temperatures up to 232°C, which exceeds any temperature used in this
process design. The cost per foot of tubing is $49.00.
15.3.2 Heating and Cooling
All upstream units either containing cells or transferring fluids to cellular
environments will be heated to 36.5°C using various methods. All WAVE bioreactor
systems will be heated using electric heating with temperature sensors and control of the
trays that hold the cell bags. The Xcellerex XDR bioreactor system in addition to the
custom 20,000L stainless steel bioreactor will use a controlled heating jacket flowing
heated sterile water at around 60°C. For all media transfer steps, the upstream process
requires heating to 36.5°C before entering a bioreactor. Likewise, all cell transfer steps
require that the temperature be maintained between 36 and 37°C during transfer to
prevent cell death or slowed product formation. For both of these operations, the
platinum silicone tubing described above in Section 15.3.1 will be jacketed with carbonsteel piping. 10% propylene glycol in U.S. Pharmacopeia (USP) grade water heated to
60°C will flow through the jacket primarily to heat culture media as it is transferred from
storage tanks at 4°C to bioreactors at 36.5°C. Lastly, all media storage tanks will have a
cooling jacket to cool media to 4°C. Chilled water will flow through the cooling jacket
Water-glycol solutions will be heated using a Chromalox water-glycol heater
engineered from welded steel with copper sheath heating elements in itst electric heating
core. The heating unit operates at a maximum temperature of 150°C and comes with
electronic digital temperature process control. Water heaters (purchased from PVI
Industries, LLC), cooling water units (purchased from Cole-Parmer), and water-glycol
heaters (purchased from Chromalox) will already be in the plant and will be included in
the annual expenses.
15.3.3 Cell Storage Tank
The engineered CHO cells will be stored in a cryogenic storage tank to maintain
viability until use. The cells come in 1 mL cryogenic vials that can be stored in Thermo
Scientific Nalgene cryogenic storage boxes, which can withstand temperatures below 180°C without deformation. Each box fits one hundred 1mL vials and fits into
Thermolyne stainless steel, Locator 8 Cryogenic Storage Vessel. This system is built to
hold liquid nitrogen with vacuum insulation, uniform temperature control, and a liquid
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level monitor. Liquid nitrogen levels must be monitored precisely and replaced when the
levels get too low to maintain the cells in a cryogenic state. The tank holds 60 Nalgene
boxes in 90L of liquid nitrogen, which evaporates at 0.4 L/day. The costs of the storage
boxes, storage vessel, and liquid nitrogen supply will be $1,700, $2,700, and 0.05$ per
gallon respectively
15.3.4 Biosafety Cabinet
A biosafety cabinet will be required to provide a sterile environment to handle
and transfer the vial of cells into the bag bioreactors in the inoculum prep section. The
biosafety cabinet is manufactured by Thermo Scientific. The biosafety cabinet is part of
the existing plant and will be included in annual expenses.
15.3.5 Product Refrigeration Unit
Until the final mAb product is shipped out of the plant for packaging and
commercial sale, it must be refrigerated at -80°C. The product refrigeration units will be
purchased from Thermo Scientific, sized at 33.5 cubic feet, which can hold about 900L.
The units have a temperature range of -86 to -50°C. Three refrigeration units will be
purchased for the Large Production Bioreactor Scheme, while two units will be
purchased for the Small Production Bioreactor Scheme. The refrigerators will cost
$15,100.
15.3.6 Biowaste and Neutralization Holding Tank
All biowaste produced in the process will need to be treated before disposal. All
waste potentially containing live culture is sent to the biowaste tank. All other waste,
such as used buffers, is sent directly to a neutralization tank. The neutralization tank will
need to hold 56,700 L for the large production bioreactor scheme so four 20,000 L tanks
will be used and it will need to hold 13,290 L for the small production bioreactor scheme
so two 20,000L tanks will be used.
In addition, there is waste from the disposable equipment such as filters and
bioreactor bags that will be handled by a waste management company. The Land
Disposal Restrictions (LDR) regulations require the treatment of all hazardous
pharmaceutical waste, most commonly by hazardous waste incineration, before it can be
discarded in a hazardous waste landfill. 30
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15.3.7 Water for Injection Still
The WFI still is used to purify water used throughout process that needs to meet
FDA guidelines. WFI is used to ensure sterility of both the product and the process
equipment to help eliminate cross-contamination issues. The WFI still will already be in
the plant (purchased from Telstar) and the costs will be included in the annual expenses.
15.3.8 Sterile Air Compressor and Filtration
Compressed, sterile air is required for all upstream bioreaction processes, since
sparged air is the source of oxygen for the cells. An air compressor containing a medicalgrade filtration unit will be purchased from Greeloy Medical. The unit requires 3200W,
with a capacity of 620 L/min at 0 bar. The maximum pressure of the unit is 8 bar and the
tank can process up to 120 L of air. The internal air filter only needs to be replaced once
every year, but will be replaced every six months to ensure continued sterility. 10 units
will be purchased for the Large Production Bioreactor Scheme, while 6 units will be
purchased for the Small Production Bioreactor Scheme. These costs will be included in
the annual expenses.
Further, sterile compressed air is also filtered just before entering each of the
bioreactors as a quality control step. The air filters that will be inserted into the air inlet
ports will be the Opticap® XL Disposable Capsule Filters with 0.22 µm Hydrophobic
Durapore® Membrane purchased from Millipore Sigma. The same filters will be used to
filter all of the vented gases from the bioreactors. The filters have a filtration area of 0.69
m2are, are constructed from polyvinylidene fluoride (PVDF), and can be sterilized by
autoclave at 126°C for 30 minutes. The filters will be replaced after each batch and cost
about 400$ per filter.
15.3.9 Clean Steam Generator
The clean steam generator uses WFI to produce steam for the SIP procedures. The
clean steam generator will already be in the plant, purchased from Spirax Sarco, and the
costs will be included in the annual expenses. It has a maximum output of 3800 kg/hour
and a maximum steam pressure of 12 bar.
15.3.10 CIP Skids
Clean-in-place (CIP) technique is used to clean equipment before the next use.
The CIP Skid used in this process will be portable with a capacity to clean process tanks
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up to 3 meters in diameter. The skid will include an option for steam heating to heat the
cleaning solution to 85°C. The cost of CIP skids will be included in the annual expenses.
15.3.11 Buffer Transfer Containers
Buffer transfer containers are used to transfer buffer to the chromatography
columns and diafiltration units. These containers will be used to mix the buffers before
being used and it will be filtered before being used. CIP and SIP operations will be used
to clean these containers after each batch. For the large production bioreactor design,
5,000L tanks will be used and for the small production bioreactor design, 1,000L tanks
will be used.
15.3.12 Filter Integrity Test
A filter integrity test will be purchased from Millipore. This will be used to ensure
that all filters are functional and do not have any tears or blockages prior to each batch.
This is important in minimizing loss from manufacturing error and will be included in the
annual expenses.
15.3.13 Water Treatment Package
Although WFI will be used for most of the water requirements in the process,
U.S. Pharmacopeia (USP) grade water is needed for temperature control needs in the
bioreactor process. This water will not be in contact with the cell culture, but it will
inserted into the stainless steel bioreactor jackets for heating and cooling purposes. The
cost for the water treatment package (MECO’s MASTERpak™ LT) is included in the
annual expenses.
15.3.14 Biowaste Inactivation System
The biowaste inactivation system is needed to kill any live cells remaining in the
bio-waste tank. This includes liquid volumes from all CIP and SIP washes from the main
bioreactors and primary recovery. The biowaste inactivation system is part of the existing
plant.
15.3.15 Waste Neutralization System
The waste neutralization system is used to adjust the pH of liquid waste, which
contains no cells, to 7.0. The waste can be disposed directly into the sewer line. The
waste neutralization system is part of the existing plant and will be included in the annual
expenses.
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15.3.16 Quality Control Lab
A quality control lab will be used to ensure the manufactured product meets the
quality specifications and FDA regulations. Various samples will be taken throughout the
process, including all upstream bioreactors, and downstream virus inactivation and virus
filtration units. This lab is part of the existing plant and will be included in the annual
expenses
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16. Specification Sheets
Blending Tank (PFD 01/P-1)
Description and Function

Operation

This blending tank will mix cell culture media powder with
WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
NaHCO3
Wet Media

Characteristics

Input (kg/batch)
1.19
49.7
0.065
0.140
0

Output (kg/batch)
0
0
0
0
50.0

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

75 L
80%
Stainless Steel 316
2/1
CIP/SIP

Temperature:
Pressure:

25C
1 bar

Blending Tank:

$12,500

Operation Conditions

Purchase Cost
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Dead-End Filter (PFD 01/P-3)
Description and Function

The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.

Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
50.0

Output (kg/batch)
50.0

Characteristics

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400
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Storage Tank (PFD 01/P-21)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
50.0

Output (kg/batch)
0.00

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

75 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$12,500
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250 mL Shaker Flask (PFD 01/P-7)
Description and Function
The 250 mL Shaker Flask is used for cell growth in first
inoculum preparation step after cryogenic recovery of the
CHO cells. The Shaker Flask is placed on a low speed orbital
shaker and the combined apparatus is incubated in a CO2
Incubator.
Vendor

Corning (Flask & Orbital Shaker)
Thermo Fisher Scientific (Incubator)

Operation

Batch

Materials Handled
Cells:
Wet Media
Product
Characteristics

Input (kg/batch)
0.00000471
0.030
0.00

Output (kg/batch)
0.0000166
0.125
0.00

Model:
Flask Capacity:
Working Capacity:
Material:
Packaging:
Sterilization:

Corning 4444-250
250 mL
80%
Pyrex
6 pc
Autoclave, 121C, 60 minutes

Model:
Speed:
Frequency Range:
Tray Size:
Base Size:

Corning LSE 6780-FP
60 rpm
50/60 Hz
30 cm x 30 cm
25.5 cm x 32.0 cm x 16.0 cm

Model:
Thermo Scientific Forma Series 3
Interior Material:
Stainless Steel 304
Dimensions (LxWxH): 54.1 cm x 68.1 cm x 50.8 cm
Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Duration:

36.5C
1 bar
7.1
40%
3 days

Purchase Cost

Shaker Flask:
Orbital Shaker:
Incubator:

$160
$900
$7,900
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25 L Single-Use Bioreactor (PFD 01/P-9)
Description and Function
The 25L WAVE Bioreactor is used for cell growth in second
inoculum preparation step. The single-use system is equipped
with a rocker, gas mixers, pumps, and cell bags. The bags are
disposable and pre-sterilized. The system also offers high
level sensors and automated control for temperature, liquid
transfer, dissolved oxygen, and pH.
Vendor

GE Healthcare and Life Sciences

Operation

Batch

Materials Handled
Cells
Wet Media
Product

Input (kg/batch)
0.0000166
0.125
0.00

Output (kg/batch)
0.0000586
12.5
0.00

Characteristics

Model:
Rocker Dimensions:
Tray 50 Dimensions:
Lid 50 Dimensions:
CBCU Dimensions:
Frequency:
Bag Size:
Sterilization:

ReadyToProcess WAVE 25
404 mm x 205 mm x 560 mm
800 mm x 70 mm x 610 mm
800 mm x 260 mm x 610 mm
276 mm x 115 mm x 280 mm
50/60 Hz
22 L
Plastic, Disposable

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation Speed:
Rocking Angle:
Duration:

36.5C
2 bar
7.1
40%
15 rpm
7
3 days

Purchase Cost

Bioreactor with control:
CBCU gas mixer:
Disposable Cellbag:

$60,000
$1,000
$500
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Diaphragm Pumps (PFD 01/P-16,22,[38/39])
Description and Function
The pumps are used to transfer media and cells for upstream
bioreaction steps. The pumps are sterile and designed for
shear-sensitive biopharmaceutical applications. The
diaphragm pumps have 4 inlet and 4 outlets per pump

Vendor

QuattroFlow

Operation

Batch

Characteristics

Model:
Pumphead Material:
Minimum Flow Rate:
Maximum Flow Rate:
Maximum Pressure:
Sterilization:

150 S
Stainless Steel 316 L
0.01 L/min
3.00 L/min
6 bar
CIP, SIP

Operation Conditions

Pressure:
Flow Rate:

4 bar
Variable (0.01-33 L/min)

Purchase Cost

Pump:

$3,000
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Diaphragm Pumps (PFD 01/P-28,[30/31])
Description and Function
The pumps are used to transfer media and cells for upstream
bioreaction steps. The pumps are sterile and designed for
shear-sensitive biopharmaceutical applications. The
diaphragm pumps have 4 inlet and 4 outlets per pump

Vendor

QuattroFlow

Operation

Batch

Characteristics

Model:
Pumphead Material:
Minimum Flow Rate:
Maximum Flow Rate:
Maximum Pressure:
Sterilization:

1200 S
Stainless Steel 316 L
0.33 L/min
20 L/min
6 bar
CIP, SIP

Operation Conditions

Pressure:
Flow Rate:

3 bar
Variable (0.33-20 L/min)

Purchase Cost

Pump:

$4,000
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100 L Single-Use Bioreactor (PFD 01/P-29)
Description and Function
The 100L WAVE Bioreactor is used for cell growth in cell
seeding. The single-use system is equipped with a rocker base
unit with internal gas pumps and cell bags. The bags are
disposable and pre-sterilized. The system also offers high
level sensors and automated control for temperature, liquid
transfer, dissolved oxygen, and pH.
Vendor
GE Healthcare and Life Sciences
Operation
Batch
Materials Handled
Cells
Wet Media
Product

Input (kg/batch)
0.0000586
12.5
0.00

Output (kg/batch)
0.000308
50.0
0.00

Characteristics

Operation Conditions

Model:
Dimensions:
Frequency:
Bag Size:
Sterilization:

WAVE Bioreactor 200
1.85 m x 1.10 m x 1.12 m
50/60 Hz
100 L
Plastic, Disposable

Temperature:
Pressure:
pH:
dO2:
Agitation Speed:
Rocking Angle:
Duration:

36.5C
2 bar
7.1
40%
25 rpm
8
3 days

Bioreactor w control:
Disposable Cellbag:

$90,000
$800

Purchase Cost
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Blending Tank (PFD 01/P-11)
Description and Function

Operation

This blending tank will mix cell culture media powder with
WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
NaHCO3
Wet Media

Input (kg/batch)
67.1
2980
3.90
8.40
0.00

Output (kg/batch)
0.00
0.00
0.00
0.00
3000

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

4,000 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Blending Tank:

$51,000
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Blending Tank (PFD 01/P-17)
Description and Function

Operation

This blending tank will mix feed supplement CellBoost 7a
media powder with WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
Wet Media

Input (kg/batch)
978
5370
7.54
0.00

Output (kg/batch)
0.00
0.00
0.00
5400

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

7,000 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Blending Tank:

$63,200
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Blending Tank (PFD 01/P-23)
Description and Function

Operation

This blending tank will mix feed supplement CellBoost 7b
media powder with WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
Wet Media

Input (kg/batch)
51.1
537
0.754
0.00

Output (kg/batch)
0.00
0.00
0.00
540

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

700 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Blending Tank:

$24,300
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Dead-End Filter (PFD 01/P-13)
Description and Function
The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.

Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
3000

Output (kg/batch)
3000

Characteristics

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400
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Dead-End Filter (PFD 01/P-19)
Description and Function
The 0.2 µm dead-end filter is used to remove larger
contaminants from blended feed supplement 7a media. The
filter capsules and housing are disposable and ready-to-use.
Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
5400

Output (kg/batch)
5400

Characteristics

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400
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Dead-End Filer (PFD 01/P-25)
Description and Function

The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.

Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
540

Output (kg/batch)
540

Characteristics

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400
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Storage Tank (PFD 01/P-15)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.
Batch

Materials Handled
Wet Media

Input (kg/batch)
3000

Output (kg/batch)
0.00

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

4,000 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$51,000

Characteristics
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Storage Tank (PFD 01/P-21)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
200

Output (kg/batch)
0.00

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

250 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$18,000

82

Storage Tank (PFD 01/P-27)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
20.0

Output (kg/batch)
0.00

Characteristics
Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

25 L
80%
Stainless Steel 316
2/1
CIP/SIP

Temperature:
Pressure:

4C
2 bar

Storage Tank:

$9,200

Operation Conditions

Purchase Cost
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500 L Single-Use Seed Bioreactors (PFD 01/P-32,33)
Description and Function
The 500L WAVE Bioreactor is used for cell growth in cell
seeding. The single-use system is equipped with a rocker base
unit with internal gas pumps and cell bags. The bags are
disposable and pre-sterilized. The system also offers high
level sensors and automated control for temperature, liquid
transfer, dissolved oxygen, and pH. Two of these bioreactors
operate in parallel.

Vendor

GE Healthcare and Life Sciences

Operation

Batch

Materials Handled
Cells
Wet Media
Product

Input (kg/batch)
0.000308
25.0
0.00

Output (kg/batch)
0.000813
250
0.00

Characteristics

Model:
Dimensions:
Frequency:
Bag Size:
Sterilization:

WAVE Bioractor 500/1000 system
2.26 m x 1.24 m x 1.60 m
50/60 Hz
500 L
Plastic, Disposable

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation Speed:
Rocking Angle:
Duration:

36.5C
2 bar
7.1
40%
15 rpm
4
3 days

Purchase Cost

Bioreactor with control:
Disposable Cellbag:

$150,000
$1,000
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2,000 L Single-Use Seed Bioreactors (PFD 01/P-36,37)
Description and Function
The 2000L Xcellerex XDR Bioreactor is used for cell growth
in cell seeding. The single-use system is equipped with a
jacketed bioreactor vessel, gas mixing cabinet, control
console, and cell bags. The bags are disposable and presterilized. The system also offers high level sensors and
automated control for temperature, liquid transfer, dissolved
oxygen, and pH. Two of these bioreactors operate in parallel.

Vendor

GE Healthcare and Life Sciences

Operation

Batch

Materials Handled
Wet Media
Product

Input (kg/batch)
0.00429
250
0.00

Output (kg/batch)Cells
0.000813
1600
0.00

Characteristics

Model:
Xcellerex XDR-2000 system
Height/Diameter Ratio:
1.5/1
Impeller Type, Angle:
4 blades, 40 pitch
Impeller/Bag Diameter Ratio: 0.34
Bag Size:
2000 L
Sterilization:
Plastic, Disposable

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation Speed:
Duration:

36.5C
2 bar
7.1
40%
110 rpm
3 days

Purchase Cost

Bioreactor with control:
Disposable Cellbag:

$250,000
$2,500
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Blending Tank (PFD 01/P-46)
Description and Function

Operation

This blending tank will mix cell culture media powder with
WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
NaHCO3
Wet Media

Input (kg/batch)
107
4470
5.85
12.6
0.00

Output (kg/batch)
0.00
0.00
0.00
0.00
4500

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

6,000 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Blending Tank:

$59,400
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Dead-End Filter (PFD 01/P-48)
Description and Function
The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.
Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
4500

Output (kg/batch)
4500

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400

Characteristics
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Storage Tank (PFD 01/P-50)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
4500

Output (kg/batch)
0.00

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

6,000 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$59,400
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Storage Tank (PFD 01/P-41)
Description and Function
The storage tank holds blended and filtered cell culture media
at 4C until further use.
Operation
Batch
Materials Handled
Wet Media

Input (kg/batch)
5200

Output (kg/batch)
0.00

Characteristics
Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

7,500 L
80%
Stainless Steel 316
2/1
CIP/SIP

Temperature:
Pressure:

4C
2 bar

Storage Tank:

$69,400

Operation Conditions

Purchase Cost
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Storage Tank (PFD 01/P-44)
Description and Function
The storage tank holds blended and filtered cell culture media
at 4C until further use.
Operation
Batch
Materials Handled
Input (kg/batch)
Wet Media

Output (kg/batch)
520

0.00

Characteristics
Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

750 L
80%
Stainless Steel 316
2/1
CIP/SIP

Temperature:
Pressure:

4C
2 bar

Storage Tank:

$25,500

Operation Conditions

Purchase Cost
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20,000 L Stainless Steel Production Bioreactor (PFD 01/P-16)
Description and Function
The 20,000L Bioreactor is used for cell growth to peak
density followed by maximum product formation. The system
is equipped with a heating jacket, mixing and sparging units,
and PID control for temperature, liquid transfer, dissolved
oxygen, dissolved carbon dioxide and pH.
Operation

Batch

Materials Handled

Input (kg/batch)
0.00429
3200
0.00

Output (kg/batch)
63.6
13500
40.1

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Impeller/Tank Diameter Ratio:
Blade Height/Impeller Diameter:
Blade Width/Impeller Diameter:
Number of Blades, Pitch:
Sterilization:

20,000 L
80%
Stainless Steel 316
2/1
1/3
1/5
1/4
4, 40
CIP/SIP

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation Power:
Air Sparging Rate:
Duration:

36.5C
2 bar
7.1
40%
0.055 W/kg
0.0194 vvm
19 days

Purchase Cost

Total Bioreactor:

$1,500,000

Cells
Wet Media
Product
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Peristaltic Pumps (PFD 01/P-2,4,6,8,10,12,14,18,20,24,26,34,35,40,42,43,45,47,49,50,53)
Description and Function
The pumps are used to transfer media and cells for upstream
bioreaction steps. The pumps are sterile and designed for
shear-sensitive biopharmaceutical applications.
Vendor
Watson-Marlow
Operation
Batch
Model:
Pumphead Material:
Support and Frame Material:
Maximum Flow Rate:
Maximum Pressure:
Sterilization:

825 series
Aluminum alloy
Stainless steel 304
33 L/min
3.5 bar
CIP, SIP

Operation Conditions

Pressure:
Flow Rate:

3 bar
Variable (0.1-33 L/min)

Purchase Cost

Pump:

$3,000

Characteristics
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Centrifuge (PFD 02/P-54)
Description and Function

This centrifuge will separate the cells from the cell culture
liquid that has the solubilized monoclonal antibody product.

Vendor

GEA

Operation

Continuous

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
75.4
0
13500
40.1

Output (kg/batch)
0
0
13500
38.5

Characteristics

Model:
Centrifuge Type:
Material:
Capacity Range:
Sterilization:

CSE 170
Disc Stack Centrifuge
Stainless Steel 316
3000-6000 L/h
CIP/SIP

Operation Conditions

Temperature:
Throughput:

25C
3375 L/h

Purchase Cost

Centrifuge:

$1,500,000
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Storage Tank 6 (PFD 02/P-56)
Description and Function

Operation

This storage tank will collect the liquid product from the
centrifuge.

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
13500
38.5

Output (kg/batch)
0
0
13500
38.5

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316 L
20,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Centrifuge:

$104,700
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Depth Microfiltration Unit (PFD02/P-58)
Description and Function
The depth filter is used to remove larger particles not removed
from centrifugation. It has two distinct layers with different
pore sizes (0.1-1m) to avoid plugging and increase filter
capacity.
Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
13500
38.5

Characteristics

Model:
Filter:
Protein Throughput:
Max. Differential Pressure:
Max. Operating Pressure:
Filter effective area:
Unit Sterilization:
Filter Sterilization:

Operation Conditions

Temperature:
Operating Pressure:

25C
1 bar

Purchase Cost

Filter Housing:
Filter:

$67,300
$750 each

Output (kg/batch)
0
0
13500
37.3

Millistak Pod Filter
X0HC
21 L/min/m2
2.1 bar
3.5 bar
1.1 m2
SIP
Disposable
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Storage Tank 7 (PFD 02/P-60)
Description and Function

Operation

This storage tank will collect the filtrate liquid from the depth
filtration unit.
Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
13500
37.3

Output (kg/batch)
0
0
13500
37.3

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
20,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$104,700
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Protein A Chromatography Column (PFD 02/P-62)
Description and Function
The Protein A Chromatography column uses a resin that
selectively binds the monoclonal antibody product. This step
is the first isolation step in the purification process and is
useful in eliminating host cell proteins, DNA, cell culture
media components.
Vendor

GE Healthcare Life Sciences

Operation

Batch

Materials Handled

Input (kg/batch)

Output (kg/batch)

Cells
Media
Centrifuge effluent
Equilibration buffer
Wash buffer
Elution buffer
Regeneration buffer
CIP buffer
Protein A waste
Product

0
0
13500
6800
800
3200
2400
3200
0
37.3

0
0
0
0
0
3200
0
0
26700
34.4

Characteristics

Model:
Column Diameter:
Bed Height:
Material of Construction:
Bed Volume:
Resin:
Binding Capacity:
Working Linear Velocity:
pH Stability:
Sterilization:

Chromaflow 1000/100-300
1.0 m
0.25 m
Stainless Steel 316 L
200 L
MabSelect Sure LX
50 g mAB/L resin
250-400 cm/hr
3-12
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Column:
Resin:

$250,000
$8,000/liter
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Storage Tank 8 (PFD 02/P-64)
Description and Function

Operation

This storage tank will collect the eluent from the Protein A
Chromatography column.

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
3200
34.4

Output (kg/batch)
0
0
3200
34.4

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
5,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$55,100
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Ultrafiltration/Diafiltration Unit (PFD 02/P-66)
Description and Function
This unit is used for buffer exchange to raise the pH of the
solution and concentrate it by 5 times. It is done using
tangential flow filtration.
Vendor
Millipore Sigma
Operation
Batch
Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
3200
34.4

Output (kg/batch)
0
0
640
33.3

Characteristics
Model:
Protein Throughput:
Max. Operating Pressure:
Filter effective area:
Unit Sterilization:
Filter Sterilization:

Cogent® TFF System
21 L/min/m2
6.8 bar
1.1 m2
SIP
Disposable

Operation Conditions

Temperature:

25C

Purchase Cost

Unit:
Filter:

$500,000
$3600/filter
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Storage Tank 9 (PFD 02/P-68)
Description and Function

Operation

This storage tank will collect the retentate from the
diafiltration operation.

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
640
33.3

Output (kg/batch)
0
0
640
33.3

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
2,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$35,900
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Cation Exchange Chromatography Column (PFD 02/P-70)
Description and Function
The cation exchange chromatography column binds positively
charged proteins and is used eliminate DNA, some host cell
proteins, and leached Protein A.

Vendor

GE Healthcare Life Sciences

Operation

Batch

Materials Handled

Input (kg/batch)

Output (kg/batch)

Cells
Media
Diafiltration effluent
Equilibration buffer
Wash buffer
Elution buffer
Regeneration buffer
CIP buffer
Cation exchange waste
Product

0
0
640
3200
3200
1290
1280
1920
0
33.3

0
0
0
0
0
1290
0
0
10240
30.7

Characteristics

Model:
Column Diameter:
Bed Height:
Material of Construction:
Bed Volume:
Resin:
Binding Capacity:
Working Linear Velocity:
Sterilization:

Chromaflow 1000/100-300
1.0 m
0.2 m
Stainless Steel 316 L
160 L
Capto S
60 g mAB/L resin
200-600 cm/hr
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Filter Housing:
Filter:

$250,000
$1,500/L
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Storage Tank 10 (PFD 02/P-72)
Description and Function
This storage tank will collect the eluent from the Cation
Exchange Chromatography.

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
1290
30.7

Output (kg/batch)
0
0
1290
30.7

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
2,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$35,900
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Virus Filtration Unit (PFD 02/P-74)
Description and Function
The virus filtration unit is used to remove viruses using size
based membrane separation.

Vendor

Sartorius

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
1290
30.7

Output (kg/batch)
0
0
1290
29.1

Characteristics

Model:
Filter effective area:
Sterilization:
Membrane:

Virosart® CPV
1.8 m2
SIP
Disposable

Operation Conditions

Temperature:

25C

Purchase Cost

Filter:

$10,100/filter
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Hydrophobic Interaction Chromatography Column (PFD 02/P-76)
Description and Function
The hydrophobic interaction chromatography column is run in
flow through mode and removes product and process-related
impurities, such as aggregates.

Vendor

Column: GE Healthcare and Life Sciences
Resin: Thermo Fisher Scientific

Operation

Batch

Materials Handled

Input (kg/batch)

Output (kg/batch)

Cells
Media
Filtrate
Equilibration buffer
Wash buffer
Elution buffer
Regeneration buffer
CIP buffer
Cation exchange waste
Product

0
0
1290
4000
2210
4000
2400
4000
0
29.1

0
0
1290
0
2210
0
0
0
14400
26.8

Model:
Column Diameter:
Bed Height:
Material of Construction:
Bed Volume:
Resin:
Working Linear Velocity:
Sterilization:

Chromaflow 1000/100-300
1.0 m
0.25 m
Stainless Steel 316 L
200 L
POROS Benzyl Ultra
200-500 cm/hr
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Column:
Resin:

$250,000
$3,800/10 L

Characteristics
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Storage Tank 11 (PFD 02/P-78)
Description and Function
This storage tank will collect the product stream from the
hydrophobic interaction chromatography.

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
3500
26.8

Output (kg/batch)
0
0
3500
26.8

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
5,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$55,100
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Ultrafiltration/Diafiltration Unit (PFD 02/P-80)
Description and Function
The diafiltration unit is used for buffer exchange for the final
solution that the product will be stored in PBS. The
ultrafiltration is used to concentrate the solution by 5 times.

Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
3500
26.8

Output (kg/batch)
0
0
700
26.0

Characteristics

Model:
Protein Throughput:
Max. Operating Pressure:
Filter effective area:
Unit Sterilization:
Filter Sterilization:

Cogent® TFF System
21 L/min/m2
6.8 bar
1.1 m2
SIP
Disposable

Operation Conditions

Temperature:

25C

Purchase Cost

Unit:
Filter:

$500,000
$3600/filter
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Sterile Filtration Unit (PFD 02/P-82)
Description and Function
The sterile filters are 0.2 μm filters that are used as the final
purification step. It is used to create a sterile product before it
is frozen and then sent to formulation.

Vendor

Sarotorius

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
700
26.0

Output (kg/batch)
0
0
700
25.2

Characteristics

Model:
Membrane Filter Material:
Max. Differential Pressure:
Filtration Area:
Unit Sterilization:
Filter Sterilization:

Sartopore 2 0.2μm
Polyethersulfone (PES)
5 bar at 20C
1.8 m2
SIP
Disposable

Operation Conditions

Temperature:
Operating Pressure:

25C
1 bar

Purchase Cost

Filter:

$650/filter
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Final Storage (PFD 02/P-84)
Description and Function

The purified product will be stored in 10L containers and
stored at -80C.

Vendor

Thermo Fisher Scientific

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
700
25.2

Output (kg/batch)
0
0
700
25.2

Characteristics

Volume:
Material:
Sterilization:

10 L
Polycarbonate
Disposable

Operation Conditions

Temperature:
Operating Pressure:

25C
1 bar

Purchase Cost

Filter:

$100/container
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Pumps (PFD 02/P-55, P-57, P-59, P-61, P-63, P-65, P-67, P-69, P-71, P-73, P-75, P-77, P-79,
P-81)
Description and Function
The pumps are used to transfer liquid. These are high-flow
hygienic pumps that are designed for low-shear sanitary
pumping. They are ideal for viscous or shear sensitive
products.
Vendor

Watson-Marlow

Operation

Batch

Characteristics

Model:
Pumphead Material:
Flow Rate:
Max Pressure:
Sterilization:

840 Peristaltic Pump
Aluminum Alloy
65-8140 L/hr
3.5 bar
CIP/SIP

Operation Conditions

Temperature:
Power:

25C
0.55-3 kW

Purchase Cost

Pump:

$3000
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Blending Tank (PFD 03/P-1)
Description and Function

Operation

This blending tank will mix cell culture media powder with
WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
NaHCO3
Wet Media

Characteristics

Input (kg/batch)
5.14
229
0.299
0.644
0.00

Output (kg/batch)
0.00
0.00
0.00
0.00
230

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

300 L
80%
Stainless Steel 316
2/1
CIP/SIP

Temperature:
Pressure:

25C
1 bar

Blending Tank:

$18,100

Operation Conditions

Purchase Cost
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Dead-End Filter (PFD 03/P-3)
Description and Function

The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.

Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
230

Output (kg/batch)
230

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Operating Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane and Housing: $400

Characteristics
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Storage Tank (PFD 03/P-5)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
230

Output (kg/batch)
230

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

300 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$18,100
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250 mL Shaker Flask (PFD 03/P-7)
Description and Function
The 250 mL Shaker Flask is used for cell growth in first
inoculum preparation step after cryogenic recovery of the
CHO cells. The Shaker Flask is placed on a low speed orbital
shaker and the combined apparatus is incubated in a CO2
Incubator.
Vendor

Corning (Flask & Orbital Shaker)
Thermo Fisher Scientific (Incubator)

Operation

Batch

Materials Handled
Cells:
Wet Media
Product
Characteristics

Input (kg/batch)
0.00000471
0.030
0.00

Output (kg/batch)
0.0000166
0.125
0.00

Model:
Flask Capacity:
Working Capacity:
Material:
Packaging:
Sterilization:

Corning 4444-250
250 mL
80%
Pyrex
6 pc
Autoclave, 121C, 60 minutes

Model:
Speed:
Frequency Range:
Tray Size:
Base Size:

Corning LSE 6780-FP
60 rpm
50/60 Hz
30 cm x 30 cm
25.5 cm x 32.0 cm x 16.0 cm

Model:
Thermo Scientific Forma Series 3
Interior Material:
Stainless Steel 304
Dimensions (LxWxH): 54.1 cm x 68.1 cm x 50.8 cm
Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Duration:

36.5C
1 bar
7.1
40%
3 days

Purchase Cost

Shaker Flask:
Orbital Shaker:
Incubator:

$160
$900
$7,900
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25 L Single-Use Bioreactor (PFD 03/P-9)
Description and Function
The 25L WAVE Bioreactor is used for cell growth in second
inoculum preparation step. The single-use system is equipped
with a rocker, gas mixers, pumps, and cell bags. The bags are
disposable and pre-sterilized. The system also offers high
level sensors and automated control for temperature, liquid
transfer, dissolved oxygen, and pH.
Vendor

GE Healthcare and Life Sciences

Operation

Batch

Materials Handled
Cells
Wet Media
Product

Input (kg/batch)
0.0000166
0.125
0.00

Output (kg/batch)
0.0000586
12.5
0.00

Characteristics

Model:
Rocker Dimensions:
Tray 50 Dimensions:
Lid 50 Dimensions:
CBCU Dimensions:
Bag Size:
Sterilization:

ReadyToProcess WAVE 25
404 mm x 205 mm x 560 mm
800 mm x 70 mm x 610 mm
800 mm x 260 mm x 610 mm
276 mm x 115 mm x 280 mm
22 L
Plastic, Disposable

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation Speed:
Rocking Angle:
Duration:

36.5C
2 bar
7.1
40%
15 rpm
7
3 days

Purchase Cost

Bioreactor:
CBCU gas mixer:
Disposable Cellbag:

$60,000
$1,000
$500
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500 L Single-Use Seed Bioreactors (PFD 03/P-23)
Description and Function
The 500L WAVE Bioreactor is used for cell growth in cell
seeding. The single-use system is equipped with a rocker base
unit with internal gas pumps and cell bags. The bags are
disposable and pre-sterilized. The system also offers high
level sensors and automated control for temperature, liquid
transfer, dissolved oxygen, and pH.

Vendor

GE Healthcare and Life Sciences

Operation

Batch

Materials Handled
Cells
Wet Media
Product

Input (kg/batch)
0.0000586
25.0
0.00

Output (kg/batch)
0.00162
250
0.00

Characteristics

Model:
Dimensions:
Frequency:
Bag Size:
Sterilization:

WAVE Bioractor 500/1000 system
2.26 m x 1.24 m x 1.60 m
50/60 Hz
500 L
Plastic, Disposable

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation Speed:
Rocking Angle:
Duration:

36.5C
2 bar
7.1
40%
15 rpm
4
6 days

Purchase Cost

Bioreactor with control:
Disposable Cellbag:

$150,000
$1,000
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Blending Tank (PFD 03/P-11)
Description and Function

Operation

This blending tank will mix feed supplement CellBoost 7a
media powder with WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
Wet Media

Input (kg/batch)
126
690
0.904
0.00

Output (kg/batch)
0.00
0.00
0.00
695

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

900 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Blending Tank:

$26,000
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Blending Tank (PFD 03/P-17)
Description and Function

Operation

This blending tank will mix feed supplement CellBoost 7b
media powder with WFI.

Batch

Materials Handled
Dry Media
Water
NaOH
Wet Media

Input (kg/batch)
6.62
69.5
0.0910
0.00

Output (kg/batch)
0.00
0.00
0.00
70.0

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

90 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Blending Tank:

$12,700
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Dead-End Filter (PFD 03/P-13)
Description and Function
The 0.2 µm dead-end filter is used to remove larger
contaminants from blended feed supplement 7a media. The
filter capsules and housing are disposable and ready-to-use.
Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
695

Output (kg/batch)
695

Characteristics

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400
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Dead-End Filter (PFD 03/P-19)
Description and Function
The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.
Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Wet Media

Input (kg/batch)
70.0

Output (kg/batch)
70.0

Characteristics

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Operation Conditions

Temperature:
Pressure:

25C
0.5 bar

Purchase Cost

Filter Membrane & Housing: $400
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Storage Tank (PFD 03/P-15)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.
Batch

Materials Handled
Wet Media

Input (kg/batch)
45.0

Output (kg/batch)
0.00

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

50 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$10,700

Characteristics
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Storage Tank (PFD 03/P-21)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
5.00

Output (kg/batch)
0.00

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

25 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$9,100
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Blending Tank (PFD 03/P-31)
Description and Function
This blending tank will mix cell culture media powder with
WFI.
Operation
Batch
Materials Handled
Dry Media
Water
NaOH
NaHCO3
Wet Media

Input (kg/batch)
19.7
874
1.44
3.11
0.00

Output (kg/batch)
0.00
0.00
0.00.
000
880

Characteristics
Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

1,100 L
80%
Stainless Steel 316
2/1
CIP/SIP

Temperature:
Pressure:

25C
1 bar

Blending Tank:

$28,200

Operation Conditions

Purchase Cost
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Dead-End Filter (PFD 03/P-33)
Description and Function
The 0.2 µm dead-end filter is used to remove larger
contaminants from blended culture media. The filter capsules
and housing are disposable and ready-to-use.
Operation
Millipore Sigma
Materials Handled
Batch

Wet Media

Characteristics

Input (kg/batch)
880

Output (kg/batch)
880

Model:
Filtration Area:
Throughput:
Max. Differential Pressure:
Sterilization:

Opticap XLT10, Sterile
0.57 m2
2,000 L/m2/h
6.9 bar at 25C
Disposable

Temperature:
Pressure:

25C
0.5 bar

Operation Conditions

Purchase Cost
Filter Membrane & Housing: $400
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Storage Tank (PFD 03/P-35)
Description and Function

Operation

The storage tank holds blended and filtered cell culture media
at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
880

Output (kg/batch)
0.00

Characteristics
Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

1,100 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$28,200
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Storage Tank (PFD 03/P-26)
Description and Function

Operation

The storage tank holds blended and filtered feed supplement
7a media at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
650

Output (kg/batch)
0.00

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

850 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$25,600
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Storage Tank (PFD 03/P-29)
Description and Function

Operation

The storage tank holds blended and filtered feed supplement
7b media at 4C until further use.

Batch

Materials Handled
Wet Media

Input (kg/batch)
65.0

Output (kg/batch)
0.00

Characteristics

Volume:
Working Capacity:
Material:
Height/Diameter Ratio:
Sterilization:

90 L
80%
Stainless Steel 316
2/1
CIP/SIP

Operation Conditions

Temperature:
Pressure:

4C
2 bar

Purchase Cost

Storage Tank:

$12,700
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2,000 L Single-Use Seed Bioreactor (PFD 03/P-37)
Description and Function
The 2000L Xcellerex XDR Bioreactor is used for cell growth
to peak density followed by maximum product formation The
single-use system is equipped with a jacketed bioreactor
vessel, gas mixing cabinet, control console, and cell bags. The
bags are disposable and pre-sterilized. The system also offers
high level sensors and automated control for temperature,
liquid transfer, dissolved oxygen, and pH. Four of these
bioreactors operate in parallel.
Vendor

GE Healthcare and Life Sciences

Operation

Batch

Materials Handled
Cells
Wet Media
Product

Input (kg/batch)
0.00162
250
0.00

Output (kg/batch)
7.35
1560
40.1

Characteristics

Model:
Xcellerex XDR-2000 system
Height/Diameter Ratio:
1.5/1
Impeller Type, Angle:
4 blades, 40 pitch
Impeller/Bag Diameter Ratio: 0.34
Bag Size:
2000 L
Sterilization:
Plastic, Disposable

Operation Conditions

Temperature:
Pressure:
pH:
dO2:
Agitation:
Duration:

36.5C
2 bar
7.1
40%
110 rpm
19 days

Purchase Cost

Bioreactor with control:
Disposable Cellbag:

$250,000
$2,500
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Peristaltic Pumps (PFD 03/P-2,4,6,8,10,12,14,16,18,20,22,24,28,30,32,34,36,38)
Description and Function
The pumps are used to transfer media and cells for upstream
bioreaction steps. The pumps are sterile and designed for
shear-sensitive biopharmaceutical applications.
Vendor
Watson-Marlow
Operation
Batch

Characteristics

Model:
Pumphead Material:
Support and Frame Material:
Maximum Flow Rate:
Maximum Pressure:
Sterilization:

825 series
Aluminum alloy
Stainless steel 304
33 L/min
3.5 bar
CIP, SIP

Operation Conditions

Pressure:
Flow Rate:

3 bar
Variable (0.1-33 L/min)

Pump:

$3,000

Purchase Cost
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Centrifuge (PFD 04/P-39)
Description and Function

This centrifuge will separate the cells from the cell culture
liquid that has the solubilized monoclonal antibody product.

Vendor

GEA

Operation

Continuous

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
75.4
0
1560
10.0

Output (kg/batch)
0
0
1560
9.62

Characteristics

Model:
Centrifuge Type:
Material:
Capacity Range:
Sterilization:

CSC 20
Disc Stack Centrifuge
Stainless Steel 316
500-1000 L/h
CIP/SIP

Operation Conditions

Temperature:
Throughput:

25C
780 L/h

Purchase Cost

Centrifuge:

$1,200,000
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Storage Tank 6 (PFD 04/P-41)
Description and Function

Operation

This storage tank will collect the liquid product from the
centrifuge.

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
1560
9.62

Output (kg/batch)
0
0
1560
9.62

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316 L
2,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$35,857
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Depth Microfiltration Unit (PFD 04/P-43)
Description and Function
The depth filter is used to remove larger particles not removed
from centrifugation. It has two distinct layers with different
pore sizes (0.1-1m) to avoid plugging and increase filter
capacity.
Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
1560
9.62

Output (kg/batch)
0
0
1560
9.34

Characteristics

Model:
Filter:
Protein Throughput:
Max. Differential Pressure:
Max. Operating Pressure:
Filter effective area:
Unit Sterilization:
Filter Sterilization:

Millistak Pod Filter
X0HC
21 L/min/m2
2.1 bar
3.5 bar
1.1 m2
SIP
Disposable

Operation Conditions

Temperature:
Operating Pressure:

25C
1 bar

Purchase Cost

Filter Housing:
Filter:

$29,200
$750 each
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Storage Tank 7 (PFD 04/P-45)
Description and Function

Operation

This storage tank will collect the filtrate liquid from the depth
filtration unit.
Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
1560
9.34

Output (kg/batch)
0
0
1560
9.34

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
2,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$35,900
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Protein A Chromatography Column (PFD 04/P-47)
Description and Function
The Protein A Chromatography column uses a resin that
selectively binds the monoclonal antibody product. This step
is the first isolation step in the purification process and is
useful in eliminating host cell proteins, DNA, cell culture
media components.
Vendor

GE Healthcare Life Sciences

Operation

Batch

Materials Handled

Input (kg/batch)

Output (kg/batch)

Cells
Media
Centrifuge effluent
Equilibration buffer
Wash buffer
Elution buffer
Regeneration buffer
CIP buffer
Protein A waste
Product

0
0
1560
1700
200
750
600
800
0
9.34

0
0
0
0
0
750
0
0
4860
8.59

Characteristics

Model:
Column Diameter:
Bed Height:
Material of Construction:
Bed Volume:
Resin:
Binding Capacity:
Working Linear Velocity:
pH Stability:
Sterilization:

Chromaflow 1000/100-300
1.0 m
0.25 m
Stainless Steel 316 L
200 L
MabSelect Sure LX
50 g mAB/L resin
250-400 cm/hr
3-12
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Column:
Resin:

$250,000
$8,000/liter

133

Storage Tank 8 (PFD 04/P-49)
Description and Function

Operation

This storage tank will collect the eluent from the Protein A
Chromatography column.

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
750
8.59

Output (kg/batch)
0
0
750
8.59

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
1,000L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$26,600
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Ultrafiltration/Diafiltration Unit (PFD 04/P-51)
Description and Function
This unit is used for buffer exchange to raise the pH of the
solution and concentrate it by 5 times. It is done using
tangential flow filtration.
Vendor
Millipore Sigma
Operation
Batch
Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
750
8.59

Output (kg/batch)
0
0
150
8.33

Characteristics
Model:
Protein Throughput:
Max. Operating Pressure:
Filter effective area:
Unit Sterilization:
Filter Sterilization:

Cogent® TFF System
21 L/min/m2
6.8 bar
1.1 m2
SIP
Disposable

Operation Conditions

Temperature:

25C

Purchase Cost

Filter Housing:
Filter:

$500,000
$3600/filter

135

Storage Tank 9 (PFD 04/P-53)
Description and Function

Operation

This storage tank will collect the retentate from the
diafiltration operation.

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
150
8.33

Output (kg/batch)
0
0
150
8.33

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
500L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$22,600
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Cation Exchange Chromatography Column (PFD 04/P-55)
Description and Function
The cation exchange chromatography column binds positively
charged proteins and is used eliminate DNA, some host cell
proteins, and leached Protein A.

Vendor

GE Healthcare Life Sciences

Operation

Batch

Materials Handled

Input (kg/batch)
Cells
0
Media
0
Diafiltration effluent
150
Equilibration buffer
800
Wash buffer
800
Elution buffer
320
Regeneration buffer
320
CIP buffer
480
Cation exchange waste
Product
8.33

Characteristics

Model:
Column Diameter:
Bed Height:
Material of Construction:
Bed Volume:
Resin:
Binding Capacity:
Working Linear Velocity:
Sterilization:

Chromaflow 1000/100-300
1.0 m
0.2 m
Stainless Steel 316 L
160 L
Capto S
60 g mAB/L resin
200-600 cm/hr
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Column:
Resin:

$250,000
$1,500/1L

Output (kg/batch)
0
0
0
0
0
320
0
0
2550
7.66
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Storage Tank 10 (PFD 04/P-57)
Description and Function
This storage tank will collect the eluent from the Cation
Exchange Chromatography.

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
320
7.66

Output (kg/batch)
0
0
320
7.66

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
500L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$22,600
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Virus Filtration Unit (PFD 04/P-59)
Description and Function
The virus filtration unit is used to remove viruses using size
based membrane separation.

Vendor

Sartorius

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
320
7.66

Output (kg/batch)
0
0
320
7.28

Characteristics

Model:
Filter effective area:
Sterilization:
Membrane:

Virosart® CPV
1.8 m2
SIP
Disposable

Operation Conditions

Temperature:

25C

Purchase Cost

Filter:

$10,000/filter
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Hydrophobic Interaction Chromatography Column (PFD 04/P-61)
Description and Function
The hydrophobic interaction chromatography column is run in
flow through mode and removes product and process-related
impurities, such as aggregates.

Vendor

Column: GE Healthcare and Life Sciences
Resin: Thermo Fisher Scientific

Operation

Batch

Materials Handled

Input (kg/batch)

Output (kg/batch)

Cells
Media
Filtrate
Equilibration buffer
Wash buffer
Elution buffer
Regeneration buffer
CIP buffer
Cation exchange waste
Product

0
0
320
1000
1780
1000
600
1000
0
7.28

0
0
320
0
1780
0
0
0
3600
6.70

Characteristics

Model:
Column Diameter:
Bed Height:
Material of Construction:
Bed Volume:
Resin:
Working Linear Velocity:
Sterilization:

Chromaflow 1000/100-300
1.0 m
0.3 m
Stainless Steel 316 L
200 L
POROS Benzyl Ultra
200-500 cm/hr
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Column:
Resin:

$250,000
$3,800/10 L
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Storage Tank 11 (PFD 04/P-63)
Description and Function
This storage tank will collect the product stream from the
hydrophobic interaction chromatography.

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
2100
6.70

Output (kg/batch)
0
0
2100
6.70

Characteristics

Material:
Volume:
Sterilization:

Stainless Steel 316
2,500L
CIP/SIP

Operation Conditions

Temperature:
Pressure:

25C
1 bar

Purchase Cost

Tank:

$35,900
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Ultrafiltration/Diafiltration Unit (PFD 04/P-65)
Description and Function
The diafiltration unit is used for buffer exchange for the final
solution that the product will be stored in PBS. The
ultrafiltration is used to concentrate the solution by 5 times.

Vendor

Millipore Sigma

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
2100
6.70

Output (kg/batch)
0
0
420
6.50

Characteristics

Model:
Protein Throughput:
Filter effective area:
Sterilization:
Membrane:

Cogent® TFF System
21 L/min/m2
1.1 m2
SIP
Disposable

Operation Conditions

Temperature:

25C

Purchase Cost

Unit:
Filter:

$500,000
$3600/filter
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Sterile Filtration Unit (PFD 04/P-67)
Description and Function
The sterile filters are 0.2 μm filters that are used as the final
purification step. It is used to create a sterile product before it
is frozen and then sent to formulation.

Vendor

Sarotorius

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
420
6.50

Output (kg/batch)
0
0
420
6.30

Characteristics

Model:
Membrane Filter Material:
Max. Differential Pressure:
Filtration Area:
Unit Sterilization:
Filter Sterilization:

Sartopore 2 0.2μm
Polyethersulfone (PES)
5 bar at 20C
1.8 m2
SIP
Disposable

Operation Conditions

Temperature:
Operating Pressure:

25C
1 bar

Purchase Cost

Filter:

$650/filter
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Final Storage (PFD 04/P-69)
Description and Function

The purified product will be stored in 10L containers and
stored at -80C.

Vendor

Thermo Fisher Scientific

Operation

Batch

Materials Handled
Cells
Media
Water
Product

Input (kg/batch)
0
0
420
6.30

Output (kg/batch)
0
0
420
6.30

Characteristics

Volume:
Material:
Sterilization:

10 L
Polycarbonate
Disposable

Operation Conditions

Temperature:
Operating Pressure:

25C
1 bar

Purchase Cost

Filter:

$100/container
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Pumps (PFD 04/P-40, P-42, P-44, P-46, P-48, P-50, P-52, P-54, P-56, P-58, P-60, P-62, P-64,
P-66)
Description and Function
The pumps are used to transfer liquid. These are high-flow
hygienic pumps that are designed for low-shear sanitary
pumping. They are ideal for viscous or shear sensitive
products.
Vendor

Watson-Marlow

Operation

Batch

Characteristics

Model:
Pumphead Material:
Flow Rate:
Max Pressure:
Sterilization:

840 Peristaltic Pump
Aluminum Alloy
65-8140 L/hr
3.5 bar
CIP/SIP

Operation Conditions

Temperature:
Power:

25C
0.55-3 kW

Purchase Cost

Pump:

$3000
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17. Equipment Cost Summary
17.1 Large Production Bioreactor Design Equipment
PFD 01
P-8
P-9
P-10
P-1
P-2
P-4
P-5
P-6

Type
Pump
WAVE Bioreactor
Pump
Blending Tank
Pump
Pump
Storage Tank
Pump

Inoculum Preparation
Specification Vendor
825 series
Watson- Marlow
25 L
GE Healthcare Life Sciences
825 series
Watson- Marlow
75 L
825 series
Watson- Marlow
825 series
Watson- Marlow
75 L
825 series
Watson-Marlow

PFD 01

Type

Seed Bioreactions
Specification Vendor

P-29
P-30, 31
P-32, 33
P-34, 35
P-36, 37
P-38, 39
P-39
P-11
P-12
P-14
P-15

WAVE Bioreactor
Pump
WAVE Bioreactor
Pump
XDR-2000
Pump
Pump
Blending Tank
Pump
Pump
Storage Tank

100 L
150S
500 L
825 series
2000 L
825 series
825 series
4000 L
825 series
825 series
4000 L

GE Healthcare Life Sciences
QuattroFlow
GE Healthcare Life Sciences
Watson- Marlow
GE Healthcare Life Sciences
Watson- Marlow
Watson- Marlow

P-16
P-17
P-18
P-20
P-21

Pump
Blending Tank
Pump
Pump
Storage Tank

1200S 5˚
7000 L
825 series
825 series
250 L

QuattroFlow

P-22
P-23
P-24
P-26
P-27

Pump
Blending Tank
Pump
Pump
Storage Tank

1200S 5˚
700 L
825 series
825 series
25 L

QuattroFlow

P-28

Pump

150S

QuattroFlow

Watson- Marlow
Watson- Marlow

Watson- Marlow
Watson- Marlow

Watson- Marlow
Watson- Marlow

Purchase Cost
$3,000
$1,000
$3,000
$12,500
$3,000
$3,000
$12,500
$3,000

Purchase
Cost
$90,000
$3,000
$300,000
$3,000
$500,000
$3,000
$3,000
$51,000
$3,000
$3,000
$51,000
$4,000
$63,200
$3,000
$3,000
$18,000
$4,000
$24,300
$3,000
$3,000
$9,200
$3,000
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PFD 01
P-52
P-40
P-41
P-42
P-43
P-44
P-45
P-46
P-47
P-49
P-50
P-51

Type
Stainless Steel
Bioreactor
Pump
Storage Tank
Pump
Pump
Storage Tank
Pump
Blending Tank
Pump
Pump
Storage Tank
Pump

PFD 02
P-54

Type
Centrifuge

P-55
P-56
P-57
P-58
P-59

Pump
Storage Tank 6
Pump
Depth Filtration
Unit
Pump

P-60
P-61

Storage Tank 7
Pump

Production Bioreactions
Specification Vendor
20,000 L
GEA

Purchase Cost
$1,500,000

825 series
7500 L
825 series
825 series
750 L
825 series
6000 L
825 series
825 series
6000 L
825 series

$3,000
$69,400
$3,000
$3,000
$25,500
$3,000
$59,400
$3,000
$3,000
$59,400
$3,000

Watson- Marlow
Watson- Marlow
Watson- Marlow
Watson- Marlow
Watson- Marlow
Watson- Marlow
Watson- Marlow

Primary Recovery
Specification Vendor
3000 – 6000
GEA
L/hr
840 series
Watson- Marlow
20,000 L
840 series
Watson- Marlow
21 L/min/m
Millipore Sigma
2

Purchase Cost
$1,500,000
$3,000
$104,700
$3,000
$67,300

840 series

Watson- Marlow

$3,000

20,000 L
840 series

Watson- Marlow

$104,700
$3,000
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PFD
02
P-62
P-63

Type

Initial Purification
Specification Vendor

Protein A Column
Pump

1.0 m
840 series

P-64
P-65
P-66
P-67

Storage Tank 8
Pump
Diafiltration Unit
Pump

P-68
P-69
P-70

Storage Tank 9
Pump
Cation Exchange
Column
Pump
Storage Tank 10

P-71
P-72

PFD 02
P-73
P-75
P-76
P-77
P-78
P-79
P-80
P-81

Type
Pump
Pump
HIC Column
Pump
Storage Tank 11
Pump
Diafiltration
Pump

GE Healthcare Life Sciences
Watson- Marlow

Purchase
Cost
$250,000
$3,000

5,000 L
840 series
750 L/hr
840 series

Watson- Marlow
Millipore Sigma
Watson- Marlow

$55,100
$3,000
$500,000
$3,000

2,000 L
840 series
1.0 m

Watson- Marlow
GE Healthcare Life Sciences

$35,900
$3,000
$250,000

840 series
2,000 L

Watson-Marlow

Polishing Steps
Specification
Vendor
840 series
Watson- Marlow
840 series
Watson- Marlow
1.0 m
GE Healthcare Life Sciences
840 series
Watson- Marlow
5,000L
840 series
Watson- Marlow
750 L/hr
Millipore Sigma
840 series
Watson- Marlow

$3,000
$36,000

Purchase Cost
$2,950
$250,000
$55,140
$2,950
$500,000
$2,950
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Type

Large Production Bioreactor Scheme: Additional Units
Specification
Units
Vendor
1

Corning

Purchase
Cost
$900

5.0% CO
Locator 8
90 L liquid N2
--

1
1

Thermo Scientific
Thermolyne

$7,900
$2,700

5

$5,000

MasterFlex
-80˚C, 33.5 ft3
900 L capacity
100 L
20,000 L
620 L/min
120 L capacity
Up to 3m processes
5,000 L

1000
4

GE Healthcare Life
Sciences
Cole-Parmer
Thermo Scientific

Orbital Shaker

60 rpm

CO Incubator
Cryogenic Storage
Vessel
CBCU Gas mixer
Pump Tubing
Product
Refrigeration
Biowaste tank
Neutralization tank
Sterile Air
Compressor
CIP Skids
Buffer Transfer
Container

2

2

1
4
10
3
10

Greeloy Medical
Sani-matic

$48,900,000
$60,300
$13,500
$400,000
$7,000
$300,000
$359,000
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17.2 Small Production Bioreactor Design Equipment
Type
Pump
WAVE Bioreactor
Pump
Blending Tank
Pump
Pump
Storage Tank
Pump

Inoculum Preparation
Specification Vendor
825 series
Watson- Marlow
25 L
GE Healthcare Life Sciences
825 series
Watson- Marlow
300 L
825 series
Watson- Marlow
825 series
Watson- Marlow
300 L
825 series
Watson-Marlow

Purchase Cost
$3,000
$1,000
$3,000
$18,100
$3,000
$3,000
$36,200
$3,000

PFD 03
P-23
P-24
P-11
P-12
P-14
P-15
P-16
P-17
P-18
P-20
P-21
P-22

Type
WAVE Bioreactor
Pump
Blending Tank
Pump
Pump
Storage Tank
Pump
Blending Tank
Pump
Pump
Storage Tank
Pump

Seed Bioreactions
Specification Vendor
500 L
GE Healthcare Life Sciences
825 series
Watson- Marlow
900 L
825 series
Watson- Marlow
825 series
Watson- Marlow
50 L
Watson- Marlow
90 L
825 series
Watson- Marlow
825 series
Watson- Marlow
25 L
Watson- Marlow

Purchase Cost
$150,000
$3,000
$26,000
$3,000
$3,000
$10,700
$3,000
$12,700
$3,000
$3,000
$9,100
$3,000

PFD 03
P-37
P-31
P-32
P-34
P-35
P-36
P-25
P-26
P-27
P-28
P-29
P-30

Type
XDR-2000
Blending Tank
Pump
Pump
Storage Tank
Pump
Pump
Storage Tank
Pump
Pump
Storage Tank
Pump

Production Bioreactions
Specification Vendor
2000 L
GE Healthcare Life Sciences
1100 L
825 series
Watson- Marlow
825 series
Watson- Marlow
1100 L
825 series
Watson- Marlow
825 series
Watson- Marlow
850 L
825 series
Watson- Marlow
825 series
Watson- Marlow
90 L
825 series
Watson- Marlow

Purchase Cost
$250,000
$28,200
$3,000
$3,000
$28,200
$3,000
$3,000
$51,200
$3,000
$3,000
$25,400
$3,000

PFD 03
P-8
P-9
P-10
P-1
P-2
P-4
P-5
P-6
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PFD 04
P-39

Type
Centrifuge

P-40
P-41
P-42
P-43
P-44

Pump
Storage Tank 6
Pump
Depth Filtration
Unit
Pump

P-45
P-46

Storage Tank 7
Pump

Primary Recovery
Specification
Vendor
500 – 1000
GEA
L/hr
840 series
Watson- Marlow
2,000 L
840 series
Watson- Marlow
21 L/min/m
Millipore Sigma
2

840 series
2,000 L
840 series

Purchase Cost
$1,200,000
$2,950
$35,857
$2,950
$29,160

Watson- Marlow

$2,950

Watson- Marlow

$35,857
$2,950

Initial Purification
Specification
Vendor
1.0 m
GE Healthcare Life Sciences
840 series
Watson- Marlow

PFD 04
P-47
P-48

Type
Protein A Column
Pump

P-49
P-50
P-51
P-52

Storage Tank 8
Pump
Diafiltration Unit
Pump

1,000 L
840 series
750 L/hr
840 series

Watson- Marlow
Millipore Sigma
Watson- Marlow

$26,567
$2,950
$500,000
$2,950

P-53
P-54
P-55

Storage Tank 9
Pump
Cation Exchange
Column
Pump
Storage Tank 10

500L
840 series
1.0 m

Watson- Marlow
GE Healthcare Life Sciences

$22,550
$2,950
$250,000

P-56
P-57

840 series
2,000 L

Watson-Marlow

Purchase Cost
$250,000
$2,950

$2,950
$35,857
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Polishing Steps
Specification

PFD 04

Type

P-58

Pump

840 series

Watson- Marlow

P-60

Pump

840 series

Watson- Marlow

$2,950

P-61
P-62
P-63
P-64

HIC Column
Pump
Storage Tank 11
Pump

1.0 m
840 series
2,500 L
840 series

GE Healthcare Life Sciences
Watson- Marlow

$250,000

Watson- Marlow

$38,704
$2,950

P-65
P-66

Diafiltration
Pump

750 L/hr
840 series

Millipore Sigma
Watson- Marlow

$500,000
$2,950

Type

Vendor

Purchase Cost
($/batch)

Small Production Bioreactor Scheme: Additional Units
Specification
Units
Vendor
1

Corning

Purchase
Cost
$900

5.0% CO
Locator 8
90 L liquid N2
--

1
1

Thermo Scientific
Thermolyne

$7,900
$2,700

5

$5,000

MasterFlex
-80˚C, 33.5 ft3
900 L capacity
50 L
20,000 L
620 L/min
120 L capacity
Up to 3m processes
1,000 L

1000
3

GE Healthcare Life
Sciences
Cole-Parmer
Thermo Scientific

$48,900,000
$45,200

Greeloy Medical

$10,700
$200,000
$4,200

Orbital Shaker

60 rpm

CO Incubator
Cryogenic Storage
Vessel
CBCU Gas mixer
Pump Tubing
Product
Refrigeration
Biowaste tank
Neutralization tank
Sterile Air
Compressor
CIP Skids
Buffer Transfer
Container

2

2

1
2
6
3
10

Sani-matic

$300,000
$265,000
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Additional Equipment Included in Annual Expenses for Both Designs
Type
Units
Vendor
1
Chromalox
Water-glycol heater
2
PVI Industries, LLC
Water heater
2
Cole-Parmer
Cooling water unit
2
Thermo Scientific
Biosafety Cabinet
1
WFI Still
1
Spirax Sarco
Clean Steam Generator
1
Millipore
Filter Integrity Test
1
MECO
Water Treatment Package
1
Biowaste Inactivation System
1
Waste Neutralization System
1
Quality Control Lab

153

18. Scheduling
Scheduling and process duration is important to consider for both the design and
operation of biopharmaceutical plants. Both the Large and Small Production Bioreactor Schemes
require 24-hour operation and supervision.
Tables 18.1 and 18.2 illustrate the Gantt chart and schedules for the Large Production
Bioreactor Scheme and Small Production Bioreactor Scheme, respectively. For the Large
Production Bioreactor Scheme, the batch time is 45 days and 14 hours with the start of each
batch occuring every 21 days and 13 hours. Since this scheme produces 25.2 kg per batch, four
batches will be required to reach the production goal of 100 kg of mAb per year. Therefore, the
total time required to reach the production goal is 111 days and 4 hours, or approximately 4
months. For the Small Production Bioreactor Scheme, the batch time is 30 days and 8 hours with
the start of each batch occuring every 9 days and 4 hours. Both the batch and cycle time are
shorter for than for the Large Production Bioreactor Scheme, however this smaller scheme is
designed to produce only 6.3 kg per batch. This requires a total of sixteen batches to reach the
annual production goal. The total time to complete sixteen batches is 178 days and 13 hours, or
approximately 6 months.
The major headings of the combined upstream and downstream processes are labeled on
the left as: Inoculum Preparation, Seeding, Production, Primary Recovery, Purification, and
Polishing. These headings correspond to the titles in the block flow diagrams in Figures 10.1 and
10.2 in Section 10. Scheduled units are labeled in accordance with the corresponding labels on
the computer-drawn flowsheets in Figures 12.1 through 12.6 and with descriptive labels for
simplicity. Each color indicates a new batch.
Although the Small Production Bioreactor Design takes longer, the smaller production
volume actually results in higher product quality and lower batch risk, as discussed in Section
2.2. The smaller design also provides more scalability with the capability to produce quantities
between 6.30 and 201 kg annually. Comparatively, the larger design produces quantities between
25.2 kg and 302 kg annually. Given the projected sales forecast of OCREVUS, both schemes can
match the maximum required annual mAb production for the duration of the patent. Likewise, in
an off-patent scenario, it is unlikely that annual production will exceed that of the on-patent
market, since competitors reduce the market available for sales. A specific, detailed economic
analysis of the advantages and disadvantages of each scheme will be discussed in Section 21.
154

Inoculation

Seeding

Production

Primary
Recovery

Purification

Polishing

P-82

P-80

P-78

P-76

P-74

P-72

P-70

P-68

P-66

P-64

P-62

P-60

P-58

P-56

P-54

P-52

P-44

P-41

P-50

P-46 - P-49

P-37

P-36

P-33

P-32

P-27

P-23 - P-26,43

P-21

P-17 - P-20,40

P-15

P-11 - P-14

P-29

P-9

P-7

P-5

PFD 01/02
P-1 - P-4

Sterile Filtration

Diafiltration

Storage 11

HIC

Virus Filtration

Storage 10

Ion Exchange

Storage 9

Diafiltration

Storage 8

Protein A

Storage 7

Depth Filter

Storage 6

Centrifuge

20000 L BR

Media Storage 4.2

Media Storage 3.2

Media Storage 5

Media Prep 5

2000 L SBR 1.2

2000 L SBR 1.1

500 L SBR 1.2

500 L SBR 1.1

Media Storage 4.1

Media Prep 4

Media Storage 3.1

Media Prep 3

Media Storage 2

Media Prep 2

100 L SBR

25 L SBR

Inoculum Flask

Media Storage 1

Media Prep 1

UNIT

DAYS

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57

Table 18.1 Gantt chart for the Large Production Bioreactor Process (PFD 01 and PFD 02).
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Inoculation

Seeding

Production

Primary
Recovery

Purification

Polishing

Centrifuge

(P-37)

P-39

HIC

Storage 11

Diafiltration

Sterile Filtration

P-63

P-65

P-67

P-59

P-61

Storage 10

Virus Filtration

P-57

Storage 9

Ion Exchange

P-55

P-51

P-53

Storage 8

Diafiltration

P-49

Protein A

2000 L BR 2

P-37

Storage 7

2000 L BR 1

(P-29

P-47

Media Storage 4.3

(P-26)

P-45

Media Storage 3.3

(P-35)

Storage 6

Media Storage 2.2

P-29

Depth Filter

Media Storage 4.2

P-26

P-43

Media Storage 3.2

P-35

P-41

Media Prep 2

Media Storage 2.1

P-31 - P-34

500 L SBR

Media Prep 4

Media Storage 4.1

P-21

P-23

Media Storage 3.1

P-15

25 L SBR

Media Prep 3

P-11 - P-14,25

P-17 - P-20,28

Inoculum Flask

P-8

Media Storage 1.2

Media Storage 1.1

Media Prep 1

UNIT

DAYS

P-7

P-5

PFD 03/04
P-1 - P-4

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54

Table 18.2 Gantt chart for the Small Production Bioreactor Process (PFD 03 and PFD 04).
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19. Fixed-Capital Investment Summary
Assuming that this plant is part of a pre-existing plant, only 4-6 months out of the year
will be dedicated to Ocrevus production. During this time, production will take place 24 hours
per day, 7 days per week in four shifts. Eight operators will be working in any given shift and
will be paid $42 per hour. Technical assistance will be provided by engineers and control
laboratory staff. These labor costs amount to about $1.3 million (MM) per large batch. Other
fixed costs include Maintenance and Overhead items which can be modeled as a fraction of
wages and depreciable capital. These costs total to about $3.1 MM per large bioreactor batch of
25 kg mAb and $1.8 MM per small bioreactor batch of 6.3 kg mAb.
The total investment required prior to the start of production is about $33.6 MM for the
large bioreactor scheme and $19.4 MM for the small bioreactor scheme. This includes the total
bare module costs of all equipment units, site preparations and service facilities, as well as any
contingencies and start-up costs. The bare module factor accounts for the costs of installation
materials and labor, freight and insurances, as well as construction overhead. While the factor for
a typical chemical engineering plant is around 3.21, a slightly lower factor will be used for this
process because most of the equipment is highly specialized for biopharmaceutical applications
and is easy to install. An average bare module factor of 2.8 will be used for all equipment cost
estimations. In the on-patent analysis, all R&D activities and clinical trial costs will also be
included in the annual fixed costs.
A summary of the investment is provided in Appendix F.1 and fixed costs are provided in
Appendix F.2.
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20. Operating Cost- Cost of Manufacture
The operating costs include all raw materials, utilities, and general expenses which scale
with the plant productivity. These costs will be incurred annually and on an ongoing basis. Table
20.1 shows the required raw materials for each production batch in the Large Production
Bioreactor scheme. Table 20.2 shows the same for the Small Production Bioreactor scheme.

Table 20.1 Raw Materials: Large Production Bioreactor Design

Upstream & Downstream Raw Materials: Large Production Bioreactor
Purchase Cost
Raw Materials
Units Specifications
Vendor
($/batch)
Cryovials

1

1000/pack

Sigma-Aldrich

$400

Cryogenic storage
boxes

3

25/pack

Thermo Scientific

$1,700

Liquid Nitrogen

2

55 gallon drum

302

25 L bottle

580

10 L bottle

58

10 L bottle

Antifoam

50

2.5 L bottle

L-glutamine

100

500 mL bottle

Millipore Sigma

$3,000

Sodium Hydroxide
Pellets

25

35 kg drum

Millipore Sigma

$640,000

Sodium Bicarbonate

1

45 kg drum

Millipore Sigma

$900

Propylene Glycol

6

55 gal drum

CHO Cell vials

1

Media Filters

7

Shake Flask

1

Shake Flask

1

ActiPro Powder
Medium
CellBoost 7a Powder
Medium
CellBoost 7b Powder
Medium

1 mL per vial
3x105 cells/mL
Opticap XLT 10
0.57 m2, 0.2µm

$60
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences

Dow Chemical
Company
Thermo Fisher
Scientific

$311,100
$1,044,000
$194,900
$8,500

$4,200
$600

Millipore Sigma

$2,800

50 mL

Corning

$8.00

250 mL
6/pack

Corning

$160.00
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Shaker Flask Clamp

1

Cellbag

1

22 L

Cellbag

1

100 L

Cellbag

2

500 L

XDR-200 Probag

2

2000 L

Air Filters

10

Depth Filters

90

Protein A Resin

200

Protein A Buffers

--

Diafiltration Filters
Tromethamine
Diafiltration Buffer
PBS Diafiltration
Buffer
Capto S Cation Ex.
Resin
Cation Ex. Buffers
Virus Filters
HIC Resin

Durapore
0.69m2, 0.22 µm
Millistak Pod
1.1 m2
MabSelect Sure LX
1 L bottle

GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences

$40
$500
$800
$2,000
$5,000
$4,000

Millipore Sigma

$67,400

GE Healthcare Life
Sciences

$1,600,000*

16400 L

Millipore Sigma

$16,200

2

Pellicon 2 Cassettes
30 kDa

Millipore Sigma

$7,200

1

50 kg

Sigma-Aldrich

$5,700

700

1 L bottle

Millipore Sigma

$23,000

16

10 L bottle

-4

10900 L
Virosart CPV
Poros Benzyl Ultra
10 L bottle
16610 L
Pellicon 2 Cassettes
30 kDa
Sartopore
0.2 µm
Nalgene
10 L
56700 L

20

HIC Buffers
Diafiltration Filters

2

Sterile Filters

70

Biotainers

70

Bleach

--

Autoclave bags

Eppendorf

160

2.5 L

GE Healthcare Life
Sciences
Millipore Sigma
Sartorius
Thermo Fisher
Scientific
Millipore Sigma

$240,000*
$15,200
$40,300
$76,000*
$13,300

Millipore Sigma

$7,200

Sartorius

$45,500

Thermo Fisher
Scientific

$7,100
$153,400

Thermo Fisher
Scientific

$400
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Table 20.2 Raw Materials: Small Production Bioreactor Design

Upstream & Downstream Raw Materials: Small Production Bioreactor
Purchase Cost
Raw Materials
Units Specifications
Vendor
($/batch)
Cryovials

1

1000/pack

Sigma-Aldrich

$400

Cryogenic storage
boxes

3

25/pack

Thermo Scientific

$1,700

Liquid Nitrogen

2

55 gallon drum

45

25 L bottle

70

10 L bottle

7

10 L bottle

Antifoam

10

2.5 L bottle

L-glutamine

100

500 mL bottle

Millipore Sigma

$3,000

Sodium Hydroxide
Pellets

1

35 kg drum

Millipore Sigma

$700

Sodium Bicarbonate

1

45 kg drum

Millipore Sigma

$900

Propylene Glycol

1

55 gal drum

CHO Cell vials

1

Media Filters

6

Shake Flask

1

Shake Flask

1

Shaker Flask Clamp

1

Cellbag

1

22 L

Cellbag

1

500 L

XDR-200 Probag

1

2000 L

Air Filters

10

Durapore
0.69m2, 0.22 µm

ActiPro Powder
Medium
CellBoost 7a Powder
Medium
CellBoost 7b Powder
Medium

1 mL per vial
3x105 cells/mL
Opticap XLT 10
0.57 m2, 0.2µm

$60
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences

Dow Chemical
Company
Thermo Fisher
Scientific

$45,700
$125,100
$23,500
$440

$800
$600

Millipore Sigma

$2,400

50 mL

Corning

$8.00

250 mL
6/pack

Corning

$160

Eppendorf

$40.00

GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences
GE Healthcare Life
Sciences

$500
$1,000
$2,500
$4,000
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Depth Filters

8

Protein A Resin

200

Protein A Buffers

--

Diafiltration Filters
Tromethamine
Diafiltration Buffer
PBS Diafiltration
Buffer
Capto S Cation Ex.
Resin
Cation Ex. Buffers
Virus Filters
HIC Resin

Millipore Sigma

$6,000

GE Healthcare Life
Sciences

$1,600,000*

4100 L

Millipore Sigma

$4,000

1

Pellicon 2 Cassettes
30 kDa

Millipore Sigma

$14,000

1

25 kg

Sigma-Aldrich

$800

420

1L

Millipore Sigma

$13,900

16

10 L bottle

-1

2720 L
Virosart CPV
Poros Benzyl Ultra
10 L bottle
5380L
Pellicon 2 Cassettes
30 kDa
Sartopore
0.2 µm
Nalgene
10 L
1400 L

23

HIC Buffers
Diafiltration Filters

1

Sterile Filters

42

Biotainers

42

Bleach

--

Autoclave bags

Millistak Pod
1.1 m2
MabSelect Sure LX
1 L bottle

160

2.5 L

GE Healthcare Life
Sciences
Millipore Sigma
Sartorius
Thermo Fisher
Scientific
Millipore Sigma

$240,000*
$3,800
$10,000
$89,000*
$4,300

Millipore Sigma

$3,600

Sartorius

$27,300

Thermo Fisher
Scientific

$4,300
$3,600

Thermo Fisher
Scientific

$200
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21. Profitability Analyses- Business Case
In order to validate the feasibility of these proposed process designs, a detailed
profitability analysis has been performed. It is assumed that a 15% internal rate of return (IRR)
will be desired within five years of the production start date. Production Year (PY) 5 has been
selected as the reasonable time point by which a return would be desired, and also provides a
uniform frame of reference for comparing all schemes. An effective tax rate of 37% has been
used for all analyses. These constraints allow the required selling price of the mAb to be
determined, and the superior design scheme to be selected.
The two process designs have been evaluated using two separate frameworks. The first is
the “off-patent” analysis, in which only the capital costs and operating costs are considered in
the economic evaluation. All R&D expenditures are exempt from the cash flow construction.
This represents the expenditures incurred by a company that is trying to manufacture a generic
drug from an existing drug whose patent has recently expired.
The second is the “on-patent” analysis, in which the R&D expenditures, extended
timeline, and probability of success of the drug has been factored in. In this case, the 15% IRR
needs to be achieved before the patent expiration date.
The Sales Forecast (Section 4) constructed from historical market data implies rapid
uptake in the first few years, with a slight, small annual growth rate after about six years of
production. Translating the sales forecast to the mass of mAb allows the required annual
production capacity to be determined. This calculation has been performed using the market
selling price of Ocrevus, at $65,000 per 1200 mg annual treatment. The results of this analysis
are shown in Table 21.1.
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Table 21.1 Annual Production Requirements

YEAR
1
2
3
4
5
6
7
8
9
10

Forecasted Ocrevus
Sales ($MM)
1,377
3,331
5,397
6,908
7,737
8,666
8,839
9,016
9,196
9,380

Treatments
Administered
21,180
51,250
83,030
106,280
119,030
133,320
135,980
138,700
141,480
144,310

mAb Required (kg)
25
62
100
128
143
160
163
166
170
173

These production requirements determine how capacity is expected to scale up from year to year
and has been factored into the operating costs on the cash flow analysis.
The desired internal rate of return (IRR) is 15%, which represents the percentage rate
earned on each dollar invested within a given time frame. This can be calculated by calculating
the net present value (NPV) of all cash flows using a discount rate equivalent to the IRR. The
formula for NPV is,
𝑇

𝑁𝑃𝑉 = ∑
𝑡=1

𝐶𝑡
− 𝐶𝑜
(1 + 𝑟)𝑡

where Ct is the cumulative cash flow at year t, Co is the total initial investment, r is the discount
rate, and t is the number of years. The year at which the cumulative NPV is equal to 0, or
become positive, is the “breakeven” year, representing to year at which the IRR has been earned.
21.1 Off-Patent Analysis
In the off-patent analysis, it has been assumed that the project timeline starts in
2018. Year 1 is dedicated to plant set-up and capital investment, while the first year of
operations and sales is Year 2, or 2019. As explained in the patent analysis (Section 9),
the price of a physician-administered drug drops between 38 and 48% following patent
expiration.16 For this reason, a conservative selling price of $35,000, or a reduction of
46% has been used in the off-patent profitability analyses.
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21.1.1 Large Production Bioreactor Design
An economic evaluation of the Large Production Bioreactor Design under
this framework shows that a 15% IRR on the $33.6 MM initial investment cannot
be earned within 5 years. Using the baseline price tag of $35,000 per 1200 mg
treatment, the desired 15% IRR can be achieved by 2024, or the sixth year of
production. At the end of Production Year 10, the cumulative Net Present Value
(NPV) is about $9.1 billion. Though the desired outcome is not achieved, this is
still a profitable scenario and can be explored and optimized further to achieve the
desired return. A summarized cash flow analysis is shown in Table 21.2. The
complete cash flow sheet for this analysis is shown in Appendix F.4.1
Table 21.2 Condensed Cash Flow for Off-Patent Large Production Bioreactor Design

YEAR

Cash Flow ($MM)

2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028

-3,093
-1,516
-890
1,532
3,171
3,775
5,199
5,734
5,850
5,967
6,087

Cumulative NPV at
15% IRR ($MM)
-3,093
-4,411
-5,085
-4,077
-2,264
-387
1,860
4,016
5,929
7,625
9,130

21.1.2 Small Production Bioreactor Design
Since the Small Production Bioreactor Design requires a smaller equipment and
thus a reduced capital investment, the outcome from this analysis is slightly more
profitable. Using the same baseline price of $35,000 per 1200 mg treatment, the desired
15% IRR on the initial investment of $19.7 MM can be attained before the end of 2022,
or the 4th year of production, and the cumulative NPV at the end of PY10 is $12.9 B. A
summarized cash flow analysis is shown in Table 21.3. The complete cash flow sheet for
this analysis is shown in Appendix F.4.2.
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Table 21.3 Condensed Cash Flow for Off-Patent Small Bioreactor Design

YEAR

Cash Flow ($MM)

2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028

-1,951
-393
-46
2,205
3,791
4,280
5,279
5,720
5,775
5,951
6,071

Cumulative NPV at
15% IRR ($MM)
-1,951
-2,293
-2,328
-878
-1,289
3,417
5,700
7,850
9,738
11,429
12,930

21.1.3 Price Sensitivity Analysis
The profitability findings reported above reflect the projections for a selling price
of $35,000 per 1200 mg treatment. This price estimate may need to be adjusted based on
market conditions, competitive products, and the company’s financial situation. Figure
21.1 shows how the selling price would affect the return on investment at Production
Year (PY) 5 for both design schemes. Figure 21.2 shows the year at which the desired
15% IRR will be attained at different prices. These analyses assume that the sales
projections remain constant regardless of price.
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Figure 21.1 Expected Return on Investment at the end of the 5th year
of production as a function of treatment price

Figure 21.2 This chart shows the year at which the desired 15% IRR will
be achieved as a function of treatment price
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21.1.4 Sales Volume Sensitivity Analysis
Another factor that heavily influences the profitability is the sales forecast. The
revenues will depend on the number of treatments administered annually, which can only
be forecasted from market data. The sales forecast, therefore, is subject to variability and
a sensitivity analysis has been conducted to make an educated decision about the price
point given the volatility of future market conditions. A range of forecasts has been
constructed by multiplying the default annual administered treatments by several factors.
Figure 21.3 shows how the sales forecast would affect the return on investment for both
design schemes. Figure 21.4 shows how long it will take to achieve a 15% IRR given the
range of sales forecasts.

Figure 21.3 This graph shows the expected return on investment at the end of production year 5
as a function of the percentage of forecasted sales truly realized
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Figure 21.4 This chart shows the year at which the desired 15% IRR will be attained as a function
of the sales forecast factor

21.2 On-Patent Analysis
The on-patent analysis requires evaluating the project over a longer timeline and
with several additional cost and logistical considerations. Of all the discovery and
development activities undertaken by research institutions and biopharmaceutical
companies, very few products are able to ultimately be sold on the market. Many
molecules are abandoned early in the development process, while others may fail to pass
the final Phase III clinical trials. According to a study conducted by the Tufts Center for
the Study of Drug Development, the probability of success for a biopharmaceutical drug
is on average 11.83%.31 Factoring in this low success rate, the effective estimated average
pre-tax industry cost for a new prescription drug approval is $2.56 billion, for which the
timeline from discovery to market is approximately 128 months. This includes all
activities associated with R&D, pilot plant development, and FDA regulated clinical
trials. Of the $2.56 billion cost, 30.8% goes towards pre-human expenditures, meaning all
activities before the product is tested in human patients. The FDA data for Ocrevus
reveals that the clinical trial start date was March 15, 2011 and the final approval date
was March 28, 2017. Based on this data, the timeline has been adjusted such that R&D
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activities start in 2012, 7 years prior to the production start date. Pre-human expenditures
have been spread across the four years from patent filing to the clinical trial start date,
while the remaining 69.2% of the cost are incurred during the seven years in clinical
trials. The baseline selling price for this framework is $65,000 per annual treatment,
which is the Roche list price for the patented drug, Ocrevus.
21.2.1 Large Production Bioreactor Design
In the Large Production Bioreactor Design, the on-patent economic analysis
shows that the desired 15% IRR will be achieved by 2023, or Production Year 5. This is
earlier than what was found in the off-patent analysis, since the higher investment cost is
more than offset by the increased revenues from the higher sales price. By Production
Year 10 or 2028, the patent expiration date, the cumulative NPV is $5.3 B. A
summarized cash flow analysis is shown in Table 21.4. The complete cash flow sheet for
this analysis is shown in Appendix F.4.3.
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Table 21.4 Condensed Cash Flow for On-Patent Large Production Bioreactor Design

YEAR

Cash Flow ($MM)

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028

-197
-197
-197
-197
-253
-253
-253
-253
-253
-253
-3,093
-746
-973
4,550
7,035
8,102
10,045
10,678
10,892
11,110
14,393

Cumulative NPV at
15% IRR ($MM)
-197
-369
-518
-647
-792
-918
-1,027
-1,122
-1,205
-1,277
-2,042
-2,202
-2,020
-1,280
-286
709
1,783
2,775
3,655
4,436
5,315

21.2.2 Small Production Bioreactor Design
In the Small Production Bioreactor Design, the on-patent analysis shows a 15%
IRR attained by the end of 2022, or Production Year 4. This scheme is slightly more
profitable, with an NPV of $6.2 B by 2028. A summarized cash flow analysis is shown in
Table 21.5. The complete cash flow sheet for this analysis is shown in Appendix F.4.4.
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Table 21.5 Condensed Cash Flow for On-Patent Small Production Bioreactor Design

YEAR

Cash Flow ($MM)

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028

-197
-197
-197
-197
-253
-253
-253
-253
-253
-253
-1,951
377
1,817
5,224
7,654
8,607
10,126
10,663
10,817
11,094
13,249

Cumulative NPV at
15% IRR ($MM)
-197
-369
-518
-647
-792
-918
-1,027
-1,122
-1,205
-1,277
-1,759
-1,678
-1,338
-490
592
1,650
2,732
3,723
4,597
5,378
6,186

172

21.2.3 Price Sensitivity Analysis
Although the selected sales price is representative of the true market price of
Ocrevus, it is possible that the price will need to be adjusted higher or lower depending
on the competitive landscape or the company’s financial situation. If the 15% IRR needs
to be achieved sooner than the current forecast, a higher price tag may be required. Figure
20.5 shows the price sensitivity to the rate of return at PY 4, while Figure 21.6 shows the
years required to achieve a 15% IRR at a range of selling points.

Figure 21.5 Expected Return on Investment at the end of the 5th year
of production as a function of treatment price
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Figure 21.6 This graph shows the year at which the desired 15% IRR
will be achieved as a function of the treatment sales price

21.2.4 Sales Volume Sensitivity Analysis
As was true for the off-patent analysis, the sales forecast is an important factor in
the profitability analysis. A range of forecasts has been constructed by assuming the true
sales realized are 25%, 50%, 100% 150%, or 200% of the forecasted sales. Figure 21.7
shows how the sales forecast would affect the return on investment for both design
schemes. Figure 21.8 shows how long it will take to achieve a 15% IRR given the range
of realized sales.
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Figure 21.7 This graph shows the expected return on investment at the end of the fifth
production year as a function of the percentage of forecasted sales that are actually realized

Figure 21.8 This graph shows the year at which the desired 15% IRR will be attained as a
function of the percentage of forecasted sales truly realized
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21.3 Summary
From the analyses of the Large and Small Production Bioreactor Designs under both offpatent and off-patent frameworks, it is clear that the Small Production Bioreactor Design is
always more profitable. This is attributed to the smaller batch size, which downsizes the required
equipment and thus the initial capital investment. Comparing the on-patent and off-patent
frameworks, it can be seen that the desired 15% IRR can be earned within a shorter time period
in the on-patent analysis, even though there are additional R&D investments required. This can
be explained by the selling price of on-patent drugs, which is typically almost double that of the
generic, off-patent counterpart.

22. Additional Considerations
22.1 Environmental Impact
The manufacturing process for monoclonal antibodies, or for any biopharmaceutical
product, has a sizeable environmental impact in the form of energy and water use and waste
disposal. Aqueous wastes such as cell media and purification buffers are the most significant
effluents in this process.32 In order to minimize the associated biohazard, these streams along
with the solid cell waste will be inactivated with heat and neutralized through pH adjustment
before they can be safely disposed.33 Further design initiatives could also be taken to explore the
possibility of recycling reagents and streams back to the process.
While the power and water consumption for traditional manufacturing processes is quite
high, the use of single-use (SU), disposable equipment significantly reduces the carbon footprint
of this project. Rigorous comparative analyses indicate that SU bioprocess technologies exhibit
lower environmental impact than reusable bioprocessing technologies in all impact categories
examined, from terrestrial ecotoxicity to marine eutrophication to ozone depletion. Several lifecycle assessments (LCAs) conducted by ThermoFisher have demonstrated that single-use
systems use less water and energy, and have a lower overall environmental impact compared to
conventional fixed systems.34 For a typical commercial mAb production process at 3 x 2,000 L
scale, a SU system used 87% less water, 29% less energy, and created 25% less CO2 emissions
than a fixed system. These differences are mainly attributed to the water usage and energy
consumption required for cleaning and sterilization processes.
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In addition to the liquid and solid waste produced, there is a large amount of carbon
dioxide that will be released. The major source for this CO2 are from the vented bioreactors,
which release the gases unused by the cells. Because air is sparged in, the cells take up the
oxygen for growth and CO2 is released. The amount CO2 released is calculated in Appendix E.
Using Sanofi as an example pharmaceutical manufacturing company, their CO2 emissions were
used as a basis for comparison. It was calculated that this process produces 4.1 million kg of CO2
annually, which is approximately percent of their 455 million kg produced in their company
annually. This means that this process produces approximately 6,400 kg CO2 per kg of mAb
produced, using a four month time span to produce 100 kg. 35

22.2 FDA Regulations
The U.S Food and Drug Administration (FDA) regulates almost every facet of
prescription drugs, including testing, manufacturing, labeling, advertising, marketing, efficacy,
and safety. The Center for Drug Evaluation and Research (CDER) is the main player in the drug
development and approval process, and has different requirements for the three main drug
product types: new drugs, generic drugs, and over-the-counter drugs.
Typically, once a promising compound is identified for developments, researchers
conduct experiments to gather information on the metabolism, mechanisms of action, optimal
dosage and administration, side-effects, biological variation, interactions, and efficacy. Before
testing the drug in people, researchers must perform either in vivo or in vitro toxicity research,
following FDA defined good laboratory practices (GLP), which set the minimum basic
requirements for study conduct, personnel, facilities, equipment, written protocols, operating
procedures, study reports, and quality assurance. The next step is to submit an Investigational
New Drug (IND) application to CDER. Thirty days after the submission, clinical research phase
trials may begin.36
The purpose of the Phase 1 trial is to test the safety and dosage of the drug in 20-100
healthy volunteers or people with the disease/condition. Approximately 70% of all drugs move
on to Phase 2, in which up to several hundred participants with the disease and tested for upto
two years for drug efficacy and side effects. This phase has a 33% passing rate. The Phase 3
study tests for efficacy and monitors adverse reactions for 1-4 years in 300-3,000 volunteers with
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the disease or condition. The final Phase 4 is another safety and efficacy trial for several
thousand volunteer patients.
If early evidence is positive, a New Drug Application (NDA) may be submitted to
demonstrate that a drug is safe and effective for its intended use in the population studied. The
review team then has 6 to 10 months to approve the drug. The approval process involves a
project manager, medical officer, statistician, pharmacologist, pharmakineticist, chemist, and
microbiologist. Each member reviews the relevant sections of the application, while FDA
inspectors travel to the clinical study sites to conduct a routine inspection. The project manager
then assembles an “action package” presenting the review team’s recommendation, and a senior
FDA official makes a decision. The time and money involved in these steps has all been factored
into the on-patent economic framework.
The FDA continues to stay involved and performs routine inspections of the
manufacturing facilities and performs post-market drug safety monitoring. Manufacturers are
required to comply with the Current Good Manufacturing Practice (CGMP) regulations, which
contain minimum requirements for the methods, facilities, and controls used in manufacturing,
processing and packing of a drug product.37 To meet these requirements, the staff will be welltrained and operators will monitor various quality checkpoints throughout the process. The use of
disposable equipment enhances sterility by preventing cross-contamination.
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23. Conclusions and Recommendations
Based on the design exercises and economic analyses, it is recommended that the Small
Production Bioreactor Design be implemented for the Ocrevus production project. This scheme,
which makes use of disposable single-use bioreactors and staggers processes into small volume
batches, is more cost effective both from a capital and operating cost perspective. It is also the
preferred choice from an engineering perspective, as it is more flexible in terms of production
scaling, it is easier to control operating conditions in smaller volume tanks, and there is reduced
risk associated with a faulty batch.
While the sales forecasts are subject to error, it can be concluded that a 15% IRR can be
achieved with both an off-patent and on-patent product. For an off-patent sales price of $35,000
per annual treatment, a 15% IRR can be achieved by 2024 even if sales are only 50% of the
projected number. For an on-patent sales price of $65,000, a 15% IRR can be achieved by 2022
under similar sales projections. Therefore, it is recommended that the off-patent drug be priced at
$35,000 and the on-patent drug at $65,000 per 1200 mg annual treatment. These prices will
ensure a 15% IRR within 6 years of production launch even if sales are much lower than
forecasted.
If a quicker return is desired, or if the market calls for the sales price to be lower than
this, the incurred costs can be reduced by choosing less specialized operating equipment. Many
of the reactors and processing units selected for this design are top-of-the-line and make use of
sophisticated control units. By employing more traditional controls and choosing generic
equipment manufacturers, many of these capital and operating costs may be reduced.
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Appendix A - Cryogenic Recovery of the CHO Cells
The CHO cells will be stored in a cryogenic freezing tank, and must be recovered before
the start of the inoculum preparation steps, which is the first step in mAb production and
processing. The protocol for recovering CHO cells are as follows.44
1. The frozen 1mL vial of CHO cells must be removed from the cryogenic storage vessel
and thawed to room temperature
2. Fresh ActiPro growth medium, which contains 2.8 g/L of sodium bicarbonate, should be
added to a 15mL conical tube along with the thawed cells..
3. The cells should be centrifuged at 1,000 rpm for 5 minutes. After centrifugation, the cells
should be in pellet form at the bottom of the conical tube.
4. Excess culture media should be suctioned from the conical tube without suctioning up the
cells, and the cells should be resuspended in 1 mL of fresh media.
5. After counting the cells with a hemocytometer, the cells should be re-inoculated in fresh
ActiPro growth medium at a density of 3x106 cells/mL in a T-75 cell culture flask.
6. The flask containing the cell culture should be incubated at 36.5°C and 7.5% CO2 for 3
days.
7. The cells should be passaged according to CHO specific protocols, but follow general
steps of: media wash to remove dead cells, trypsin incubation for cell detachment from
the culture surface, trypsin neutralization and centrifugation, and counting for
resuspension at a density of 3x106 cells/mL in a T-75 cell culture flask.
8. The cells should be passaged as in Step 7 at least 2 times before transferring cells to
inoculum preparation steps.
9. Just before seeding into the inoculum preparation steps, the cells should be counted for
resuspension at a density of 3x105cells/mL in 30 mL of fresh ActiPro growth media.
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Appendix B - Growth Media and Feed Supplement Reconstitution
The media used in the upstream production process will be purchased as a powder.
Before being added to the bioreactors, it needs to be reconstituted with WFI, as shown in the
media prep trains in Section 12. The following protocols will be used.
ActiPro Medium Reconstitution Protocol38
1. Fill a clean mixing vessel to 96% of the final volume with high-quality purified
water, such as WFI, at ambient temperature (18°C to 25°C) and start mixing.
2. Add 22.36 g/L ActiPro powder slowly to the vessel, avoiding formation of
clumps. Mix until no clumps of powder remain. The solution will remain cloudy
in this step, but should be clear of any clumps or dry powder residues.
3. Slowly add 6.5mL/L of a 5 N NaOH solution or 3.25 mL/L of a 10 N NaOH
solution and mix until solution is clear.
4. Add 1.8g/L sodium bicarbonate into the vessel and mix until dissolved.
5. Adjust the pH to between 6.90 and 7.35 by dropwise addition of 5 N or 10 N
NaOh or HCl. After adjusting, continue mixing for an additional 20 minutes to
ensure that all components are completely dissolved.
6. Adjust to the final volume with WFI and mix for an additional 10 minutes.
7. Measure and record the final pH and osmolality. The expected pH is 6.90 and
7.55 and the expected osmolality is 270 to 330 mOsmol/kg.
8. Sterilize immediately by membrane filtration. Use a low-binding filter membrane.
9. Store the reconstituted medium protected from light at 2°C to 8°C until use.
CellBoost 7a Powder Supplement Reconstitution39
1. Fill a clean mixing vessel to 80% of the final volume with WFI at ambient
temperature and start stirring.
2. Add 181.04 g/L CellBoost 7a powder slowly to the vessel, avoiding formation of
clumps. Mix for 30 minutes. The solution will remain cloudy in this step, but
should be clear of any clumps or dry powder residues.
3. Slowly add 18.6 mL/L of a 5 N NaOH solution or 9.3 mL/L of a 10 N NaOH
solution and mix for 60 minutes.
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4. Adjust the pH to between 6.60 and 6.80 by dropwise addition of 5 or 10 N NaOH
or HCl. After adjusting, continue stirring for an additional 60 minutes to ensure
that all components are completely dissolved.
5. Adjust to the final volume with high-quality purified water, such as WFI, and stir
for an additional 10 minutes.
6. Measure and record the final pH and osmolality. The expected pH is 6.60 and
6.80 and the expected osmolality is 247 to 303 mOsmol/kg.
7. Sterilize immediately by membrane filtration. Use a low-binding filter membrane
type.
8. Store the reconstituted supplement protected from light at 2°C to 8°C until use.
CellBoost 7b Powder Supplement Reconstitution39
1. Fill a clean mixing vessel to 80% of the final volume with WFI at ambient
temperature and start stirring.
2. Add 94.6 g/L CellBoost 7b powder slowly to the vessel, avoiding formation of
clumps. Mix for 30 minutes. The solution will remain cloudy in this step, but
should be clear of any clumps or dry powder residues.
3. Slowly add 160.5 mL/L of a 5 N NaOH solution or 80.25 mL/L of a 10 N NaOH
solution and mix for 60 minutes.
4. Adjust the pH to between 11.0 and 11.4 by dropwise addition of 5 or 10 N NaOH
or HCl. After adjusting, continue stirring for an additional 60 minutes to ensure
that all components are completely dissolved.
5. Adjust to the final volume with high-quality purified water, such as WFI, and stir
for an additional 10 minutes.
6. Measure and record the final pH and osmolality. The expected pH is 11.0 and
11.4 and the expected osmolality is 218 to 266 mOsmol/kg.
7. Sterilize immediately by membrane filtration. Use a low-binding filter membrane
type.
8. Store the reconstituted supplement protected from light at 2°C to 8°C until use.
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Appendix C - Clean-in-Place (CIP) & Steam-in-Place (SIP) Protocol
Clean-in-Place Protocol40
The Clean-in-place (CIP) process typically involves three cycles after draining the
process tank, which can be accomplished during harvest or transfer of the cells.
1.

Initially rinse the tank using room temperature, or warm, water for injection
(WFI) using a volume proportioned to the inner surface area of the vessel at a
flow rate sufficient to forcefully-impinge on the vessel surface to flush the easyto-remove contents/debris.

2.

Clean/wash using heated caustic solution at about a 3 to 8 wt% sodium hydroxide
aqueous solution, at a flow rate sufficient to forcefully-impinge on the vessel
surface. This solution may me heated to 85°C. The wash volume used may equal
the rinse volume used in Step 1.

3. Wash with WFI for a final rinse. The totalized final rinse volume used may equal
the rinse volume used in Step 1.
Steam-in-place Protocol41
Once the CIP cycle is complete it will be followed by a Sterilize (or Steam) In
Place (SIP) step. This involves flowing steam into and through the vessel and all process
connections that require thermal sterilization, such as transfer lines, vent lines, and
valves. Once all surfaces are brought to greater than 121°C, the system is held at that
temperature for more than 15 minutes, often 30 to 60 minutes. Once the SIP time period
has elapsed, the steam flow is stopped, and sterile air is admitted into the tank to displace
the steam and to maintain a slight positive pressure to ensure no-entry of native
contamination. Often live steam will continue to be supplied to lines connected to sterile,
process vessels, with closed, isolation valves used to prevent additional steam from
entering the sterile vessel. Steam traps are connected to the low-points of these lines,
served with live steam, to provide an exit point for steam condensate. To estimate the
amount of steam needed for each piece of equipment, an estimate is needed of: the
volume of steam needed to fill the vessel and all related pipeline connections plus the
steam needed to bring the temperature of the process equipment mass from its starting
temperature to the SIP/sterilization temperature. Manufacturing facilities often have on188

site fossil-fuel powered boilers; however, if lacking this an electrically-powered steam
generator (often significantly smaller than gas or oil fired, will serve the purpose if the
peak steam usage rate can be met.
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Appendix D - Oxygen Transfer and Gas Sparging
Oxygen mass transfer and gas sparging rates are critical parameters for cell survival and
high product formation in the upstream cell bioreactions. Oxygen (O2) mass transfer was
calculated based on a desired setpoint of 40% dissolved O2 and a given requirement of 0.19 pmol
of O2 per cell per hour. Using Equation D.1, the oxygen uptake rate by the cells was calculated.
𝑂𝑈𝑅 = 𝑞𝑂2 × [𝐶𝑒𝑙𝑙𝑠]𝑚𝑎𝑥 × 𝑀𝑊𝑂2

(D.1)

where, OUR = oxygen uptake rate [g/L/h]
qO2 = oxygen requirement [mol/cell/h]
[Cells]max = maximum cell concentration in the reactor [cells/L]
MWO2 = molecular weight of oxygen [g/mol]
Then, assuming the oxygen uptake rate was equivalent to the oxygen transfer rate (OTR),
an oxygen mass transfer coefficient was calculated using Equation D.2
∗
𝑂𝑈𝑅 = 𝑂𝑇𝑅 = 𝑘𝐿𝑎 × 𝐶𝑂2
× (1 − 𝐷𝑂)

(D.2)

where, OTR = oxygen transfer rate [g/L/h]
kLa = oxygen mass transfer coefficient [h-1]
C*O2 = solubility of O2 in water at 1 atm, 36.5°C [g/L]
DO = setpoint for dissolved oxygen in water
Using the calculated oxygen mass transfer coefficient, which should have a value
between 12 and 15 h-1, the Van’t Riet equation shown in Equation D.3 was applied to find the
superficial gas velocity assuming the total specific energy dissipation rate in the bioreactor was
55 W/m3, or 0.055 W/kg, assuming water is the main volumetric component in the bioreactor.
The total specific energy dissipation rate includes both the impeller and gas sparging
operations.42
𝑘𝐿𝑎 = 𝐴(𝜀𝑇 )𝛼 (𝑢𝑠 )𝛽

(D.3)

where, A = constant, coalesced system
⍺, β = constants, coalesced system
ɛT = total specific energy dissipation rate [W/kg]
us = superficial gas velocity [m/s]
By multiplying the newly calculated superficial gas velocity by the cross-sectional area of
the tank, the required sparged flow rate of oxygen for adequate cell growth can be evaluated.
Note that the cross-sectional area of the tanks were calculated based on the assumption of
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cylindrical geometry with a height to diameter ratio of 2:1. The relevant equations for these
calculations can be found in Equations D.4 and D.5.
𝑄𝑂2 = 𝑢𝑠 × 𝐶𝑆𝐴 × 1000
𝑄𝑎𝑖𝑟 =

𝑄𝑂2 ×𝜌𝑂2 ×𝑀𝑊𝑂2 ×𝑅×𝑇

𝑄𝑣𝑣𝑚,𝑎𝑖𝑟 =

0.21×𝑃

(D.4)
(D.5)

𝑄𝑎𝑖𝑟 ×60
𝑉𝑡𝑎𝑛𝑘

where, QO2 = required flow rate of sparged oxygen [L/h]
CSA = cross-sectional area of a cylindrical tank [m2]
⍴O2 = density of O2 at 1 atm, 36.5°C [g/L]
R = gas constant [J/mol K]
T = temperature of bioreactor [K]
P = pressure of bioreactor [Pa]
Qair = required flow rate of sparged air [L/h]
Qvvm, air = required flow rate of sparged air [vvm, volume of air sparged
under standard conditions per volume of liquid per minute]
Vtank = volume of the bioreactor [L]
ɛT = total specific energy dissipation rate [W/kg]
us = superficial gas velocity [m/s]
Because the solubility of oxygen in water at atmospheric pressure and 36.5°C is so low at
a value of 0.00678 mg/L, it is not accurate to assume 100% of the sparged air will be taken up by
the cells. Therefore, a conservative estimate of 30% of the sparged air was assumed to be taken
up by the cells as oxygen, with the remaining gases filling the headspace and eventually being
vented.
All gas sparging rates should be below values of 0.05 vvm to reduce foaming and
prevent formation of large bubbles that will be toxic to the cells upon dissipation.42
All values for known variables, along with the calculated air sparging rates for larger
bioreactor volumes are listed below in Table D.
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Table D. Oxygen mass transfer rate and gas flowrates for large volume bioreactors

qO2
[Cells]max
MWO2
C*O2
DO
A
α
β
εT
CSA, H/D = 2
ρO2, 1 atm, 36.5˚C
MWO2
R
T
P
Vtank
Tank Size
500 L
2,000 L
20,000 L

Known Variables
(mol/cell/h) 0.19
(cells/L) 9x103
(g/mol) 32
(g/L) 0.00678
0.4
0.026
0.4
0.5
(W/kg) 0.055
(m2) 6.80
(g/L) 1.26
(g/mol) 32
(J/mol K) 8.31
(K) 310
(Pa) 200,000
(L) 20,000
Air sparging rate [vvm], assuming
30% uptake
0.0423
0.0211
0.00981
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Appendix E - Exhaust Venting Rates
Because only 30% of sparged air is taken up by the cells, this leaves 70% of the sparged
air to fill the remaining headspace and eventually to be released into the atmosphere through the
exhaust vents in each of the bioreactors. In addition, to O2 and N2, CO2 must also be stripped
from the culture solution and vented from the bioreactors. Cells produce CO2 as a result of
glucose uptake and use as energy, however CO2 concentration is a highly controlled parameter
that acutely affects cell growth and product quality. It can also displace oxygen as the main gas
dissolved in the culture media, which limits further the amount of oxygen available for cellular
uptake. The molar ratio of O2 uptake to CO2 production by the cells was assumed to be 1, and
from this the amount of CO2 that needs to be stripped and vented can be calculated. All values
for known variables, along with the calculated CO2, O2, and N2 venting rates for larger bioreactor
volumes are listed below in Table E.
Table E. Venting rates for Oxygen, Nitrogen, and Carbon Dioxide in large volume bioreactors

Known Variables
ρO2, 1 atm, 36.5˚C
ρN2, 1 atm, 36.5˚C
ρCO2, 1 atm, 36.5˚C
qCO2
Tank Size

500 L
2,000 L
20,000 L

CO2
venting
[kg/h]
0.000026
0.0000685
1.02

(g/L) 1.26
(g/L) 1.09
(g/L) 1.72
(mol/cell/h) 0.19x10-12
O2 venting
N2 venting
[kg/h]
[kg/h]
0.116
0.464
2.15

0.38
1.53
7.09
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Appendix F - Economics
F.1 Investment Summary
Large Production Bioreactor Scheme:
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Small Production Bioreactor Scheme:

203

F.2 Fixed Costs
Large Production Bioreactor Scheme:
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Small Production Bioreactor Scheme:
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F.3 Working Capital
Large Production Bioreactor Scheme:

Small Production Bioreactor Scheme:
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F.4 Cash Flow Diagrams
F.4.1 Off-Patent Analysis
Large Production Bioreactor Scheme:
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Small Production Bioreactor Scheme:
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F.2 On-Patent Analysis
Large Production Bioreactor Scheme:
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Small Production Bioreactor Scheme:
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ReadyToProcess™

WAVE 25 rocking
bioreactor system
The single-use ReadyToProcess WAVE™ 25 rocking bioreactor
system is a reliable and intuitive cell culture system for working
volumes up to 25 L (Fig 1). The system is based on a well-known
rocking technology that provides mixing and aeration to the culture,
which is maintained in an inflated, disposable Cellbag™ bioreactor
cultivation chamber.
With ReadyToProcess WAVE 25, the rocking technology is enhanced
with features such as advanced sensors and intelligent control
strategies. System operation is easily managed via the intuitive
and user-friendly UNICORN™ system control software. The system
is designed for fast installation and convenient handling, and it
delivers a reliable and accurate performance suitable for research,
process development, and manufacturing operations.

ReadyToProcess WAVE 25 offers the following benefits:
•

Robust and reliable performance

•

Intelligent and accurate process control

•

Designed for ease of use

•

Flexible operations with possibility of use in single or
dual culture mode

•

Suitable for manufacturing in a regulated environment

System benefits
Robust and reliable performance
ReadyToProcess WAVE 25 is designed to make hardware,
consumables, and software work together in an integrated
manner. The system has been tested in real applications for
reliable performance. To decrease the risk for data losses,
the system comprises two, mirrored, solid-state drives
for data storage.

Intelligent and accurate process control
The system is equipped with advanced sensors and automated
controllers for temperature, liquid handling, pH, and dissolved
oxygen (DO). The system dynamics have been methodically
characterized and the results used to create a library of
predefined control parameters tailored for different cultivation

gelifesciences.com/upstream

Fig 1. ReadyToProcess WAVE 25 bioreactor system.

volumes. The system can automatically determine suitable
parameters for a run, a feature that facilitates fast start-up and
enables accurate and stable control.

Easy to use
ReadyToProcess WAVE 25 system is designed for ease of use.
Cellbag bioreactor attachment is straightforward and system
operation is conveniently managed with the UNICORN software,
with menus and process pictures that are easily accessible
and interpretable. The harvest operation is facilitated by an
innovative tilt function that avoids the need for heavy lifting.

Flexible operations with possibility of use in single or
dual culture mode
With ReadyToProcess WAVE 25, one or two cultures can be run
at the same time with high control accuracy. When dual mode is
used, two cultivations can be run using the same or different bag
sizes and/or working volumes. Parameters such as temperature,
pH, and DO can be controlled independently in the two Cellbag
bioreactors. Separate pump units control liquid addition and/or
removal, for example, to enable tailored feeding strategies, base
addition, or perfusion in the two parallel cultures.

Suitable for manufacturing in a regulated environment

used together with a tray and a disposable Cellbag bioreactor.
When operated in dual culture mode, culturing can be performed
in two separate Cellbag bioreactors simultaneously, although
controlled separately. The rocker has multiple functions, amongst
them including temperature control, culture mixing, and weight
measurement. The CBCU contains a gas mixer that delivers gas
of a defined composition to the culture and is used together with
the optical sensors of the Cellbag bioreactor for online control of
culture pH and DO. Liquid is delivered accurately to the culture
by ReadyToProcess Pump 25. The pump unit has a flow range
covering multiple applications, from additions of feed and base to
perfusion culturing. Up to two CBCU gas mixers and up to three
pump units can be connected to ReadyToProcess WAVE 25. An
overview of the ReadyToProcess WAVE 25 system is shown in
Figure 2. The individual components are described in detail below.

ReadyToProcess WAVE 25 is designed to meet the demands and
standards that are required in a regulated environment. The
documentation is extensive and includes material certificates,
system specifications, installation and operational qualification
(IQ/OQ) protocols, and a detailed user manual. The UNICORN
software is suitable for use in a manner that complies with 21 CFR
Part 11 and Good Automated Manufacturing Practice (GAMP™) 5.

System overview
ReadyToProcess WAVE 25 system components
The ReadyToProcess WAVE 25 system consists of a rocker, CBCU
gas mixers, and pumps, all operated by the UNICORN software
installed on a client computer. The rocker is the main unit and is
Graphical user
interface

Lid

Client computer
Installed with UNICORN software.
Can control up to three
ReadyToProcess WAVE 25 systems

Tray

ReadyToProcess Pump 25
Peristaltic pump

ReadyToProcess WAVE 25, rocker
Rocker, temperature sensors,
scale, embedded controller,
and dual hard drives

ReadyToProcess CBCU
Gas flow/mix controller,
pH and DO sensors

System setup and integration of subunits
ReadyToProcess WAVE 25, rocker
• Rocking
• Weight measurement
• Temperature measurement

UNICORN software
• Administration
• System control
• Method editor
• Evaluation

Controller with
dual hard drives

ReadyToProcess Pump 25
• Acid/base for pH control
• Feed/harvest for perfusion or medium addition
• Up to three pump 25 units can be connected

ReadyToProcess CBCU
• Gas flow/mix
• pH measurement
• DO measurement
• Up to two CBCU can be connected

LAN
OPC

SCADA
(not included)

UNICORN
database

UNICORN software
At home or within
enterprise network

E-mail
notifications

Firewall
Fig 2. ReadyToProcess WAVE 25 system overview. The System Control module on the client computer is used to start and monitor the cultivation process.
One UNICORN client can control up to three ReadyToProcess WAVE 25 systems simultaneously. SCADA = supervisory control and data acquisition,
OPC = open platform communications, LAN = local area network.
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ReadyToProcess WAVE 25, rocker

Temperature sensors

The rocker is the main hardware unit of the system and provides
mixing through the rocking, reliable temperature measurement
from integrated sensors, and accurate weight measurement
from integrated load cells. The ergonomic design makes handling
convenient and easy. The ability to handle the bioreactor in a
tilt position facilitates sampling and harvest (Fig 3). The minimal
footprint facilitates placement when space is limited.
(A)

(B)

Fig 5. Integrated temperature sensors for convenient handling and reliable
temperature control.
40

Trays and lids
Trays are available in three different sizes for culturing of up to
5 L, 10 L, and 25 L, respectively. The trays are easily attached to
the rocker when in the tilt position. A snap lock mechanism allows
Cellbag bioreactors to be correctly installed and rapidly changed
(Fig 4). To protect light-sensitive components of the culture
medium and to prolong the life of the optical sensors, lids are
available for all tray sizes.
Snap locks

35
Temperature (°C)

Fig 3. (A) The ergonomic design makes activities such as sampling and
harvest convenient and easy. (B) ReadyToProcess WAVE 25 in tilt position.

30

25

20
0

30

Time (min)

Heating, left culture
Temp. set point, left culture

60

90

Heating, right culture
Temp. set point, right culture

Fig 6. Temperature is accurately controlled independently in two separate
5 L cultures using the dual functionality (ambient temperature 22°C).

Mixing and gas transfer

Fig 4. The tray has an easy lock mechanism for convenient and proper
attachment of Cellbag bioreactors.

Temperature control
Efficient and evenly distributed heating is provided by the tray
heater plate. The temperature control is managed by sensors
that are integrated in the rocker base unit to enable reliable
temperature measurement and to minimize the need for
calibration when changing trays (Fig 5). To minimize the risk
for overheating, heating is only enabled when the rocker is in
motion. For accurate, stable, and fast temperature control, the
heater power output is automatically adjusted based on the
Cellbag bioreactor size and content weight. Temperature control
in two separate Cellbag bioreactor cultures when using the dual
functionality is shown in Figure 6.

The adjustable rocking parameters are speed, angle, and motion.
The parameter settings, in combination with the cell culture
volume, affect the mixing and gas transfer rate in the Cellbag
bioreactor. The speed parameter determines the number of
rocking cycles per minute, and the angle parameter relates to the
tray’s degree of tilting at the turning points. The motion parameter
determines the acceleration profile. The lowest motion parameter
setting, 15%, gives an almost constant speed throughout the
rocking cycle. In contrast, the highest setting, 100%, gives a faster
speed in the middle of the cycle and slower at the turning points.
Whereas oxygen transfer coefficient increases with increasing
rocking speed and angle, the rocking motion pattern only has a
minor effect on the oxygen transfer rate (Fig 7).

KA1658100118DF 3

Rocking speed (rpm)

Rocking speed (rpm)

Rocking speed (rpm)

10
9
25
5
20
8
15
7
6
10
5
4
3
2
10 12 14 16 18 20 22 24 26 28 30

Oxygen transfer coefficient

Angle (°)

Angle (°)

Rocking speed (rpm)

10
50
9
35 45
10
8
15
40
7
30
20
25
6
5
4
5
3
2
10 12 14 16 18 20 22 24 26 28 30

Volume = 10 L
10
25
9
5
8
20
15
7
10
6
5
4
3
2
10 12 14 16 18 20 22 24 26 28 30

Angle (°)

Angle (°)

Motion parameter
setting = 15%

Rocking speed (rpm)

10
85
9
70
80
60
8
75
65
50
7
55
45
6
35
5
4
25
40
20
30
3
15
2
10 12 14 16 18 20 22 24 26 28 30

Volume = 6 L
10
9
45
10
8
40
20
35
7
25 30
6
15
5
4
5
3
2
10 12 14 16 18 20 22 24 26 28 30

Angle (°)

Angle (°)

Motion parameter
setting = 100%

Volume = 2 L
10
90
9
55
70 85
75
8
80
65
7
60
6
35 40 45
30
5
50
25
4
20
3
15
2
10 12 14 16 18 20 22 24 26 28 30

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5

Rocking speed (rpm)

Fig 7. 4D contour plot of the oxygen transfer coefficient at the highest (100%) and lowest (15%) rocking motion parameter settings.

Weight measurement

Table 1. ReadyToProcess CBCU gas mixer overview

Load cells integrated in the rocker provide accurate and
continuous weight measurement of the culture and eliminate
the need for external scales. In dual mode, separate weight
measurements are provided for each Cellbag bioreactor. The
load cells communicate with the system control function
for proper media handling and tailored regulation of pH and
temperature. The weight measurement functionality is also used
for automatic calibration of the pumps in perfusion cultures. An
adjustable foot enables equal weight distribution between the
load cells even on nonlevel surfaces, for increased precision of
the weight measurement.

Feature

Description

CO2/O2/air mix
controller

Depending on the configuration, air is mixed with CO2
and/or O2 according to the set-points. Nitrogen can
be used instead of air for maintaining a low oxygen
environment for near-anaerobic applications.

Gas flow controller

The gas-mix flow is measured and controlled by a
mass flow controller (MFC). A correct volumetric flow
is achieved by compensation for CO2 concentration.
Quick filling of gas into the Cellbag bioreactor, enabled
by the fast-fill function, significantly reduces start-up
time. An alarm will inform the user if pressure sensors
detect under or overpressure at the gas inlets or
within the Cellbag bioreactor.

pH measurement

The pH is measured with optical pH sensors
preinstalled in Cellbag bioreactors of pHOPT
type. The sensor is connected to the CBCU via an
optical fiber cable.

DO measurement

The DO level is measured with optical DO sensors
preinstalled in Cellbag bioreactors of DOOPT
type. The sensor is connected to the CBCU via an
optical fiber cable.

Data storage and communication
Data and control parameters from the cell culture run are stored
on two independent, mirrored, solid-state drives integrated in
the rocker. Thus, once cultivation has been started and data
from the instrument modules have been collected, the run can
continue without the need for a network connection. The use of
two solid-state drives enables culturing without losing any data
even if only one drive is functional. After a run, data is stored in
a UNICORN database on an external computer. For facilitated
integration into a larger manufacturing operation, the rocker also
contains software for enabling direct communication with the
system via an open platform communication (OPC) link.

Three CBCU configurations are available:
•
•
•

CO2, O2, and pH
CO2, O2, and DO
CO2, O2, pH, and DO

The most suitable CBCU configuration will depend on the
specific application.

ReadyToProcess CBCU

ReadyToProcess Pump 25

The ReadyToProcess CBCU gas mixer is a compact unit with
multiple functions. The unit is primarily used for providing gas to
the culture and for monitoring of pH and DO. The unit contains
a mass flow controller, sensors for gas pressure and O2 and CO2
concentrations, and transmitters for pH and DO (Table 1).

The ReadyToProcess Pump 25 is a peristaltic unit incorporating
two roller pumps for feed, harvest, and pH control. The pump
design makes tubing installation convenient and easy. Tubing sizes
from 0.5 mm (1/50”) to 4.8 mm (3/16”) internal diameter can be
used to support flow rates from 0.07 to 100 mL/min. Flow rate is
regulated by weight feedback from the scale and is controlled by
automatic adjustments of the pump speed. Manual adjustment of
the flow rate is also possible.

4

KA1658100118DF

Up to three pump units with a total of six pump heads can be
connected to the rocker. Up to six pump roles can be selected
from a set of 12 options (left: acid, base, feed1, feed2, feed3, or
harvest; and right: acid, base, feed1, feed2, feed3, or harvest) for
the dual mode and seven options (acid, base, feed1, feed2, feed3,
feed4, or harvest) for the single mode.
Media handling and perfusion using calibrated pumps
Calibration of pumps can be performed manually or automatically
during an ongoing perfusion process. Automatic calibration is
possible for flow rates above 3.5 L/d and is easily managed by
entering the tubing diameter in the UNICORN control software.
Automated pH control
To minimize fluctuations in pH during adjustments with CO2/base
or acid/base, the flow rate of the acid/base pumps needs to be
rigorously controlled. The ReadyToProcess WAVE 25 system uses
combined information from the load cells, the current process pH
value, the pump tubing diameter, and the acid/base molarity for
calculation of the needed flow rate during the run.
Automation of process parameters in pH and DO control
The UNICORN software automatically sets the desired PID
(Proportional-integral-derivative) control parameters based on
Cellbag bioreactor size and gas flow set-point. The system also
adapts the parameters during the run, for optimization to reach a
new set-point or to maintain a current set-point.

UNICORN software
UNICORN system control software consists of four modules:
Administration, Method editor, System control, and Evaluation. A
comprehensive help tool is also included.
Administration
The Administration module is used to administer all functions of
the UNICORN software. Available functions include user and email
setup, controlling access to groups and network users, defining
and editing system properties, database management, and
logging records of usage and activity.
Method editor
Instructions to control a bioreactor run can be defined in a
method. The Method editor module is used to create, edit, save,
and work with methods. An existing method can be changed
to simplify the editing process. Individual changes can be saved
for later use on systems that have the same instrument and
component configuration.
System control
The System control module is used to connect to the system as
well as to start, view, and control a run (Fig 8). Default parameter
values for an instrument can be viewed and edited in the System
settings dialog before a run is started or during an ongoing
run using manual instructions. It is also possible to connect
to other systems.

Fig 8. Monitoring and controlling all aspects of the culture is managed
through the user-friendly interface.

The user-friendly and intuitive Process picture pane enables
manual interaction with the system and provides status of the
run parameters. Data is shown in the process picture but can also
be viewed as curves in the Charts tab. Curves and information
about the run are saved in a database, which can be opened in
the Evaluation module. The default view shows the curves most
commonly used. The user can customize which curves to display
and the color and style of the displayed curves.
Evaluation
In the Evaluation module, content of the result files can be viewed,
analyzed, and compiled as reports. Reports can be customized,
saved, and printed.
Alarms, notifications, and data logging
The UNICORN software allows easy access to all operations, data,
and alarm conditions. A dynamic, graphical user interface shows
the real-time status of the run, while data are automatically saved.
From the UNICORN software, the system is easily configured
to trigger an alarm when certain conditions are met. Individual
deviation alarms can be set for all essential parameters (heating,
gas flow, weight, O2, CO2, pH, and DO). The regulation of alarm
sensitivity and delay is defined by the user. If such an alarm
condition is triggered, the part of the system generating the alarm
is highlighted in the graphical user interface and an alarm dialog
is displayed. The alarm dialog displays information about the
alarm, such as date and time of occurrence, as well as a help text
describing the cause of the alarm and how to solve the problem.
The system is easily configured to send email notifications of
alarms and errors.
Regulatory readiness
The ReadyToProcess WAVE 25 system is suitable for
biomanufacturing of regulated products under various Quality
Management Systems. The use of UNICORN software in a 21 CFR
Part 11 and GAMP 5 compliant manner enables use of the system
in a regulated environment. Individual user access permissions
can be set and individual users are password-protected. Active
processes can be locked to enable unattended operations
without the risk of unauthorized interference. All records are
stored in a single, unalterable database, including results and
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extended run documentation. Additional validation support
includes comprehensive documentation on control system
validation as well as IQ/OQ services. The IQ/OQ offers proven
test procedures, verifying that the equipment has been installed
in accordance with system drawings and specifications. The
IQ/OQ also assures that the system operates as specified in the
design, satisfying functional requirements. The IQ/OQ protocols
enable quality assurance and allow regulatory reviewers to verify
that all functional testing of the quality critical equipment and
components, including the requirements of 21 CFR Part 11, has
been performed and documented.

The architecture in Figure 9 shows a system consisting of an
embedded personal computer (EPC) on the WAVE 25 system and a
Client PC (any Windows system) on DeltaV.
UaGateway is used as data communication tunneller between the
WAVE 25 and the DeltaV systems. Two OPC UaGateway instances
are required for communication: the first instance is installed on
the WAVE 25 system, the second instance goes on the DeltaV OPC
server on the user’s network. Because two OPC servers do not
communicate directly according to the OPC protocol, a third-party
data manager or an OPC bridge software needs to be added and
configured to allow communication between the two OPC servers.

Available validation support documentation includes:
•
•
•

WAVE 25 EPC

External PC

UNICORN

DeltaV™

UNICORN OPC layer

OPC mirror

OPC DA to UaGateway

OPC UA to DA Gateway

Detailed description of the development model used for
UNICORN software
21 CFR Part 11 system assessment in checklist format
Audit report and 21 CFR Part 11 conclusion on functionality by
an external, independent expert

Networking capabilities
UNICORN 7 operates in Windows® 7 and Windows 10 environments,
and the network ability allows real-time control from a remote
or local computer. Communication is Ethernet-based and each
instrument is controlled by a built-in instrument server. One
database can be connected to 32 systems, and up to three
instruments can be controlled simultaneously from one UNICORN
client. Results are saved locally, in the rocker, during the run and then
stored on the database server. Because results and instructions are
saved locally on the embedded drives, a run can continue even in the
event of a network communication failure.
Many users within biopharmaceutical and pharmaceutical
operations require automation in seed train and process
development. Although UNICORN provides the capability to
control standalone WAVE 25 bioreactors, many users of the
Emerson DeltaV™ Distributed Control System (DCS) prefer a
single interface to monitor and control all unit operations together,
including a WAVE 25 bioreactor system.
OPC UaGateway®
As an alternative to UNICORN communication, a WAVE 25 system
can also be setup to communicate set points and monitor process
values from the DeltaV operator station. To accomplish this, the
Open Platform Communications (OPC) UaGateway option that
comes with the WAVE 25 system can be used. The OPC UaGateway
provides a more streamlined connection for process control
and monitoring; it eliminates complexities associated with the
Distributed Component Object Model (DCOM)-based configuration.

GE owned

GE owned – New

Non GE

Fig 10. UaGateway architecture.

Please note that UNICORN client license is still required to perform for
the system’s initial configuration and definition. It is recommended
to install UNICORN on the OPC server on the DeltaV network. Please
contact your local representative for further information.

Cellbag bioreactors
Presterilized Cellbag bioreactors are single-use bags for the
noninvasive mixing of culture medium and cells during cultivation
(Fig 11). Cellbag bioreactors require no sterilization or cleaning
steps. The disposable bioreactors provide a suitable environment
for cell growth while minimizing the cross-contamination risk.
Optical
DO sensor
embedded
in bag

Air outlet
filter

Optional
tubing

Air inlet
filter

Inoculation/
harvest lines

Optical
pH sensor
embedded
in bag

Cellbag rod

Optional
tubing

Needleless
sampling port

Optional
tubing

Fig 11. Presentation of typical Cellbag bioreactor fittings.

OPC
communication
Fig 9. Setup of the WAVE 25 Bioreactor System on a client PC with DeltaV.

The bags are manufactured from multilayer, laminated, clear
USP Class VI plastics and are easily connected to the full suite
of ReadyToProcess cell culture, purification, and fluid handling
products. Table 2 shows possible combinations of Cellbag
bioreactors and trays when culturing in single or dual mode.
Cellbag bioreactors are available in two films: Bioclear™ 10 and the
low-antioxidant Bioclear 11. For more information about Cellbag
bioreactors, see data file 28951136.
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Table 2. Possible combinations of Cellbag bioreactors and trays when
culturing in single or dual mode

Cellbag
bioreactor
size (L)*

Bioreactor
culture
volume (L)

Tray
Single
culture mode

Dual
culture mode

2

0.3† to 1

Tray 10, Tray 20

Tray 20

10

0.5 to 5

Tray 10, Tray 20

Tray 20

20

1 to 10

Tray 20

Not applicable

22

1 to 10

Tray 50

Tray 50

50

5 to 25

Tray 50

Not applicable

* All Cellbag bioreactor sizes are available with internal perfusion filter for perfusion cultures and/or
can be equipped with single use optical pH (pHOPT) and DO (DOOPT II) sensors.
† Cellbag bioreactors with optical sensors require 300 mL minimal working volume. Depending on
application and configuration, it might be possible to cultivate below the recommended minimum
volume. However, it is highly recommended to stay above this volume for applications that require
high agitation and pH and DO control. The temperature, pH, and DO sensors need to be submerged
in liquid throughout the complete rocking cycle to function correctly.

System specifications
System specifications are listed in Table 3.
Table 3. ReadyToProcess WAVE 25 system specifications

General system specifications
Control system

UNICORN 6.3.2 or later version

Dimensions, W × H × D
Rocker
Tray 10
Tray 20
Tray 50
Lid 10
Lid 20
Lid 50
CBCU
Pump 25

404 × 205 × 560 mm
475 × 60 × 430 mm
740 × 70 × 480 mm
800 × 70 × 610 mm
475 × 230 × 430 mm
740 × 245 × 480 mm
800 × 260 × 610 mm
276 × 117 × 360 mm
275 × 115 × 280 mm

Weight
Rocker
Tray 10
Tray 20
Tray 50
Lid 10
Lid 20
Lid 50
CBCU
Pump 25

24.0 kg
4.5 kg
7.3 kg
9.5 kg
1.7 kg
3.3 kg
3.9 kg
4.8 kg
3.8 kg

Power supply

100 to 240 V, ~ 50 to 60 Hz

Power consumption

1500 VA

Enclosure protective class

IP 21
Normal use
1.3 L/min
0.2 L/min
0.7 L/min

Gas supply (per CBCU)
External air supply, 1.0 to 1.5 bar
External CO2 supply, 1.0 to 1.5 bar
External O2 supply, 1.0 to 1.5 bar

Fast fill
3.5 L/min
0.5 L/min
1.7 L/min

Environmental aspects
Operating ambient temperature range

15°C to 32°C

Operating humidity range

20% to 80% relative humidity
(noncondensing)

ReadyToProcess WAVE 25, rocker
Rocking speed control range1

2 to 40 rpm

Rocking angle control range1

2° to 12°

Rocking motion control range

15% to 100%

Medium weight control range

0.2 to 25 kg

Scale, absolute accuracy

± (0.050 + 1% of load) kg

Scale, left/right absolute
accuracy (dual mode)

± (0.1 + 6% of load) kg

Temperature sensor

Pt100 Class A

Temperature measurement range

2°C to 50°C

Temperature measurement accuracy

± 0.3°C in the range of 15°C to
50°C within ± 5°C from calibration
temperature

Temperature control range

(ambient temperature + 5°C) to 40°C

Temperature control accuracy
(excl. measurement error)

± 0.2°C

Temperature set point
difference (dual mode)

Max. 10°C at ambient temperature
(21°C)
Set point difference reduced by
1°C for each °C increase in ambient
temperature (e.g., at ambient 25°C,
max. set point difference is 6°C)

1

When cultivating in a 50 L Cellbag bioreactor at maximum working volume of 25 L, rocking speed
and angle multiplied should not exceed 240 rpm degrees. For example, if the rocking angle is set to
12 degrees, the rocking speed should not be set higher than 20 rpm.

ReadyToProcess CBCU
Gas flow control range

50 to 1000 mL/min

Total gas flow accuracy
(reference flow – set point)

± (10 + 3% of read value) mL/min

Fast-fill flow

~ 3 L/min

CO2 control range

0% to 15% CO2

CO2 measurement
accuracy at 5% CO2

± 0.5% CO2 when mixed only
with air/N2

CO2 control accuracy
(versus set point)

± 0.4% CO2

O2 control range

0% to 50% O2 when mixed with N2,
21% to 50% O2 when mixed with air

O2 measurement accuracy

± (0.6% + 1% of read value) % O2
within 0% to 50% O2 when mixed
only with air/N2

O2 control accuracy
(versus set point)

± 0.6% O2

pH measurement range

pH 4.5 to 8.5

pH control range

pH 6.0 to 8.0

pH measurement accuracy

± 0.05 pH within ± 0.25 pH from offset
calibration pH
± 0.1 pH within 0.25 to 0.5 pH from
offset calibration

pH control accuracy
(versus set point)

± 0.05 pH

DO measurement range

0% to 250% air saturation

DO measurement accuracy

± 5% air saturation (excl. atmospheric
pressure variations)

DO control range

0% to 100% air saturation

ReadyToProcess Pump 25
Pump flow rate range

0.1 to 144 L/d (0.07 to 100 mL/min)

Pump flow accuracy

± (0.1 + 5% of read value) mL/min
after calibration

Accumulated pumped
volume accuracy

± 10% of measured volume

Supported tubing dimensions

i.d. 0.5 to 4.8 mm (1/50” to 3/16“)
wall thickness: 1.6 mm (1/16”)

Applications
ReadyToProcess WAVE 25 is designed for a variety of cell culture
applications involving mammalian, insect, and plant cells:
•
•
•
•

Batch culture
Fed-batch culture
Perfusion culture
Cultivation of adherent cells
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Ordering information
Product

Description

ReadyToProcess WAVE 25

Rocker

Product code

Related literature

Product code

28988000

UNICORN 7.0.2 Manual Package

29191514
29278101

ReadyToProcess CBCU pH

Gas flow/mix and pH

29044213

OPC UaGateway Manual

ReadyToProcess CBCU DO

Gas flow/mix and DO

29044216

UNICORN OPC Manual

29110887

UNICORN 7 software, data file

29135786

ReadyToProcess CBCU Full

Gas flow/mix,
pH, and DO

29044081

UNICORN 7 Academia Package

29203853

ReadyToProcess Pump 25

Pump

29032003

UNICORN 7 Process Development Package

29203854

UNICORN 7 WrkStn pure-BP-exp

License

29128116

UNICORN 7 Manufacturing Package

29203855

UNICORN 7 Remote

License

29115426

License

29115427

Disposable Cellbag bioreactors for
WAVE Bioreactor systems, data file

28951136

UNICORN 7 Dry
UNICORN 7 Evaluation Classic

License

29115456

Validation Support File UNICORN 7.0

28962650

ReadyToProcess WAVE 25, site preparation guide

29056702

ReadyToProcess WAVE 25, operating instructions

29009597

ReadyToProcess WAVE 25, system handbook

29009598

UNICORN 7.0.2 DVD pack

Media (no license)

29195162

OPC DA to UaGateway Converter

Software

29292362

OPC UA to DA Tunneller

Software

29292368

Tray 10

–

29044472

Tray 20

–

29044473

Tray 50

–

29044474

Lid 10

–

29044475

Lid 20

–

29044476

Lid 50

–

29044477

Filter heater*

–

29044471

Bag sensor adaptor
2.5 m assembly†

Fiber cable for pH
and DO control

28984189

Tub kit CBCU

1

29112187

Adjustable foot wrench‡

1

29112525

* One delivered with the rocker, additional needed for dual functionality.
† Depending on configuration, one or two fiber cables are delivered with the CBCU unit.
‡ One delivered with the rocker.
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_a^cTRcX^]PVPX]bcRa^bbR^]cP\X]PcX^]
0b_Pac^UATPShC^?a^RTbb_[PcU^a\cWTF0E41X^aTPRc^a
QaX]Vb TgXQX[XchP]Sb_TTSc^d_bcaTP\P]SS^f]bcaTP\
_a^RTbbX]V^UQX^[^VXRP[bCWT_a^SdRcaP]VTR^\_aXbTb
F0E41X^aTPRc^abhbcT\bF0E4<XgTacdQX]V
bTP[TabP]SUdbTabW^[[^f QTaP]S]^a\P[ ^f [cTab
_aT_PRZTSRWa^\Pc^VaP_WhR^[d\]bP]S«:C0aTPSh
RWa^\Pc^VaP_WhbhbcT\fXcWPSXb_^bPQ[T ^f_PcWPbfT[[
PbcWTPbbT\Q[XTbP]SR^]]TRcX^]bX]QTcfTT]CWT_[PcU^a\
XbbRP[PQ[TUa^\cWT[PQQT]RWc^\P]dUPRcdaX]V
WAVE Bioreactor 200 system delivers:
~ 2^]eT]XT]RT)?aTbcTaX[XiTSbX]V[TdbT2T[[QPVQX^aTPRc^ab
_a^cTRcPVPX]bccWTaXbZ^URa^bbR^]cP\X]PcX^]aT`dXaT
]^R[TP]X]VP]SX]e^[eT\X]X\P[eP[XSPcX^]P]ScWThPaT
bd__[XTSX]PaTPShc^dbTU^a\Pc
~ AT[XPQX[Xch)2T[[QPVQX^aTPRc^abX]R[dSX]VP[[ ccX]VbP]S
[cTabPaTbd__[XTSbcTaX[TP]SaTPShU^adbTCWThPaT
bdXcPQ[TU^aR6<?R^\\TaRXP[_a^SdRcX^]P]SPQX^bPUTch
RPQX]TcXb]^caT`dXaTSU^aX]^Rd[PcX^]^abP\_[X]V
~ 5[TgXQX[Xch)<d[cX_[TX]bcad\T]cR^] VdaPcX^]bU^abdb_T]bX^]
\XRa^RPaaXTaQPcRWUTSQPcRW^a_TaUdbX^]Rd[cdaT
~ ETabPcX[Xch)CWT!bhbcT\XbRP_PQ[T^UWP]S[X]VRd[cdaT
e^[d\TbUa^\ c^ ;

Fig 1. CWTF0E41X^aTPRc^a!bhbcT\XbbdXcPQ[TU^aRd[cdaTe^[d\Tb^U
c^ ;

System descriptions
CWTF0E41X^aTPRc^a!bhbcT\R^\_aXbTbX]cTVaP[a^RZX]V
cT\_TaPcdaTfTXVWcP]SPXa ^fR^]ca^[[TabCWTbT[U
R^]cPX]TSbhbcT\XbSTbXV]TSU^adbTfXcWf^aZX]VRd[cdaT
e^[d\Tb^U c^ ;X]P__[XRPcX^]bbdRWPbX]^Rd[d\
bRP[Td_A3R^\\TaRXP[_a^SdRcX^]ePRRX]T_a^SdRcX^]
P]SP]cXQ^Sh\P]dUPRcdaT5^aPSSXcX^]P[ TgXQX[Xch^_cX^]P[
\^Sd[TbX]R[dSX]V3>2>!>!fTXVWc_TaUdbX^]P]S_7
R^]ca^[RP]QTPSSTSfWX[TQdX[cX]4cWTa]TcP]S<>31DB
SPcP_^acbP[[^fR^\\d]XRPcX^]fXcW^cWTab^UcfPaT

Applications
CWTF0E41X^aTPRc^abhbcT\XbbdXcPQ[TU^adbTfXcW
P]RW^aPVTST_T]ST]cRT[[bX]PSSXcX^]c^RT[[bdb_T]bX^]b
P]SWPbP__[XRPcX^]bX])
~ <^]^R[^]P[P]cXQ^SXTb
~ 8]bTRcRT[[Rd[cdaT
~ EXadb_a^SdRcX^]
~ 6a^fX]V_PcW^VT]b^a^cWTaWXVWR^]cPX]\T]cbhbcT\b
~ 8]^Rd[d\bRP[Td_
~ ?a^cTX]Tg_aTbbX^]
~ ?aX\PahRT[[[X]TTg_P]bX^]

Components

UNICORN™ DAQ

Touchscreen

D=82>A=30@ b^UcfPaTUPRX[XcPcTbaTP[cX\TSPcP
PR`dXbXcX^]U^acWT\P]PVT\T]cP]STeP[dPcX^]^UaTbd[cb
Ua^\RT[[Rd[cdaTb_TaU^a\TSdbX]Vd_c^U^daSXUUTaT]cF0E4
1X^aTPRc^abhbcT\bR^]]TRcTSc^PbX]V[T?2CWTF0E4
1X^aTPRc^abhbcT\RP]QTR^]]TRcTSSXaTRc[h^a]Tcf^aZTS
c^cWTb^UcfPaT_a^eXSX]VPR^\\^]_[PcU^a\P]SdbTa
X]cTaUPRTU^a\^]Xc^aX]VP]Sbc^aX]VaTbd[cSPcP0Sh]P\XR
VaP_WXRP[dbTaX]cTaUPRTX]U^a\bh^dPQ^dccWTaTP[cX\T
bcPcdb^UcWTad]QTX]V\^]Xc^aTS3daX]VPad]SPcPXb
Pdc^\PcXRP[[hbPeTSc^P[^RP[WPaSSaXeT^abTaeTaX]P
bTRdaTP]Sd]P[cTaPQ[TaTbd[c [TU^aPSSTSbTRdaXch

CWTR^[^ac^dRWbRaTT]5XV![^RPcTS^]cWTR^]ca^[_P]T[^U
cWTF0E41X^aTPRc^a!bhbcT\T]PQ[TbcWTbTcd_R^]ca^[
P]SeXTfX]V^UP[[RT[[Rd[cdaT_PaP\TcTabfWX[TSPcPRP]QT
\^]Xc^aTSVaP_WXRP[[hX]aTP[cX\TCWT\PX]\T]d_a^eXSTb
P]^eTaeXTf^UZTh^_TaPcX]VR^]SXcX^]bP]SXcXbcWT\PX]
PRRTbbbRaTT]U^aP[[R^]ca^[b3XUUTaT]cR^]ca^[Qdcc^]bPaT
SXb_[PhTSST_T]SX]V^]cWT^_cX^]bT]PQ[TS?aTbbX]VcWT
STbXaTSQdcc^]fX[[cPZTh^dc^cWTaTb_TRcXeTR^]ca^[bRaTT]
CWTc^dRWbRaTT]XbW^dbTSX]PbcPX][TbbbcTT[T]R[^bdaTP]S
RP]QTcX[cTSP]Sa^cPcTSU^aTPbXTaeXTfX]V

Quick-release bag holder
AP_XSaT[TPbT2P\[^RZ[TeTabbTRdaTcWT2T[[QPVQX^aTPRc^a
X]_[PRT^]cWTa^RZX]V_[PcU^a\P[[^fX]VQPVbc^QT
PccPRWTSP]SaT\^eTSX]\X]dcTbCWTW^[STaSTbXV]T]bdaTb
cWPccWT2T[[QPVQX^aTPRc^aXb[^RZTSX]cWT^_cX\P[_^bXcX^]
U^a^ghVT]caP]bUTaP]S\XgX]V
Fig 2. CWTc^dRWbRaTT]
_a^eXSTbTPbhPRRTbbc^
P[[R^]ca^[Ud]RcX^]b

Expansion slots
>_cX^]P[\^Sd[TbbdRWPbcWTSXbb^[eTS^ghVT]3>>!2>!
_7P]SSdP[bhbcT\R^]ca^[[TabRP]QTPSSTSc^bcP]SPaS
F0E41X^aTPRc^abhbcT\bc^\^]Xc^aP]SR^]ca^[PSSXcX^]P[
_PaP\TcTabPbh^daaT`dXaT\T]cbRWP]VTCWTbT\^Sd[Tb
_[dVX]c^cWTUa^]cP]SQPRZX]bcad\T]c_P]T[b5XV"^UcWT
QPbTd]XcP]SPaTT]PQ[TSeXPcWTX]bcad\T]c{bR^] VdaPcX^]
P]SRP[XQaPcX^]Ud]RcX^]bX]^aSTac^SXb_[PhcWT\^Sd[T
ePaXPQ[TbP]SR^]ca^[b^]cWTR^[^ac^dRWbRaTT]B_PaTaPRZb
PaTX]R[dSTSU^aUdcdaTX]bcad\T]c^_cX^]b

Stainless steel construction
CWTbcPX][TbbbcTT[W^dbX]V^UF0E41X^aTPRc^a!bhbcT\
R^\_[TcT[hT]R[^bTbcWTSXb_^bPQ[T2T[[QPVQX^aTPRc^aP]S
_a^cTRcbXcUa^\PRRXST]cP[SP\PVTCWTW^dbX]VXbRP_PQ[T
^UR^]cPX]X]V_^cT]cXP[b_X[[bCWTF0E41X^aTPRc^a!
bhbcT\Xb\^d]cTS^]RPbcTabU^a\^QX[Xch

Optional components
pH monitor
CWT_7\^]Xc^a_a^eXSTbP\_[X RPcX^]SXb_[PhP]SSPcP
caP]b\XbbX^]^U_7P[[^fX]VaTP[cX\T\TPbdaT\T]c^U_7X]
cWT2T[[QPV1X^aTPRc^aCWT_7\^]Xc^afPbSTbXV]TSU^adbT
fXcW_7bT]b^aX]cTVaPcTSX]c^cWTF0E42T[[QPV

Dissolved oxygen monitor
CWT3>\^]Xc^a_a^eXSTbP\_[X RPcX^]SXb_[PhP]SSPcP
caP]b\XbbX^]^U3>R^]RT]caPcX^]P[[^fX]VaTP[cX\T
\TPbdaT\T]c^U3>R^]RT]caPcX^]X]bXSTcWT2T[[QPV
QX^aTPRc^aCWT3>\^]Xc^aR^]ca^[[TafPbSTbXV]TSU^adbT
fXcW3>bT]b^aX]cTVaPcTSX]c^cWTF0E42T[[QPVP]SXcRP]
X]RaTPbTcWTa^RZX]VaPcT^aVPbR^]RT]caPcX^]Pdc^\PcXRP[[h
c^\PX]cPX]^][X]TR^]ca^[^U3>

Fig 3. 4g_P]bX^]b[^cbPaT_a^eXSTSU^acWT
X]bcP[[PcX^]^U^_cX^]P[X]bcad\T]cPcX^]

Linear electronic motor
0]T[TRcaXR[X]TPa\^c^aXbdbTSc^a^RZcWTQPbTd]Xcb^U
cWTF0E41X^aTPRc^a!bhbcT\D][XZTVTPaTS\^c^ab
cWXbT[TRca^\PV]TcXRSTeXRTWPb^][h^]T\^eX]V_PacP]S
_a^eXSTbVaTPcTaaT[XPQX[XchCWT[X]TPa\^c^aU^[[^fbP_aTbTc
P]S^_cX\P[b_TTSP]SPRRT[TaPcX^]_a^ [Tc^_a^eXSTcWT
\^bcTUUTRcXeTfPeTU^aTU RXT]c[^fbWTPa\XgX]V

!  !(!"& "00

O2/air mix controller
CWT>!PXa\XgR^]ca^[[TaR^]]TRcbc^Pbd__[h^U^ghVT]
P]S[^f_aTbbdaT=!bd__[hXUaT`dXaTSc^_a^eXST>!PXa
R^]RT]caPcX^]bQTcfTT]P]S$>!CWTX]bcad\T]c
R^]ca^[bT]aXRWTS^ghVT][TeT[bU^aX]bTRcRT[[QPRd[^eXadb
P]SWXVWRd[cdaTST]bXchP__[XRPcX^]b*XcXbP[b^dbTUd[U^a
\PX]cPX]X]V[^f^ghVT]T]eXa^]\T]cbU^a]TPaP]PTa^QXR
P__[XRPcX^]b

Technical information and specifications

CO2/air mix controller
CWT2>!PXa\XgR^]ca^[[TaR^]]TRcbc^Pbd__[h^U 2>!
c^_a^eXST2>!PXaR^]RT]caPcX^]bQTcfTT]P]S $
2>!CWTX]bcad\T]cXbdbTUd[U^a_7R^]ca^[^UQXRPaQ^]PcT
QdUUTaTSRT[[Rd[cdaT\TSXP

WAVE Bioreactor 200 system
5TPcdaTb

C^dRW_P]T[^_TaPc^aX]cTaUPRT
3XaTRcSaXeTT[TRca^]XR[X]TPa\^c^a

Temperature control

0SYdbcPQ[Ta^RZX]VaPcTUa^\#c^!$a^RZb\X]
fXcWPRRT[TaPcX^]R^]ca^[

CT\_TaPcdaTXbaTVd[PcTSU^abX]V[TP]SSdP[F0E41X^aTPRc^a
bhbcT\b5XV#

0SYdbcPQ[Ta^RZX]VP]V[TUa^\!c^(8]cTVaP[
cT\_TaPcdaTR^]ca^[[TafXcWWTPcTa8]cTVaP[
fTXVWcR^]ca^[[Ta

37

8]cTVaP[PXaU[^fR^]ca^[[Ta

35

8]cTVaP[?83R^]ca^[[TaU^aPdc^\PcXRcT\_TaPcdaT
>!2>!3>P]S_7PSYdbc\T]c

Temperature (°C)

ATP[cX\TSPcP\^]Xc^aX]V
AB#'$<>31DBR^\\d]XRPcX^]b_^ac

33

1PbTC4cWTa]TcR^\\d]XRPcX^]b_^acAT\^cT
P[Pa\R^]cPRcP]S_aX]cTaX]cTaUPRTBcPX][TbbbcTT[
R^]cPX]\T]cT]R[^bdaT

5 L/100 L
50 L/100 L
50 L/200 L
100 L/200 L

31
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3X\T]bX^]b
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1PbTd]Xc) '$!¾ (%¾

FTXVWcT\_ch

"$ZV&'[Q

DcX[XcXTb

E^[cPVT)  !!!!#E02
5aT`dT]Rh)$%7i
<PgX\d\RdaaT]c) $0
?^fTa) !:E0

4]eXa^]\T]cP[

CWXbT`dX_\T]cXbSTbXV]TSU^adbTd]STacWT
U^[[^fX]VR^]SXcX^]b)
~8]S^^adbT
~$2c^#2
~D_c^'\PgX\d\aT[PcXeTWd\XSXchaWPc
" 2STRaTPbX]V[X]TPa[hc^$aWPc#2

Time (min)
Fig 4. CT\_TaPcdaTR^]ca^[Ua^\!&2c^"&2X]$;$;X] ;QPV$;
;X]!;QPV

Dual Cellbag control system
CWTF0E41X^aTPRc^a!bhbcT\RP]QTR^] VdaTSU^a
TXcWTabX]V[T^aSdP[2T[[QPVQX^aTPRc^aR^]ca^[8]cWTSdP[
QPVR^] VdaPcX^]cWT\T]d^]cWTc^dRWbRaTT]f^d[S
SXb_[Ph[TUcP]SaXVWcQPVeP[dTbU^aRTacPX]_PaP\TcTab
bdRWPbQPV_aTbbdaTP]ScT\_TaPcdaT8]cWTbX]V[TQPV
R^] VdaPcX^]^][hSPcPU^acWT[TUcWP]SbXSTQPVXbbW^f]
8]bcad\T]cbR^] VdaTSPbSdP[QPVbhbcT\bRP]QTbTcc^
bX]V[TQPV^_TaPcX^]dbX]VcWTbTcd_bRaTT]

!\\&"¾#"¾##X]

Analog output card
D_c^TXVWcRWP]]T[b^UP]P[^V^dc_dcbPaTPePX[PQ[TPb
P]^_cX^]U^aR^]ca^[[X]VX]bcad\T]cePaXPQ[TbbdRWPb
a^RZX]Vb_TTSfTXVWcPXa ^fcT\_TaPcdaT_73>2>!
P]S>!fXcWX]cWTXa_aTbTcaP]VTbCWT31!$_X]P]P[^V
^dc_dcR^]]TRc^aXb[^RPcTS^]cWTaTPa_P]T[^UcWTa^RZTa
QPbTd]XcCf^P]P[^V^dc_dcRPaSbPaTaT`dXaTSU^aSdP[
R^] VdaTSbhbcT\b

Loadcell
4[TRca^]XR[^PSRT[[\^Sd[Tb_a^eXST^][X]T\TPbdaT\T]c^U
2T[[QPVQX^aTPRc^afTXVWcP]SRP]QTdbTSU^aPdc^\PcTS
[[X]VP]SWPaeTbcX]V^U\TSXP0QdX[cX]_d\_R^]ca^[[Ta
\PX]cPX]bPR^]bcP]ce^[d\TU^a_TaUdbX^]^_TaPcX^]b
;^PSRT[[\^Sd[TbPaT^_cX^]P[UPRc^ahX]bcP[[TSPRRTbb^aXTb
U^aF0E41X^aTPRc^a!bhbcT\

!(!"& "00  "

Ordering information
Product

Code number

BHBC4<!472>!

!'#

$$&

BHBC4<!472>!>!

!'#

$$$

BHBC4<!472>!>!0=

!'#

$$!

BHBC4<!472>!?7>?C0=

!'('#($#

BHBC4<!47>!3>>?C880=

!(#!'

BHBC4<!472>!>!3>>?C88?7>?C0=

!( %#

BHBC4<!473

!'("%%'%

BHBC4<!4732>!0=

!'#

$#$

BHBC4<!4732>!>!0=

!'#

$##

BHBC4<!4732>!?7>?C0=

!'('#($"

BHBC4<!473>!3>>?C880=

!(#!'!

BHBC4<!4732>!>!3>>?C88?7>?C0=

!( %"&

Related literature
3Xb_^bPQ[T2T[[QPVQX^aTPRc^abU^a
cWTF0E41X^aTPRc^abhbcT\3PcPUX[T

!'($

ATPShC^?a^RTbbR^]]TRcXeXch3PcPUX[T

!( "''#

F0E4?>3888]cTVaPcTS2^]ca^[[Ta3PcPUX[T

!'(%%$&

F0E41X^aTPRc^a! P]S!$bhbcT\b3PcPUX[T

!'($!$'

F0E41X^aTPRc^a$ bhbcT\3PcPUX[T

!(!"& !

"%

64X\PVX]PcX^]Pcf^aZP]S64\^]^VaP\PaTcaPST\PaZb^U
6T]TaP[4[TRcaXR2^\_P]h
«:C02T[[QPVATPShC^?a^RTbbD=82>A=F0E41X^aTPRc^a
F0E4<XgTaP]SF0E4?>3PaTcaPST\PaZb^U647TP[cWRPaT
R^\_P]XTb

5^a[^RP[^U RTR^]cPRcX]U^a\PcX^]eXbXc
www.gelifesciences.com/contact
fffVT[XUTbRXT]RTbR^\aTPShc^_a^RTbb
647TP[cWRPaT1X^BRXT]RTb01
1YÝaZVPcP]"
&$ '#D__bP[P
BfTST]

! !6T]TaP[4[TRcaXR2^\_P]h0[[aXVWcbaTbTaeTS
5Xabc_dQ[XbWTS9d]! !
0[[V^^SbP]SbTaeXRTbPaTb^[SbdQYTRcc^cWTcTa\bP]SR^]SXcX^]b
^UbP[T^UcWTR^\_P]hfXcWX]647TP[cWRPaTfWXRWbd__[XTbcWT\
0R^_h^UcWTbTcTa\bP]SR^]SXcX^]bXbPePX[PQ[T^]aT`dTbc
2^]cPRch^da[^RP[647TP[cWRPaTaT_aTbT]cPcXeTU^acWT\^bcRdaaT]c
X]U^a\PcX^]
647TP[cWRPaTD:;X\XcTS
0\TabWP\?[PRT
;Xcc[T2WP[U^]c
1dRZX]VWP\bWXaT7?&(=0
D:
647TP[cWRPaT4da^_T6\Q7
<d]iX]VTaBcaPbbT$
3&(
5aTXQdaV
6Ta\P]h
647TP[cWRPaT1X^BRXT]RTb2^a_
'2T]cT]]XP[0eT]dT?>1^g "!&
?XbRPcPfPh=9''$$ "!&
DB0
647TP[cWRPaT9P_P]2^a_^aPcX^]
BP]ZT]1[SV"!$ 7hPZd]X]RW^
BWX]YdZdZdC^Zh^ %(&"
9P_P]

imagination at work
!(!"& "00 %! !

647TP[cWRPaT
;XUTBRXT]RTb
3PcP [T!(!"& !00

ATPShC^?a^RTbb

F0E41X^aTPRc^a$ bhbcT\
F0E41X^aTPRc^a$ bhbcT\5XV Xb_Pac^U
647TP[cWRPaT;XUTBRXT]RTbATPShC^?a^RTbb_[PcU^a\^U
aTPShc^dbT_a^SdRcbCWTbhbcT\XbPRT[[Rd[cdaTSTeXRT
U^acWT_a^SdRcX^]^UaTR^\QX]P]c_a^cTX]bX]\P\\P[XP]
P]SX]bTRcRT[[[X]TbX]QPcRWUTSQPcRWP]S_TaUdbX^]
Rd[cdaT2d[cdaT\TSXd\P]SRT[[bPaT[^PSTSX]c^PbX]V[T
dbT_aTbcTaX[XiTSQPVZ]^f]PbcWT2T[[QPVQX^aTPRc^aCWT
2T[[QPVQX^aTPRc^aXb_[PRTS^]P]T[TRcaXRa^RZX]VQPbTCWT
a^RZX]V\^cX^]^UcWXbQPbTX]SdRTbfPeTbX]cWTRT[[Rd[cdaT
dXSfXcWX]cWT2T[[QPVQX^aTPRc^ac^_a^eXSTTU RXT]c\XgX]V
P]SVPbcaP]bUTaCWTaTbd[cX]VT]eXa^]\T]cfXcWX]cWT2T[[QPV
QX^aTPRc^aRP]TPbX[hbd__^ac ¾ &RT[[b\;CWT2T[[QPV
QX^aTPRc^aaT`dXaTb]^R[TP]X]V^abcTaX[XiPcX^]_a^eXSX]VTPbh
^_TaPcX^]P]S_a^cTRcX^]PVPX]bcRa^bbR^]cP\X]PcX^]
0b_Pac^UATPShC^?a^RTbb_[PcU^a\cWTF0E41X^aTPRc^a
QaX]Vb TgXQX[XchP]Sb_TTSc^d_bcaTP\P]SS^f]bcaTP\
_a^RTbbX]V^UQX^[^VXRP[bCWT_a^SdRcaP]VTR^\_aXbTb
F0E41X^aTPRc^abhbcT\bF0E4<XgTacdQX]V
bTP[TabP]SUdbTabW^[[^f QTaP]S]^a\P[ ^f [cTab
_aT_PRZTSRWa^\Pc^VaP_WhR^[d\]bP]S«:C0aTPSh
RWa^\Pc^VaP_WhbhbcT\fXcWPSXb_^bPQ[T ^f_PcWPbfT[[
PbcWTPbbT\Q[XTbP]SR^]]TRcX^]bX]QTcfTT]CWT_[PcU^a\
XbbRP[PQ[TUa^\cWT[PQQT]RWc^\P]dUPRcdaX]V
WAVE Bioreactor 500/1000 system delivers:
~ 2^]eT]XT]RT)?aTbcTaX[XiTSbX]V[TdbT2T[[QPVQX^aTPRc^ab
_a^cTRcPVPX]bccWTaXbZ^URa^bbR^]cP\X]PcX^]aT`dXaT
]^R[TP]X]VP]SX]e^[eT\X]X\P[eP[XSPcX^]P]ScWThPaT
bd__[XTSX]PaTPShc^dbTU^a\Pc
~ AT[XPQX[Xch)2T[[QPVQX^aTPRc^abX]R[dSX]VP[[ ccX]VbP]S
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Fig 1. CWTF0E41X^aTPRc^a$ bhbcT\XbbdXcPQ[TU^aRd[cdaTe^[d\Tb
^U$c^$;

System descriptions
CWTF0E41X^aTPRc^a$ bhbcT\R^\_aXbTbX]cTVaP[
a^RZX]VcT\_TaPcdaTfTXVWcP]SPXa ^fR^]ca^[[TabCWT
bT[UR^]cPX]TSbhbcT\XbSTbXV]TSU^adbTfXcWf^aZX]V
Rd[cdaTe^[d\Tb^UQTcfTT]$P]S$;X]P__[XRPcX^]b
bdRWPbX]^Rd[d\bRP[Td_A3_a^RTbbSTeT[^_\T]c
R^\\TaRXP[_a^SdRcX^]ePRRX]T_a^SdRcX^]P]SP]cXQ^Sh
\P]dUPRcdaT5^aPSSXcX^]P[ TgXQX[Xch^_cX^]P[\^Sd[Tb
X]R[dSX]V3>2>!>!fTXVWc_TaUdbX^]P]S_7R^]ca^[RP]
QTPSSTSfWX[TQdX[cX]4cWTa]TcP]S<>31DBSPcP_^acb
P[[^fR^\\d]XRPcX^]fXcW^cWTab^UcfPaT

Applications
CWTF0E41X^aTPRc^abhbcT\XbbdXcPQ[TU^adbTfXcW
P]RW^aPVTST_T]ST]cRT[[bX]PSSXcX^]c^RT[[bdb_T]bX^]b
P]SWPbP__[XRPcX^]bX])

~ 5[TgXQX[Xch)<d[cX_[TX]bcad\T]cR^] VdaPcX^]bU^abdb_T]bX^]
\XRa^RPaaXTaQPcRWUTSQPcRW^a_TaUdbX^]Rd[cdaT

~ <^]^R[^]P[P]cXQ^SXTb

~ ETabPcX[Xch)CWT$ bhbcT\XbRP_PQ[T^UWP]S[X]V
Rd[cdaTe^[d\TbUa^\$c^$;

~ EXadb_a^SdRcX^]

~ 8]bTRcRT[[Rd[cdaT
~ 6a^fX]V_PcW^VT]b^a^cWTaWXVWR^]cPX]\T]cbhbcT\b
~ 8]^Rd[d\bRP[Td_
~ ?a^cTX]Tg_aTbbX^]
~ ?aX\PahRT[[[X]TTg_P]bX^]

Components

Quick-release bag holder

Touchscreen

AP_XSaT[TPbT2P\[^RZ[TeTabbTRdaTcWT2T[[QPVQX^aTPRc^a
X]_[PRT^]cWTa^RZX]V_[PcU^a\P[[^fX]VQPVbc^QT
PccPRWTSP]SaT\^eTSX]\X]dcTbCWTW^[STaSTbXV]T]bdaTb
cWPccWT2T[[QPVQX^aTPRc^aXb[^RZTSX]cWT^_cX\P[_^bXcX^]
U^a^ghVT]caP]bUTaP]S\XgX]V

CWTR^[^ac^dRWbRaTT]5XV![^RPcTS^]cWTR^]ca^[_P]T[^U
cWTF0E41X^aTPRc^a$ bhbcT\T]PQ[TbcWTbTcd_
R^]ca^[P]SeXTfX]V^UP[[RT[[Rd[cdaT_PaP\TcTabfWX[TSPcP
RP]QT\^]Xc^aTSVaP_WXRP[[hX]aTP[cX\TCWT\PX]\T]d
_a^eXSTbP]^eTaeXTf^UZTh^_TaPcX]VR^]SXcX^]bP]SXcXb
cWT\PX]PRRTbbbRaTT]U^aP[[R^]ca^[b3XUUTaT]cR^]ca^[
Qdcc^]bPaTSXb_[PhTSST_T]SX]V^]cWT^_cX^]bT]PQ[TS
?aTbbX]VcWTSTbXaTSQdcc^]fX[[cPZTh^dc^cWTaTb_TRcXeT
R^]ca^[bRaTT]CWTc^dRWbRaTT]XbW^dbTSX]PbcPX][TbbbcTT[
T]R[^bdaTP]SRP]QTcX[cTSP]Sa^cPcTSU^aTPbXTaeXTfX]V

Optional components
pH Monitor
CWT\^]Xc^aT]PQ[Tb^][X]T\TPbdaT\T]c^U_7dbX]VP
bX]V[TdbTT[TRca^RWT\XRP[_a^QT_aTX]bcP[[TSX]2T[[QPV
QX^aTPRc^ab

Dissolved oxygen monitor

Fig 2. CWTc^dRWbRaTT]
_a^eXSTbTPbhPRRTbb
c^P[[R^]ca^[Ud]RcX^]b

CWTSXbb^[eTS^ghVT]3>\^]Xc^a_a^eXSTbP\_[X RPcX^]
SXb_[PhP]SSPcPcaP]b\XbbX^]^U3>R^]RT]caPcX^]P[[^fX]V
aTP[cX\T\TPbdaT\T]c^U3>R^]RT]caPcX^]X]bXSTcWT
2T[[QPVQX^aTPRc^aCWT3>\^]Xc^aR^]ca^[[TafPbSTbXV]TS
U^adbTfXcW\X]XPcdaT QTa^_cXRSXbb^[eTS^ghVT]_a^QTb
3>>?C?A>14P]SXcRP]X]RaTPbTcWTa^RZX]VaPcT
Pdc^\PcXRP[[hc^\PX]cPX]^][X]TR^]ca^[^U3>

O2/air mix controller
Expansion slots
>_cX^]P[\^Sd[TbbdRWPbcWTSXbb^[eTS^ghVT]3>>!2>!
_7P]SSdP[bhbcT\R^]ca^[[TabRP]QTPSSTSc^bcP]SPaS
F0E41X^aTPRc^abhbcT\bc^\^]Xc^aP]SR^]ca^[PSSXcX^]P[
_PaP\TcTabPbh^daaT`dXaT\T]cbRWP]VTCWTbT\^Sd[Tb
_[dVX]c^cWTUa^]cP]SQPRZX]bcad\T]c_P]T[b5XV"^UcWT
QPbTd]XcP]SPaTT]PQ[TSeXPcWTX]bcad\T]c{bR^] VdaPcX^]
P]SRP[XQaPcX^]Ud]RcX^]bX]^aSTac^SXb_[PhcWT\^Sd[T
ePaXPQ[TbP]SR^]ca^[b^]cWTR^[^ac^dRWbRaTT]B_PaTaPRZb
PaTX]R[dSTSU^aUdcdaTX]bcad\T]c^_cX^]b

CWT>!PXa\XgR^]ca^[[TaR^]]TRcbc^Pbd__[h^U^ghVT]
P]S[^f_aTbbdaT=!bd__[hXUaT`dXaTSc^_a^eXST>!PXa
R^]RT]caPcX^]bQTcfTT]P]S$>!CWTX]bcad\T]c
R^]ca^[bT]aXRWTS^ghVT][TeT[bU^aX]bTRcRT[[QPRd[^eXadb
P]SWXVWRd[cdaTST]bXchP__[XRPcX^]b*XcXbP[b^dbTUd[U^a
\PX]cPX]X]V[^f^ghVT]T]eXa^]\T]cbU^a]TPaP]PTa^QXR
P__[XRPcX^]b

CO2/air mix controller
CWT2>!PXa\XgR^]ca^[[TaR^]]TRcbc^Pbd__[h^U 2>!
c^_a^eXST2>!PXaR^]RT]caPcX^]bQTcfTT]P]S $
2>!CWTX]bcad\T]cXbdbTUd[U^a_7R^]ca^[^UQXRPaQ^]PcT
QdUUTaTSRT[[Rd[cdaT\TSXP

Analog output card

Fig 3. 4g_P]bX^]b[^cbPaT_a^eXSTSU^acWT
X]bcP[[PcX^]^U^_cX^]P[X]bcad\T]cPcX^]

Linear electronic motor
0]T[TRcaXR[X]TPa\^c^aXbdbTSc^a^RZcWTQPbTd]Xcb^UcWT
F0E41X^aTPRc^a$ bhbcT\D][XZTVTPaTS\^c^ab
cWXbT[TRca^\PV]TcXRSTeXRTWPb^][h^]T\^eX]V_PacP]S
_a^eXSTbVaTPcTaaT[XPQX[XchCWT[X]TPa\^c^aU^[[^fbP_aTbTc
P]S^_cX\P[b_TTSP]SPRRT[TaPcX^]_a^ [Tc^_a^eXSTcWT
\^bcTUUTRcXeTfPeTU^aTU RXT]c[^fbWTPa\XgX]V
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Loadcell
4[TRca^]XR[^PSRT[[\^Sd[Tb_a^eXST^][X]T\TPbdaT\T]c^U
2T[[QPVQX^aTPRc^afTXVWcP]SRP]QTdbTSU^aPdc^\PcTS
[[X]VP]SWPaeTbcX]V^U\TSXP0QdX[cX]_d\_R^]ca^[[Ta
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Ordering information

WAVE Bioreactor 500/1000 system
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Xcellerex XDR cell culture
bioreactor systems
™

The Xcellerex XDR bioreactor product line offers the benefits
of single-use technology and stirred-tank design in a modular,
turnkey, bioreactor platform (Fig 1). Designed for scalability and
robustness, the XDR bioreactor systems provide the performance
and flexibility needed from process development to large-scale
biopharmaceutical manufacturing. XDR bioreactor systems can be
operated in batch, fed-batch, and perfusion modes.

XDR bioreactor systems offer the following benefits:
•

Separation of gas and electrical power for enhanced safety

•

Scalable and predictable stirred-tank performance up to 2000 L

•

Single-use technology eliminates costly and time-consuming
cleaning and cleaning validation

•

Advanced automation and modular system design
to support a variety of installation scenarios

•

Process and operational support from staff with
extensive manufacturing experience

System overview
The full line of XDR bioreactor systems are designed and
characterized to deliver scalable process equivalence from 4.5 L to
2000 L working volume, in both GMP and non-GMP environments.
The system design is based on the same foundational principles
as conventional stainless steel bioreactors. Consistent vessel
geometries, tight relationship between consumables and
equipment features, and a host of accessories combine for
an easily scalable, single-use product line. Traditional scaling
methodology, based on measures such as shear, tip speed,
power per unit volume, kLa, and specific process sensitivities,
can be used during scale-up. Technology transfer using the XDR
systems is straightforward, minimizing the need for costly and
time-consuming process redesign. For enhanced utility across the
bioreactor platform, the minimum working volume is as low as
20% of the maximum working volume.

gelifesciences.com/xcellerex

Fig 1. Bioreactor system components: XDR vessel and X-Station
mobile control console.

The bioreactor bag assembly (XDA) is disposed after culture
termination and eliminates costly and time-consuming
cleaning-in-place (CIP) and steam-in-place (SIP) operations. The
XDA bag assembly is prepackaged with a low profile impeller, a
variety of sparge components, filters, and tubing, for quick and
hassle-free installation. The flexibility of single-use technology
enables quick changeover between productions, for efficient
equipment utilization. Interconnection of bioreactor bag and
equipment is key in achieving the excellent performance that XDR
bioreactor systems deliver.
The modularity of the XDR product line stems from three
main subsystem components: bioreactor vessel with frame,
I/O cabinet, and X-Station mobile control console. The XDR
product line is further enhanced by the dual-panel I/O cabinet
design, which separates gas management from electrical
power. Additionally, high and low voltage power are in separate
subsections of the main I/O cabinet. The system components
can be used together for a complete turnkey system with true
plug-and-play performance. Alternatively, the components can
be used separately and integrated into existing infrastructure,
for enhanced flexibility. The jacketed vessel has a consistent
design and delivers integrated heating and cooling for efficient

temperature control throughout all scales. The versatile I/O
cabinet houses all critical process instrumentation such as
probe transmitters and peristaltic pumps: up to four internal
and two external pumps are configurable. The gas management
cabinet can be configured or customized with up to six mass flow
controllers as well as up to four internal and two external pumps.
The X-Station mobile control console is the heart of the product
line’s turnkey capability. The power and versatility of the X-Station
allow for up to six XDR bioreactor systems to be controlled
from one single control unit. This truly modular design creates a
process-ready system upon delivery and also supports integration
into a user-preferred automation platform.

XDR system components
Well-mixed bioreactor vessel
Constructed of 304 grade stainless steel (304 SS), the jacketed
vessel enables efficient heat transfer and, together with an external
temperature control unit (TCU), offers highly accurate temperature
control of the cell culture. The bioreactor vessel features load cells for
weight measurement and locking casters with leveling feet. Other
features include a bioreactor bag tubing manager for convenient
positioning and routing of the bag tubing and a high-performance,
bottom-mounted, magnetically coupled drive system. Because of
the bottom drive, there are no shafts to install from the top of the
bioreactor vessel, minimizing ceiling height requirements. To aid
in coupling and decoupling of the drive system with the bioreactor
bag, motor lifting assistive devices are integral with the two largest
bioreactor systems.
The systems are equipped with inlet and exhaust filter holders and
vessel sidewall viewing ports. A lower sidewall port opening makes
room for a sampling port as well as probes for pH, dissolved oxygen
(DO), and temperature. An optional perfusion-specific bag loading
door is available to accommodate cell retention devices. The 1000 L
and 2000 L systems feature integrated bag loading doors that, along
with the semiautomatic bag hoist, simplifies bag insertion without
the need for climbing ladders. An efficient exhaust gas filter heater
is also included to avoid condensate that could compromise exhaust
filter performance.
The complete XDR bioreactor system product portfolio supports
operating volumes from 4.5 L up to 2000 L. The smallest
process development system is discussed in detail in a separate
data file (29092927).

Versatile I/O cabinet
Two 304 SS I/O cabinets functionally separate devices for gas
management, as well as pumps and transmitters for pH and
DO measurement. Standard XDR gas and liquid management
configurations cover the majority of cell culture applications.
Probes on the bioreactor system provide real-time data,
monitored throughout the process run using Wonderware™
software. Profibus™ communication standard is used for device
communication and communication to the X-Station. For custom
installations, direct Profibus communication between the I/O
cabinet and other automation systems (e.g., Rockwell, DeltaV™,
Honeywell, Siemens) can be accomplished.
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Liquid management
The I/O cabinet can be configured with up to four pumps including
on-off and variable speed peristaltic pumps. The on-off pumps
utilize a Watson-Marlow™ 114 pump head, while the variable
speed pumps utilize Watson-Marlow 313 or 520 pump heads
depending on configuration. The pumps have ranges to support
liquid addition or removal. They can also be programmed for
fed-batch and perfusion culturing and easily calibrated using
Wonderware software.

Gas management
Up to six mass flow controllers offer multiple sparging regimes,
CO2 abatement at large-scale, and overlay gas addition. The XDR
systems include a gas manifold to distribute the various gases to
the available bag destinations: sparger or headspace. The dual-panel
XDR now includes a separate gas management cabinet.

Measurements of DO and pH
DO and pH can be measured using conventional polarographic
sensors and glass electrodes, respectively. These sensors
can be autoclaved prior to use in a specially designed probe
sheath. Aseptic insertion into the bioreactor bag is conveniently
done using single-use connector technology. Alternatively,
an optical DO sensor and a single-use pH probe are available
ready for use to minimize start-up time. The flexibility of the
system allows the sensor technology to be mixed for use of
conventional and single-use technologies simultaneously.
All sensors are connected to the I/O cabinet transmitters.
The dual-panel XDR includes options for Rosemount 56 and
Mettler-Toledo MT-800 transmitters.

Measurement of dissolved carbon dioxide
Conventional, reusable, insertion-type probe technology is used for
monitoring of dissolved carbon dioxide. A dedicated transmitter is
available optionally for integration into the I/O cabinet.

Plug-and-play X-Station mobile control console
X-Station is a stand-alone, mobile control console featuring intuitive
process control, data historian, and industrial-quality automation
hardware and software (Fig 2). The control system provides real-time
data acquisition, enables accurate process control, and offers
convenient, real-time trending. X-Station is capable of measuring and
controlling up to six XDR bioreactor systems simultaneously.
Inside the 304 SS cover is housed a
scalable programmable logic controller
(PLC)/programmable automation
controller (PAC) and a server-class
computer running user interface and
data historian software. X-Station
comes with a 19” touchscreen,
industrial, wash down-resistant
mouse, a QWERTY keyboard, and
a built-in uninterruptible power
supply (UPS). Profibus and Ethernet
communication standards are
included for equipment and local area
network connectivity.

Fig 2. The X-Station
mobile control console.

XDA bioprocessing consumables
The XDA bioreactor bag is an essential part of the process
performance achieved with XDR bioreactor systems. Constructed
with a contact layer of USP class VI-compliant low-density
polyethylene (LDPE) plastic, the bioreactor bags are robust to
withstand process conditions. All bioreactor bag assemblies
incorporate a seal-less, bottom-mounted, impeller/sparger
assembly with a centrally positioned integral magnet (Fig 3A).
Installed in the bioreactor vessel, the impeller/sparger assembly
couples with the magnetic drive head, creating a powerful and
robust agitation system with minimal risk of seal leakage. Up
to eight sparge elements are included in the impeller/sparge
assembly (Fig 3B). Each sparge element can be configured with
various porosities, drilled holes, or a combination of both to
support both macro- and microsparging. Each of the standard
sparge elements has been validated to provide out-of-the-box
performance consistent with current cell culture practices.
A)

Liquid addition
and gas overlay

Sample line
Sensor ports
Thermowell

B)

Drain line
Fig 3. (A) Impeller for XDR-2000 with four pitched blades. (B) Impeller/sparger
assembly for XDR-200 with three pitch blades and eight sparge elements.

The XDA bioreactor bags are available in Pro, Development,
or Custom formats (Fig 4). Pro-type bags are available for all
bioreactor systems and have validated sparge configurations,
established based on customer feedback and our own
biomanufacturing experience. Development bags are available
for XDR-50 and XDR-200 bioreactor systems and differ from the
Pro bags primarily in the configuration of the sparge elements.
Development bags can be used in a broad array of process
development activities where various micro- or macrosparging
regimes are evaluated. Custom bioreactor bags can be modified
with tubing type and quantity, connection type, filter element,
or sparger configuration. Custom bags can also incorporate
a CO2 -removal sparge wand to address processes sensitive
to dissolved CO2.
All bioreactor bags for cell culture include a magnetically coupled,
M40e 40°, pitched-blade impeller with ceramic bearings. Ceramic
bearings, originally developed for aggressive mixing applications
and fermentation, provide excellent overall performance. The
medical-grade ceramic bearings meet the relevant industry
requirements for leachables, extractables, and particulates
according to the bag validation guide (for more information,
please contact your sales representative). Special impellers are
available for microcarrier applications.

Fig 4. XDR-2000 Pro bag assembly.

Additional bag components include tubing with a combination
of weldable sections and aseptic connectors for liquid
addition/removal, a disposable pressure sensor, and filters for
exhaust, sparge, and overlay/headspace gas. XDA bioreactor
bags support both insertion-type reusable probes and single-use
probes. Probe configurations include reusable probes only,
single-use probes only, or mixed reusable and single-use probes.
For details on probes, see section “Measurement of DO and pH”.
To assist in efficient bioreactor operation, a number of
supplementary XDA bag-related accessories are optionally
available. Like the main bioreactor bags, these accessories are
tightly coupled to the equipment design to be adaptable to varied
process requirements and to support operational efficiency. XDA
accessories include seal-and-store sample manifolds, foam traps,
X-Connect tubing sets, and exhaust filter tubing sets.

Qualification support
The XDR bioreactor systems are designed for use in environments
that require 21 CFR Part 11 and GAMP™ 5. The systems are
delivered with an operating manual, system specification,
drawings to support qualification, and major component
documentation. Industry standard installation and operation
qualification (IQ/OQ) packages are available as an option.
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Applications

Customization

XDR cell culture bioreactor systems have successfully been
used to cultivate a wide range of cell types and organisms
including CHO cells, Vero cells, and MDCK cells. In addition,
a fermentor system is available for microbial applications
including E. coli, Pseudomonas spp., and yeast (see data
file 29092929). XDR bioreactor systems can be operated
in batch, fed-batch, and perfusion (or chemostat) modes.
Bioreactor bag design can be process-dependent, requiring
customization for proper use and performance.

The XDR bioreactor offers standard configurations capable
of addressing a broad set of cell culture applications.
The product platform offers a variety of customizable
options, which broaden its application. Contact your local
GE representative to match your process to the XDR
configuration that is right for your application.

Vessel specifications
Standard cell culture specifications are listed in Table 1.
Table 1. Specifications of standard configuration XDR cell culture bioreactor systems

XDR-50*

XDR-200

XDR-500

XDR-1000

XDR-2000

50

200

500

1000

2000

Specifications
Max. working volume (L)
Min. working volume (L)

22

40

100

200

400

Volume turn-down ratio

2.2:1

5:1

5:1

5:1

5:1

Aspect ratio (H/D)

2.25:1

1.5:1

1.5:1

1.5:1

1.5:1

Vessel

Jacketed 304 SS

Filter heat assembly

1

Additional lter heater assemblies (optional)

1

Bag hoist

Not applicable

Not applicable

Not applicable

Semi-automatic

Semi-automatic

3 blades at
40° pitch

3 blades at
40° pitch

3 blades at
40° pitch

3 blades at
40° pitch

4 blades at
40° pitch

3

3

4

4

4

pH probes†

1 (2 optional)

2

2

2

2

DO probes†

1 (2 optional)

2

2

2

2

Impeller, M40e pitched-blade type
Custom bag assembly
Process instrumentation

CO2 probes (optional)

1 internal, 1 external

MFC§ (standard)

4

Additional MFC‡ (optional)

2

Internal pumps (standard)

4 (2x low flow, 2x high flow)

External pumps (optional)§
Temperature control unit¶ (heating,
kW/cooling, HP)
Load cells

2
3/1

9/1.5

9/1.5

9/1.5

9/1.5

3

4

4

4

4

X-Station control unit
Interfaces

19”/52.4 mm touchscreen, wash-down compatible keyboard and mouse; includes built-in UPS

Hardware

Rockwell™/Allen Bradley™

Operator interface
HMI†† Data Historian
Compliance

Wonderware HMI††
Wonderware
21 CFR Part 11 compliant‡‡

* For specifications of XDR-50 MO fermentation system, please see data file 29092929.
† Single-use or reusable probes
‡ Thermal mass flow controllers
§ External pumps are Profibus devices and might be Watson-Marlow 520, 620, or 720 series depending on required flow rate.
¶ Optional standalone heating/cooling TCU listed. Other TCU configurations available, including units that use facility chilled water/glycol.
†† Human-machine interface
‡‡ Customer will need to implement appropriate operating procedures to be fully 21 CFR Part 11 compliant. The XDR is built to support this two-part compliance.
Note: For specifications of XDR-10 bioreactor system, please see data file 29092927
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Consumable specifications
Table 2. Specifications of standard configuration for XDA bags for XDR cell culture bioreactor systems

Product description

Product code

XDR-50 DEV
Minimum volume: 22 L; nominal volume: 50 L; headspace volume: 13 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.61, 40° pitch, center

A

B

C

D

E

F

G

H

I

J

K

L

E

F

G

H

I

J

K

L

888-0356-C

Film: ASI™ PL-01026/01077
A, B, D, G, H: 1 in of 1/4” × 3/8” C-Flex® 374
E: 1 in of 3/8” × 5/8” C-Flex 374
A, G, H (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 48 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
B, D (liquid additions): 48 in of 1/4 in × 7/16 in C-Flex 374, plugged, pinch clamp

5
3

IMP

7

1

C (vent filter): CFVTV0.2-33A filter (Meissner), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with
ReadyMate™ connector, pinch clamp
E (liquid addition): 60 in of 3/8 in × 9/16 in Platinum-cured Silicon to 18 in of 3/8 in × 5/8 in C-Flex 374 terminated
with ReadyMate connector, pinch clamp
F (headspace gas): pressure sensor, A50V002P2NV filter (Pall), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with
instant tube fitting, pinch clamp
I (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
J, K (probe ports): female Kleenpak™ port for probe connection
L (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
M, O (liquid additions): 10 in of 3/4 in ×1 in C-Flex 374 terminated with ReadyMate connector
N (liquid addition): 18 in of 3/8 in × 5/8 in C-Flex 374 reduced to 18 in of 1/4 in × 7/16 in C-Flex 374,
plugged, pinch clamp
Sparge 2: 2 µm sintered disk
Sparge 4, 6: 2 µm sintered disk with 5 × 0.5 mm drilled holes
Sparge 5: 20 µm sintered disk
Sparge 8: 2 µm sintered disk with 5 × 1 mm drilled holes
Sparge 2 and 5: tubing from each port combined to A50V002P2NV filter (Pall) to 3 in of 1/4 in × 7/16 in C-Flex 374
terminated with instant tube fitting, pinch clamp
Sparge 4, 6 and 8: tubing from each port combined to A50V002P2NV filter (Pall) to 3 in of 1/4 in × 7/16 in C-Flex
374 terminated with instant tube fitting, pinch clamp
Sparge 1 , 3 and 7 (drain): tubing from each port combined to 48 in of 3/8 in × 5/8 in C-Flex 374 terminated with
ReadyMate connector, pinch clamp

XDR-50 PRO
Minimum volume: 22 L; nominal volume: 50 L; headspace volume: 13 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.61, 40° pitch, center

A

B

C

D

888-0086-C

Film: ASI PL-01026/01077
A, B, D, G, H: 1 in of 1/4 in × 3/8 in C-Flex 374
E: 1 in of 3/8 in × 5/8 in C-Flex 374
A, G, H (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 48 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
B, D (liquid additions): 48 in of 1/4 in × 7/16 in C-Flex 374, plugged, pinch clamp
C (vent filter): CFVTV0.2-33A filter (Meissner), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate
connector, pinch clamp

5
3

IMP

7

1

E (liquid addition): 48 in of 3/8 in × 5/8 in C-Flex 374, plugged, pinch clamp
F (headspace gas): pressure sensor, A50V002P2NV filter (Pall), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with
instant tube fitting, pinch clamp
I (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
J, K (probe ports): female Kleenpak port for probe connection
L (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
Sparge 5: 2 µm sintered disk, 48 in of 1/4 in × 7/16 in C-Flex 374 to A50V002P2NV filter (Pall) to 3 in
of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
Sparge 1, 3 and 7 (drain): tubing from each port combined to 48 in of 3/8 in × 5/8 in C-Flex 374, plugged, pinch clamp
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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XDR-50 PRO FLEX
Minimum volume: 22 L; nominal volume: 50 L; headspace volume: 13 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.61, 40° pitch, center

A

B

C

D

E

F

G

H

I

J

K

L

888-0086-F

Film: ASI PL-01026/01077
A, B, D, G, H: 1 in of 1/4 in × 3/8 in C-Flex 374
E: 1 in of 3/8 in × 5/8 in C-Flex 374
A, G, H (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 48 in 1/8 in × 1/4 in C-Flex 374, plugged,
pinch clamp
B, D (liquid additions): 48 in of 1/4 in × 7/16 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
C (vent filter): CFVTV0.2-33A1 filter (Meissner), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with
ReadyMate connector, pinch clamp

5
3

IMP

7

1

E (liquid addition): 48 in of 3/8 in × 5/8 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
F (headspace gas): pressure sensor, A50V002P2NV filter (Pall), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with
instant tube fitting, pinch clamp
I (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
J, K (probe ports): female Kleenpak port for probe connection
L (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
Sparge 5: 2 µm sintered disk, 48 in of 1/4 in × 7/16 in C-Flex 374 to A50V002P2NV filter (Pall) to 3 in of
1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
Sparge 6: 2 µm sintered disk with 5 × 1 mm drilled holes, 48 in of 1/4 in × 7/16 in C-Flex 374 to A50V002P2NV
filter to (Pall) 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
Sparge 1, 3 and 7 (drain): tubing from each port combined to 48 in of 3/8 in × 5/8 in C-Flex 374 terminated with
ReadyMate connector, pinch clamp

XDR-200 DEV
Minimum volume: 40 L; nominal volume: 200 L; headspace volume: 60 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.38, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0151-C
O

A B
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female
Kleenpak, pinch clamp
Sparge 1 and 5: 20 µm sintered disk
Sparge 2, 6: 2 µm sintered disk
Sparge 3 and 7: 2 µm sintered disk with 5 × 1 mm drilled holes
Sparge 4 and 8: 2 µm sintered disk with 5 × 0.5 mm drilled holes
Sparge 1 & 5, 2 & 6, 3 & 7, 4 & 8: tubing from each port for each pair combined to 84 in of 1/8 in × 1/4 in C-Flex 374
to CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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H I J K L M
N

3

IMP
1

7

XDR-200 PRO
Minimum volume: 40 L; nominal volume: 200 L; headspace volume: 60 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.38, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0067-C
O

A B
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp

5
H I J K L M

3

IMP

N

1

A B

O

7

H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female
Kleenpak, pinch clamp
Sparge 1, 4 and 6: 2 µm sintered disk
Sparge 1, 4 and 6: tubing from each port combined to 96 in of 1/8 in × 1/4 in C-Flex 374 to CFVTV0.2-33A filter
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp

XDR-500 PRO
Minimum volume: 100 L; nominal volume: 500 L; headspace volume: 125 L
Impeller: M40e, 3 blades, 10.5 in diameter, Di/Dt*: 0.35, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0070-C
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex
374, plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp

5
H I J K L M

3

IMP

N

1

A B

P

7

H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female
Kleenpak, pinch clamp
Sparge 1, 3, 5 and 7: 2 µm sintered disk
Sparge 1, 3, 5 and 7: tubing from each port combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A filter
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp

XDR-500 PRO FLEX
Minimum volume: 100 L; nominal volume: 500 L; headspace volume: 125 L
Impeller: M40e, 3 blades, 10.5 in diameter, Di/Dt*: 0.35, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0070-F
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A1 filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374
terminated with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp

5
H I J K L M
N
O

3

IMP

7

1

H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (sparge line): 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A1 filter (Meissner), 3 in of 1/4 in × 7/16” C-Flex
374 terminated with instant tube fitting, pinch clamp with internal 2 mm drilled hole Sparge-T
O (drain): 36 in of 3/4 in × 1 in C-Flex 374 terminated with ReadyMate connector
P (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate
connector, pinch clamp
Sparge 1, 3, 5 and 7: 2 µm sintered disk
Sparge 1, 3, 5 and 7: tubing from each port combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A1
filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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XDR-1000 PRO
Minimum volume: 200 L; nominal volume: 1000 L; headspace volume: 210 L
Impeller: M40e, 3 blades, 12.5 in diameter, Di/Dt*: 0.33, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0071-C
O

A B
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp

5
H I J K L M

3

IMP

N

1

A B

P

7

H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female
Kleenpak, pinch clamp
Sparge 1 to 8: 2 µm sintered disk, all ports combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A filter
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp

XDR-1000 PRO FLEX
Minimum volume: 200 L; nominal volume: 1000 L; headspace volume: 210 L
Impeller: M40e, 3 blades, 12.5 in diameter, Di/Dt*: 0.33, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0071-F
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, ReadyMate Connector, pinch clamp

5
H I J K L M
N

3

IMP

O

1

A B

O

7

H (sample lines): 12 in of 1/8 in × 1/4” in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (Sparge-T): 2 mm drilled hole Sparge-T
O (vent filter): 48 in of 1 in × 1 3/8 in C-Flex 374 terminated with ReadyMate connector
Sparge 1 to 8: 2 µm sintered disk, all ports combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A filter
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp

XDR-2000 PRO
Minimum volume: 400 L; nominal volume: 2000 L; headspace volume: 500 L
Impeller: M40e, 4 blades, 16.5 in diameter, Di/Dt*: 0.34, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0081-C
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 3/4 in × 1 in C-Flex 374 terminated with ReadyMate connector
O (vent filter): KA3V002PV1G filter (Pall), Y with 36 in of 3/4 in × 1 in C-Flex 374 terminated
with ReadyMate connector
Sparge 1 to 8: 20 µm sintered disk, all ports combined to 120 in of 1/2 in × 3/4 in C-Flex 374 to KA2V002PV1G
filter (Pall), pinch clamp, 1-1/2” TC at filter inlet
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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XDR-2000 PRO FLEX
Minimum volume: 400 L; nominal volume: 2000 L; headspace volume: 500 L
Impeller: M40e, 4 blades, 16.5 in diameter, Di/Dt*: 0.34, 40° pitch, 15° off center
Film: ASI PL-01026/01077

888-0081-F
P

A B
C D E

F G

A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374,
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, ReadyMate conector, pinch clamp

5
H I J K L M
N
O

3

IMP

7

1

H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (Sparge-T): 2 mm drilled hole Sparge-T
O (drain): 36 in of 1 in × 1 3/8” in C-Flex 374 terminated with ReadyMate connector
P (vent filter): KA3V002PV1G filter (Pall), Y with 36 in of ¾ in × 1” C-Flex 374 terminated
with ReadyMate Connector
Sparge 1 to 8: 20 µm sintered disk, all ports combined to 120 in of 1/2 in × 3/4 in C-Flex 374 to KA2V002PV1G
filter (Pall), pinch clamp, 1-1/2” TC at filter inlet
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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Opticap® XL and XLT Disposable Capsule Filters with
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Supporting Documentation

Request More
Information

Related Product & Applications

Specifications
Specifications (Autoclavable Capsules)

Filtration Area

Opticap XL3

Opticap XL5

Opticap XL10

0.16 m²

0.29 m²

0.54 m²

Materials of Construction
Filter

Polyethersulfone (PES)

Polyethersulfone (PES)

Polyethersulfone (PES)

Film Edge

Polypropylene

Polypropylene

Polypropylene

Supports

Polypropylene

Polypropylene

Polypropylene

Structural
Components

Polypropylene/Polysulfone

Polypropylene/Polysulfone

Polypropylene/Polysulfone

Vent Oring

Silicone (SI)

Silicone (SI)

Silicone (SI)

Vent/Drain

1/4 in. hose barb with double silicone Oring seal

Maximum
Differential
Pressure, bar
(psid)

Forward: 6.9 bar (100 psid) intermittent @ 25 °C; 5.5 bar (80 psid) @ 25 °C; 1.0 bar (15 psid) @ 80 °C. Reverse: 2.1 bar (30 psid) @ 25 °C,
intermittent

Bubble Point

≥4000 mbar (58 psig) air with water

Air Diffusion

≤9.1 mL/min @ 2.8 bar (40 psig) in water

Bacterial
Retention

Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta (ATCC® 19146) per ASTM® F83883 methodology

Bacterial
Endotoxins

Aqueous extraction contains ≤0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test

≤16.4 mL/min @ 2.75 bar (40 psig) in water

≤30 mL/min @ 2.75 bar (40 psig) in water

http://www.emdmillipore.com/US/en/product/Opticap-XL-and-XLT-Disposable-Capsule-Filters-with-Millipore-Express-SHF-0.2nbspm-Hydrophilic-Membrane,MM_NF-C9127?Cata

4/16/2018

Good
Manufacturing
Practices

Opticap® XL and XLT Disposable Capsule Filters with Millipore Express® SHF 0.2&nbsp;μm Hydrophilic Membrane - Millipore Express SHF
These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

NonFiber
Releasing

Component materials meet the "nonfiber releasing" criteria as defined in 21 CFR 210.3 (b) (6).

Indirect Food
Additive

All component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177182.

Typical Clean Water Flow Rate vs Pressure Drop (Autoclavable Capsules)

Opticap® XL 3 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XL 5 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XL 10 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XLT 10 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XLT 20 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XLT 30 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Specifications (Sterile and Gamma Compatible Capsules)

Filtration Area

Opticap XL 150

Opticap XL 300

Opticap XL 600

220 cm²

480 cm²

970 cm²

Materials of Construction
Filter

Polyethersulfone (PES)

Polyethersulfone (PES)

Polyethersulfone (PES)

Supports

Polyethylene

Polyethylene

Polyethylene

Structural
Components

Gamma stable polypropylene/Polysulfone

Gamma stable polypropylene/Polysulfone

Gamma stable polypropylene/Polysulfone

Vent Oring

Silicone (SI)

Silicone (SI)

Silicone (SI)

Vent/Drain

1/4 in. Hose Barb with double Oring seal

1/4 in. Hose Barb with double Oring seal

1/4 in. Hose Barb with double Oring seal

Maximum
Differential
Pressure, bar
(psid)

Forward: 6.9 bar (100 psid) intermittent @ 25 °C; 5.5 bar (80 psid) @ 25 °C; 1.0 bar (15 psid) @ 80 °C. Reverse: 2.1 bar (30 psid) @ 25 °C,
intermittent

Bubble Point

≥4000 mbar (58 psig) air with water

Air Diffusion

≤1.4 mL/min @ 2.75 bar (40 psig) in water

Bacterial
Retention

Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta (ATCC® 19146) per ASTM® F83883 methodology

Bacterial
Endotoxins

Aqueous extraction contains ≤0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test

≤2.8 mL/min @ 2.8 bar (40 psig) in water

≤5.8 mL/min @ 2.8 bar (40 psig) in water

http://www.emdmillipore.com/US/en/product/Opticap-XL-and-XLT-Disposable-Capsule-Filters-with-Millipore-Express-SHF-0.2nbspm-Hydrophilic-Membrane,MM_NF-C9127?Cata
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Opticap® XL and XLT Disposable Capsule Filters with Millipore Express® SHF 0.2&nbsp;μm Hydrophilic Membrane - Millipore Express SHF

TOC/Conductivity
at 25 °C

Gamma sterilized filters meet the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI flush of: 2 liter

Gamma sterilized filters meet the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI flush of: 2.5 liters

Gamma sterilized filters meet the WFI
requirements of USP <643> for Total Organic
Carbon and USP <645> for Water
Conductivity after a WFI water flush of:
3 liters

Oxidizable
Substances

Will meet the USP Oxidizable Substances
Test requirements after a water flush of
≥1 L

Will meet the USP Oxidizable Substances
Test requirements after a water flush of ≥1 L

Will meet the USP Oxidizable Substances
Test requirements after a water flush of ≥1 L

Sterilization
Gamma
compatible
capsules

Gamma compatible to 45 kGy; 3 autoclave cycles of 60 min @ 123 °C; not inline steam sterilizable

Sterile capsules

3 autoclave cycles of 60 min @ 123 °C; not inline steam sterilizable

Sterility

Sterile capsules meet current USP and AAMI guidelines for sterility utilizing a validated sterilization cycle

Component
Material Toxicity

Component materials meet the criteria of the USP <88> Reactivity Test for Class VI Plastics. These products meet the requirements of the
USP <88> Safety Test, utilizing a 0.9% sodium chloride extraction.

USP Toxicity

Nontoxic per MEM elution ISO® 109935

Good
Manufacturing
Practices

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

NonParticle
Releasing

Passes USP test for particulates in injectables.

NonFiber
Releasing

Component materials meet the "nonfiber releasing" criteria as defined in 21 CFR 210.3 (b) (6).

Indirect Food
Additive

All component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177182.

Filtration Area

Opticap XLT10

Opticap XLT20

Opticap XLT30

0.57 m²

1.14 m²

1.71 m²

Materials of Construction
Filter

Polyethersulfone (PES)

Polyethersulfone (PES)

Polyethersulfone (PES)

Film Edge

Polyethylene

Polyethylene

Polyethylene

Supports

Polyester

Polyester

Polyester

Structural
Components

Gamma stable polypropylene/Polysulfone

Gamma stable polypropylene/Polysulfone

Gamma stable polypropylene/Polysulfone

Vent Oring

Silicone (SI)

Silicone (SI)

Silicone (SI)

Vent/Drain

1/4 in. Hose Barb with double Oring seal

Maximum
Differential
Pressure, bar
(psid)

Forward: 6.9 bar (100 psid) intermittent @ 25 °C; 5.5 bar (80 psid) @ 25 °C; 1.0 bar (15 psid) @ 80 °C. Reverse: 2.1 bar (30 psid) @ 25 °C,
intermittent

Bubble Point

≥4000 mbar (58 psig) air with water

Air Diffusion

≤32.7 mL/min @ 2.75 bar (40 psig) in water

Bacterial
Retention

Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta (ATCC® 19146) per ASTM® F83883 methodology

Bacterial
Endotoxins

Aqueous extraction contains ≤0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test

≤65.5 mL/min @ 2.75 bar (40 psig) in water

≤98.2 mL/min @ 2.75 bar (40 psig) in water

http://www.emdmillipore.com/US/en/product/Opticap-XL-and-XLT-Disposable-Capsule-Filters-with-Millipore-Express-SHF-0.2nbspm-Hydrophilic-Membrane,MM_NF-C9127?Cata

4/16/2018

Opticap® XL and XLT Disposable Capsule Filters with Millipore Express® SHF 0.2&nbsp;μm Hydrophilic Membrane - Millipore Express SHF

TOC/Conductivity

Autoclaved filter meets the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI water flush of: 11
liters at 25 °C

Autoclaved filter meets the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI water flush of: 22
liters at 25 °C

Autoclaved filter meets the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI water flush of: 33
liters at 25 °C

Oxidizable
Substances

Will meet the USP Oxidizable Substances
Test requirements after a water flush of
≥1.5 L

Will meet the USP Oxidizable Substances
Test requirements after a water flush of ≥3 L

Will meet the USP Oxidizable Substances
Test requirements after a water flush of
≥4.5 L

Sterilization
Gamma
compatible
capsules

Gamma compatible to 45 kGy; 3 autoclave cycles of 60 min @ 123 °C; not inline steam sterilizable

Sterile capsules

3 autoclave cycles of 60 min @ 123 °C; not inline steam sterilizable

Sterility

Sterile

Component
Material Toxicity

Component materials meet the criteria of the USP <88> Reactivity Test for Class VI Plastics. These products meet the requirements of the
USP <88> Safety Test, utilizing a 0.9% sodium chloride extraction.

USP Toxicity

Nontoxic per MEM elution ISO® 109935

Good
Manufacturing
Practices

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

NonFiber
Releasing

Component materials meet the "nonfiber releasing" criteria as defined in 21 CFR 210.3 (b) (6).

Indirect Food
Additive

All component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177182.

Typical Clean Water Flow Rate vs Pressure Drop (Sterile and Gamma Compatible Capsules)

Opticap® XL 150 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XL 300 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XL 600 Capsule Filters with 0.2 µm
Millipore Express® SHF Membrane

Opticap® XL 3 Capsule Filters with 0.2 µm

Opticap® XL 5 Capsule Filters with 0.2 µm

Opticap® XL 10 Capsule Filters with 0.2 µm

Millipore Express® SHF Membrane

Millipore Express® SHF Membrane

Millipore Express® SHF Membrane

http://www.emdmillipore.com/US/en/product/Opticap-XL-and-XLT-Disposable-Capsule-Filters-with-Millipore-Express-SHF-0.2nbspm-Hydrophilic-Membrane,MM_NF-C9127?Cata
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Opticap® XL and XLT Disposable Capsule Filters with Millipore Express® SHF 0.2&nbsp;μm Hydrophilic Membrane - Millipore Express SHF

Opticap® XLT 10 Capsule Filters with 0.2 µm

Opticap® XLT 20 Capsule Filters with 0.2 µm

Opticap® XLT 30 Capsule Filters with 0.2 µm

Millipore Express® SHF Membrane

Millipore Express® SHF Membrane

Millipore Express® SHF Membrane

Recently Viewed

Recommended Products
®

Opticap XL and XLT Disposable
Capsule Filters with Millipore
Express® SHF 0.2 μm
Hydrophilic Membrane
Opticap® XL and XLT capsule
filters eliminate the time and
expense associated with
assembling, cleaning, and
validating stainless steel housings.

Opticap® Gamma
Compatible XL 3
Millipore
Express® SHC...

Opticap® XL4
Durapore®
0.22 µm 9/16 in.
HB/HB

Opticap® XL5
Durapore®
0.22 µm 11/2 in.
TC/TC
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Tubing Application
Guide

Pushing the Boundaries of
Peristaltic Pump Technology
with Unique Formulations

®
Drug Discovery

e

®

Longer life (up to five times) and lower spallation compared
to other platinum silicone tubing. Ultra-smooth inner surface.
Biocompatible for sensitive applications. Autoclavable.
Meets FDA, USP Class VI, and EP standards, and exceeds
3A sanitary standards. Max temp: 450°F (232°C).
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ste le

x

BioPharm Plus Tubing

Ma

Pharmaceuticals S

Tubing Application Guide

ve
Exclusi

Applications: filtration; fermentation; dispensing solutions and media.
• Excellent pumping accuracy for high repeatability
and consistent performance over time

• No leachable additives or plasticizers to
impart taste or contamination

• Smooth inner bore results in less
particle entrapment

• Sterilize to maintain system sterility
• Tolerates high-pressure applications

• Low spallation maintains purity of fluid

Biopharmaceuticals S

Nutraceuticals

®

Ma

e
rf
ste le

x

C-FLEX® Tubing

ve
Exclusi

Excellent biocompatibility; contains no toxic materials.
Heat sealable and weldable. Autoclavable. Meets FDA and
USP Class VI standards. Max temp: 275° F (135°C).

Applications: biopharmaceutical processing and storage; botanical production.
• Combines the biocompatibility of silicone with
chemical resistance of Tygon®, but with longer
pumping life
• Nonpyrogenic, noncytotoxic, and nonhemolytic
properties maintain purity and sterility of fluids

Pharmaceutical S

Life Science S

• Low protein binding ensures minimal
degradation or loss of sample
• Chemically resistant to acids and bases
for longer tubing life

Electronics S

Semiconductor

PharmaPure® Tubing
Nontoxic and nonhemolytic, excellent biocompatibility. Longest
pumping life of any high-performance formulation; low extractability.
Autoclavable. Meets FDA, EP, and USP Class VI standards.
Max temp: 275°F (135°C).
Applications: sterile filling; filtration; transfer of cell media.
• Ultra-low spallation maintains fluid purity and
extends the life of filters

• Tolerates continuous-pressure applications
up to 40 psi (2.7 bar)

• Low permeability provides barrier to chemicals
that damage tubing

• Long tubing life means time and
cost savings

ColeParmer.com

Chemical S

Printing S

Automotive

e

Ma

®

Best combination of pumping life and chemical resistance.
Excellent durability. Plasticizer-free inner liner provides low
spallation. Autoclavable. Meets FDA standards.
Max temp: 165°F (74°C).

rf
ste le

x

Chem-Durance™ Tubing

ve
Exclusi

Applications: transfer of sensitive fluids; ink and solvent production.
• Chemical-resistant inner liner allows use
with harsh chemicals

• Flexible outer jacket dissipates heat
generated from rollers for longer tubing life

• Low spallation maintains purity of fluid

• Hydrophobic, smooth-bore inner liner means
negligible absorption of fluids or leachables

Chemical S

Pharmaceutical S

Food & Beverage

Tygon® Chemical Tubing
Best chemical resistance of any Tygon formulation. Compatible
with many popular solvents. Autoclavable. Complies with FDA 21
CFR 177.2600 criteria. Max temp: 135°F (57°C).
Applications: disinfectant transfer; dispensing of food additives.
• Plasticizer- and oil-free to ensure accurate
results from analytical tests; does not yield
taste into fluids
• Clear tubing for easy flow monitoring

• Low gas permeability and extractability
maintains integrity of fluid
• Very good chemical compatibility affords
longer tubing life

• Sterilize to maintain system sterility

Manufacturing S

Semiconductor

Viton® Tubing

e
rf
ste le

®

x

Resistant to corrosives, solvents, and oils at elevated
temperatures. Low gas permeability.
Max temp: 400°F (205°C).

Ma

Chemical S

ve
Exclusi

Applications: transfer harsh chemicals through process line.
• Exclusive Masterflex® formulation—highest
fluorine content of any Viton for enhanced
chemical compatibility
• Tolerates some of the harshest chemicals used
in the semiconductor industry

• Resistant to corrosive solvents and
aliphatic and aromatic hydrocarbons
• Ultra-low gas permeability maintains
integrity of fluid

ColeParmer.com

625 E. Bunker Court
Vernon Hills, IL 60061
Call toll-free 800-323-4340
Phone: 847-549-7600
Fax: 847-247-2929
www.coleparmer.com

Electronics S

In Canada

In the United Kingdom

In India

International customers

Call toll-free 800-363-5900
Phone: 514-355-6100
Fax: 514-355-7119
www.coleparmer.ca
Phone: 91-22-6716-2222
Fax: 91-22-6716-2211
www.coleparmer.in

Semiconductor S

Free phone: 0500-345-300
Phone: 020-8574-7556
Fax: 020-8574-7543
www.coleparmer.co.uk

Call 847-549-7600 to reach our
International Sales Department
or contact your local dealer.

Industrial S

Chemical S

FREE TECHNICAL
APPLICATIONS ASSISTANCE!
Food & Beverage

e
rf
ste le

®

x

PTFE Tubing
The only peristaltic-compatible PTFE tubing available!

Ma

In the U.S.

ve
Exclusi

Excellent fluid purity, chemical resistance, and very low gas permeability.
Autoclavable. Meets FDA and USP Class VI standards. Max temp: 500°F (260°C).

Applications: vulcanization; feeding and metering of aggressive chemicals; dispensing of fruit extracts and flavoring.
• Chemically inert; offering the best chemical
resistance of any pump tubing

• Inert fluoropolymer will not leach into or absorb
out of fluid being pumped

• Rigid tubing structure provides tolerance for
high-pressure applications up to 100 psi (6.8 bar)

Pharmaceutical S

Water S

Wastewater

High-Pressure PharMed® BPT
and High-Pressure Norprene® Tubing
High-Pressure PharMed BPT: Over 10,000 hours of tubing life. Heat sealable,
bondable, and autoclavable. Resists ozone and UV radiation. Meets FDA and
USP Class VI standards. NSF-listed. Max temp: 270°F (135°C).
High-Pressure Norprene: Up to 10,000 hours tubing life. Resists heat, ozone,
acids, and alkalis. Heat sealable, non-aging, non-oxidizing, and autoclavable.
Best choice for pressure/vacuum applications. Max temp: 270°F (135°C).
Applications: sterile filtration; chemical injection.
• Thick-walled tubing withstands pressures up to
100 psi (6.8 bar) with precise, repeatable flow

• Chemical-resistant Norprene handles a variety
of chemicals and solutions

• Noncytotoxic and nonhemolytic properties make
PharMed BPT ideal for tissue and cell culture work

1759

GLOSSARY

MASTERFLEX® RESOURCES ONLINE

Cytotoxic—having a toxic effect on cells
Hemolytic—causing the destruction of red blood cells
Leachables—chemicals released from tubing that may
contaminate fluid being pumped
Pyrogenic—showing measurable traces of bacterial endotoxins
Spallation—the generation of particles from the inner
bore of the tubing

Pump system selection:
Masterflex.com/pumpconfigurator
Tubing compatibility:
Masterflex.com/mflexChem
Peristaltic pump applications:
Masterflex.com/pumpSolutions

ColeParmer.com
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Corning® Erlenmeyer bafﬂed cell culture ﬂasks 250 mL Erlenmeyer Flask w/ Vent Cap, polycarbonate, sterile, 50/cs | Sigma-Aldrich
CLS431407  Corning® Erlenmeyer baffled cell culture flasks

CLS431407 SIGMA

Corning® Erlenmeyer baffled cell culture flasks
250 mL Erlenmeyer Flask w/ Vent Cap, polycarbonate, sterile, 50/cs
Synonym: Corning Erlenmeyer flasks, baffled cell culture flasks, cell culture flasks, conical flasks, plastic Erlenmeyer
flasks, shaker flasks
SDS

SIMILAR PRODUCTS

eCl@ss 32040501

https://www.sigmaaldrich.com/catalog/product/sigma/cls431407?lang=en&region=US&cm_sp=Insite-_-prodRecCold_xorders-_-prodRecCold2-1
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Corning® Erlenmeyer bafﬂed cell culture ﬂasks 250 mL Erlenmeyer Flask w/ Vent Cap, polycarbonate, sterile, 50/cs | Sigma-Aldrich

Properties
Related Categories

Corning, Corning Erlenmeyer Flasks and Fernbach Flasks,
Polycarbonate, Corning Flasks, Corning LSE Equipment,
Corning LSE Shakers & Vortexers,
More...

material

polycarbonate flask
polypropylene cap (EasyGrip vent)
widemouth

sterility

sterile; γirradiated

feature

disposable
graduations 25 mL
graduations

packaging

pack of 1
case of 50

mfr. no.

Corning, 431407

flask capacity

250 mL

neck diam.

25 mL

suitability

suitable for (ideal for all shaker culture
applications as well as liquid handling and
storage)
Show Fewer Properties

Description
General description
Corning® Erlenmeyer Baffled Cell Culture Flasks
Corning baffled bottom Erlenmeyer flasks are sterile, disposable and are ideal for all shaker culture applications as well as liquid handling and storage. Like all
Corning flasks, the flasks are certified nonpyrogenic and sterile. The 125 mL through 1 L Erlenmeyer flasks are available with standard twoposition plug seal
caps or filtered vent caps. The 2 L and 3 L flasks are available with vent caps.
Features and Benefits:
More Robust
• Polycarbonate construction: USP Class VI material provides excellent optical clarity and mechanical strength
• Unlike PETG, flasks will not collapse when autoclaving media or sanitizing waste
• Unlike glass, flasks will not break when dropped
More Reliable
• RNase and DNasefree
• Moldedingraduations for accuracy
• Vent cap option for continuous gas exchange while ensuring sterility and preventing leakage
• Individual packaged and radiation sterilized
• All flasks have the highest Sterility Assurance Level (SAL) of 106
• Certified nonpyrogenic
• Made from optically clear polycarbonate
• Ideal for shaker culture applications
• Vent caps available for applications requiring sterile gas exchange
• Sterilized by gamma radiation and certified nonpyrogenic
Note: Erlenmeyer flasks can be used with Corning LSE™ orbital shaker

Legal Information
Corning is a registered trademark of Corning, Inc.
LSE is a trademark of Corning, Inc.

Price and Availability
SKUPack Size
CLS43140750EA

Availability

Price
Quantity
(USD)

641.70

https://www.sigmaaldrich.com/catalog/product/sigma/cls431407?lang=en&region=US&cm_sp=Insite-_-prodRecCold_xorders-_-prodRecCold2-1
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Corning LSE Low Speed Orbital Shaker Low speed orbital shaker:BioPharmaceutical

Our pricing tem i unavaila le. You are viewing li t price.
Plea e call 1-800-766-7000 to place our order or tr our ite again later.

Corning™ L

™ Low peed

Or ital haker

Catalog No.

10-320-813

$1,363.68 / Ca e

Ideal for taining and de taining fragile gel ,
wa hing lot and general mixing application
Manufacturer: Corning™ 6780FP

De cription
Gentle motion prevent foaming of liquid
Analog control with ea -turn kno
19mm or it for lotting, gel taining and general mixing
peed can e et from 3 to 60rpm
Timer can e et for up to 2 hour or for continuou operation
afe for cold room and incu ator u e
120V, 50/60Hz
Thi product( ) re ide on a Fi her cienti c G A or VA contract. If ou are viewing thi page a a nonregi tered u er, the price( )
di pla ed i Li t Price. To view our G A or VA contract pricing, log in u ing our account num er, or ecome a regi tered u er
contacting one of our Cu tomer ervice team . You can al o view our contract price
earching for thi item( ) on G A
Advantage. To place an order, contact Fi her cienti c Cu tomer ervice.

peci cation
Model

6780-FP

Or it

1.9cm

Hertz

50/60Hz

Length ( ngli h) xterior

10 in.

Length (Metric) xterior

25.5cm

Plug T pe

U

Voltage

120V

Height ( ngli h)

6 in.

Height (Metric)

16cm

T pe

Or ital haker

Width ( ngli h)

12.5 in.

peed Range

https://www.ﬁshersci.com/shop/products/corning-lse-low-speed-orbital-shaker-low-speed-orbital-shaker/10320813

3 to 60rpm
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Corning LSE Low Speed Orbital Shaker Low speed orbital shaker:BioPharmaceutical

Width (Metric)
lectrical Requirement

32cm

Controller T pe

Analog

120V 50/60Hz

https://www.ﬁshersci.com/shop/products/corning-lse-low-speed-orbital-shaker-low-speed-orbital-shaker/10320813

2/2

Thermo Scientific Forma Series 3
Water Jacketed CO2 Incubator

SPECIFICATIONS AND
ORDERING INFORMATION

Specifications
Temperature
Control
Range
Uniformity
Tracking Alarm
Temperature Safety
Sensor
Controller
Setability
CO2/O2
CO2/O2 Control
CO2 Range
O2 Range
Inlet Pressure
CO2 Sensor
O2 Sensor
Readability & Setability
Tracking Alarm
Humidity
RH
Humidity Pan
Display (opt.)
Fittings
Fill Port
Drain Port
Access Port
CO2 Inlet
Unit Heat Load
115V/230V
Shelves
Dimensions
Construction
Surface Area
Max. per Chamber
Standard, Maximum

±0.1°C
5°C above ambient to 55°C (131°F)*
±0.2°C @ 37°C (98.6°F)**
+/-1°C
Precision thermistor
Independent analog electronic
0.1°C
Better than ±0.1%
0–20%
1–20%
15 PSIG (1.0 bar)
T/C or IR
Fuel cell
0.1%
+/-1%

Construction
Water Jacket Volume
Interior Volume
Interior
Exterior
Outer Door Gasket
Inner Door Gasket
Electrical
4110/4120/4130/4140
4111/4121/4131/4141
Circuit Breaker/
Power Switch
Convenience Receptacle
Plug
Alarm Contacts

Ambient to 95% @ 37°C (98.6°F)
3.2 qt. (3.0 liters) standard
In 1% increments
3/8" hose (barbed)
1/4" hose (barbed)
1.3" (3.3cm) with removable silicone plug with filter
1/4" hose (barbed)

Data Outputs (opt.)
Dimensions
Exterior
Interior
Weight
Net
Net Operational
Shipping (Motor)

11.7 gal. (43.5 liters)
6.5 cu. ft. (184.1 liters)
Type 304, mirror finish, stainless steel
18 gauge, cold-rolled steel, powder coated
Four-sided, molded, magnetic vinyl
Removable, cleanable, feather-edged, silicone
115V, 50/60 Hz, 3.6 FLA (operating range 90–125V)
230V, 50/60 Hz, 2.0 FLA (operating range 180–250V)
6 Amps/2 Pole
75 Watts max. (one per chamber)
115V: NEMA 5-15P Plug
230V: CEE 7/7 Plug
Power interruption; deviation of temp, CO2, O2,
RH; customer connections through jack on back of unit
USB (standard), 4–20 milliamp (optional)
26.0"W x 39.5"H x 25.0 USB Port (standard), 4-20 ma
(optional)"F-B (66.0cm x 100.3cm x 63.5cm)
21.3"W x 26.8"H x 20.0"F-B
(54.1cm x 68.1cm x 50.8cm)
265 lb (120.2 kg)
365 lb (165.6 kg)
324 lb (147.0 kg)

344 BTUH (100 Watt)
18.5" x 18.5" (47.0cm x 47.0cm)
Stainless steel, perforated
2.4 sq. ft. (0.2 sq. m)
40.8 sq. ft. (3.8 sq. m)
4, 17

Orderimg Information
C a t. N o .
4110
4111
4120
4121
4130
4131
4140
4141

CO2
T/C
T/C
IR
IR
T/C
T/C
IR
IR

O2
No
No
No
No
Yes
Yes
Yes
Yes

Voltage
115
230
115
230
115
230
115
230

All units are UL Listed to United States and Canadian requirements and bear the CE Mark.
*50°C (122°F) on Model 4120 (4121), 45°C (113°F) on Models 4130 (4131) and 4140 (4141).
**Truncated

See how Thermo Scientific C02 incubators provide optimal cell growth.
Learn more at www.thermoscientific.com/co2incubators

C

© 2015 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries.
Australia +61 39757 4300
Austria +43 1 801 40 0
Belgium +32 53 73 42 41
China +800 810 5118 or
+400 650 5118
France +33 2 2803 2180
Germany national toll free 0800 1 536 376
Germany international +49 6184 90 6000
India toll free 1800 22 8374
BRCO2FORMA3 0115

India +91 22 6716 2200
Italy +39 02 95059 552
Japan +81 3 5826 1616
Netherlands +31 76 579 55 55
New Zealand +64 9 980 6700
Nordic/Baltic/CIS countries
+358 9 3291 0200
Russia +7 812 703 42 15
Spain/Portugal +34 93 223 09 18

Switzerland +41 44 454 12 22
UK/Ireland +44 870 609 9203
USA/Canada +1 866 984 3766
Other Asian countries +852 2885 4613
Countries not listed +49 6184 90 6000
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Cryogenic Storage Boxes for Locator™ and Locator Plus Systems

PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page?
Simply enter the quantity you want to purchase and the current availability will appear below the item.

Thermo Scientiﬁc Nalgene

Cryogenic Storage Boxes for
Locator™ and Locator Plus Systems
Email This Page

Print Page

DESCRIPTION
Request A Customer Account
Obtain a comprehensive solution when plastic is preferred to
ﬁberboard. Thermo Scientiﬁc™ Nalgene™ Cryogenic Storage Boxes
for Locator™ and Locator Plus Systems ﬁt in Thermo Scientiﬁc
stainless-steel, ultra-low temperature freezer racks.

Please Enter Your Order Info
Filter by:

Avail. Qty

CLEAR FILTERS

PRODUCT DETAIL
5149D15
Mfr. No. CS509X3
Description
Ampule Box, 25-Place For Locator 8

5149D25

List Price/Quantity

$723.86 /CS
(80/CS)

List Price/Quantity

https://www.thomassci.com/Laboratory-Supplies/Cryogenic-Storage-Containers/_/Cryoboxes-for-Locator-Systems

Total

$0.00
0

Total

1/3

4/16/2018

Cryogenic Storage Boxes for Locator™ and Locator Plus Systems

Mfr. No. CS509X4
Description
Ampule Box, 81-Place For Locator 4

5149D35
Mfr. No. CS509X5
Description
Ampule Box, 81-Place For Locator Jr

1187N35
Mfr. No. CS509X10
Description
4" Vial Box for 5mL Nalgene Vials, 81

List Price/Quantity

Total

$0.00

$556.87 /CS

0

(40/CS)

List Price/Quantity

Total

$0.00

$276.88 /CS
(20/CS)

0

List Price/Quantity

Total

$0.00

$40.85 /EA

0

(1/EA)

vials/box

1187N36
Mfr. No. CS509X24
Description
2" Vial Box for 1 & 1.5mL Nalgene Vials, 100

List Price/Quantity

$159.70 /CS
(10/CS)

Total

$0.00
0

vials/box

ADD TO FREQUENT BUY LIST
You must be logged in to add items to a list. Please log in here.

$0.00 (0 Items)
ADD TO SHOPPING CART

Write A Review
Rating (required)

Comments (required)
https://www.thomassci.com/Laboratory-Supplies/Cryogenic-Storage-Containers/_/Cryoboxes-for-Locator-Systems
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Spec Sheet QF150S
Effective:
Replaces:

October 2014
NEW

QF150S

Quaternary Diaphragm Pumps
Multiple-Use – Biotech/Biopharma
Features
•
•
•
•
•
•
•
•
•
•

Applications

4-piston technology
Includes control panel
Gentle product treatment
No particle generation
Low pulsation
Linear flow characteristic
Hygienic design
Self-priming
Safe dry-run operation
Also available as single-use version

•
•
•
•
•

Filtration systems (TFF, etc.)
Chromatography systems
Feeding pump
Virus filtration
Sterile filtration

Technical Data
QF150S Standard Motor
Flow Rate Maximum:

QF150S Standard Motor
Product Wetted Materials (Standard):

Eccentric Shaft 5°

180 l/h (48 gph)

Flow Rate Minimum:
Eccentric Shaft 5°

1 l/h (0.26 gph)

Pump Housing

SS316L

Valve Plate

SS316L

Diaphragms

TPE

Valves

EPDM

O-rings

EPDM

Pressure:
Temperature of Fluid < 40° C (104° F)

6 bar (87 psi)

Temperature of Fluid > 40° C (104° F)

4 bar (58 psi)

Maximum Temperature:

Certificates/Proofs (Optional):
USP <88> Cl. VI; FDA21CFR177;
BSE/TSE Safe
Stainless Steel Parts (product wetted) 3.1; Surface Roughness; Ferrite Content
Elastomere (product wetted)

Fluid

80° C (176° F)

CIP

90° C (194° F)

SIP

130° C (260° F)

Autoclave

130° C (260° F)

Suction Lift Dry at 3000 rpm:
Eccentric Shaft 5°
Volume Specifications:
Approximated Volume per
Revolution at Free Output
Filling Volume Without Connectors

2 - 3 m (6.6 - 9.8 ft)

Rated speed

3000 min-1 (50 Hz)

Voltage

230/115 V

Power

0.05 KW

Pump Dimension with Motor and Housing:
Length

280.5 mm (11.04")

1.2 ml

Width

115 mm (4.53")

15 ml

Height

184 mm (7.24")

Connection Specification (Standard):

Pump Weight with Motor and Housing:

Connectors

1/4" TC

Position of Connectors

Inline

Number of Flow Directions

Motor (Standard):

4

Other connection specifications, materials and motors available on request.

8.4 kg (19 lb.)

Performance Charts

Accessories
Power Box
• Plug & Play installation
• Protects system and pump from overpressure
• Configurable pressure switch setpoint
• Reset button for pump reset
• To be used with pressure switch (also available)

Distributed by:

QF150S

© 2014 ALMATEC

Almatec reserves the right to modify the information and illustrations contained in this document
without prior notice. This is a non-contractual document.

ALMATEC Maschinenbau GmbH
Carl-Friedrich-Gauß-Str. 5
47475 Kamp-Lintfort, Germany
O: +49/2842/961-0, F: +49/2842/961-40
www.quattroflow.com
info@almatec.de

Spec Sheet QF1200S
Effective:
Replaces:

October 2014
NEW

QF1200S

Quaternary Diaphragm Pumps
Multiple-Use – Biotech/Biopharma
Features
•
•
•
•
•
•
•
•
•

Applications

4-piston technology
Gentle product treatment
No particle generation
Low pulsation
Linear flow characteristic
Hygienic design
Self-priming
Safe dry-run operation
Also available as single-use version

•
•
•
•
•

Filtration systems (TFF, etc.)
Chromatography systems
Feeding pump
Virus filtration
Sterile filtration

Technical Data

QF1200S Standard Motor
QF1200S Standard Motor

Connection Specification (Standard):

Flow Rate Maximum:

Connectors

3/4" TC
Inline

Eccentric Shaft 3°

800 l/h (211 gph)

Position of Connectors

Eccentric Shaft 5°

1,200 l/h (317 gph)

Number of Flow Directions

Flow Rate Minimum*:

4

Product Wetted Materials (Standard):

Eccentric Shaft 3°

10 l/h (2.64 gph)

Pump Housing

SS316L

Eccentric Shaft 5°

20 l/h (5.3 gph)

Valve Plate

SS316L

Diaphragms

TPE

Pressure:
Temperature of Fluid < 40° C (104° F)

6 bar (87 psi)

Valves

EPDM

Temperature of Fluid > 40° C (104° F)

4 bar (58 psi)

O-rings

EPDM

Maximum Temperature:

Certificates/Proofs (Optional):
Fluid

80° C (176° F)

CIP

90° C (194° F)

SIP

130° C (260° F)

Autoclave

130° C (260° F)

Pump Speed Range:
rpm

30 - 2,400

Suction Lift Dry at 1800 rpm:
Eccentric Shaft 3°

2.5 - 3 m (8.2-9.8 ft)

Eccentric Shaft 5°

4 - 4.5 m (13.1-14.7 ft)

Volume Specifications:
Approximated Volume per
Revolution at Free Output
Filling Volume Without Connectors

9.6 ml (5°)
5.8 ml (3°)
75 ml

Other connection specifications, materials and motors available on request.
* When using pump with control box: 20 l/h (5.28 gph) and 40 l/h (10.6 gph)

USP <88> Cl. VI; FDA21CFR177;
BSE/TSE Safe
Stainless Steel Parts (product wetted) 3.1; Surface Roughness; Ferrite Content
Elastomere (product wetted)

Motor (Standard):
Rated speed

1375 min-1 (50 Hz)

Voltage

230/400 V

Power

0.37 KW

Pump Dimension with Motor and Housing:
Length

487 mm (19.17")

Width

159 mm (6.26")

Height

210 mm (8.27")

Pump Weight with Motor and Housing:
24 kg (53 lb.)

Performance Charts

Eccentric Shaft: 3º

Eccentric Shaft: 5º

Depending on the selected motor/frequency drive combination, the motor frequency and the resulting pump speed might differ.

Accessories
Control Box

Power Box

• Variable speed controller with
integrated touch pad for manual
speed control

• Plug & Play installation

• Configurable for remote
speed control with 4-20 mA
analogue input

• Configurable pressure switch
setpoint

• 230V / 50 Hz or 115 V / 60 Hz
• Hygienic 1.4301 housing, IP 54
• Easy plug & play installation

Diaphragm Sensor

• Sensor installed in ring
drive unit
• Protects system and pump from
overpressure
• Detection of all liquids
• Signal output to a controller,
if diaphragm is ruptured

• Reset button for pump reset
• To be used with pressure switch
(also available)

Distributed by:

QF1200S

© 2014 ALMATEC

Almatec reserves the right to modify the information and illustrations contained in this document
without prior notice. This is a non-contractual document.

ALMATEC Maschinenbau GmbH
Carl-Friedrich-Gauß-Str. 5
47475 Kamp-Lintfort, Germany
O: +49/2842/961-0, F: +49/2842/961-40
www.quattroflow.com
info@almatec.de

series

800

825 series hygienic pump

Watson-Marlow Bredel

FEATURES
• Flow rates up to 575 gph (36 L/min) at 50 psi (3.5 bar) continuous pressure
• Clean-in-place and steam-in-place sterilization at full velocity with no bypass
required
• Ideal for viscous or shear sensitive products
• Bioprene or STA-PURE tube certified to USP Class VI and FDA approved with
hygienic stainless steel connectors
• Bioprene tubing available in two hardnesses for pressures up to 30 psi (2 bar)
and 50 psi (3.5 bar). STA-PURE tubing is rated for pressures up to
50 psi (3.5 bar)
• Pumpheads to accept B5 output flange-mounted gear motors in a range of
single and three phase fixed and electronic variable speeds
• Hinged door with only two captive bolts makes tube inspection and change
extremely simple and safe
• Explosion proof version available
• Options include stainless steel pushbar and swivel caster set for mobile
applications and a wide variety of connectors

PERFORMANCE

Speed
(rpm)

Flow rate
(gph)

Flow rate
(L/min)

Fitted Motor Power
(hp)

30
56
84
101

157
293
439
528

10
18
28
33

0.75
1.0
1.5
2.0

1.5

0

3
50

7
10
100 160

13
210

17 20
260 310

23 26
370 420

30 33
470 520

L/min
gph

1.25

0.93

1.0

0.75
0.55 kW

hp 0.75
0.5

0.37

0.25

0.19

0

0

10

20

30

40

50 60
rpm

70

80

90

100

For variable speed units and other gearing or build options, please contact your local representative, or the Watson-Marlow Bredel Applications Engineering department.

DRAWINGS

16.85”
7.87”
SEE NOTE

10.71”
21.06”

12.60”
7.24”

3.19”

9.65”
19.29”

11.81”

2.52”

4 SLOTS FOR 5/8” BOLTS

21.26”
Length dependant on selection of gearbox and motor

SPECIFICATIONS
Environment Temperature
Fluid Temperature
Max Operating Speed
Max Pressure
Suction Pressure
Pump weight
Control ratio
Noise
Supply
Door Switch
Power

MATERIALS OF CONSTRUCTION
40°F to 104°F
-32°F to 175°F
109 rpm
50 psi continuous (3.5 Bar)
Up to 28 ft water
Dependant upon drive. Nominally 250 lbs
Dependant upon VFD selection
< 75dB(A) at 1m
230/460/575 3ph 60Hz, 115/230 1ph 60Hz
50 Watt, 240VAC (not suitable for XP
environments)
Up to 2 hp

Component
Pumphead body
Pumphead door
Pumphead rotor hub
Rotor rollers
Support frame
Door fixings
Motor fixings
Frame fixings

Material
Aluminum alloy with epoxy polyester
powder coat finish
Aluminum alloy with epoxy polyester
powder coat finish
Aluminum alloy with epoxy polyester
powder coat finish
Stainless steel 316
Stainless steel 304
Stainless steel 304
Zinc plated high tensile steel bolts,
stainless steel nuts and washers
Stainless steel 304

ORDER INFORMATION

Sanitary

Description

Partcode

Bioprene TM hose

088.0250.E0M

1" Tri-clamp, 316SS

089.0250.00T

Bioprene TH hose

088.0250.E0H

1" Tri-clamp, PVDF

089.0250.00K

Sta-pure hose

089.0250.000

1" Male Cam & Groove, 316SS

089.0250.00Q

All flow rates shown were obtained pumping water at 68°F with zero suction and delivery heads.
Watson-Marlow, Bioprene and Marprene are trademarks of Watson-Marlow Limited.
Disclaimer: The information contained in this document is believed to be correct but Watson-Marlow Limited accepts
no liability for any errors it contains, and reserves the right to alter specifications without notice. LoadSure is a
trademark of Watson-Marlow Limited. ® Chem-Sure and ® STA-PURE are registered trademarks of W.L Gore &
Associates Inc. Please state the product code when ordering pumps and tubing.

Bredel

PUMPS

Watson-Marlow Bredel Pumps
37 Upton Technology Park
Wilmington, MA 01887
Tel: 800 282 8823 Fax: 978 658 0041
www.watson-marlow.com support@watson-marlow.com

825rg - us -02

Element and Connector product codes
Description

Â

Sterilizing-grade
Durapore 0.22 µm
Hydrophobic Filters
®

Reliable filters for the sterile filtration
of gases and liquids
! Ideal for particle and

microorganism removal

! Excellent resistance to

thermal and hydraulic stress

! Validated to withstand multiple

sterilization cycles

! Scalable — from bench-top

to full-scale production

! Wide selection of

D A T A

S H E E T

configurations to meet
your process needs

Durapore hydrophobic membrane cartridges and capsules are sterilizing-grade
filters that provide sterility assurance, high flow rates and high throughput. They
are used for sterile tank and gas venting, as well as for the filtration of liquids in
small and large volume systems. Durapore 0.22 µm hydrophobic polyvinylidene
fluoride (PVDF) membrane reliably eliminates contaminants and microorganisms
in sterilizing applications, even at high pH.

Broad Chemical Compatibility,
Low Extractables
Contributing to clean manufacturing
processes, Durapore filters are made
of just two materials—PVDF membrane
and polypropylene support structure
—this ensures broad chemical
compatibility and low gravimetric
extractables.
Regulatory Compliance
Filters with hydrophobic Durapore
0.22 µm membrane are designed,
developed, and manufactured in
accordance with a Quality Management System approved by an accredited registering body to an ISO ® 9000
Quality Systems Standard and are
shipped with a Certificate of Quality.

Each Opticap® XL capsule and
Durapore cartridge filter is integrity
tested during manufacturing and is
supported with a comprehensive
Validation Guide for compliance
with regulatory requirements.
For traceability and easy identification, each filter is labeled with the
product name and identifying
characteristics.
Multiple Formats Available
Sterilizing-grade hydrophobic
Durapore membranes are available
in three formats and multiple configurations that vary by filtration surface
area and type of inlet/outlet
connection.

Membrane Types

Filter Formats

• Durapore 0.22 µm hydrophobic

• Opticap XL disposable capsule filters
• Optiseal® cartridge filters
• Cartridge filters

From process
development
to full-scale
production,
Millipore
has the right
solution for you!

Opticap XL Disposable Capsule Filters

Opticap XL Filters

Table of Contents
Opticap XL Capsule Filters
Specifications . . . . . . . . . . . .4
Typical Flow Rate and
Pressure Drop . . . . . . . . . . .6
Ordering Information . . . . . . .7

Optiseal Cartridge Filters
Specifications . . . . . . . . . . . .5
Typical Flow Rate and
Pressure Drop . . . . . . . . . . .6
Ordering Information . . . . . . .7

Cartridge Filters
Specifications . . . . . . . . . . . .5
Typical Flow Rate and
Pressure Drop . . . . . . . . . . .6
Ordering Information . . . . . . .7
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Opticap XL disposable capsule filters
with hydrophobic Durapore membrane
are available in multiple filtration
areas, providing an optimal choice for
every application. Each Opticap XL
capsule is integrity tested during the
manufacturing process. The Opticap
XL capsule patented design allows
unparalleled thermal and hydraulic
stress resistance in a disposable filter,
resulting in reliability, high confidence
in the sterility process, and improved
cleanliness. The unique capsule
design with pleated hydrophobic
Durapore membrane minimizes hold-up
volume and reduces production losses.

Convenient and Easy to Use
Opticap XL capsule filters eliminate the
time and expense associated with
assembling, cleaning, and validating
stainless steel housings. Adjustable,
easy-to-turn
upstream vents
and drain valves
with O-ring seals
allow easy process
control. Other easeof-use features include flow direction
arrows and ribbed housing for easy
gripping, even with gloved-hands.
The Right Size
A wide range of filtration areas is
available to fit all of your application
needs, and to allow easy scale-up of
your small volume filtration steps to
larger, full-scale filtration processes.
The Right Connections
Self-contained, disposable Opticap XL
capsule filters are supplied with a
choice of inlet and outlet connections
to optimize your filtration process.
Connections include hose barb,
fractional sanitary flange, and
sanitary flange, which provide the
highest flow rate.

Optiseal Cartridge Filters

Cartridge Filters

Optiseal Filters

Cartridge Filters

Featuring a unique cartridge-to-housing
sealing mechanism and pleated membrane configuration, these Durapore
0.22 µm hydrophobic cartridges offer
maximum sterility assurance. Each
cartridge filter is integrity tested during
the manufacturing process.

Hydrophobic Durapore cartridge filters
provide high throughput and minimal
differential pressure. Cartridges are
robust, resilient, and designed to
withstand multiple steam-in-place
cycles. Each cartridge filter is integrity
tested during the manufacturing
process.
Durapore cartridge filters are
available in five cartridge lengths,
from five to thirty inches, and provide
a full range of filtration areas to suit
every size system. Three connection
options are offered for easy adaptation to existing housings.
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Specifications
Opticap XL 5

Opticap XL 10

21.6 cm (8.5 in.)
10.7 cm (4.2 in.)
14.5 cm (5.7 in.)

33.5 cm (13.2 in.)
10.7 cm (4.2 in.)
14.5 cm (5.7 in.)

0.35 m2 (3.7 ft2)

0.69 m2 (7.4 ft2)

Nominal Dimensions

Maximum length:
Body diameter:
Vent to vent diameter:
Filtration Area
Materials of Construction

Filter membrane:
Film edge:
Supports:
Structural components*:
Vent O-rings:

Hydrophobic PVDF
Polypropylene
Polypropylene
Polypropylene
Silicone

Vent/Drain

ª in. hose barb with double O-ring seal

Maximum Inlet Pressure

5.5 bar (80 psi) at 23 °C
2.8 bar (40 psi) at 60 °C
1.0 bar (15 psi) at 80 °C

Maximum Differential Pressure

Forward:
Reverse:

5.5 bar (80 psid) at ambient temperature, 1.0 bar (15 psid) at 80 °C
3.4 bar (50 psid) at ambient temperature

Bubble Point at 23 °C

≥ 1170 mbar (17.0 psig) nitrogen
with 70/30 IPA/water

Nitrogen Diffusion

Through a water wet membrane at ambient room temperature at 1720 mbar (25 psig) nitrogen:
≤ 5 cc/min
≤ 10 cc/min

Bacterial Endotoxin

Aqueous extraction contains < 0.5 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test.

Bacterial Retention

Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta ATCC® 19146 per ASTM® methodology.

Sterilization

May be autoclaved for 20 cycles of 30 minutes at 126 °C.

Good Manufacturing Practices

These products are manufactured in a Millipore facility which adheres to FDA Good Manufacturing Practices.

Non-Fiber Releasing

Durapore membrane meets the criteria for a “non-fiber releasing” filter as defined in 21 CFR 210.3 (b) (6).

Component Material Toxicity

Component materials were tested and meet the criteria of USP <88> Reactivity Tests for Class VI Plastics.
Durapore filters meet the requirements of the USP <88> Safety Test.

European Pressure Equipment
Directive

Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive,
97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel
Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe
use. In compliance with Article 3 § 3 of this Pressure Equipment Directive, this product does not bear the CE mark.

*Cage, core, end caps, and capsule housing
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> 1240 mbar (18.0 psig) nitrogen
with 60/40 IPA/water

Specifications
Optiseal Filters

5-inch Cartridge

Per 10-inch Cartridge

12.0 cm (4.7 in.)
6.9 cm (2.7 in.)

12.5 cm (5 in.)
6.9 cm (2.7 in.)

25 cm (10 in.)
6.9 cm (2.7 in.)

0.18 m2 (1.9 ft2)

—

0.7 m2 (7.4 ft2)

Hydrophobic PVDF
Polypropylene
Silicone

Hydrophobic PVDF
Polypropylene
Silicone

Double 2-123 O-ring

Code 7 (2-226) O-ring with locking tab and spear
Code 5 (2-222) O-ring with spear
Code 0 (2-222) O-ring

Nominal Dimensions

Maximum length:
Outside diameter:
Filtration Area
Materials of Construction

Filter membrane:
Supports:
O-rings:
Connections

Maximum Differential Pressure

Forward:
Reverse:

5.5 bar (80 psid) at 25 °C; 3.5 bar (50 psid) at 80 °C; 0.35 bar (5 psid) at 135 °C
3.4 bar (50 psid) at 25 °C

Bubble Point at 23 °C

≥ 2000 mbar (29 psig) in water
≥ 1240 mbar (18 psig) in 60/40 IPA/water
≥ 1170 mbar (17 psig) in 70/30 IPA/water

≥
≥
≥
≥

2000 mbar (29 psig) in water
1240 mbar (18 psig) in 60/40 IPA/water
1170 mbar (17 psig) in 70/30 IPA/water
1170 mbar (17 psig) in 100 IPA

Nitrogen Diffusion

At 1.0 bar (15 psig) in 60/40 IPA/water at 23 °C:
≤ 2 cc/min
At 1.7 bar (25 psig) in water at 23 °C:
≤ 5.0 cc/min

At 1.7 bar (25 psig) in water at 23 °C:
≤ 5.0 mL/min
≤ 10.0 mL/min

Bacterial Endotoxin

< 0.5 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test.

Bacterial Retention

Quantitative retention of Brevundimonas diminuta (ATCC 19146) following ASTM F838-83 methodology
at a minimum challenge level of 107 CFU/cm2.

Sterilization

30 steam-in-place cycles of 30 min at 135 °C;
10 autoclave cycles of 30 min at 126 °C.

30 steam-in-place cycles at 30 min at 126 °C;
30 autoclave cycles of 60 min at 126 °C.
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Typical Air Flow Rate and Pressure Drop
Opticap XL 5 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, HH Fitting*
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Ordering Information
Device

Connections

Qty/Pk

Catalogue No.

Opticap XL 5 Capsules

38 mm (1∞ in.) sanitary flange inlet and outlet

1/pk

KVGB A05 TT1

19 mm (º in.) sanitary flange inlet and outlet

1/pk

KVGB A05 FF1

14 mm ( 9/16 in.) hose barb inlet and outlet

1/pk KVGB A05 HH1

38 mm (1∞ in.) sanitary flange inlet and outlet

1/pk

KVGB A10 TT1

19 mm (º in.) sanitary flange inlet and outlet

1/pk

KVGB A10 FF1

14 mm ( 9/16 in.) hose barb inlet and outlet

1/pk KVGB A10 HH1

Optiseal Cartridges

Double 2-123 O-ring

6/pk

LAGB 04T P6

5-inch Cartridges

Code 7 (2-226) O-ring with locking tab

1/pk

CVGB 75S 01

10-inch Cartridges

Code 7 (2-226) O-ring with locking tab and spear

3/pk

CVGB 71T P3

Code 5 (2-222) O-ring with spear

3/pk

CVGB 51T P3

Code 0 (2-222) O-ring

3/pk

CVGB 01T P3

Code 7 (2-226) O-ring with locking tab and spear

3/pk

CVGB 72T P3

Code 5 (2-222) O-ring with spear

3/pk

CVGB 52T P3

Code 0 (2-222) O-ring

3/pk

CVGB 02T P3

Code 7 (2-226) O-ring with locking tab and spear

3/pk

CVGB 73T P3

Code 5 (2-222) O-ring with spear

3/pk

CVGB 53T P3

Code 0 (2-222) O-ring

3/pk

CVGB 03T P3

Opticap XL 10 Capsules

20-inch Cartridges

30-inch Cartridge
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Discover the More in Millipore™
In every application, every step and every scale, count on Millipore to be
everywhere for you—from monoclonals to vaccines, from clinical through
pilot to full-scale manufacturing. Our technologies are used by most of the
world’s major biopharmaceutical companies. But we deliver more than
advanced separation, purification, sterilization and quality control products.
With Millipore, you get services to optimize and validate your processes,
comprehensive resources to streamline and enhance your operation,
unmatched know how forged from 50 years’ experience—
and solutions that integrate it all. For higher yields, improved process
economics and faster speed to market, discover the more in Millipore.

To Place an Order or Receive Technical Assistance
For additional information call your nearest Millipore office:
In the U.S. and Canada, call toll-free 1-800-MILLIPORE (1-800-645-5476)
In the U.S., Canada and Puerto Rico, fax orders to
1-800-MILLIFX (1-800-645-5439)
Outside of North America contact your local office.
To find the office nearest you visit www.millipore.com/offices.
Internet: www.millipore.com
Technical Service: www.millipore.com/techservice

Â

Millipore, Durapore, Opticap and Optiseal are registered trademarks of Millipore Corporation.
Discover the More in Millipore is a trademark of Millipore Corporation.
ISO is a registered trademark of the International Organization for Standardization.
ASTM is a registered trademark of American Society for Testing and Materials.
ATCC is a registered trademark of American Type Culture Collection.
Lit. No. DS8932EN00 Rev. B 1/06 06-011
© 2006 Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.
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Silent Oil Free Air Compressor
Model

GA84

Power 3200W
Note:Powerful Air Compressor

Powerful Dental Air Compressor (piston type)
Model No.: GA84
Brand: Greeloy (made in Shanghai, China)
Specification:
Power: 3200W (4pcs 800W motor)
Volt./Hz: 110~240V 50~60Hz
Speed: 1400/1750 r.p.m
Air Flow: 620L/min at 0Bar
Noise Level: 56dB
Max Pressure: 8Bar
Restart Pressure: 5Bar
Tank Capacity: 120L
Weight: 94/125kg
Product Size: 1105*450*645mm
Remark:
All Greeloy air compressors, can be with air dryer system & silent cabinet.
Advantages:
※ Super silent.
Low working noise, create a quiet working environment.
※ Low vibration.
With special rubberfeet, reduce vibration during operation.
※ Pure air flow.
Oil free design, no lubrication oil needed during operation.
※ Core technology.
Diamond hardness cylinder ensure durable working performance.
※ Fashion and durable design.
Compact structure, light weight. Under normal situation, can be used for more than 20000hours.
※ Use safety.
With multiple self protection system, if here will be abnormal with pressure, current or voltage, the motor would cut o
※ Easy operation.
Quite simple operation, connect to power supply, then no need any more maintenance, just drainage regularly.
※ Low energy consumption.
Full automatic design, automatic stop and restart control, low consumption.
※ High precision filtration.
With double filters, ensure high precision of outlet air flow.
※ Tank inside has done antirust treatment.
Ensure pure outlet air flow for medical equipments.

http://www.greeloy.com/en/product/31545.html
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Bio-Pharm

UltraFlow : Powerful CIP in
a Compact, Portable Design.
TM

UltraFlow 110

UltraFlow 45

The Sani-Matic UltraFlow is a
self-contained, compact and portable
Clean-In-Place (CIP) System programmed
to accommodate a variety of recirculated
CIP applications. Designed for critical
cleaning, the UltraFlow meets cGMP
and ASME-BPE standards.

sanimatic.com

The Sani-Matic UltraFlow needs a mere 6 gallons of water
to operate vs. conventional CIP Systems, which must maintain
a significant quantity of water in the supply tank to prevent
pump cavitation.

Advantages
• Small Footprint. Space-saving design for installations with limited floor space. Fits through standard
doorways with ease.
• Wide Operating Range. The systems range from 2–45 gpm and 5–110 gpm and are able to clean small
and large applications
• Self-Cleaning. Self-cleans without extra steps, and eliminates cross-contamination.
• Portable. Positioned on low-friction casters for easy movement between process suites. No expensive
supply and return line installation required.
• Water & Chemical Savings. The high-turbulent flow rate and low water requirements for operation
reduce the amount of water and chemicals needed for a complete clean.
• Low Outlets? No Problem. Returns solutions with entrained air to accommodate vessels with low
and restricted outlets.
UltraFlow Schematic
Plant
Water
Supply

LE

FE

PI

CIP
Supply

Chemical

Wash

Water Flow
Air Flow

TE
CE
CE

TE

LE

Air Separation
Chamber

CIP
Return

Documentation
Standard

Optional

• Operation and maintenance manuals

• Functional Specifications (FS)

• Recommended spare parts list

• Configuration Specification (CS)

• Instrument list

• Factory Acceptance Test (FAT)

• Instrumentation calibration procedures

• Site Acceptance Test (SAT)

• Performance data

• Installation and Operation Qualification (IQ/OQ)

• Material certificates

• Traceability matrix

• Weld qualification and inspection records

• ISA data sheets

• Inspection test results, reports and certificates

• Cleaning and passivation report

• Component catalog cut sheets

• Digital weld video record (Borescope)

• As-built assembly drawings

• Printer

• As-built process and instrumentation diagrams

• Hydrostatic test certificate

• As-built electrical drawings

• ASME data for heat exchanger

• PLC and HMI application files

• Riboflavin coverage test

sanimatic.com

Features
UltraFlow 110

UltraFlow 45

• 74" L x 33" W x 80" H (height may vary
with options)

• 68" L x 24" W x 74" H (height may vary
with options)

• Operating range of 5–110 gpm @ 60 psi

• Operating range of 2–45 gpm @ 50 psi

• Electric or steam heat

• Electric or steam heat

• For process tank diameters up to 10'

• For process tank diameters up to 4.5'

• For process line diameters up to 3"

• For process line diameters up to 2"

• Mass flow meter

• Turbine flow meter

Standard for Both Models
• Wetted surface: 316L stainless steel, 25 Ra
Non-wetted surface: 304 stainless steel, 32 Ra
• UL listed, 304 stainless steel, NEMA 4X enclosure
• Allen-Bradley CompactLogix
• Allen-Bradley PanelView Plus HMI
• Ethernet communication
• 40 customizable cleaning cycle programs
• Eductor return system

• A single centrifugal CIP supply pump
• Modulating diaphragm control valves to set cleaning circuit
flow rates and to control the rate of discharge to drain
• Two chemical delivery systems comprised of pneumatic
diaphragm pumps, removable chemical reservoirs
• Chemical conductivity, proof of rinse conductivity
• Supply and return temperature sensors
• Electric flow-through heater
• Discharge pressure gauge

Optional for Both Models
• 15 Ra Electropolish (EP) finish

• Vent filter assembly

• Allen-Bradley PanelView Plus 1000

• Pressure transmitter

• Printer

• Mass or turbine flow meter alternate

• Stainless steel motor

• Fixed position leveling feet

• Shell and tube heater

• Frame weld finish upgrade

• Air blow manifold

• Sanitary flex hose package

• Chemical reservoir low level switches

• Piping insulation

• One chemical delivery system (standard offers two)

• Fixed position seismic zone calculations

• One water supply valve (standard offers two)

• Passivation

• CIP supply routing valves

• Spare parts budget

• Water connection bleed valves

• Larger electric heater

• Sample valve

• Sani-Matic Start-up Services

Operating Requirements
UltraFlow 110

UltraFlow 45

• Instrument Air

½" NPT, 10 scfm @ 90 psi

• Instrument Air

½" NPT, 10 scfm @ 90 psi

• Water Supply

Two 1" tri-clamps, WFI, DI, potable
≤ 2 gpm @ 25 psi, 20°–80° C

• Water Supply

Two 1" tri-clamps, WFI, DI, potable
≤ 2 gpm @ 25 psi, 20°–80° C

• Drain

3" tri-clamp (programmable to meet app)

• Drain

2" tri-clamp (programmable to meet app)

• Dry Weight

1,400 lbs (approximate)

• Dry Weight

900 lbs (approximate)

• Electrical Power
(with electric heat)

15 kW, 50 amps (standard) or 30 kW, 68
amps (optional) @ 460 VAC, 3 Ph, 60 Hz

• Electrical Power
(with electric heat)

12 kW, 27 amps (standard) or 24 kW, 43
amps (optional) @ 460 VAC, 3 Ph, 60 Hz

• Electrical Power
(with steam heat)

27 amps @ 460 VAC, 3 Ph, 60 Hz

• Electrical Power
(with steam heat)

11 amps @ 460 VAC, 3 Ph, 60 Hz

• Plant Stream

1 ½" flange, 540 lbs/hr @ 50 psi

• Plant Stream

¾" flange, 195 lbs/hr @ 50 psi

• Plant Condensate

1" flange

• Plant Condensate

½" flange

• CIP Supply

2" tri-clamp, 5–110 gpm @ 60 psi

• CIP Supply

1 ½" tri-clamp, 2–45 gpm @ 50 psi

• CIP Return

3" tri-clamp, 5–110 gpm @ 11' of head
@ 80° C

• CIP Return

2" tri-clamp, 2–45 gpm @ 8.5' of head
@ 80° C

• Vent/Overflow

2" tri-clamp

• Vent/Overflow

2" tri-clamp

July 2016

Cleaning Confidence.
Repeatable results you can count on every time you clean your process parts and equipment.
That’s Cleaning Confidence from Sani-Matic.

sanimatic.com

Sani-Matic, Inc.

1915 S. Stoughton Rd., Madison, WI 53716

(p) 800-356-3300

(f) 608-222-5348
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TSU™ Series -86°C Upright Ultra-Low Temperature Freezers Products

T U™ erie -86°C Upright UltraLow Temperature Freezer
n ure ultimate protection and optimum
capacit for our mo t critical ample with
T U™ erie −86°C Upright Ultra-Low
Temperature Freezer .

Product Code.

15694394

£14392.07 / ach

Quantit
Call for late t availa ilit
+44 (0)1509 555 500

rand: Thermo cienti c T U700V
Code : N W
Additional Detail : Weight : 411.00000kg

De cription
Choice of ve capacitie maximize ample torage while minimizing the freezer' ph ical pace in ide the la
High-performance mode provide the tighte t temperature uniformit and peak variation†—for mo t application , energ aving mode o er excellent temperature control, plu up to 15% aving on energ u age compared to high performance
mode
Increa e the internal capacit of 2 inch vial over previou generation freezer —gain up to 76% more capacit in the ame
footprint†— with 1mL Cr ank tu e
Five ize accommodate an ize la , featuring the indu tr ' leading capacit per footprint peci cation ‡
Monitor the freezer' health 24/7 and acce a detailed event log
O tain a record, impl download a report of the current event log to a porta le drive
nvironmentall -friendl , CFC/HCFC free refrigerant
High-e cienc compre or o er exceptional performance and relia ilit
razed plate heat exchanger for more e cient heat tran fer—induction razed joint to reduce leak potential and improve
relia ilit
Power management tem protect again t a wide range of voltage variation and i ea il acce i le through the touchcreen di pla
Remote alarm contact compati le with external alarm and monitoring tem
Two rear acce , 1in. (25mm) port allow for the u e of inexpedient pro e or in trumentation
tore up to 15 ear worth of temperature and event data on our on- oard computer
U e the new U port to download freezer temperature and event log data, or freezer etting from one freezer to another
Provide protection again t du t on the conden er, which can cau e reduced refrigeration performance and increa ed ri k to
ample
tore up to 278 l . of ample (depending on freezer model) on our reinforced, tainle teel helving
4×7 heated ga ket provide four touchpoint of ecurit and even zone of protection, maximizing ca inet temperature and
eliminating fro t uild-up
Four pol t rene in ulated inner door help maintain ca inet temperature during opening and feature em edded rare earth
magnet , eliminating expo ed latche or magnet
everal optional feature including LN2 and CO2 ack-up tem, chart recorder, tainle teel inventor racking olution ,
and hand -free locking option
† Compared to energ - aving and high-prformance mode .
https://www.ﬁshersci.co.uk/shop/products/tsu-series-86-c-upright-ultra-low-temperature-freezers-13/15694394
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TSU™ Series -86°C Upright Ultra-Low Temperature Freezers Products

‡ a ed on internal performance data; Data on le Ma 2011

peci cation
Amperage

9.5A

Di pla

Touch creenLCD

Hertz

50Hz

Hold

700 oxe

In ulation

Vacuum Panel and
Water lown Foam

hipping Weight (Metric)

432kg

ackup

CO2 or LN2 Optional

Acce

tem
ecurit

Ke Lock tandard,
Padlock Compati le,
Ke Card Optional

Certi cation /Compliance

cULu , C li ted

De cription

Capacit : 33.5 cu. .
(948.7L); Hold 700
oxe ; 230V/50Hz

Dimen ion (L x W x H)
xterior
Plug T pe
T pe

Door
lectrical Requirement

37.6 x 49.2 x 78 in. (96
x 125 x 198cm)
uropean
Ultra Low Freezer,
Upright
ingle
230V 50Hz

Health Monitoring

On creen, Log File

Inner Door

4

Line Voltage Indicator

On- oard Datalogging

Line voltage and
uck/ oo t
tandard

helve

3

Vial Capacit

70,000 x 2mL

Capacit (Metric) helf

432kg

Chart Recorder

7-da Ink or Inkle
(Optional)

Data Output

R -485, 4-20mA, dr
contact - tandard

Capacit (Metric)

949L

Dimen ion (D x W x H)
Interior

28.3 x 40 x 51.2 in. (72
x 102 x 130cm)

Temperature Range

−50° to −86°C

Voltage

230V

Door Opening Recover

39 min.

nerg U age

18.5/21.8kW-hr/da

Footprint (Metric)

1.19 q. meter

Interior

Painted teel tandard, tainle teel - Optional

Operating Mode

High Performance or
nerg
cienc

Peak Variation at -80C

+2.2/-5.5°C

mart View Compati ilit

https://www.ﬁshersci.co.uk/shop/products/tsu-series-86-c-upright-ultra-low-temperature-freezers-13/15694394

mart-Vue Compati le
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TSU™ Series -86°C Upright Ultra-Low Temperature Freezers Products

Regulator Approval
etpoint ecurit

C

Vial to nerg Ratio

tandard - Individual
u er name and
pa word

Voltage Compen ation

Vial to Footprint Ratio
(Metric)

58.824 vial /cu. m

Warm up Time -80 C to
-50C

241 min.

Water Cooled

Optional

Product Line

Thermo cienti c

1.31 watt /100mL vial
( ox)
uck/ oo t

Weight (Metric)

432kg

Warrant

Warrant varie
countr , plea e contact
u for detail

In trument & quipment ervice
Product Code

15410842

rand

Unit La ervice ™
UL _ A IC_C -2

Unit La ervice ™ Unit a ic
Plan Cold torage Group 2

15420822

Unit La ervice ™
UL _ XT_WTY_C -2

Unit La ervice ™ Unit xt
Warrant Cold torage Group 2

15430852
Unit La ervice ™ Unit Full
Plan Cold torage Group 2

Unit La ervice ™
UL _FULL_C -2

De cription

Price

Unit a ic Plan
Cold torage
group 2

£298.00
ach

Unit xt Warrant
Cold torage
group 2

£557.00
ach

Unit Full Plan
Cold torage
group 2

£1418.00
ach

https://www.ﬁshersci.co.uk/shop/products/tsu-series-86-c-upright-ultra-low-temperature-freezers-13/15694394

Quantit &
Availa ilit

timated
hipment
date
from
upplier
11-052018

timated
hipment
date
from
upplier
30-042018

timated
hipment
date
from
upplier
30-042018
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Packaged Systems

MWS

Water and Water/Glycol
System
• Heat Water and Water/Glycol
Solutions to 300˚F (150˚C)
• 50 - 800 kW
• 240 V, 480 V and 600 V, 3 -Phase,
60 Hz
• Compact Footprint for
Installation
• 150# Welded Steel Construction
• Long Life 0.475 in. (12.1 mm)
dia. Copper Sheath Heating
Elements
• High Temperature Centrifugal
Pump - rated to 300˚F (150˚C)
• Electronic Digital Temperature
and Process Control
• Discharge Pressure Gauge
• UL NEMA 12 Electrical Enclosure
Complete with Contactors,
Temperature Safety Limit,
Transformers and Pilot Light(s)
• External Cold Expansion Tank
(Optional)
• External Heat Exchanger
(Optional)

Description

Construction

Chromalox MWS - Mid-Size Water/Glycol
System - is engineered to operate to 300˚F
(150˚C) with either water or water/glycol
fluids. Its electric heating core assures
responsive and precise temperature control
in a space saving package. The system is
suitable for a large range of heating needs
with a compact design. The MWS operates in
a closed loop system using a cold expansion
tank (optional).

Chromalox MWS systems are ruggedly
constructed for industrial applications. The
heavy-duty, steel support base features channel grooves for forklift transport. The heater
chamber is fully welded and houses Chromalox brand, long-lasting heating elements.
The panel is fully UL-listed and assembled
in-house. The pump is air-cooled with a
mechanical seal, rated to 300˚F (150˚C). The
final assembly is fully-shop tested prior to
shipment.

Applications
Chromalox MWS system is great for applications such as reactors, evaporators, dryers,
platen presses, heat excangers, roll heating, or
any jacketed kettles / vessels / tanks.
Hot water systems can be used in a variety of
industries such as chemical, plastics, cosmetics, automotive, rubber, refining, pharmaceutical, non-woven / textiles/ fibers, aerospace, or
any other industrial market.

D-6

WARNING — In hazardous areas, pipe surfaces could achieve temperatures high enough
to cause auto-ignition of the hazardous material present. Consult Article 500 of the National
Electric Code for further information on the
maximum allowable temperature for a specific
application.

Packaged Systems

MWS

Water and Water/Glycol
System (cont’d.)
H
H

D

W

D

MWS 50-250 kW Unit
(Front View)
Options
• Electronic Solid State (SCR) Trim Power
Control
• Strainer
• Powder Coated or Stainless Steel Side
Coverings
• Dedicated Fill Connection
• NEMA 4 or 4X (Stainless) Construction
• Class 1, Div 2 Hazardous Area Rating (with
purge)
• Panel Disconnect Switch
• Heater On/Off Switch
• Suction Pressure Guage
• Inlet / Outlet 150# Gate Valves
• Drain / Bleed Values
• Digital Overtemperature Controller
• Relief Valve
• ASME Design & Certified, Section VIII, for
100 psi (7 bar) at 300˚F (150˚C)
• High Flow Pump (300 GPM, 450-800 kW
only)
• Heat Exchanger (shipped loose for customer
installation)
• Expansion Tank (shipped loose for customer
installation)
• Liquid Level Switch for Expansion Tank

HEAT TRANSFER

W

MWS 300-600 kW Unit
(Rear View)

Unit Proportions
Unit
Size

1
2

Weight Width
(Lbs.) (In.)

Depth
(In.)

Height
(In.)

Flow
Rate1
GPM

Pressure1 Motor
TDH
HP

System
Inlet/Outlet Capacity
Connection
(Gal.)

50 - 150 kW

900

36

42

96

60

100

3

2", 150#

25

175 - 250 kW

1400

36

42

96

120

100

5

3", 150#

35

300 - 400 kW

2000

48

54

96

200

100

10

3", 150#

55

450 - 600 kW

2600

48

54

96

2002

1002

102

3", 150#2

65

650 - 800 kW

3600

61

54

99

2002

1002

102

3", 150#2

85

Refer to Pump Graph in instruction manual for full operating range.
Option for 300 GPM 15 HP pump with 4", 150# inlet/outlet.

Standard Features

Benefits

Electronic Process Control ........................................................................ Precise process control
Element Overtemperature Protection ........................ Protect elements and fluid from overheating
Air-Cooled Mechanical Seal..................................................................No external cooling needed
Insulated Heating Chamber ........................................Maximize efficiency by minimizing heat loss
Discharge Pressure Gauge ..................................................Confirm pump operating performance
Compact Footprint ......................................................................................... Space saving design
Fully Pre-wired & Tested .......................................................................... Ready to operate on site
Centrifugal Pump .............................................................................Minimize piping configuration
Temperature rating to 300˚F (150˚C) .......................................................Covers most applications
150# ANSI Flange Connection........................................................... Easy fit up to installed piping
Start / Stop buttons with Motor Starter............................................... Complete operating system
Pilot Lights for Power, Heater, & Pump................................ Visual indication of system operation
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Packaged Systems

MWS

Water and Water/Glycol
System (cont’d.)
Ordering Information
To Order — Complete the Model Number
using the Matrix provided.

MWS

Mid-Size Water and Water Glycol System
Code

Unit Temperature Rating1

300

300˚F (150˚C)
Code Kilowatts
50
75
100
125

50 kW
75 kW
100 kW
125 kW

150
175
200
250

150 kW
175 kW
200 kW
250 kW

300
350
400
500

550 500 kW
600 600 kW
800 800 kW

Code

Enclosure Types

E1
E4
E4X
E4NP

General Purpose
Moisture Resistant
Moisture / Corrosion Resistant (Stainless Steel)
Class 1, Div 2 rating - Nitrogen Purge (by customer)
Code
(Blank)
ST
SR
GV
FC
DB
PD
HW
SG
DT
SV
PC
SS
AE
HF
XX

Option
No Options
SCR Trim
Strainer2
I/O Gate Valves2
Dedicated Fill Connection2
Drain / Bleed Valves
Panel Disconnect
Heater On/Off Switch
Suction Pressure Guage
Digital Overtemp Control
Safety Relief Valve - 125psi
Power Coated Skins
Stainless Skins
ASME Designed & Certified
300 GPM Pump3
Custom Feature
Code

Voltage

240
480
600

240 V (only available for 50 and 75 kW units)
480 V
600 V
Code
3P

MWS - 300 - 150P -

300 kW
350 kW
400 kW
500 kW

E4

GV

480V

3P

Phase
Three-Phase
Code

Kilowatts

150

kW

150kW Typical Model No.

Example of Final Model Description: MWS-300-150P-E4GV 480V 1-3P 150kW
1
Unit operating temperature based on 104°F (40°C) max. ambient, indoor invironment
2
When ordering more than one of these options, some items will be shipped loose to avoid
damage during shipment. Simple assembly will be required for installation.
3
300 GPM option comes with 15 HP motor and 4", 150# inlet/outlet connections.
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Technical data

Operating principle

MODEL

Overall dimmensions

Main Utilities

No. of
effects

Width
(W)
mm

Height
(H1)
mm

Height
(H2)
mm

Depth
(D)
mm

Distillate
output
l/h

Heating steam
@ 8 bar
kg/h

Cooling water
(25-50º C)
l/h

WFIS 3-250

3

2.140

2.000

2.900

1.300

270

130

1.095

800

WFIS 3-500

3

2.105

1.900

2.875

960

500

235

2.030

1.000

WFIS 4-500

4

2.500

1.900

2.875

960

500

190

1.185

1.200

WFIS 4-750

4

2.910

2.100

3.100

1.100

775

295

1.835

1.350

WFIS 4-1250

4

3.040

2.230

3.090

1.180

1.200

460

2.840

1.500

WFIS 5-500

5

2.915

1.900

2.875

960

500

165

650

2.100

WFIS 5-750

5

3.420

2.100

3.070

1.100

775

255

1.005

2.300

WFIS 5-1250

5

3.590

2.230

3.090

1.180

1.200

390

1.555

2.500

WFIS 5-2000

5

3.700

2.400

3.550

1.500

2.075

680

2.690

3.000

WFIS 5-3000

5

4.200

2.685

3.830

1.500

3.065

1.000

3.970

3.400

WFIS 5-4500

5

4.400

2.950

3.975

1.600

4.585

1.500

5.940

3.800

WFIS 6-2000

6

4.270

2.400

3.550

1.500

2.075

605

1.150

4.200

WFIS 6-3000

6

4.880

2.980

3.830

1.500

3.065

890

1.695

4.700

WFIS 6-4500

6

5.315

2.950

3.975

1.548

4.585

1.335

2.540

5.200

WFIS 6-6500

6

5.900

3.080

4.420

1.630

6.535

1.900

3.615

5.800

WFIS 6-9000

6

6.900

3.080

4.420

1.800

9.060

2.635

5.015

6.500

WFIS 6-12000

6

6.675

3.170

4.500

2.100

12.640

3.680

11.665

7.200

WFIS 7-3000

7

5.560

2.980

3.830

1.500

3.065

815

0

6.000

WFIS 7-4500

7

6.050

2.950

3.975

1.550

4.585

1.220

0

7.400

Approx.
Weight
Kg

Feed water (PW) is pre-heated by means of two DTS heat exchangers, which use
respectively the heat of the pure steam and distillate water outlet and the plant steam
outlet. The first column of the CS water still is equal to our CPS steam generators, heated
also with plant steam.

DTS PRE-HEATER

WFIS 7-6500

7

6.710

3.080

4.420

1.630

6.535

1.740

0

8.800

DTS HEAT EXCHANGER

WFIS 7-9000

7

7.510

3.080

4.420

1.800

9.060

2.410

0

10.300

PLANT STEAM HEATED

WFIS 7-12000

7

7.700

3.170

4.500

2.400

12.645

3.365

0

12.500

The pure steam produced in the first column is used as the heating medium for the next
one, so it condenses and turns into WFI. Simultaneously, the partial amount of nonevaporated water goes to the next column, so it is also partially evaporated as pure steam
and used as heating energy for the next column.

PURE STEAM HEATED

Here, the pure steam also condenses (resulting in WFI distillate) and it is transferred by
pressure to the successive columns.

Control system
The control system is based on a
PLC wire operator supervision via a
user-friendly touch-screen HMI with
the following menu:

WFIS
H2
H1*

W
D
* WFIS OUTLET

COLUMN
COLUMN
CONDENSER

Options and accessories
• Feed water conductivity monitoring
• Pure steam take from the first column
• Elevated WFIS condenser
• Hot standby mode
• Sanitisation/Sterilization of the separator columns and WFIS condensers
• Protective mesh guarding
• On-line TOC monitoring device
• WFI storage and distribution skid.

• Mimics of the equipment, showing
the operational state in real time
• Process parameters (temperature,
pressure and conductivity)
• Setting up of parameters
• Alarm information
• Start-up and alarm recognition.

Telstar
Av. Font i Sagué, 55
Parc Científic i
Tecnològic Orbital 40
08227 Terrassa (Spain)
T +34 937 361 600
F +34 937 861 380

Options include: paper or electronic
chart recorder for pure steam
conductivity, temperature, extra
feed water conductivity meter, online TOC monitoring, etc.

Puretech
Perrywood Business Park,
Salfords Redhill,
Surrey (England) RH1 5DZ
T +44 (0) 1737 378000
F +44 (0) 1737 378055

www.telstar-lifesciences.com

ISO 9001: Certified Company
BR-WFI-EN-1110
Telstar Puretech reserves the right to improvements and specifications changes without notice.

Telstar North America
1504 Grundy’s Lane
Bristol, PA 19007 (USA)
T +1 215 826 0770
F +1 215 826 0222

www.puretech.uk.com

Water For Injection Stills

WFIS
Water For Injection Stills

A choice of quality
Telstar Puretech Multiple Effect Water for Injection Stills are designed and
constructed to produce pyrogen-free sterile water (WFI) in full compliance
with cGMP guidelines as per FDA and EMEA requirements.
Engineering and manufacturing practices follow ISO 9001 procedures,
ASME BPE criteria, GAMP guidelines, etc. Design and construction meets
the most stringent Regulations and Codes from Europe, USA and others
concerning safety and pressure vessels.
To ensure the equipment meets your requirements, we work in partnership
with you and a dedicated team follows your order as a unique project. We
develop specific Quality Plans (DQ, IQ and OQ) and undertake factory
acceptance testing (FAT) to give assurance, performance and quality.

WFI applications
WFI water for injection, as defined in the Ph Eur and the USP, is used
for the preparation of medicines for injectable administration, where
water is used as a vehicle (water for injections in bulk), to disolve or
dilute substances or preparations for injectable administration before use
(sterile water for injections). According to the Ph. Eur water for injections
can only be produced by distillation, of drinking water or purified water.

Design & construction features
Compact and Modular

Simple and Efficient Design

The unit and all its components such as feed water pump,
pre-heater and condensers are mounted on a stainless steel
AISI 304 skid.

The lower part of the column consists of a double tube sheet shell
heat exchanger with a large central pipe surrounded by a bundle of
peripheral seamless pipes. This arrangement produces a natural fluid
circulation: ascendant inside the peripheral pipes and descendant
inside the central one. Steam flows up very slowly but droplets cannot
reach the top of the column as they fall down simply by gravity. Thus,
impurities such as particles and pyrogens contained in the droplets
are dragged down towards the bottom of the column where they are
automatically blown down. Pure steam from the first column serves
as heating energy in the next column where it condenses as WFI.
This can be reproduced several times, so called multiple effects, up
to 7 columns. The more effects we install, the less heating energy and
cooling water required.

All parts in contact with the media are made of stainless steel
AISI 316L, insulated with mineral wool (asbestos-free material)
with external cladding made of stainless steel AISI 304. Inner
surfaces are polished to Ra ≤ 0.64 µm and electro polishing is
an available option.
Hygienic design: Including clamp connections, orbital welding
techniques for tubing and components, minimisation of dead
legs and proper piping slopes for self-drainability, double tube
sheet construction in first column, condenser and pre-heaters,
diaphragm valves for distillate/reject, etc.

Ease of Maintenance and Installation
The heat exchangers are totally accessible and no internal elements
are located within the column. This makes inspection much easier than
other designs, with long pipes or internal heat exchangers.
The replacement of column gaskets can be done easily and quick,
without needing to dismantle the column, which removes the need for
very high technical areas in order to take off any internal part.
Heat exchanger pipes are always totally immersed in water, so there is
a very low tendency to build up scale inside the tubes. Moreover, as
they are shorter than other designs, they are less stressed by vibrations
and risk of corrosion is significantly reduced.
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automatically blown down. Pure steam from the first column serves
as heating energy in the next column where it condenses as WFI.
This can be reproduced several times, so called multiple effects, up
to 7 columns. The more effects we install, the less heating energy and
cooling water required.

All parts in contact with the media are made of stainless steel
AISI 316L, insulated with mineral wool (asbestos-free material)
with external cladding made of stainless steel AISI 304. Inner
surfaces are polished to Ra ≤ 0.64 µm and electro polishing is
an available option.
Hygienic design: Including clamp connections, orbital welding
techniques for tubing and components, minimisation of dead
legs and proper piping slopes for self-drainability, double tube
sheet construction in first column, condenser and pre-heaters,
diaphragm valves for distillate/reject, etc.

Ease of Maintenance and Installation
The heat exchangers are totally accessible and no internal elements
are located within the column. This makes inspection much easier than
other designs, with long pipes or internal heat exchangers.
The replacement of column gaskets can be done easily and quick,
without needing to dismantle the column, which removes the need for
very high technical areas in order to take off any internal part.
Heat exchanger pipes are always totally immersed in water, so there is
a very low tendency to build up scale inside the tubes. Moreover, as
they are shorter than other designs, they are less stressed by vibrations
and risk of corrosion is significantly reduced.

Technical data

Operating principle

MODEL

Overall dimmensions

Main Utilities

No. of
effects

Width
(W)
mm

Height
(H1)
mm

Height
(H2)
mm

Depth
(D)
mm

Distillate
output
l/h

Heating steam
@ 8 bar
kg/h

Cooling water
(25-50º C)
l/h

WFIS 3-250

3

2.140

2.000

2.900

1.300

270

130

1.095

800

WFIS 3-500

3

2.105

1.900

2.875

960

500

235

2.030

1.000

WFIS 4-500

4

2.500

1.900

2.875

960

500

190

1.185

1.200

WFIS 4-750

4

2.910

2.100

3.100

1.100

775

295

1.835

1.350

WFIS 4-1250

4

3.040

2.230

3.090

1.180

1.200

460

2.840

1.500

WFIS 5-500

5

2.915

1.900

2.875

960

500

165

650

2.100

WFIS 5-750

5

3.420

2.100

3.070

1.100

775

255

1.005

2.300

WFIS 5-1250

5

3.590

2.230

3.090

1.180

1.200

390

1.555

2.500

WFIS 5-2000

5

3.700

2.400

3.550

1.500

2.075

680

2.690

3.000

WFIS 5-3000

5

4.200

2.685

3.830

1.500

3.065

1.000

3.970

3.400

WFIS 5-4500

5

4.400

2.950

3.975

1.600

4.585

1.500

5.940

3.800

WFIS 6-2000

6

4.270

2.400

3.550

1.500

2.075

605

1.150

4.200

WFIS 6-3000

6

4.880

2.980

3.830

1.500

3.065

890

1.695

4.700

WFIS 6-4500

6

5.315

2.950

3.975

1.548

4.585

1.335

2.540

5.200

WFIS 6-6500

6

5.900

3.080

4.420

1.630

6.535

1.900

3.615

5.800

WFIS 6-9000

6

6.900

3.080

4.420

1.800

9.060

2.635

5.015

6.500

WFIS 6-12000

6

6.675

3.170

4.500

2.100

12.640

3.680

11.665

7.200

WFIS 7-3000

7

5.560

2.980

3.830

1.500

3.065

815

0

6.000

WFIS 7-4500

7

6.050

2.950

3.975

1.550

4.585

1.220

0

7.400

Approx.
Weight
Kg

Feed water (PW) is pre-heated by means of two DTS heat exchangers, which use
respectively the heat of the pure steam and distillate water outlet and the plant steam
outlet. The first column of the CS water still is equal to our CPS steam generators, heated
also with plant steam.

DTS PRE-HEATER

WFIS 7-6500

7

6.710

3.080

4.420

1.630

6.535

1.740

0

8.800

DTS HEAT EXCHANGER

WFIS 7-9000

7

7.510

3.080

4.420

1.800

9.060

2.410

0

10.300

PLANT STEAM HEATED

WFIS 7-12000

7

7.700

3.170

4.500

2.400

12.645

3.365

0

12.500

The pure steam produced in the first column is used as the heating medium for the next
one, so it condenses and turns into WFI. Simultaneously, the partial amount of nonevaporated water goes to the next column, so it is also partially evaporated as pure steam
and used as heating energy for the next column.

PURE STEAM HEATED

Here, the pure steam also condenses (resulting in WFI distillate) and it is transferred by
pressure to the successive columns.

Control system
The control system is based on a
PLC wire operator supervision via a
user-friendly touch-screen HMI with
the following menu:

WFIS
H2
H1*

W
D
* WFIS OUTLET

COLUMN
COLUMN
CONDENSER

Options and accessories
• Feed water conductivity monitoring
• Pure steam take from the first column
• Elevated WFIS condenser
• Hot standby mode
• Sanitisation/Sterilization of the separator columns and WFIS condensers
• Protective mesh guarding
• On-line TOC monitoring device
• WFI storage and distribution skid.

• Mimics of the equipment, showing
the operational state in real time
• Process parameters (temperature,
pressure and conductivity)
• Setting up of parameters
• Alarm information
• Start-up and alarm recognition.

Telstar
Av. Font i Sagué, 55
Parc Científic i
Tecnològic Orbital 40
08227 Terrassa (Spain)
T +34 937 361 600
F +34 937 861 380

Options include: paper or electronic
chart recorder for pure steam
conductivity, temperature, extra
feed water conductivity meter, online TOC monitoring, etc.
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Feed water (PW) is pre-heated by means of two DTS heat exchangers, which use
respectively the heat of the pure steam and distillate water outlet and the plant steam
outlet. The first column of the CS water still is equal to our CPS steam generators, heated
also with plant steam.

DTS PRE-HEATER

WFIS 7-6500

7

6.710

3.080

4.420

1.630
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8.800
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The pure steam produced in the first column is used as the heating medium for the next
one, so it condenses and turns into WFI. Simultaneously, the partial amount of nonevaporated water goes to the next column, so it is also partially evaporated as pure steam
and used as heating energy for the next column.

PURE STEAM HEATED

Here, the pure steam also condenses (resulting in WFI distillate) and it is transferred by
pressure to the successive columns.

Control system
The control system is based on a
PLC wire operator supervision via a
user-friendly touch-screen HMI with
the following menu:

WFIS
H2
H1*
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* WFIS OUTLET

COLUMN
COLUMN
CONDENSER

Options and accessories
• Feed water conductivity monitoring
• Pure steam take from the first column
• Elevated WFIS condenser
• Hot standby mode
• Sanitisation/Sterilization of the separator columns and WFIS condensers
• Protective mesh guarding
• On-line TOC monitoring device
• WFI storage and distribution skid.

• Mimics of the equipment, showing
the operational state in real time
• Process parameters (temperature,
pressure and conductivity)
• Setting up of parameters
• Alarm information
• Start-up and alarm recognition.
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Data Sheet

Millistak+® Pod disposable
depth filter system

Innovative, High-Performance Pod Filters are
ideal for Primary and Secondary Clarification
in Lab, Pilot and Process-Scale Applications.
Millistak+® depth filter media is offered
in a scalable, disposable format, the Pod
Filter System. Accommodating applications
from lab to pilot to process scale, the Pod
format offers greater flexibility because of
its unique modular and 100% disposable
design.
The Millistak+® Pod system is ideal for a wide variety
of primary and secondary clarification applications,
including cell cultures, yeast and E. coli lysates post
centrifuge, E. coli refolds, media, vaccines, plasma
proteins and sera.
Millistak+® Pod filters are available in three distinct
series of media grades in order to meet your specific
application needs. Millistak+® DE, CE and HC media
deliver optimal performance through a gradient density
matrix as well as positive surface charge properties.

Benefits
• Low hold-up volume for greater product yield
• Broad range of media types offered in single and
multilayer products
• Millistak+® HC dual-action media improves
prefiltration and compresses clarification
• Flexible, modular format offers scalability from
5 to 12,000 liters or more
• Patented disposable design eliminates need for
housing, CIP or cleaning validation
• Self-contained Pod filters protect operators from
exposure to biohazards
• Robust construction is easy to use and set up
• Smaller footprint facilitates use in tight spaces

EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany

Linear Scalability
The innovative Pod filter system consists of eight filter sizes
and two expandable holders. No matter what size Pod filter
you choose, the same flow path and configuration ensures
a linearly scalable solution from bench to process scale.

Easy to Use

• Pilot scale holder — accommodates up to two full size
Pod filters for configurations from 0.11 m2 to 2.8 m2
depending on media type. An optional accessory kit
expands capacity to five full scale Pod filters.
• Disposable adapters — connect Pod filters to process
piping, creating disposable flow path.
• Disposable diverter plates — enable more than one media
grade on a single rack

With the compact, modular design of our Pod system,
you can increase productivity and shorten cycle times.
Installation and set-up of the Pod system is simple and
straightforward. The unique design of the disposable
adapters and disposable manifolds makes it easy to connect
the Pod filters to the rest of the unit operations in the
process. The self-contained and disposable nature of the
system protects operators from exposure to biohazards and
eliminates maintenance as well as cleaning validation
requirements.

Configurations
• µPod® filter — 23 cm2
• Lab scale Pod filter — 0.027 m2, 0.054 m2

Millistak+® Depth Filter Media
Available in three media series, the proven filtration
performance of Millistak+® filter media in the Pod format
provides greater flexibility and reduced cycle times.
Millistak+® Pod filters incorporate multiple graded-density
layers and adsorptive, positively-charged filter media.
Composed of select grade cellulose fiber and diatomaceous
earth, the Millistak+® DE series not only improves the
manufacturing process, but also increases contaminant
holding. In addition, the Millistak+® CE series consists of
single layer media with cellulose fibers that are suitable for
coarse filtration applications.
Millistak+® HC series improves productivity by combining
multiple media grades into one device enabling compression
of multiple filtration stages downstream of the bioreactor.

• Millistak+® DE and CE media — 0.11 m2,
0.77 m2, or 1.4 m2 filtration area.
• Millistak+® HC media — 0.11 m2, 0.55 m2, or
1.1 m2 filtration area.

D0HC
C0HC
BIHC
AIHC
F0HC

Millistak+® grades with diatomaceous earth and cellulose

X0HC

multi layer

• Process scale holder — accepts from five to ten Pod filters
per rack. Up to three racks can be stacked for process
flexibility.

DE25

CE20

DE40
DE45

CE25
CE30
CE35

Millistak+® grades with diatomaceous earth

DE50

DE55
DE60
DE65

CE40
CE45

Millistak+® grades with cellulose only

single layer

DE30
DE35

CE15

CE50

Millistak+® grades with activated carbon

DE70

CR40

60 µm
40
Nominal Micron Rating (µm)

20

15

10

5

1

DE75

0.5

0.1

Typical Extractables
Single Layer Millistak+® CE & DE Media

Millistak+® HC Media (non X0HC)

Millistak+® X0HC/F0HC Media

Conductivity

1.52 - 1.94 µS/cm post autoclave (1 cycle of
60 minutes at 123 ºC) and pure water flush
of 5 L/ft2 (50 L/m2) of media surface area

3.64 - 10.5 µS/cm post autoclave (1 cycle of
60 minutes at 123 ºC) and pure water flush
of 10 L/ft2 (100 L/m2) of media surface area

19.34 - 53.2 µS/cm (X0HC) and
21.4 - 42.7 µS/cm (F0HC) post autoclave
(1 cycle of 60 minutes at 123 ºC) and
pure water flush of 10 L/ft2 (100 L/m2) of
media surface area

NVR Gravimetric
Extractables

Not Tested

420 - 750 mg/f2 (process scale) and
630 - 1251 mg/m2 (lab-scale) per 24 hour
static soak in pure water (type 1 DI water)
post autoclave (1 cycle of 60 minutes at
123 ºC) and pure water flush of 10 L/ft2
(100 L/m2) of media surface area

Not Tested

TOC

910 - 1800 ppb post autoclave (1 cycle of
60 minutes at 123 ºC) and pure water flush
of 5 L/ft2 (50 L/m2) of media surface area

720 - 4600 ppb post autoclave (1 cycle of
60 minutes at 123 ºC) and pure water flush
of 10 L/ft2 (100 L/m2) of media surface area

1200 - 2800 ppb (X0HC) and 460 - 3200 ppb
(F0HC) post autoclave (1 cycle of 60 minutes
at 123 ºC) and pure water flush of 10 L/ft2
(100 L/m2) of media surface area

Metals
(mg/ft2 Media)

DE Series

CE Series

A1HC Series

X0HC Series

F0HC Series

Sodium

≤ 11.5

≤ 9.91

≤ 38.2

≤ 14.02

≤17.313

Calcium

≤0.050

≤ 1.46

≤ 7.30

≤ 9.60

≤5.170

Potassium

≤0.351

≤ 0.042

≤ 1.18

≤ 0.82

≤0.439

Magnesium

≤ 0.129

≤ 0.662

≤ 2.31

≤ 3.905

≤1.464

Iron

≤ 0.042

≤ 0.042

≤ 0.090

< 0.001*

<0.041

Lead

≤ 0.0004

≤ 0.0004

<0.001

<0.001*

<0.001

Aluminum

≤ 0.025

≤ 0.059

≤ 0.141

≤ 0.084

≤0.021

Titanium

<0.001*

<0.001*

≤0.019

≤ 0.04

<0.001

Chromium

≤0.001

0.0003

≤0.003

≤0.001

<0.001

Manganese

≤0.001

≤0.001

≤ 0.487

≤ 0.425

≤0.370

Cobalt

≤0.0002

0.0002

≤0.002

≤0.001

≤0.002

Nickel

≤0.001

≤ 0.0004

≤0.013

≤ 0.013

≤0.022

Copper

≤0.003

≤ 0.0004

≤ 0.167

≤ 0.009

≤0.019

Zinc

≤0.002

≤ 0.003

≤0.112

≤ 0.046

≤0.052

Mercury

≤ 0.0004

≤ 0.0004

<0.001*

<0.001*

<0.001

Arsenic

≤0.003

≤ 0.002

≤ 0.011

≤ 0.009

≤0.004

*Pilot and process scale only

Small Scale:
HC, DE, CE: 23 cm2

Lab Scale:
HC, DE, CE: 270 - 540 cm2

Pilot Scale:
HC: 0.11 - 5.5 m2
DE or CE: 0.11 - 7.1 m2

Process Scale:
HC: 5.5 - 33 m2
DE or CE: 7.1 - 43 m2

Millistak+® Pod Filter Specifications
Surface Area

23 cm2
(HC, CE and DE media)

1.2 ft2 (0.11 m2)
(HC, CE and DE media)

5.9 ft2 (0.55 m2)
(HC media)

8.3 ft2 (0.77 m2)
(CE and DE media)

11.8 ft2 (1.1 m2)
(HC media)

Materials of Construction
Filter Media:

Cellulose fibers with inorganic filter aid (CE Media contains cellulose only)

Filter Membrane:

Mixed esters of cellulose (grades A1HC and B1HC only)

Pod Housings:

Glass Filled Polypropylene

Adapters:

Glass Filled Polypropylene*

Gaskets and Plugs:

Thermo Plastic Elastomer (TPE)*

Inlet, Vent and Outlet
Connections

Female Luer

Flat seal

Pod Dimensions
Length:

3.5 in. (8.9 cm)

24.2 in. (62 cm)

24.2 in. (62 cm)

24.2 in. (62 cm)

24.2 in. (62 cm)

Height:

2.6 in. (6.6 cm)

12.5 in. (32 cm)

12.5 in. (32 cm)

12.5 in. (32 cm)

12.5 in. (32 cm)

Thickness:

1.6 in. (4.1 cm)

1.2 in. (3 cm)

2.8 in. (7.1 cm)

3.1 in. (7.9 cm)

4.8 in. (12.2 cm)

Maximum Operating
Pressure

50 psig (3.5 bar) at ≤40° C

Maximum Differential
Pressure
Forward:

30 psid (2.1 bar) at
40 °C

Reverse:

15 psid (1.0 bar) at
40 °C

50 psig (3.5 bar) at 25 °C; 15 psig (1.0 bar) at 80° C

30 psid (2.1 bar) at 25° C; 15 psid (1.0 bar) at 80° C
30 psid (2.1 bar) at 25° C

Sterilization

2 cycles of 60 minutes
at 123° C

Indirect Food Additive

All components meet the FDA indirect food requirements cited in 21 CFR 177-182.

Toxicity

All component materials meet the requirements of the current USP <88> biological reactivity test for class VI plastics.

Bacterial Endotoxin

< 0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) test.

CE Pressure

This filter has been designed and manufactured according to the essential requirements of the Pressure.

Equipment Directive

Equipment Directive 97/23/EC. Only 0.77 m2, 1.1 m2 and 1.4 m2 filters carry the CE mark.*

1 cycle of 60 minutes at 123° C

* Pilot and process scale only.

Millistak+® Pod Filter Specifications
Surface Area

15.4 ft2 (1.4 m2)
(CE and DE media)

0.29 ft2 (0.027 m2)

0.58 ft2 (0.054 m2)

Materials of Construction
Filter Media:

Cellulose fibers with inorganic filter aid (CE Media contains cellulose only)

Filter Membrane:

Mixed esters of cellulose (grades A1HC and B1HC only)

Pod Housings:

Glass Filled Polypropylene

Adapters:

Glass Filled Polypropylene*

Gaskets and Plugs:

Thermo Plastic Elastomer (TPE)*

Pod Dimensions
Length:

24.2 in. (62 cm)

8.5 in. (22 cm)

8.5 in. (22 cm)

Height:

12.5 in. (32 cm)

5.3 in. (14 cm)

5.3 in. (14 cm)

Thickness:

5.0 in. (12.7 cm)

2.9 in. (7.9 cm)

3.7 in. (9.4 cm)

Maximum Operating Pressure
Maximum Differential Pressure
Forward:
Reverse:

50 psig (3.5 bar) at 25 °C; 15 psig (1.0 bar) at 80 °C

30 psig (3.5 bar) at 37 °C

30 psid (2.1 bar) at 25 °C; 15 psid (1.0 bar) at 80 °C

30 psid (2.1 bar) at 4-37 °C
30 psid (2.1 bar) at 37 °C

30 psid (2.1 bar) at 25 °C

Sterilization

May be autoclaved for 1 cycle of 60 minutes at 123 °C

Indirect Food Additive

All components meet the FDA indirect food requirements cited in 21 CFR 177-182.

Toxicity

All component materials meet the requirements of the current USP <88> biological reactivity test for class VI plastics.

Bacterial Endotoxin

< 0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) test.

CE Pressure

This filter has been designed and manufactured according to the essential requirements of the Pressure

Equipment Directive

Equipment Directive 97/23/EC. Only 0.77 m2, 1.1 m2 and 1.4 m2 filters carry the CE mark.

* Pilot and process scale only.

2 cycles of 60 minutes at 123 °C

Water Permeability

Conductivity / TOC
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Flow Rate 10 L/min

40

60

80

100

Flush Volume (L/m2)

TOC Flush-up
Flow Rate 10 L/min

0.30

4

0.25

3

0.20

2

0.11
0.55
1.1 m 2

1
0

0.15

m2
m2

0.10
0.50

0

0.5

1.0

1.5

2. 0

2 .5

3.0

3.5

0.00

bar

100

Flow Rate (gpm)

Water Flow Rates
Millistak+® CE Series

Millistak+® DE Series
Water Flow Rate
L/min/m2 at 10 psid, 23° C
3054.9 - 5611.5
2082.6 - 3825.5
1425.8 - 2619.1
974.1 - 1789.3
665.5 - 1222.4
454.6 - 835.1
310.6 - 570.5
212.2 - 389.8

Media Type/Grade
CE15
CE20
CE25
CE30
CE35
CE40
CE45
CE50

Millistak+® HC Series
Media Type/Grade
DE60
A1HC
DE75
DE50
B1HC
DE75
DE30
C0HC
DE60
CE25
D0HC
DE40
DE60
F0HC
IM75
IM75
X0HC
IM83

Water Flow Rate
L/min/m2 at 10 psid, 23° C
99.0 - 181.9
31.6 - 58.0
212.2 - 389.8
31.6 - 58.0
974.1 - 1789.3
99.0 - 181.9
1425.8 - 2619.1
454.6 - 835.1
99.0 - 181.9
39.1 - 54.6
39.1 - 54.6
21.2 - 27.7

Media Type/Grade
DE25
DE30
DE35
DE40
DE45
DE50
DE55
DE60
DE65
DE70
DE75

Water Flow Rate
L/min/m2 at 10 psid, 23° C
1425.8 - 2619.1
974.1 - 1789.3
665.5 - 1222.4
454.6 - 835.1
310.6 - 570.5
212.2 - 389.8
145.0 - 266.3
99.0 - 181.9
67.7 - 124.3
46.2 - 84.9
31.6 - 58.0

Choose the Right Media
Media Grade

Application

Characteristics

Media Construction

Single-layer CE*

Cellulose

CE15 to 50

Single-layer DE*

Cellulose + inorganic filter aid

DE 25 to 75

Triple-layer A1HC

Post-TFF (Prostak™ system) clarification fluids

Tightest media combination with an additional membrane
layer to protect downstream membrane filters

DE60 + DE75 + RW01

Triple-layer B1HC

Post-centrifuge or settled permeate containing
cellular particulate

A more open first layer withan additional membrane
layer to protect downstream membrane filters

DE50 + DE75 + RW01

Double-layer C0HC

Perfusion bioreactor fluid

Two layers of a more open DE media

DE30 + DE60

Double-layer D0HC

Primary clarification directly out of the bioreactor

A more open CE layer and DE media combination

CE25 + DE40

Double-layer X0HC

Secondary clarification of bioreactor harvests,
primarily for cell cultures

Two DE layers. Provides sterile filter protection without
an RW01 membrane

IM75 + IM83

Double-layer F0HC

Secondary clarification of pretreated harvest by
acid precipitation or flocculation, E. coli and yeast

Two DE layers. Provides sterile filter protection without
an RW01 membrane

DE60 + IM75

*For clarification of serum, plasma, vaccines, cell culture or other fluids, choice of media grade should be based on small-scale trials.

Ordering Information
µPod® Filter

2

M
Millistak+®

CE15
CE20
CE25
CE30
CE35
CE40

CE45
CE50
DE25
DE30
DE35
DE40

C

L

Size
23C = 23 cm2

Media Type and grade
A1HC
B1HC
C0HC
D0HC
F0HC
X0HC

3

DE45
DE50
DE55
DE60
DE65
DE70
DE75

3

Connection
L = Luer Fitting

Package Quantity
3 = 3/pack

µPod® Filter Accessories
µPod® Tubing Kit Catalogue No. MTUBEKITL1
Gauge 0 - 60 psi and Connection Fittings Catalogue No. XXPXLGAGE

Lab Scale Pod Filter

M

H

Millistak+®
Media Type and grade
A1HC
B1HC
C0HC
D0HC
F0HC

X0HC
CE15
CE20
CE25
CE30

CE35
CE40
CE45
CE50

DE25
DE30
DE35
DE40

DE45
DE50
DE55
DE60

DE65
DE70
DE75

Size
027 = 0.027 m2
054 = 0.054 m2

1

Connection
Package Quantity
H = 1/4 in. (6 mm) 1 = 1/pack
Hose Barb

Multi Layer Process Scale Pod Filter

F

M
Size
01 = 0.11 m2
05 = 0.55 m2
10 = 1.1 m2

Media Type and grade

Millistak+®

A1HC
B1HC

C0HC
D0HC

X0HC
F0HC

S

Connection
FS = Flat seal

1
Package Quantity
1 = 1/pack

Single Layer Process Scale Pod Filter

M

F

Millistak+®

Media Type and grade
CE15
CE20
CE25
CE30

CE35
CE40
CE45
CE50

DE25
DE30
DE35
DE40

DE45
DE50
DE55
DE60

DE65
DE70
DE75

Size
01 = 0.11 m2
07 = 0.77 m2
13 = 1.4 m2

S

Connection
FS = Flat seal

Pilot and Process scale pods require a pod holder. Lab scale pods and µPod® filters do not require a holder.
Please contact your local sales representative for more information.

1
Package Quantity
1 = 1/pack

To place an order or receive
technical assistance
In the U.S. and Canada, call toll-free
1(800)-645-5476
For other countries across Europe, call
+44 (0) 115 943 0840
For other countries across Europe and the world,
please visit www.emdmillipore.com/offices
For Technical Service, please visit
www.emdmillipore.com/techservice

www.emdmillipore.com/millistak
EMD Millipore, the M logo, Millistak+ and µPod are registered trademarks of Merck KGaA, Darmstadt, Germany.
Prostak is a trademark of Merck KGaA, Darmstadt, Germany. Lit No. DS0217EN00 Vers. 9.0 DP-SBU-11-04134
07/2016 © 2016 EMD Millipore Corporation. All rights reserved.
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Hardware for Pod disposable
depth filter systems
Innovative, high-performance Pods are ideal
for primary and secondary clarification in lab,
pilot and process-scale applications.
Millistak+® and Clarisolve® depth filter media are offered
in a scalable, disposable format, the Pod Filter System.
Accommodating applications from lab to pilot to process
scale, the Pod format offers greater flexibility because of
its unique modular design.
The Pod system is ideal for a wide variety of primary
and secondary clarification applications, including cell
cultures, yeast and E. coli lysates post centrifuge, E. coli
refolds, media, vaccines, plasma proteins and sera.
The system’s modular design allows users to operate the
system with as few as one at pilot scale and as many
as 30 Pod filters installed at the process scale. These
options make it easy to configure a system for a specific
application, and conveniently reconfigure it as process
capacity requirements scale-up or down.

Benefits
• Modular format offers scalability from 5 to
12,000 liters or more
• Optional 100% disposable flow path eliminates
need for housing, CIP, cleaning validation
• Robust construction is easy to use and set up
• Increase your installed surface area by 6x within
the same footprint

EMD Millipore is a division of Merck KGaA, Darmstadt, Germany.

Linear Scalability
The innovative Pod filter system consists of seven filter
sizes and two expandable holders. No matter what size
Pod filter you choose, the same flow path and configuration ensures a linearly scalable solution from bench to
process scale.

Easy to Use
With the compact, modular design of our Pod
system, you can increase productivity and shorten
cycle times.

• Process scale holder — accepts from five to ten
Pods per rack. Up to three racks can be stacked for
process flexibility. Total surface area is dependent
on media grade.
• Disposable adapters — connect Pods to process
piping, creating disposable flow path.
• Disposable diverter plates — enable more than one
media grade on a single rack
• Disposable feed and filtrate manifolds —
make your flow path 100% disposable by replacing
the stainless steel manifolds with disposable versions.
Available for 1, 2, and 3 rack process scale holders.

Installation and set-up of the Pod system is simple and
straightforward. The unique design of the disposable
adapters makes it easy to connect the Pods to the process
piping. The self-contained and disposable nature of the
system protects operators from exposure to biohazards
and eliminates maintenance as well as cleaning validation
requirements.

Configurations
• Pilot scale holder — accommodates up to two full
size Pods. An optional accessory kit expands capacity
to 5 full scale Pods. Total surface area is dependent on
media grade.

The Pod pilot scale holder
supports your process as
you scale up.

Pod Holder Specifications*
Surface Area

Pilot Scale

Process Scale

Materials of construction
Manifold
Diverter plate
End plates

N/A
Polypropylene
304 stainless steel

316 L stainless steel
Polypropylene
304 stainless steel

All metal surfaces in contact with process fluids

N/A

316 L stainless steel

Manifold surface finish, internal

N/A

Electropolished, Ra <0.5 µm (<20 micro-inches)

End plate clamp and guide rods

17–4 PH steel

17–4 PH steel

All other metal surfaces

304 stainless steel

304 stainless steel

TC gaskets

Thermoplastic Elastomer (TPE)

Thermoplastic Elastomer (TPE)

TC clamp

304 stainless steel 2 piece clamp

304 stainless steel 2-piece clamp

Performance properties

Capable of supporting and sealing pod filters up to 50 psig maximum operating pressure at 25 °C.
Inlet and outlet connection to the pods and vents are via disposable adapters.

Maximum differential pressure
Forward
Reverse
Regulatory information

50 psid (3.5 bar) at 25 °C; 15 psid (1.0 bar) at 80 °C
30 psid (2.1 bar) at 25 °C
Sealing materials and plastics in contact with the product meet USP <88> biological reactivity test for
Class VI plastics and are Title 21 CFR 177.2600 and 177.1550 compliant.

Pod Disposable Manifold Specifications*
Pod Disposable Manifold

Specifications

Materials of construction
Polypropylene
Double braided silicon tubing
Silicone gaskets
Glass filled nylon clamps

Max. operating pressure: 50 psi
Hot water sanitization: 1 cycle of 80 °C for 30 minutes
Toxicity: Component materials comply with the requirements of USP <88> biological reactivity tests for
Class IV plastics

*No holder required for lab scale pod

Ordering Information
Description

Qty/Pk

Catalogue No.

Pilot Scale Holder
For pod configurations from 1 to 2 filters

1

MP0DPIL0T

Pilot holder expansion kit allows for pod configurations up to 5 filters

1

MP0DPIL0TX

1-rack holder; for 5 to 10 filters; Gemü® valves

1

MP0DSYS1A

1-rack holder; for 5 to 10 filters; ITT valves

1

MP0DSYS1B

1-rack holder; for 5 to 10 filters; no valves

1

MP0DSYS1N

1-rack expansion kit; for 5 to 10 filters; no valves or casters

1

MP0DSYS1X

2-rack holder; for 5 to 20 filters; Gemü® valves

1

MP0DSYS2A

2-rack holder; for 5 to 20 filters; ITT valves

1

MP0DSYS2B

3-rack holder; for 5 to 30 filters; Gemü® valves

1

MP0DSYS3A

3-rack holder; for 5 to 30 filters; ITT valves

1

MP0DSYS3B

Process Scale Holders

Holder Replacement Parts*
Hydraulic pump

MP0DHYPUMP

Hydraulic system pressure gauge

MP0DHYGAGE

Hydraulic fluid

MP0DHFLUID

Clamp insert

MP0DINSERT

1.5 in. TC stainless steel clamp for use with MP0DINSERT

YY2004045

Clamp rod knob

MP0DCRKN0B

Clamp rod for 2 filters

MP0DCR0D02

Clamp rod for 5 filters

MP0DCR0D05

Clamp rod for 10 filters

MP0DCR0D10

Manifold elbow, 90 °C, 1.5 in. 316 stainless steel

MP0DSSELB0

Manifold tee, 1.5 in. 316 stainless steel

MP0DSSTEE

Manifold spool, 1 in. x 6.60 in. L

MP0DMANSPH

Manifold spool, 1.5 in. x 13.16 in. L

MP0DMANSPV

Manifold bracket assembly

MP0DMANBRK

Replacement diaphragm for 1 in. Gemü® MPODVALVEA

MPODVLVADIA

Replacement diaphragm for 1 in. ITT MPODVALVEB

MPODVLVBDIA

Holder Accessories*
1-rack Disposable feed and filtrate manifold

MP0DDSPMAN1

2-rack Disposable feed and filtrate manifold

MP0DDSPMAN2

3-rack Disposable feed and filtrate manifold

MP0DDSPMAN3

Disposable adapter kit** 3 through adapters, 3 blind adapters

1

MP0DADAPT

Disposable adapter kit** 6 through adapters, required if using MP0DDIVERTR

1

MP0DADPTF

1.5 in. TC sanitary gauge, 0–4 bar (0–60 psi)

1

MP0D60PSIG

1.5 in. TC EPDM gasket

10

HGTC150EP

1.5 in. TC stainless steel clamp

1

YY2004045

Diaphragm valve, 1 in. Gemü®

1

MP0DVALVEA

Diaphragm valve, 1 in. ITT

1

MP0DVALVEB

Disposable diverter plate

10

MP0DDIVERTR

Pod pilot holder handle

1

MP0DPLTHNDL

End Plate Replacement Kit
This kit replaces the bronze bushings with linear ball bearings to facilitate movement of the end plate.
The kits come with one end plate, new guide rods and associated hardware.
Pod Retrofit Kit for MP0DPILOT

MP0DRET1

Pod Retrofit Kit for MP0DPILOT with extension rods

MP0DRET2

Pod Retrofit Kit for process scale holders

MP0DRET3

*Consult your sales associate for replacement part and accessory availability.
**The disposable adapter kit must be ordered with individual Pod filters in order to install the Pod filter in the holder.

To Place an Order or Receive
Technical Assistance
In the U.S. and Canada, call toll-free
1(800)-645-5476
For other countries across Europe, call
+44 (0) 115 943 0840
For other countries across Europe and the world,
please visit www.emdmillipore.com/offices
For Technical Service, please visit
www.emdmillipore.com/techservice

www.emdmillipore.com
EMD Millipore, the M mark, Millistak+ and Clarisolve are registered
trademarks of Merck KGaA, Darmstadt, Germany.
Gemü is a registered trademark of Gebroder Müller Apparatebau GmbH & Co.
Lit No. DS3388EN00 Rev. B 06/2014 DP SBU-11-04244 Printed in the U.S.A.
©2014 EMD Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.
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Process columns

Chromaflow™ columns
Chromaflow columns are a family of convenient to use,
process-scale columns. A patented nozzle in the top and
bottom of the column allows packing, unpacking, and
cleaning when fully assembled, that is with the lid in place.
Chromaflow columns simplify chromatographic procedures
and offer:
• convenience
• saving of labor
• reproducibility
• contained packing
• scalability

General column description
Chromaflow low-pressure columns (Fig 1) are available in
a choice of dimensions and materials. The complete range
offers inner diameters (i.d.) from 300 to 2000 mm (Table 1),
with column tubes manufactured from cast acrylic (Fig 1). All
dimensions are available with variable bed heights, providing
a wide variety of bed volumes. All columns are pressure rated
for operation at 3 bar.

Fig 1. A Chromaflow column, 2000 mm i.d.

Chromaflow columns incorporate a patented, pack-in-place
nozzle (Fig 2) through which process liquids enter and exit.
Manual or automated versions of the nozzles are available.
The automated nozzle is controlled from the packing station
or the nozzle control unit. The nozzle has three positions to
facilitate the different aspects of column operation: packing,
operation, unpacking and cleaning. In addition to this packin-place functionality, the nozzle also contains the process
liquid flow path to provide a consolidated solution to the
process stream handling.

Fig 2. The Chromaflow nozzle that enables packing in place in a fully
assembled column (GE Healthcare patent).

Bed supports are available in 316L stainless steel or
polyethylene. The multilayer, woven stainless steel bed
supports have very high chemical resistance and longevity
for use in applications where salt concentrations are low and
pH is above 5. Polyethylene bed supports are recommended

for applications with low pH and high salt concentrations.
All other wetted parts in columns with polyethylene bed
supports are manufactured from plastic or noncorrodible
materials for use in low pH /high salt applications.

gelifesciences.com

The construction materials include 316L stainless steel,
acrylic, polypropylene, polyethylene, PEEK 450 G, EPDM rubber
and FEP encapsulated silicone. These materials have high
chemical resistance to the liquids typically used in process
chromatography (Table 2). Furthermore, all polymeric materials
are approved according to USP class VI tests for toxicity.

risk of the operator coming into contact with hazardous
chemicals and of the target product being exposed to
contamination. In this way, overall safety and hygienic
operation are improved.

As an option, a dedicated packing station is available for
Chromaflow columns. The packing station speeds up the
packing procedure by eliminating the more time-consuming,
manual maneuvers (Fig 3).

The column has a three-position nozzle located in the center
of the top and bottom bed support. These three positions
enable packing, unpacking, operation and cleaning to be
performed without any adjustments to the assembled
column, that is the lid remains in place.

Comprehensive documentation is delivered with each column
and includes a User manual, a Maintenance manual, assembly
drawings, a full spare part list, materials certificates etc.
A Validation Support File containing information on column
component composition, materials of construction and
toxicity studies is also available.

Principle of operation

Flow profiles from the two nozzles are identical. Packing
direction will depend on the characteristics of the media and
packing method used. The three positions are illustrated in
Figure 4.

Packing position
The bottom nozzle is extended part of
the way (mid position) into the column.
The top nozzle is fully retracted. Slurry
enters the column via the bottom nozzle
and excess liquid exits via the top mobile
phase outlet. After packing, the slurry
lines are isolated from the mobile phase
and can be cleaned independently from
the rest of the column.

Fig 3. Packing Chromaflow columns with the dedicated packing station is
convenient and simple.

Convenient and labor saving
Once the column is assembled and the lid in place, no
lifting gear is required for packing, operation, unpacking or
cleaning-in-place (CIP). This means that a single operator can
perform all column operations, thereby reducing labor costs
and increasing convenience in large-scale operations.

Reproducibility
Packing with the lid in place allows the packing parameters
to be easily set and fixed. Manual operation is minimized and
standard operating procedures can be followed, helping to
give reproducible column packing and results.

Contained packing
Improved safety is another advantage of the Chromaflow
column concept. Because all the column operations are
performed in a “closed system” environment, there is less
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Running position
The bottom and top nozzles are
retracted. Mobile phase enters the
column directly into an annulus,
immediately behind the bed support.
The annulus is cut through at an angle to
ensure that linear flow is kept constant
during distribution of the mobile phase
across the bed.

Unpacking position
In this position, both bottom and
top nozzles are fully extended into
the column thereby exposing a third
passage through which medium leaves
the column.
Cleaning solution can be pumped
through the nozzles and sprayed into the
column. In this way the column is easily
and effectively cleaned without exposing
the interior or the medium to the
environment, and without dismantling
the column.
Fig 4. The three positions of the Chromaflow nozzle showing
packing from the top.

Scalability

Chromaflow 400 SFP columns

Chromaflow columns are available in a wide range of
dimensions, all designed and constructed around the
same design principle. Standard range columns come in
dimensions from 400 to 1000 mm, for more information
about columns and dimensions, see Ordering information.
Scaling up a chromatographic process from small to larger
diameters is easily performed with maintained reproducibility,
safety and convenience.

Chromaflow 400 SFP (small flow path) columns are specially
designed for low-flow applications. The dimensions in the
mobile phase have been optimized to reduce dead volumes
to a minimum and the area behind the nozzle tip has also
been reduced.

Column dimensions

Table 2 lists the major components of Chromaflow columns
in contact with process fluids (wetted parts) and Table 3 lists
the chemical resistance of materials using data compiled
from several published sources. It is important to note that
columns with stainless steel bed supports and other stainless
steel wetted components must be appropriately maintained
when exposed to NaCl. Since salt can be corrosive to
stainless steel over time, it is recommended that residual
salt is removed by rinsing columns with at least five column
volumes (CV) of clean water.

A selection of Chromaflow columns in the range 400 to
2000 mm i.d. are presented in Table 1. The adapter stroke
length is a standard 200 mm. Variable bed heights are
available in the ranges 100 to 300 mm, 200 to 400 mm and
300 to 500 mm.

Column materials and their chemical
resistance

Table 1. Weights, volumes and dimensions for variable bed height Chromaflow columns

Max operating
pressure (bar)

Volume
(L)

Column overall
height (mm)

Weight,
dry (kg)

Footprint
(mm × mm)

Chromaflow column 400/100-300*

3

12.6–37.8

1568

230

700 × 700

Chromaflow column 600/100-300

3

28.3–84.9

1568

375

800 × 800

Chromaflow column 800/100-300

3

50.3–150.9

1572

610

1000 × 1000

Chromaflow column 1000/100-300

3

78.5–235.5

1573

930

1200 × 1200

Chromaflow column 1200/100-300

3

113.1–339.3

Chromaflow column 1400/100-300

3

153.9–461.7

Chromaflow column 1600/100-300

3

201.1–603.3

Chromaflow column 1800/100-300

3

254.5–763.5

Chromaflow column 2000/100-300

3

314.2–942.6

Description

* The first figure in the column name indicates the inner diameter and the second figure indicates stroke length.

Table 2. Major components and their composition

In contact with
process stream

Component

Material

Column tube

Acrylic or stainless steel 316L

Yes

Column lids

Stainless steel 316L

No

Distributor

Polypropylene

Yes

Bed support

Stainless steel 316L or polyethylene

Yes

Chromaflow nozzle

Polypropylene, stainless steel 316L, PEEK 450 G

Yes

Seals

EPDM or FEP encapsulated silicone

Yes

Stand

Stainless steel 316

No

EPDM = ethylene propylene diene, FEP = fluoroethenepropene, PEEK = polyetherether ketone

18-1138-92 AF
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Table 3. Chemical resistance of materials used in Chromaflow columns (60 days)

Chemical
Acetic acid 1.7 M
EtOH 20% 1
EtOH 40%
Ethylene glycol 50%
Formaldehyde 1.7 M
Formic acid 10%
Glycerol 100%
Hydrochloric acid 0.1 M
Isopropyl alcohol 30%
Nitric acid 0.1 M
Phosphoric acid 25%
Sodium chloride 0.5 M
Sodium hydroxide 2 M3
Trifluoroacetic acid 0.1%
Triton™ X-100 100%
Urea 8 M
+ Resistant (+) Limited resistance
1
2
3

Acrylic

SS 316L

EPDM

FEP

PEEK 450 G

PE

PP

+
+
–
+
+
(+)
+
+
–
+
+
+
+
(+)
+
+

+
+
+
+
+
+
+
–
+
+
(+)
+2
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
(+)
+
+
+
+
+
(+)
(+)
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

– Not recommended

Do not expose acrylic to concentrations of ethanol greater than 20%. Do not exceed the following parameters during storage: 5 yr, 23°C, 0.5 bar g.
NaCl can cause corrosion on stainless steel at pH <5. Do not use NaCl in storage solutions. Rinse with at least 5 CV of clean water after use with NaCl.
Maximum exposure 4 h.

SS=stainless steel, EPDM=ethylene propylene diene, FEP=fluoroethenepropene, PEEK=polyetherether ketone, PE=polyethylene, PP=polypropylene.

Sanitizing Chromaflow columns
The design of Chromaflow columns facilitates cleaning-inplace. Below is a recommended cleaning protocol suitable for
most applications.
1. Circulate 1.5 CV of 20% acetic acid at a low flow velocity
(60 cm/h) for 15 min, upward flow. Then reverse the flow
for 15 min.
2. Repeat this procedure with 1.0 M NaOH.
3. Following step 2, slowly circulate 1.0 M NaOH in the
column for 60 min.
4. Re-equilibrate the column with a storing or starting buffer.

Chromaflow Packing stations
Chromaflow Packing stations make column priming and
packing a simple operation, reducing the operator’s time
to a minimum. The packing stations consist of a control
panel with pumps and valves fitted underneath (Fig 5).
Valves and diaphragm pumps are actuated pneumatically
from the control panel. As they are brought into operation
indicators on the control panel display the relevant flow
paths. For operation, packing stations only require a supply of
compressed air. To select an appropriate packing station for
your column and media, refer to Tables 4 and 5.

4
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Fig 5. Chromaflow Packing station Pack 100.

Table 4. Specifications of Chromaflow packing stations

Designation*
Pack 50
715
Pack 100

Pump

Pump flow
capacity
(L/min)

Req. air
supply
(m3/min)

Inlet piping/
outlet i.d.
(mm)

TC
connections
(mm)

Weight,
dry
(kg)

Size
W×H×D
(mm)

Tapflo™ T53

10–50

0.5

22.1/22.1

50.5

115

810 × 1175 ×

Tapflo T103

30–100

1.0

34.8/22.1

50.5

130

810 × 1175 × 715

* Packing stations, Pack 200 and Pack 400 with pump flow capacities of 60 to 200 l/min and 100 to 400 l/min are available as custom orders.

Table 5. Approximate packing flow rates for different media at two different bed heights

Column
diameter (mm)
400
600
800
1000
Bed height (mm)
150
300
150
300
150
300
150
300
Flow
cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min
Sepharose™
Fast Flow media

500

11

250

Sepharose
Big Beads media 1600

34

1200

5.5
25

500

24

250

12

500

42

250

21

500

66

1600

75

1200

57

1600

134

1200

101

1600

209

250

33

1200 157

What else do I need?

Assembly or disassembly of the column

The column

An adequate sized wrench is needed for assembly or
disassembly of the column. A hoist is needed to remove the
adapter or top lid from the column.

The columns are supplied ready for use and are equipped
with adjustable feet. Castors can be ordered separately for
columns up to 1000 mm in diameter.

Isolating the column after packing
We recommend using sanitary stainless steel valves (of the
appropriate inner diameter) on the mobile phase to prevent
contamination of the packed bed. For storage purposes, blind
flanges with a clamp and gasket can be used to seal off the
column.

Connecting the column to your system and
packing station
Clamps and gaskets of suitable size are required to connect
the sanitary flanged inlet/outlet to either valves or tubing of
the same type. Preflanged tubing is also available.

Spare parts to keep on site
It is recommended that nozzle seals, column seals, and
column bed support kits are kept as spare parts.

Useful accessories
Safety valve: Precalibrated valve which releases pressure if
the calibrated value is exceeded. Recommended to install on
the mobile phase inlet if no other pressure sensor is included
in the chromatography system. The T-junction, clamps and
gaskets must be ordered separately.
Pressure sensor: The sensor is installed inline, preferably
on the mobile phase inlet. Clamps and gaskets have to be
ordered separately.

18-1138-92 AF
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Ordering information
Columns
Chromaflow columns
with acrylic tubes

Bed support
Bed support
10 mm SS sinter 20 mm SS sinter

Bed support
20 mm PE sinter

I.d. 400 mm Man. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1150-40
18-1157-42
18-1157-44

18-1159-40
18-1159-42
18-1159-44

18-1161-40
18-1161-42
18-1161-44

I.d. 400 mm Auto. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1157-41
18-1157-43
18-1157-45

18-1159-41
18-1159-43
18-1159-45

18-1161-41
18-1161-43
18-1161-45

I.d. 400 mm SFP* Man. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1170-53
11-0011-80
11-0011-82

18-1176-12
11-0011-83
11-0011-84

11-0011-85
11-0011-86
11-0011-87

I.d. 400 mm SFP Auto. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

11-0011-89
11-0011-88
11-0011-90

11-0011-91
11-0011-92
11-0011-93

11-0011-94
11-0011-95
11-0011-96

I.d. 600 mm Man. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1150-60
18-1157-62
18-1157-64

18-1159-60
18-1159-62
18-1159-64

18-1161-60
18-1161-62
18-1161-64

I.d. 600 mm Auto. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1157-61
18-1157-63
18-1157-65

18-1159-61
18-1159-63
18-1159-65

18-1161-61
18-1161-63
18-1161-65

I.d. 800 mm Man. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1150-80
18-1157-82
18-1157-84

18-1159-80
18-1159-82
18-1159-84

18-1161-80
18-1161-82
18-1161-84

I.d. 800 mm Auto. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1157-81
18-1157-83
18-1157-85

18-1159-81
18-1159-83
18-1159-85

18-1161-81
18-1161-83
18-1161-85

I.d. 1000 mm Man. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1150-10
18-1158-12
18-1158-14

18-1160-10
18-1160-12
18-1160-14

18-1162-10
18-1162-12
18-1162-14

I.d. 1000 mm Auto. nozzle
Stroke length 100-300
Stroke length 200-400
Stroke length 300-500

18-1158-11
18-1158-13
18-1158-15

18-1160-11
18-1160-13
18-1160-15

18-1162-11
18-1162-13
18-1162-15

For column specifications other than listed in the table, please contact your local GE Healthcare representative.
* SFP = Small Flow Path on mobile phase, only available on 400 mm i.d. columns.
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Packing stations

Pack 50
Pack 100
Pack 200
Pack 400

Min
(L/min)

Max
(L/min)

10
30
60
100

50
100
200
400

Code number
18-1163-74
18-1162-08
Custom order
Custom order

Accessories
Designation
Valves
4 port 2 way, i.d. 10 mm, 25 mm TC
4 port 4 way, i.d. 10 mm, 25 mm TC
3 port 2 way, i.d. 15 mm, 25 mm TC
4 port 4 way, i.d. 20 mm, 51 mm TC
3 port 2 way, i.d. 22 mm, 51 mm TC
3 port 2 way, i.d. 35 mm, 51 mm TC
Valve sealing washer

Code number
18-1012-56
18-1012-57
44-5499-90
44-2302-01
44-1583-01
44-5494-65
18-1128-69

Fits 10 mm 2- and 4-way valves

PVC tubing with sanitary fitting 25 mm TC
i.d. 10 mm, 900 mm
i.d. 10 mm, 1400 mm
i.d. 10 mm, 1700 mm
i.d. 10 mm, 2000 mm

18-1012-62
18-1012-63
18-1012-64
18-1012-87

i.d. 14 mm, 750 mm
i.d. 14 mm, 1800 mm

18-1027-28
18-1027-29

PVC tubing with sanitary fitting 51 mm TC
i.d. 22 mm, 900 mm
i.d. 22 mm, 1400 mm
i.d. 22 mm, 2000 mm
i.d. 22 mm, 4000 mm

44-1616-09
44-1616-08
44-1616-07
44-1616-06

Clamp gasket
25 mm i.d., 10 mm
25 mm i.d., 12 mm
51 mm i.d., 22 mm
51 mm i.d., 38 mm
Clamp 25 mm
Clamp 51 mm
Blind flange 25 mm incl. gasket
Blind flange 51 mm incl. gasket

18-1035-79
18-0200-00
44-7133-01
44-0515-01
18-1001-31
44-7134-01
18-1001-25
44-7135-01

Safety valve, 3 bar, 51 mm TC
Safety valve, 5 bar, 51 mm TC
T-junction i.d., 10 mm, 2×25 mm TC, 1×51 mm TC

18-5738-01
44-5498-97
18-1003-63

Castors, assembly kit 400-600
Castors, assembly kit 800-1000

18-1171-51
18-1171-52

Designation

Code number

Media stirrers
Media stirrer, 80 cm
Media stirrer, 150 cm

18-1149-80
18-1149-81

Connectors
i.d. 10, 25 mm TC-3/4″-20 UNF threaded
i.d. 10, 25 mm TC-i.d. 14, 51 mm TC
i.d. 14, 51 mm TC-i.d. 22, 51 mm TC

18-1012-68
18-1027-25
18-1027-26

Chromaflow Nozzle control unit

18-1164-61

Chromaflow Nozzle pipings
Chromaflow Nozzle piping 400 1/2”
Chromaflow Nozzle piping 400 3/4”
Chromaflow Nozzle piping 400 1”
Chromaflow Nozzle piping 600 1/2”
Chromaflow Nozzle piping 600 3/4”
Chromaflow Nozzle piping 600 1”
Chromaflow Nozzle piping 800 1/2”
Chromaflow Nozzle piping 800 3/4”
Chromaflow Nozzle piping 800 1”
Chromaflow Nozzle piping 1000 1/2”
Chromaflow Nozzle piping 1000 3/4”
Chromaflow Nozzle piping 1000 1”

18-1172-01
18-1172-00
18-1171-99
18-1172-06
18-1172-05
18-1172-04
18-1171-94
18-1171-93
18-1171-92
18-1172-09
18-1172-08
18-1172-07

The kit contains a complete set of wheels, fasteners and adapters for a column.

Pressure sensor i.d. 10 mm, 25 mm TC

44-0507-02

Pressure sensor i.d. 22 mm, 51 mm TC

44-0507-03

18-1138-92 AF
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647TP[cWRPaT
;XUTBRXT]RTb
3PcP [T!'('&%!00

0U ]XchRWa^\Pc^VaP_Wh

<PQBT[TRcBdAT;G
<PQBT[TRcBdAT;GXbP]P[ZP[XbcPQX[XiTS_a^cTX]0STaXeTS
PU ]Xch\TSXd\fXcWPQX]SX]VRP_PRXchU^a\^]^R[^]P[
P]cXQ^SXTb<0QbTgRTTSX]VcWPc^U<PQBT[TRcBdATPc
[^]VTaaTbXST]RTcX\Tb0bP]TgP\_[TPc%\X]aTbXST]RT
cX\TcWTSh]P\XRQX]SX]VRP_PRXch^U<PQBT[TRcBdAT;G
U^aWd\P]8V6XbP__a^gX\PcT[h%V[CWXbb_TRXP[
R^\QX]PcX^]^UWXVWQX]SX]VRP_PRXch_[dbP[ZP[X]TbcPQX[Xch
VXeTb\P]dUPRcdaTab^U<0Qb\P]h^__^acd]XcXTbc^
X\_a^eT_a^RTbbTR^]^\XRbP]S_a^SdRc`dP[Xch
7XVWSh]P\XRQX]SX]VRP_PRXch312WT[_bdbTab
_a^RTbbUTTSUa^\WXVWTg_aTbbX^]RT[[Rd[cdaTbfXcW
X]RaTPbTSP]cXQ^ShcXcTabX]bW^acTacX\T^afXcWb\P[[Ta
RWa^\Pc^VaP_Whd]Xc^_TaPcX^]b4]WP]RTSP[ZP[X]T
bcPQX[Xch\TP]bcWPcaTVd[PaR[TP]X]VX]_[PRT28?RP]
QT_TaU^a\TSfXcWR^bcTUUTRcXeTPVT]cbbdRWPbb^SXd\
WhSa^gXST=P>7c^_a^[^]VcWT\TSXd\{bf^aZX]V[XUTcX\T
Key performance benefits of MabSelect SuRe LX include:
~ >dcbcP]SX]VQX]SX]VRP_PRXchU^aTgP\_[TP__a^g
%V[\TSXd\U^aWd\P]8V6Pc%\X]aTbXST]RTcX\T
~ @dXRZTU RXT]c_a^RTbbX]V^U[PaVTe^[d\Tb^UWXVWcXcTa
QX^aTPRc^aUTTSb
~ 7XVWTaST]bXchT[dPcTbX]RaTPbT^_TaPcX]V TgXQX[XchP]S
P[[^fb\P[[Tad]Xc^_TaPcX^]b
~ 4UUTRcXeT28?fXcW <=P>7^eTaWd]SaTSb^U
_daX RPcX^]RhR[TbX\_a^eTb_a^RTbbTR^]^\h
~ 4]WP]RTS_a^cTPbTaTbXbcP]RT^UcWT_a^cTX]0[XVP]S
aTSdRTb[TPZPVT
~ 6T]TaXRT[dcX^]R^]SXcX^]bU^aSXUUTaT]c<0QbT]PQ[T
_[PcU^a\_daX RPcX^]b

Fig 1. CWTbXV]XUXRP]c[hWXVWTaQX]SX]VRP_PRXch^U<PQBT[TRcBdAT;G
_a^cTX]0QPbTSPUUX]Xch\TSXPP[[^fb<0Q\P]dUPRcdaTabc^_a^RTbbWXVW
cXcTaUTTSbX]aT[PcXeT[hb\P[[_a^SdRcX^]R^[d\]b

Medium characteristics
Well-established in bioprocessing
CWT<PQBT[TRc\TSXPUP\X[hU^acWT_a^RTbbbRP[T
RP_cdaTP]S_daX RPcX^]^U<0QbR^\_aXbTb<PQBT[TRc
<PQBT[TRcGcaP<PQBT[TRcBdATP]S<PQBT[TRcBdAT;G
<PQBT[TRcBdAT;GWPbQTT]UdacWTaSTeT[^_TSUa^\
<PQBT[TRcBdATc^VXeTTeT]WXVWTaQX]SX]VRP_PRXchPc
[^]VTaaTbXST]RTcX\TCPQ[T [XbcbcWT\PX]RWPaPRcTaXbcXRb
^U<PQBT[TRcBdAT;G
Table 1. <PX]RWPaPRcTaXbcXRb^U<PQBT[TRcBdAT;G
<PcaXg
;XVP]S
;XVP]SR^d_[X]V
2^d_[X]VRWT\Xbcah
0eTaPVT_PacXR[TbXiTS$e
3h]P\XRQX]SX]VRP_PRXchs
<PgX\d\\^QX[T_WPbTeT[^RXcht
_7f^aZX]VaP]VT
2WT\XRP[bcPQX[Xch
2[TP]X]VX]_[PRTbcPQX[Xch
3T[XeTahR^]SXcX^]b

AXVXSWXVW[hRa^bb[X]ZTSPVPa^bT
0[ZP[XbcPQX[XiTS_a^cTX]0STaXeTSE. coli
BX]V[T_^X]cPccPRW\T]c
4_^gh
'$\
0__a^g%\VWd\P]8V6\[\TSXd\Pc
%\X]aTbXST]RTcX\T
$R\W
" !
BcPQ[TX]P[[P`dT^dbQdUUTabR^\\^][h
dbTSX]_a^cTX]0RWa^\Pc^VaP_Wh
 $<=P>7
!TcWP]^[

S$EXbcWT\TSXP]_PacXR[TbXiT^UcWTRd\d[PcXeTe^[d\TSXbcaXQdcX^]
3TcTa\X]TSPc QaTPZcWa^dVWQhUa^]cP[P]P[hbXbPcP\^QX[T_WPbTeT[^RXch^U
R\WX]PR^[d\]fXcWPQTSWTXVWc^U R\aTbXST]RTcX\TXb%\X]ATbXST]RTcX\T
XbT`dP[c^QTSWTXVWcR\SXeXSTSQh]^\X]P[ dXSeT[^RXchR\WSdaX]VbP\_[T[^PSX]V
=^\X]P[ dXSeT[^RXchXbT`dP[c^e^[d\TcaXR ^faPcT\[WSXeXSTSQhR^[d\]Ra^bb
bTRcX^]P[PaTPR\!

s

3TcTa\X]TSX]P]0gX2Wa^\"R^[d\]QTSWTXVWc!R\^_TaPcX]V_aTbbdaT[Tbb
cWP]!QPa

t

High binding capacity meets modern processing
demands

DBC, 10% breakthrough (mg/ml)

8]RaTPbX]VST\P]SU^a<0QbPbQX^_WPa\PRTdcXRP[bWPb
_a^\^cTScWTSTeT[^_\T]c^URT[[Rd[cdaTbfXcWX]RaTPbTS
Tg_aTbbX^][TeT[b>eTaaTRT]chTPabcWTP]cXQ^ShcXcTab
^U\P\\P[XP]RT[[Rd[cdaTbWPeTaXbT]SaP\PcXRP[[hCXcTab
^U$c^ V[PaT]^cd]dbdP[c^SPh8U<0Q_daX RPcX^]
_a^RTbbTbPaTc^WP]S[TWXVWcXcTaQX^aTPRc^aUTTSb`dXRZ[h
P]SR^bcTUUTRcXeT[hcWTh\dbc^UUTabXV]X RP]cX]RaTPbTb
X]Sh]P\XRQX]SX]VRP_PRXch312BTeTaP[bcdSXTbbW^f
cWPccWXbRP]QTPRWXTeTSQhX]RaTPbX]VaTbXST]RTcX\TfXcW
<PQBT[TRcBdAT;G5XV!
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Fig 2. 3h]P\XRQX]SX]VRP_PRXchX]RaTPbTbPbPUd]RcX^]^UaTbXST]RTcX\T

<^aT^eTaSXaTRcR^\_PaXb^]bQTcfTT]<PQBT[TRcBdAT;G
P]S<PQBT[TRcBdATfWXRWP[aTPShTgWXQXcbPWXVW312
bW^fcWPccWTU^a\Ta^UUTab\^aTcWP]!WXVWTa312Pc
TgcT]STSaTbXST]RTcX\Tb0c%\X]U^aTgP\_[TcWT312
^U<PQBT[TRcBdAT;GPc QaTPZcWa^dVWU^abTeT]<0Qb
XbR[TPa[hbd_TaX^ac^cWPc^U<PQBT[TRcBdAT5XV"CWTbT
SPcPR^] a\cWPccWTX]RaTPbTSRP_PRXcXTbaP]VTUa^\
P__a^gX\PcT[h!c^$
MabSelect SuRe LX

DBC, 10% breakthrough (mg/ml)
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CWXbWXVWRP_PRXchP[b^caP]b[PcTbc^b\P[[TaT[dcX^]_^^[
e^[d\TbcWPcXbWXVWTaP]cXQ^ShR^]RT]caPcX^]b[PaVT_^^[
e^[d\TbPaTPR^\\^]Q^cc[TZ]TRZX]\P]h\P]dUPRcdaX]V
UPRX[XcXTbc^SPh=^cTcWPccWTWXVWaXVXSXch^UcWT\TSXd\
bTTQT[^f_Ta\XcbcWTdbT^UWXVWTaQTSWTXVWcbfWXRW
X]RaTPbTbcWT TgXQX[Xch^U_a^RTbbSTbXV]P]S[PaVTbRP[T
^_TaPcX^]b

High alkaline stability extends working lifetime
28?fXcW=P>7XbPZThbcT_X]cWTR^bcTUUTRcXeT_a^SdRcX^]
^U_daT<0Q_a^SdRcbPcX]SdbcaXP[bRP[T7^fTeTa
PU ]Xch\TSXPQPbTS^]]PcXeT^aaTR^\QX]P]c_a^cTX]0
a?a^cTX]0[XVP]SbPaT_PacXRd[Pa[hbT]bXcXeTc^=P>7P]S
cWXbXbVT]TaP[[haTVPaSTSPbPSaPfQPRZ^UcWT\TcW^S
<PQBT[TRcBdAT;G^eTaR^\TbcWXb[X\XcPcX^]QhdbX]V
cWTbP\TP[ZP[XbcPQ[X[XiTS[XVP]SPb<PQBT[TRcBdATCWT
[XVP]SfPbSTeT[^_TSQh_a^cTX]T]VX]TTaX]V^]T^UcWT
8V6QX]SX]VS^\PX]b^U_a^cTX]00\X]^PRXSb_PacXRd[Pa[h
bT]bXcXeTc^P[ZP[XfTaTXST]cX TSP]SbdQbcXcdcTSfXcW
\^aTbcPQ[T^]TbCWT ]P[R^]bcadRcXbPcTcaP\Ta^UcWT
T]VX]TTaTSS^\PX]fXcWP2cTa\X]P[RhbcTX]TfWXRW
T]PQ[TbbX]V[T_^X]cPccPRW\T]cc^cWT\PcaXgCWTaTbd[cX]V
WXVW[h_daT[XVP]SXbX\\^QX[XiTSc^cWTPVPa^bT\PcaXgeXP
PRWT\XRP[[hbcPQ[TcWX^TcWTa[X]ZPVT
CWTX]RaTPbTSP[ZP[X]TbcPQX[XchP[[^fbeTahTUUTRcXeT28?
fXcW c^$<=P>7^eTa\P]h_daX RPcX^]RhR[Tb5XVb'
P]S(8]PSSXcX^]cWT[XVP]SbW^fbX\_a^eTSbcPQX[Xchc^
_a^cTPbTbR^\_PaTSfXcWa?a^cTX]0CWXbPccaXQdcTP[b^
TgcT]Sbf^aZX]V[XUTcX\TP]S\X]X\XiTb[XVP]S[TPZPVT
5dacWTa\^aTPbcWTT]VX]TTaTS_a^cTX]0[XVP]S^U
<PQBT[TRcBdAT;GS^Tb]^cTgWXQXcPU ]XchU^acWT5PQ
aTVX^]^UP]cXQ^SXTb\^aTVT]TaXRT[dcX^]R^]SXcX^]bRP]QT
T\_[^hTSR^\_PaTSfXcWa?a^cTX]00]cXQ^SXTbRP]cWdbQT
T[dcTSPcP\^aTW^\^VT]T^db_7aP]VT BTT5XVdaT&
U^a\^aTSTcPX[b

Rigid, highly cross-linked matrix allows high flow
rates

MabSelect SuRe

;XZT^cWTa\TSXPX]cWT<PQBT[TRcUP\X[h<PQBT[TRcBdAT;G
UTPcdaTbPaXVXSWXVW[hRa^bb[X]ZTSPVPa^bTQPbT\PcaXg
cWPcP[[^fb\dRWWXVWTa ^faPcTbX]_a^RTbbbRP[T
_daX RPcX^]cWP]R^]eT]cX^]P[Ra^bb[X]ZTSPVPa^bTb^U
bX\X[Pa_^a^bXchCWXb_Ta\XcbWXVWcWa^dVW_dc_daX RPcX^]^U
<0QbUa^\[PaVTe^[d\Tb^UUTTS5XVdaT#bW^fb_aTbbdaT
^fRdaeTbU^a<PQBT[TRcBdAT;G_PRZTSX]PaP]VT^U
R^[d\]bXiTb
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Fig 3. BXV]XUXRP]c[hX]RaTPbTS312^U<PQBT[TRcBdAT;GR^\_PaTSc^
<PQBT[TRcBdATPcPaTbXST]RTcX\T^U%\X]

!  !'('&%!00

7XVWaXVXSXchP[[^fbR^[d\]RP_PRXchc^QTX]RaTPbTSU^a
WXVWcXcTaUTTSbQhX]RaTPbX]VcWTR^[d\]QTSWTXVWc
Ad]]X]VPcWXVWTaQTSWTXVWcbP]S ^faPcTbVXeTbVaTPcTa
TgXQX[XchfWT]STbXV]X]V_a^RTbbTbP]SRP]aTSdRTcWT
]TTSc^_daRWPbT]TfWPaSfPaT7XVWTaQTSWTXVWcb
P[b^\TP]b\P[[SXP\TcTaR^[d\]bP]ScWdbPaTSdRTS
T`dX_\T]cU^^c_aX]c

Method development and scale-up

HiScale™ 50, 10 cm bed height
HiScale 50, 21 cm bed height
AxiChrom 100, 20 cm bed height
AxiChrom 300, 20 cm bed height

1200

CWT_aX\PahPX\^U\TcW^SSTeT[^_\T]cXbc^TbcPQ[XbWP]S
^_cX\XiTcWTR^]SXcX^]bcWPcfX[[QX]ScWTWXVWTbcP\^d]c^U
cPaVTc\^[TRd[TX]cWTbW^acTbccX\TP]SfXcWcWTWXVWTbc
_a^SdRcaTR^eTah

Flow velocity (cm/h)

1000

CWTSTVaTTc^fWXRW8V6QX]Sbc^_a^cTX]0ePaXTbfXcW
aTb_TRcc^Q^cW^aXVX]P]SP]cXQ^ShbdQR[Pbb8]VT]TaP[
W^fTeTaWd\P]^aWd\P]XiTSP]cXQ^SXTbTgRT_cU^a
bdQR[Pbb"WPeTWXVWPU ]XchU^a_a^cTX]0
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Fig 4. ?aTbbdaTU[^fRdaeTbU^a<PQBT[TRcBdAT;G_PRZTSPcSXUUTaT]cQTS
WTXVWcbX]7XBRP[T$P]S0gX2Wa^\ P]S"R^[d\]bCWT\TSXd\{b
aXVXSQPbT\PcaXgP[[^fbWXVWU[^faPcTbX]_a^RTbbbRP[T_daXUXRPcX^]b

BioProcess™ medium with full support
<PQBT[TRcBdAT;GP[b^QT[^]Vbc^cWT1X^?a^RTbb\TSXP
UP\X[hcWPcXbSTeT[^_TSP]Sbd__^acTSU^acWT[PaVTbRP[T
\P]dUPRcdaT^UQX^_WPa\PRTdcXRP[bCWXbbd__^acX]R[dSTb
eP[XSPcTS\P]dUPRcdaX]V\TcW^SbbTRdaT[^]VcTa\\TSXP
bd__[hbPUTP]STPbhWP]S[X]VP]SATVd[Pc^ahBd__^ac
5X[TbAB5c^PbbXbc_a^RTbbeP[XSPcX^]P]SbdQ\XbbX^]b
c^aTVd[Pc^ahPdcW^aXcXTb8]PSSXcX^]5PbcCaPZCaPX]X]V
4SdRPcX^]_a^eXSTWXVW[TeT[WP]Sb^]caPX]X]VU^aP[[ZTh
Pb_TRcb^UQX^_a^RTbbSTeT[^_\T]cP]S\P]dUPRcdaX]V

Operation
Equipment
<PQBT[TRcBdAT;GRP]QTdbTSfXcW\^bc\^STa]
RWa^\Pc^VaP_WhT`dX_\T]cUa^\[PQ^aPc^ahc^_a^SdRcX^]
bRP[TCPQ[T![XbcbbdXcPQ[TT\_chR^[d\]bUa^\
647TP[cWRPaTC^T]bdaTQTbc_TaU^a\P]RTPc_a^RTbbbRP[T
_PRZ<PQBT[TRcBdAT;GPcQTSWTXVWcb^U c^"R\
Table 2. ATR^\\T]STS647TP[cWRPaTR^[d\]UP\X[XTbU^a_PRZX]V
<PQBT[TRcBdAT;G

Column family range

Inner diameter (mm)

;PQ^aPc^ahbRP[T)

7XBRP[T

?X[^cP]S_a^SdRcX^]bRP[T)

0gX2Wa^\
1?6
2Wa^\PU[^ft

%!%P]S$
$ 
"s
#'

 8]cT[[XVT]c?PRZX]V\TcW^SU^a<PQBT[TRcBdATRP]QTdbTS
 CWT_aTbbdaTaPcX]V^U1?6#$Xbc^^[^fU^adbTfXcW<PQBT[TRc\TSXP

s

<PQBT[TRcBdAT;GXbbd__[XTS_aT [[TSX](%fT[[
?aTSXRc^a_[PcTbfWXRWbd__^acWXVWcWa^dVW_dc_a^RTbb
STeT[^_\T]c7C?3QhP[[^fX]V_PaP[[T[bRaTT]X]V^U
RWa^\Pc^VaP_WXRR^]SXcX^]bbdRWPb_7P]SR^]SdRcXeXch
3T ]TSR^]SXcX^]bU^a[^PSX]VfPbWX]VT[dcX^]28?
TcRRP]cWT]QTeTaX TSP]S^_cX\XiTSfXcWb\P[[
_aT_PRZTS7XBRaTT]#&\[R^[d\]bC^VTcWTafXcW
PRWa^\Pc^VaP_WhbhbcT\bdRWPb«:C0PeP]ccWT
7XBRaTT]U^a\PcWT[_bSTeT[^_P]TU RXT]cP]Sa^Qdbc
bT_PaPcX^]\TcW^S
5dacWTaSTeT[^_\T]cP]S^_cX\XiPcX^]dbX]V7XBRP[T
R^[d\]bcWT]_Ta\XcbbcaPXVWcU^afPaSbRP[Td_U^a6<?
R[X]XRP[caXP[b^aUd[[bRP[T\P]dUPRcdaX]V^]0gX2Wa^\
R^[d\]b

Loading and elution
CWTWXVWbT[TRcXeXch^U<PQBT[TRcBdAT;GaT]STab
TU RXT]RhaT[PcTS_PaP\TcTabbdRWPbbP\_[T[^PS ^f
aPcTQTPSbXiTP]SQTSWTXVWc[TbbX\_^acP]cU^aaTb^[dcX^]
CWT_aX\PahPX\^U\TcW^S^_cX\XiPcX^]XbcWTaTU^aTc^
TbcPQ[XbWcWTR^]SXcX^]bcWPcfX[[QX]ScWTWXVWTbcP\^d]c^U
cPaVTc\^[TRd[TP]SVXeTcWTWXVWTbc_a^SdRcaTR^eTah
Ch_XRP[[hR[PaX TSUTTSbc^RZXb[^PSTSSXaTRc[h^]c^cWT
R^[d\]CWTP\^d]c^UP]cXQ^ShcWPcRP]QT[^PSTS
XbSTcTa\X]TSQhcWTSh]P\XRQX]SX]VRP_PRXch312
BX]RT312X]RaTPbTbPbPUd]RcX^]^UaTbXST]RTcX\TP]S
ePaXTbQTcfTT]SXUUTaT]c<0QbP]SbcPacX]V\PcTaXP[bfT
aTR^\\T]SSTcTa\X]X]V312PcSXUUTaT]caTbXST]RTcX\Tb
5XV!C^^QcPX]WXVWP]SaT_a^SdRXQ[ThXT[Sb^eTaWd]SaTSb
^URhR[TbcWT[^PSbW^d[S]^a\P[[h]^cTgRTTS(^U312
0UcTaX]cTa\TSXPcTfPbWX]VcWTcPaVTc<0QXb]^a\P[[h
T[dcTSPc_7"c^#4[dcX^]R^]SXcX^]bU^aPb_TRX R<0QRP]
QTSTcTa\X]TSQh_TaU^a\X]VT[dcX^]X]P[X]TPa_7VaPSXT]c
5XVdaT$bW^fbP]TgP\_[Tad]U^a<PQBT[TRcBdAT4[dcX^]
_7fPb"%&Pc_TPZ\PgX\d\P]S"$%Pc _TPZ
\PgX\d\XTSTbRT]SX]V1PbTS^]cWXbaTbd[cP]T[dcX^]
_7^U"$f^d[SaTbd[cX]WXVWhXT[SbP]S]Paa^fT[dcX^]
_TPZb

 ?PRZX]VX]bcadRcX^]bU^a<PQBT[TRc\TSXPX]2Wa^\P ^fR^[d\]bPaTSTbRaXQTSX]
0__[XRPcX^]]^cT &$!

t

;PaVTa_PRZbcPcX^]bRP]QTaT`dXaTSU^a[PaVTaSXP\TcTab
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Running conditions
Column:
7XBRaTT]<PQBT[TRcBdAT#&\[
Sample:
\[^UR[PaXUXTS27>UTTSR^]cPX]X]V &!\V<0Q\[
Binding buffer: !\<RXcaPcT_7%
Elution buffer: !\<RXcaPcT_7"
Gradient:
;X]TPa!\<RXcaPcTQdUUTa_7%c^"X] 2E
Flow rate:
$\[\X]
System:
«:C0PeP]c!$

fXcWQ^cW<PQBT[TRcfXcWPcaPSXcX^]P[a?a^cTX]0[XVP]S
P]SfXcW<PQBT[TRcBdATFXcW<PQBT[TRccWT<0QbT[dcT
PcSXUUTaT]c_7bQdcU^a<PQBT[TRcBdATP[\^bcP[[T[dcTPc
P\^aTW^\^VT]T^db_70bX\X[PaQTWPeX^aXbTg_TRcTSU^a
<PQBT[TRcBdAT;G
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Fig 5. 3TcTa\X]X]V^_cX\d\T[dcX^]_7WT[_bT]bdaTPWXVWhXT[S^UcWT<0Q
_a^SdRc

3TbXV]^U4g_TaX\T]cb3^4RP]P[b^QTdbTSc^^_cX\XiT
T[dcX^]R^]SXcX^]b8]cWT3^4TgP\_[TbW^f]X]5XVdaT%
T[dcX^]_7fPbePaXTSQTcfTT]"!$c^#P]S ^faPcT
QTcfTT]"P]S \[\X] c^"R\W7XVWTbchXT[Sb
P]S[^fTbc_^^[e^[d\TbfTaT^QcPX]TSPc[^fT[dcX^]_7
fWX[T]^\PY^aTUUTRc^U ^faPcTR^d[SQT^QbTaeTSCWT
^_cX\P[T[dcX^]_7U^acWTX]eTbcXVPcTS<0QfPb"%^aQT[^f
Yield (%)
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DbT^U c^$<=P>7XbaTR^\\T]STSU^a28?P]S
bP]XcXiPcX^]0bfT[[PbQTX]VP]TUUTRcXeTR[TP]X]VPVT]c
=P>7XbP[b^X]Tg_T]bXeTP]STPbhc^WP]S[TX]Qd[Z
`dP]cXcXTb8cXbcWdbP]PccaPRcXeTRW^XRTU^a[PaVTbRP[T
R^\\TaRXP[\P]dUPRcdaTab^U\^]^R[^]P[cWTaP_TdcXR
P]cXQ^SXTb
0[XUTcX\TbcdShfXcW<0QR^]cPX]X]VUTTSbc^RZWPbbW^f]
cWPccWT312P]ShXT[S^U<PQBT[TRcBdAT;GPaTbcPQ[T
^eTa _daX RPcX^]RhR[TbfXcW <=P>7P]ScWPccWT
[TeT[b^U[TPRWTS_a^cTX]0P]SW^bcRT[[_a^cTX]baT\PX]
R^]bcP]c5XVdaT'bW^fb312SPcPP]S5XVdaT(^eTa[Ph
RWa^\Pc^VaP\bUa^\cWXbbcdSh
4UUTRcXeTbP]XcXiPcX^]^U<PQBT[TRcBdAT;GXbP[b^_^bbXQ[T
dbX]VPR^\QX]PcX^]^U <=P>7P]S#Xb^_a^_h[
P[R^W^[
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Fig 7. BRPccTa_[^cbW^fX]VcWTSXbcaXQdcX^]^UT[dcX^]_7^UePaX^dbWd\P]
P]cXQ^SXTbP]S5RUdbX^]_a^cTX]b^]<PQBT[TRcP]S<PQBT[TRcBdAT
AT_aX]cUa^\Biotechnol. Bioeng. fXcWR^dacTbh^U0\VT]
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Fig 6. 3^4^_cX\XiPcX^]^UT[dcX^]R^]SXcX^]b^]<PQBT[TRcBdAT;G
2E,R^[d\]e^[d\T

Generic elution promotes platform purification
<PQBT[TRcBdAT;GP[[^fbcWTdbT^UVT]TaXRT[dcX^]
R^]SXcX^]bU^aSXUUTaT]c\^]^R[^]P[P]cXQ^SXTbfWXRWXb
PSeP]cPVT^dbfWT]STbXV]X]VVT]TaXR_daX RPcX^]_[PcU^a\
_a^RTbbTb5XVdaT&bW^fbcWTT[dcX^]_7U^aSXUUTaT]c<0Qb
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DBC, 10% and 80% breakthrough (mg/ml)
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Fig 8. 3h]P\XRQX]SX]VRP_PRXch\TPbdaT\T]cbU^a<PQBT[TRcBdAT;G^eTa
_daXUXRPcX^]RhR[TbfXcW <=P>7Pb28?PVT]cAC,aTbXST]RTcX\T

Ordering information
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Fig 9. >eTa[Ph^URWa^\Pc^VaP\bUa^\ad]bfXcWWPaeTbcTSRT[[Rd[cdaT
UTTS7225'V<0Q[Ua^\RhR[T"0]TfQPcRW^U7225fXcWP<0Q
R^]RT]caPcX^]^U  V[fPbP__[XTSUa^\RhR[T'&

0]TgcT]STS[XUTcX\TbcdSh^]Wd\P]8V6fXcWaT_TPcTS
QdUUTaRhR[TbP[b^ST\^]bcaPcTScWPc312XbbcPQ[T-($
U^a\^aTcWP]"RhR[TbfXcW <=P>75^a$<=P>7
312VaPSdP[[hSTRaTPbTbPUcTaRhR[T!$QdcbcX[[aT\PX]b
PQ^eT(U^a RhR[TbPccWXbWXVWTaR^]RT]caPcX^]
5d[[STcPX[bRP]QTU^d]SX]0__[XRPcX^]]^cT);XUTcX\T
_TaU^a\P]RTbcdSh^U<PQBT[TRcBdAT;GSdaX]VaT_TPcTS
R[TP]X]VX]_[PRTbTTAT[PcTS[XcTaPcdaT

Storage
Bc^aTd]dbTS<PQBT[TRcBdAT;GX]XcbR^]cPX]TaPcP
cT\_TaPcdaT^U!2c^'24]bdaTcWPccWTbRaTfc^_XbUd[[h
cXVWcT]TS4`dX[XQaPcT_PRZTSR^[d\]bX]QdUUTaR^]cPX]X]V
!TcWP]^[^a!QT]ih[P[R^W^[c^_aTeT]c\XRa^QXP[
Va^fcW
0UcTabc^aPVTT`dX[XQaPcTfXcWbcPacX]VQdUUTaP]S_TaU^a\P
Q[P]Zad]X]R[dSX]V28?QTU^aTdbT

Reference


6W^bT6et al.0]cXQ^ShePaXPQ[TaTVX^]X]cTaPRcX^]bfXcW_a^cTX]0)
8\_[XRPcX^]bU^acWTSTeT[^_\T]c^UVT]TaXR_daX RPcX^]_a^RTbbTb
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64X\PVX]PcX^]Pcf^aZP]S64\^]^VaP\PaT
caPST\PaZb^U6T]TaP[4[TRcaXR2^\_P]h
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Data Sheet

Cogent® Process-Scale
Tangential Flow Filtration System
A fully-automated, configurable, TFF system suited
for manufacturing of biopharmaceuticals and
cGMP process-scale applications
The fully automated Cogent® TFF system is
designed to separate and purify monoclonal
antibodies, vaccines, plasma, and therapeutic
proteins. It is ideally suited for both pilot and
production scale applications, thereby
supporting rapid scale up from small to large
scale operations.
Benefiting from our leading bioprocess
knowledge and engineering expertise,
the Cogent® Process Scale System is the
culmination of 25 years of custom system
design and incorporates many unique,
innovative and intelligent design features.
This system has a very low hold-up volume
for maximum volume concentration and
optimal product recovery, thus enhancing
process performance.

Benefits:
• Modular standard options allow the unique system
configuration that best matches process
requirements while minimizingupfront investment.
• Full process automation eases the consistent
production of preclinical and clinical scale
quantities of high-value drug products to
cGMP standard.
• Optimized design and component integration of

NovAseptic® valves and TFF cassette holders result
in a low minimum working volume and ensure
maximum product recovery.
• Designed to maximize TFF performances in
fed-batch, concentration, total recycle or
single pass mode.
• Comprehensive services ensure rapid
implementation and optimized performance.

EMD Millipore is a division of Merck KGaA, Darmstadt, Germany

Configure your system according to your process needs…
Option 1: Tank
(50, 100, 200L)
Jacketed for
temperature regulation

Option 7: Filtrate
conductivity
Measurement of a wide
range of products (WFI,
buffer solutions, protein
solutions) or post CIP
flushing monitoring

Option 10: Retentate pH
In-process monitoring of
product pH

10

9

Option 9: Retentate
conductivity
In-process monitoring of
product conductivity

7

18
1

19

13

Option 19: Spray ball valve
Tank cleaning using the
spray ball

2

12

Option 12: Tank
NovAseptic® GMP mixer
Ensures product
homogeneity, specially
important during
diafiltration step. Aseptic
design, minimized shearing

2

Option 18: Retentate
and Filtrate NovaSeptum®
Sampling port
In-process sterile sampling
of product

Option 13: Tank Outlet
Level Switch
Allows to stop the feed
pump when air reaches this
sensor. E.g: In Mini loop
concentration mode, detects
the end of the step (tank
fully empty).

Option 2: Mini loop
Minimizes the recirculation
volume to reach high
concentration and minimal
product volume

Option 3: Transfer Pump
Transfer of product / buffers
into the feed tank from
any other tank. Allows
fed-batch mode, and
diafiltration.

Option 8: Filtrate pH
pH monitoring during
cleaning and sanitization
procedures

Option 11: Filtrate UV
In-process monitoring of
protein content in filtrate
during ultrafiltration

11

17

16
8

Options 16/17: Filtrate
Mass / Magnetic flowmeter
Filtrate flow and total
volume monitoring in
diafiltration mode

3

Options 14/15:
Process Scale Holder
Can be configured either
with manual or hydraulic
closure. Hydraulic closure
can be done with a hand
pump or with an automated
hydraulic box.

14

6
15

4

5

Options 4/5: Feed Magnetic
/ Mass Flowmeter
Feed flow monitoring

Option 6: Transfer Inlet
Manifold
Allows connecting several
inlets to the transfer pump
head (product/WFI/CIP)
at the same time, avoiding
many connections /
disconnections

...and build a consistent user experience

3

Total Process Control
and Connectivity
The Cogent® Process Scale system is easily controlled
via the Common Control Platform® (CCP®) software, a
powerful, intuitive and graphical software that provides
real-time monitoring and total in-depth control of
your TFF process.
Using robust PCs, PLCs, and SCADA® technology, it
meets the most stringent standards for connectivity,
reliability and ease of use.

Benefits:
• Create process operations using the recipe
editor, monitor or control the process in the
home screen, and create reports for the batch
using the configurable report generator
• Developed under GAMP guidelines and FDA 21
CFR Part 11 compliance-ready, including audit
trails and electronic signatures for verification

• Sensor combinations can be adapted to process
requirements allowing the maximum confidence
in process monitoring
• Utilities to connect all of your separation
unit operations to a central network or
DCS (e.g. Delta V)
• Used on multiple unit operations CCP® software
provides one familiar interface to simplify
software management and reduce learning curves

Embedded NovAseptic® Valves,
Mixer and Connectors
Engineered for optimal performance, reliability, durability
and ease of maintenance.
The design and development of each component is based
on more than 20 years’ experience, focused on aseptic
application. This is why we choose to call it ‘‘Aseptic by
Design.”

NovAseptic® GMP mixer

Benefits:
• Comply with cGMP Design Qualification criteria
for aseptic processing
• NovAseptic® connector ensures no dead legs
and maximum product recovery with zero hold
up volume.
• Comply with the most stringent cleaning and
sterilization requirements

•

•
•
•
•

4

Mixer is clean running and is suitable for
general mixing, heat transfer and shear
sensitive applications.
Reduced bioburden
Lower cost of maintenance
Diamond coated mixer bearings ensure
long life and optimum performance.
Ability to mix the “last drop”, ensures
complete product recovery

Unparalleled Ultrafiltration
Plug and Play
The Pellicon® Process-scale Holder is uniquely designed
to reduce the time required to install and remove
TFF cassettes at production scale while keeping the
flow path unchanged.
The holder can be configured with a manual or hydraulic
closure. Hydraulic closure can be done with a hand pump
or with an automated hydraulic box which allows local
or distant control.

Benefits:
• Compact footprint
• TFF cassettes can be installed/removed quickly
• Easy to vent and fully drainable, maximizes
product recovery

• Easy retrofit from manual to hydraulic closure
• Flow path unchanged, minimizes future
re-qualification and validation effort in
new process applications

Air Integrity Test
In order to ensure that the cassettes have been installed properly and has not sustained any damage during
storage and handling, we recommend integrity testing prior to startup and after each post use cleaning.
Air Integrity Test accessories consist of a set of air pressure regulators and fittings including assembly procedure
to guarantee an easy plug and play solution.

Pellicon® 3 Ultrafiltration Cassettes
The tangential flow filtration cassette of choice for demanding filtration processes requiring unbeatable performance
consistency. For use in applications including: monoclonal antibodies, recombinant and non-recombinant proteins,
albumin, hormones, vaccines, and growth factors.
Biomax® membrane

Ultracel® membrane

Pellicon® 3 cassettes with Biomax® membranes are
designed for the filtration of therapeutic proteins,
albumin, hormones, vaccines and growth factors. These
advanced, high-performance cassettes are ideal for
today’s processes that require higher operating pressures,
temperatures and higher caustic cleaning regimes.

Pellicon® 3 Cassettes with Ultracel® membrane are the
device of choice for today’s higher titer therapeutic
antibodies as well as the more demanding filtration
processes that require low protein fouling. The new
D screen is optimized for applications that require
higher viscosity and concentration applications.

Benefits:
• Robust, void-free membranes for optimum
product recovery and performance consistency
• All thermoplastic design, protective end cap and
integrated gasket provides great process
consistency and ease of use
• Predictable and fast process scalability from lab
to production scale

•

•
•

•

Robust product design ideally suited to filtration
processes with higher operating pressures,
temperatures and caustic cleaning regimes
Automated manufacturing delivers unbeatable
performance consistency and reliability
Proven process expertise and technical support
to partner with you from development to
full scale manufacturing
Optimized flow path for higher flux and resolution
separation capability
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Provantage® Bioprocess
Consulting Services

Optimize

Provantage® Bioprocess Consulting Services leverage
our core expertise, products, services and technology
in downstream production to help solve your business
problem or challenge. Our commitment to your project
outcomes and timelines is managed with our stage gate
approach and a dedicated project manager.

Starting with a comprehensive technical assessment and
characterization of your existing TFF step, EMD Millipore
application specialists can recommend and implement
TFF enhancements that use best-practice operating
conditions and state of the art processes to deliver an
optimized and validatable TFF process at your targeted
scale, in a timely manner.

Application Expertise

Transfer

Our Biomanufacturing Sciences Network (BSN) is a global
team of over 85 engineers, scientists and technology
specialists who provide expertise and peer-to-peer
support in process development and manufacturing.
We act as an extension of your team, helping you to
minimize potential risk and streamline your operations.
With over 3,000 client engagements, our toolkit of best
practices will ensure your project is delivered on time
and within budget.

During the lifecycle of a biopharmaceutical, technical
transfers occur at various stages: from research to
clinical development to commercial manufacturing,
and from one manufacturing facility to another.
EMD Millipore leverages experienced technical staff,
strong project management, and good documentation
practices on both sides throughout the course of transfer
activities to ensure a robust and successful transfer.

Troubleshoot
Design and Implement
From lab-scale to pilot and manufacturing facility
start-up, EMD Millipore is a partner of choice for
providing consultative expertise on current best
practices to integrate device, hardware and process
technology, and process automation. We can provide
consultative evaluations for TFF optimization and
operating strategies.

EMD Millipore has extensive experience in troubleshooting and investigating manufacturing, method and
process development issues. Our experienced team
works together collectively with your technical project
team to identify the root cause and to develop a robust,
acceptable path forward.

Optimize

Develop
With our 35+ year history manufacturing and
implementing TFF technologies, EMD Millipore
application specialists develop reproducible,
scalable and robust TFF processes that meet your
specific requirements and your required scale.

Develop

Supply

High
Performance
Products

Design

Global
Facilities and
Resources

Best in Class
Applications and
Integration
Knowledge

Troubleshoot
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Transfer

Provantage® implementation
services
In the biopharmaceutical industry, implementing new
equipment with respect to Quality rules and guidelines
can be challenging. To help you stay ahead in today’s
demanding and competitive production environment,

our Provantage® Services group provides unparalleled
support for implementation of the Cogent® Process
Scale System. With a wide range of comprehensive
packages to meet your unique manufacturing
requirements, resulting in peace of mind and
maximum operational flexibility.

SAT and IQ/OQ

Operator training

Qualification package GMP

•

•

CCP® Software Design

Single Molecule cGMP package

•

•

•

Full cGMP package

•

•

•

CCP® Software Training

Support for PQ

•
•
•

•

Benefits:
• Qualify your system with our IQ/OQ service
protocols and use our qualified Field Service
Engineers with years of product experience to
ensure your system functions as specified in
cGMP environments
• Train your operators with an interactive,
hands-on courses for either system operation,
or advanced CCP® software recipe creation
training by certified trainers

•

•

Get the support of our experienced
Biomanufacturing Engineers during your
Process Performance Qualification
Maintain your system with annual preventive
maintenance by qualified Field Service Engineers
to ensure the lifetime of the system and
ultimately reduce your capital expenditures

Provantage® Lab Services
Establishing an effective cleaning and sanitization plan
for equipment used is a fundamental cGMP requirement
necessary to assure the quality and consistency of your
drug substance. Effective and consistent membrane
cleaning and sanitization after each process cycle is
the single most important factor in maintaining
system performance.
Cleaning and sanitization after every cycle removes
residual foulants and contaminants from the membrane,
preventing batch-to-batch carry over, maintaining
optimal performance and maximizing the useful life of
the filter cassettes.
Effectiveness is measured by the ability to control and
eliminate microbial contamination, and to remove
process foulants to restore membrane performance
such that consistent flux and separation are achieved
batch after batch.

Multiple Process
& Cleaning Cycles

Process Run to
Concentrate Protein

Cleaning
Regime

Critical
Flush

NWP
Measurement

Look for Consistent &
Reproducible Results
t Process Flux
t Pressure Profiles
t Retention
t Product Yield
t Cleaning
t Chemical Usage
t Cycle Times
t Pressure Profiles
TOC Residuals in
Permeate and
Retentate Flush Water
Reproducible NWP
within 20% of
Pre-Process NWP
Analyze Trends for
Corrective Action

Our Provantage® TFF Cleaning Services can help you
develop cleaning and sanitization procedures that
assure the safety and purity of your product and
maximize the useful life of your TFF cassettes.
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To place an order or receive
technical assistance
In the U.S. and Canada, call toll-free 1-800-645-5476
For other countries across Europe and the world,
please visit: www.emdmillipore.com/offices
For Technical Service, please visit:
www.emdmillipore.com/techservice

www.emdmillipore.com/offices
EMD Millipore, the M logo, Provantage, Biomax, Ultracel, Pellicon, Common Control
Platform, CCP, Cogent, and the M mark are registered trademarks of Merck KGaA,
Darmstadt, Germany. NovAseptic is a registered trademark of Millipore AB.
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Pellicon 2 Filters
and Holders
®

High-performance tangential flow filters
for biopharmaceutical process development,
scale-up/scale-down and concentration/
purification/cell harvesting applications
! Leading-edge void-free

membranes to match virtually
any separation challenge

! Short flow path for higher

flux and higher resolution
separation capability

! Choice of flow channel

configuration providing
process optimization
capability

! Predictable, fast, scale-up

D A T A

S H E E T

! True linear scalability from

laboratory size modules to
industrial assemblies for
processing thousands of liters

Typical Applications
Concentration, desalting or buffer
exchange of:
• Protein solutions
• Polysaccharide solutions
• Virus suspensions
Harvest, washing or clarification of:
• Cell cultures and lysates
• Colloidal suspensions
• Viral cultures
Superior TFF Performance
For research, process development,
scale-up and production, Pellicon 2
filters and holders offer the following
benefits:
Consistent High Flux and High
Product Recovery
Millipore’s Biomax® polyethersulfone
and Ultracel® PLC-composite regenerated cellulose membranes have
void-free structures that guard against
leakage of solutes through microdefects
normally associated with voids
beneath the thin skins of conventional
UF membranes (Figures 1 and 2).
These void-free membranes are
more permeable, resulting in high-flux
with equivalent or superior product
retention (Figure 3). These void-free
membranes provide the advantages
of fast, high yield processing and
smaller systems.
The long established Durapore®
hydrophilic PVDF microfiltration membrane is well known for its exceptional
combination of high flux, low protein
binding and high product recoveries.

Figure 1. Void-free Biomax 10 modified

polyethersulfone membrane

Figure 2. Conventional 10 kD polyether-

sulfone membrane with sub-surface voids

Pellicon 2 Filters Proof of Performance
Linear Scalability

Improved Flux
100.00

60

80.00

Feed to Retention Pressure Drop - psi

Pellicon 2 cassette with
Biomax-10 membrane
and type “A” screen

90.00

Flux - L/m2h

70.00
60.00
50.00
40.00
30.00
20.00
10.00
0.00

Conventional cassette
with 10kD modified
polyethersulfone membrane

1.7

2.7

4.5

7.4

12.2

20.1

Maxi filter 2.5 m2/26.9 ft2
Mini filter 0.1 m2/1.1 ft2

50

Cassette filter 0.5 m2/5.4 ft2

40
30
20
10
0

33.1

0

Feed pressure: 5.6 bar/80 psi
Retentate pressure: 2.1 bar/30 psi
Temperature: 10 – 13.5 °C
Initial volume 28 L
Final volume: 2 L
Conclusion
Pellicon 2 filters with Biomax membranes provide up
to two-times the process flux of conventional
cassettes resulting in faster processing and smaller
systems.

1

2

3

4

5

6

7

8

9

10 11 12

Average Crossflow per Area - L/min/m2

BSA Concentration in %

Temperature: 8 °C

Figure 4. Feed to retentate pressure drop

versus average crossflow on a 10% BSA
solution
80
70
60

Figure 3. Flux versus BSA concentration
Flux - L/m2h

Easy, Reliable Linear Scale-Up from
the Lab to the Production Plant
Pellicon 2 Mini filters scale-up easily
and reliably from the laboratory to the
production plant (Figures 4 and 5).
By ensuring every flow channel has
the same length, height and turbulence
promoter as well as flow direction and
materials of construction, we maintain
the same ultrafilter/microfilter performance at all scales. Thus, rapid and
reliable translation of processes from
lab to manufacturing scale is easily
achieved.
Linear Scale-Up
Mini filters (0.1 m2/1.1 ft2) and holders
are designed for laboratory ultrafiltration/microfiltration of 100 mL to 10 L
volumes, yet scale up linearly to
Pellicon 2 Cassette (0.5 m2/5.4 ft2)
and Maxi (2.5 m2/26.9 ft2) filters
used in the pilot or manufacturing
plant to process volumes from one liter
to thousands of liters.
Thus, whether you operate 0.1 m2
or 100 m2 of installed area, every
Pellicon 2 filter operates with the same
pressure drop, flow velocity and concentration profile for true, rapid and
simple linear scale-up.

50
40
30
20

Maxi filter 2.5 m2/26.9 ft2

10

Cassette filter 0.5 m2/5.4 ft2

0

0

Mini filter 0.1 m2/1.1 ft2

10

20

30

40

50

60

70

80

90

100

Average Transmembrane Pressure - psi

Temperature: 8 °C
Feed to retentate pressure drop: 2.8 bar/40 psi
Conclusion
(Figures 4 and 5) Pellicon 2 family of cassette filters
scale linearly from 0.1 to 0.5 to 2.5 m2 (1.1 to 5.4
to 26.9 ft2) sizes for rapid, accurate and safe
process scale-up and transfer.

Figure 5. Flux versus average transmem-

brane pressure on a 10% BSA solution.
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Improved Reliability
50
45

30 kD Modified
Polyethersulfone

40

Air Flow - std mL/min

10 kD Polyethersulfone
30 kD
Polyethersulfone

10 kD Modified
Polyethersulfone

35
30
25

Pellicon 2 cassettes
with Biomax-10
membrane

20
15
10
5
0

0

10

20

30

40

50

60

70

80

90

Air Pressure - psi

Conclusion
The void-free structure of Biomax membranes is
demonstrated by low, linear air diffusion values. This
performance ensures better process reliability and
safety and better product retention for higher yields.

Figure 6. Integrity test comparison-air flow
through wetted cassettes

Greater Process Reliability and
Reproducibility
The combination of defect-free
membranes with Millipore’s highly
reliable manufacturing processes,
offers greater consistency of process
parameters.
The high quality of Millipore’s
ultrafiltration membranes is further
ensured by our pioneering multiplesolute mixed-dextran retention profile
test. Unlike the single solute protein
retention test, Millipore’s retention
profile test measures and ensures
reproducible retention performance
of our UF membranes over the entire
range of molecular weights retained
by the membrane, not ¡ust at one or
two molecular weights.
Low Product Loss
Pellicon 2 filters have a low minimum
working volume – as low as 175 mL
of retentate volume per square meter
of membrane area. This low retentate
volume permits high concentration
factors to be reached with low starting
volumes and maximizes the recovery
of small sample volumes.
To prevent product loss, Pellicon 2
filters are 100% tested in manufacturing
to ensure that every filter is integral.
In addition, Biomax and Ultracel
membranes are exposed to a new
high-pressure integrity test that provides
greater sensitivity. The integrity test
procedure and specifications are
supplied so users can confirm integrity
at high pressure when the filter is
installed (Figure 6).

Biocompatibility
All wetted parts have been tested and
meet the requirements of the USP
Class VI biological test for plastics.
Superior Filter Quality
Pellicon cassettes are subjected to a
complete array of quality control
release tests.
A Certificate of Quality is included
with every cassette.
Each casette is identified with a
unique serial number.
Validatable
Since 1973, Pellicon filters and
systems have been successfully used
for development and scale-up of
processes for manufacturing injectable
protein and polysaccharide drugs, in
the serum fractionation, biotechnology,
vaccine and pharmaceutical
industries.
Pellicon 2 filters and systems were
developed based upon Millipore’s
experience serving these applications,
and are supported by an extensive
Validation Support Data Package
proving performance claims and
demonstrating the suitability of these
filters for drug manufacturing in
validated processes. This package is
available upon request.
Millipore can further assist your
validation efforts through:
• Design and fabrication of standard
and custom turnkey TFF systems for
drug manufacturing facilities
• Installation and operational
qualification services for these
systems
• Validation support services for
tangential flow filter use in drug
manufacturing processes.
• Training on TFF process scale-up,
optimization and development.
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A Choice of Feed Channel Screens
For optimal performance in a range
of applications Pellicon 2 filters
incorporate three types of
feed-channel screens:
• Type A screen (tight screen) is
optimized to operate Biomax
membranes with maximum flux with
low-viscosity solutions.

Normalized Recirculation Rates

• Type C screen (coarse screen) is
optimized to operate PLC series
membranes with maximum flux.
The Type C screen is also
available with Biomax-50, 100,
300, 500 and Biomax 1000
membranes for concentration and
diafiltration of viscous solutions.

Screen Selection Guidelines

• Type V screen (open channel) is
optimized for very viscous solutions
or solutions with higher levels of
suspended solids.

Parameter

Typical ∆P

Unit

Screen Type

A

Recirculation Rate

L /min/m2

Differential Pressure

bar/psi

C

V

4/6

5/35

1.4/20

0.4/6

Solution Type

Screen Type

Dilute protein solution or low viscosity solutions
(MAbs, interferons)

A screen
(tight screen)

Concentrated protein solutions or high viscosity solutions
(IgG, biopolymers)

C screen
(course screen)

High viscosity solutions (polysaccharides,
certain microfiltration or clarification applications)

V screen
(loose screen)

Specifications
Temperature Range
Mini, Cassette and Maxi:
4 to 50 °C
Maximum Forward Transmembrane Pressure

For More Detailed Information
Request literature number P17512 –
User Guide for Pellicon Filters.

Device Size (m2)

Biomax

Ultracel

0.1

6.8 bar (100 psi) Max

6.8 bar (100 psi) Max

0.5

6.8 bar (100 psi) at 30 °C

3.4 bar (50 psi) at 30 °C

2.5

6.8 bar (100 psi) at 30 °C

3.4 bar (50 psi) at 30 °C

Maximum Reverse Transmembrane Pressure
Device Size (m2)

Biomax

Ultracel

0.1

0.33 bar (5 psi)

0.33 bar (5 psi)

0.5

0.33 bar (5 psi)

0.33 bar (5 psi)

2.5

0.33 bar (5 psi)

0.33 bar (5 psi)

Prefiltration Required
Mini, Cassette and Maxi:
100 µm
Dimensions
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Device

Width

Length

Thickness

Mini

5.6 cm

21 cm

1.5 cm (V screen-2.16 cm)

Cassette

17.8 cm

21 cm

1.5 cm (V screen-2.16 cm)

Maxi

17.8 cm

21 cm

7.6 cm (V screen-9.0 cm)

Membrane Selection Guideline
Membrane Type

Materials

Benefits

Biomax

Modified polyethersulfone

Highest flux ultrafiltration membrane
Excellent chemical resistance
Void-free structure for higher yield and reliability

Ultracel PLC

Regenerated cellulose
(ideal for protein solutions < 20 g/L)

Extremely low protein binding hydrophilic membrane

PLC membranes are composite
membranes cast on a microporous
substrate for defect-free membranes
with superior adhesion.

Highest product recovery and improved performance
with difficult to process streams (antifoams, lipids,
protein transmission applications)

Brings higher resolution, improved
yields and superior back-pressure
resistance
Durapore

Hydrophilic PVDF

Very hydrophilic microporous membrane for cell
harvest or clarification applications

Pellicon 2 Membrane Selection Chart
Approximate Molecular Weight
(range of solutes retained >99%, kD)

Membrane

NMWL (kD)
or Microns

Membrane
Material

pH
Range

High Flux Biomax Membranes – Void-free for Higher Yield and Reliability
12 – 25
(growth factors, hormones)
Biomax-5

5

modified polyethersulfone

1 – 14

25 – 50

(growth factors, hormones)

Biomax-8

8

modified polyethersulfone

1 – 14

50 – 100

(albumin, hemoglobin)

Biomax-10

10

modified polyethersulfone

1 – 14

100 – 140 (enzymes)

Biomax-30

30

modified polyethersulfone

1 – 14

140 – 300 (IgG’s)

Biomax-50

50

modified polyethersulfone

1 – 14

300 – 500 (small viruses and antigens)

Biomax-100

100

modified polyethersulfone

1 – 14

>500

Biomax-300

300

modified polyethersulfone

1 – 14

>0.03 µm (large viruses, colloids, particulates)

Biomax-500

500

modified polyethersulfone

1 – 14

>0.03 µm (large viruses, cells, colloids, particulates)

Biomax-1000

1000

modified polyethersulfone

1 – 14

Ultracel PLC Series – for High Recoveries
8 – 18
(proinsulin, hematopoetic factors)

PLCCC

5

regenerated cellulose

2 – 13

18 – 60

(hemoglobin, enzymes)

PLCGC

10

regenerated cellulose

2 – 13

60 – 200

(monoclonal IgG’s)

PLCTK

30

regenerated cellulose

2 – 13

200 – 500 (small viruses, viral antigens)

PLCHK

100

regenerated cellulose

2 – 13

>500

PLCMK

300

regenerated cellulose

2 – 13

PLCXK

1000

regenerated cellulose

2 – 13

0.1 µm

hydrophilic PVDF

2 – 11

(IgM’s, large viruses)

(large viruses, IgM’s)

>0.03 µm (large viruses, cells, colloids, particulates)

Durapore Membranes – for Microporous Applications
Clarify cell lysates and protein solutions,
VVPP
clarify viral cultures
Harvest & wash colloidal suspensions, bacterial cells;
clarify protein solutions and viral cultures

GVPP

0.22 µm

hydrophilic PVDF

2 – 11

Harvest & wash colloidal suspensions, cell & viral
cultures, clarify protein solutions & viral cultures

HVMP

0.45 µm

hydrophilic PVDF

2 – 11

Harvest cell cultures or colloidal suspensions

DVPP

0.65 µm

hydrophilic PVDF

2 – 11
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Ordering Information
Pellicon 2 Filters
Filters with A Screens (Tight Screen)
Membrane

0.1 m /1.1 ft
2

2

0.5 m /5.4 ft
2

2

Filters with Type C Screens (Coarse Screen)

2.5 m /26.9 ft
2

2

0.1 m2/1.1 ft2

0.5 m2/5.4 ft2

2.5 m2/26.9 ft2

Biomax Series – Modified Polyethersulfone
Biomax 5

P2B0 05A 01 P2B0 05A 05

P2B0 05A 25

+

+

+

Biomax 8

P2B0 08A 01 P2B0 08A 05

P2B0 08A 25

+

+

+

Biomax 10

P2B0 10A 01 P2B0 10A 05

P2B0 10A 25

+

+

+

Biomax 30

P2B0 30A 01 P2B0 30A 05

P2B0 30A 25

+

+

+

Biomax 50

P2B0 50A 01 P2B0 50A 05

P2B0 50A 25

P2B0 50C 01 P2B0 50C 05

P2B0 50C 25

Biomax 100

P2B1 00A 01 P2B1 00A 05

P2B1 00A 25

P2B1 00C 01 P2B1 00C 05

P2B1 00C 25

Biomax 300

+

+

+

P2B3 00C 01 P2B3 00C 05

P2B3 00C 25

Biomax 500

+

+

+

P2B5 00C 01 P2B5 00C 05

P2B5 00C 25

Biomax 1000

+

+

+

P2B0 1MC 01 P2B0 1MC 05 P2B0 1MC 25

Ultracel PLC Series – Regenerated Cellulose, Composite Construction
5 kD

NA

NA

NA

P2C0 05C 01 P2C0 05C 05 P2C0 05C 25

10 kD

NA

NA

NA

P2C0 10C 01 P2C0 10C 05 P2C0 10C 25

30 kD

NA

NA

NA

P2C0 30C 01 P2C0 30C 05 P2C0 30C 25

100 kD

NA

NA

NA

P2C1 00C 01 P2C1 00C 05 P2C1 00C 25

300 kD

NA

NA

NA

P2C3 00C 01 P2C3 00C 05 P2C3 00C 25

1000 kD

NA

NA

NA

P2C0 1MC 01 P2C0 1MC 05 P2C0 1MC 25

Durapore – Hydrophilic PVDF
0.1 µm

+

+

+

P2V V PPC 01

P2V V PPC 05

P2V V PPC 25

0.22 µm

+

+

+

P2GV PPC 01 P2GV PPC 05

P2GV PPC 25

0.45 µm

+

+

+

P2HV MPC 01 P2HV MPC 05 P2HV MPC 25

0.65 µm

+

+

+

P2DV PPC 01

P2DV PPC 05

P2DV PPC 25

Each Pellicon filter is packed one per box and includes Operating Instructions. A Certificate of Quality is included in every box.
Silicone intercassette gaskets are required for use with Pellicon 2 filters. Two gaskets are packed in the box with every Pellicon 2 filter.
+
= On request (custom order)
NA = not available
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Filters with V Screens (Loose Screen)
0.1 m2/1.1 ft2

0.5 m2/5.4 ft2

2.0 m2/21.5 ft2

P2B0 05V 01

P2B0 05V 05

P2B0 05V 20

P2B0 08V 01

P2B0 08V 05

P2B0 08V 20

P2B0 10V 01

P2B0 10V 05

P2B0 10V 20

P2B0 30V 01

P2B0 30V 05

P2B0 30V 20

P2B0 50V 01

P2B0 50V 05

P2B0 50V 20

P2B 100V 01

P2B1 00V 05

P2B1 00V 20

P2B3 00V 01

P2B3 00V 05

P2B3 00V 20

P2B5 00V 01

P2B5 00V 05

P2B5 00V 20

P2B0 1MV 01 P2B0 1MV 05

P2B0 1MV 20

P2C0 05V 01 P2C005V 05

P2C0 05V 20

P2C0 10V 01 P2C0 10V 05

P2C0 10V 20

P2C0 30V 01 P2C0 30V 05

P2C0 30V 20

P2C1 00V 01 P2C1 00V 05

P2C1 00V 20

P2C3 00V 01 P2C3 00V 05

P2C3 00V 20

P2C0 1MV 01 P2C0 1MV 05

P2C01MV 20

P2V V PPV 01

P2V V PPV 05

P2V V PPV 20

P2GV PPV 01

P2GV PPV 05

P2GV PPV 20

P2HV MPV 01 P2HV MPV 05

P2HV MPV 20

P2DV PPV 01

P2DV PPV 20

P2DV PPV 05

Pellicon 2 Mini Holder
Pellicon 2 Mini holder operates one to
three Mini filters in parallel for total
areas of 0.1 to 0.3 m2 (1.1 – 3.3 ft2).
This sanitary holder is tightened with a
small torque wrench to compress the
filters between a manifold plate that
conveys fluids in and out of the filters
and an end plate that seals the filters
together. The Mini holder is designed
for process development and small
volume pharmaceutical manufacturing.
Materials of Construction
Manifold and End Plates:
316 L stainless steel
Base, Tie Rods, Spacers and Washers:
304 stainless steel
Feet:
Thermoplastic rubber
Gaskets:
Silicone
Nuts:
Silicone bronze
Separator Plates
An optional separator plate allows
processing simultaneously with up to
three 0.1 m2/1.1 ft2 cassettes to
determine the best molecular weight
cut-off in a single study on the same
feed material.
Connections
All manifold connections are standard
∞-inch sanitary clamp type.
Operating Parameters
Temperature Range:
4 to 50 °C. The Mini holder can
be autoclaved without filters
installed. The filters themselves
cannot be autoclaved.
Maximum Pressure:
6.8 bar
Dimensions
Height: 260 mm; Width: 114 mm
Length: 140 mm; Weight: 5 kg
Holder Manifold Volume:
Feed plus retentate: 5.3 mL
Permeate:

6.4 mL
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Stainless Steel Pellicon Holder
XX42P0080
The stainless steel Pellicon filter holder,
designed for sanitary applications, can
be used alone or to expand existing
cassette ultrafiltration (CUF) systems or
to replace existing holders.
It requires only to be connected to
an existing sanitary pump and piping
for tangential flow microporous filtration
or ultrafiltration.
It can accomodate up to 5 m2/55 ft2
filter area as shipped with long tie
rods or 0.5 to 2.5 m2 (5.4 – 26.9 ft2)
with accessory short tie rods.
Materials of Construction
Wetted Surfaces:
316 L stainless steel
Non-wetted Surfaces:
Silicon bronze nuts
Dimensions
Length: 28 cm; Width: 19 cm
Height: 25 cm
Operating Parameters
Operating Temperature Range:
4 to 50 °C. The Pellicon holder can
be autoclaved without pressure
gauges and filters; holder with
gauges cannot be steamed.
Pellicon filters cannot be steamed
or autoclaved.
Connections
Sanitary º" TC connections;
1∞" TC connections for gauges.
Shipping Weight
24 kg
To Place an Order or Receive
Technical Assistance
For additional information call your
nearest Millipore office:
In the U.S. and Canada,
call toll-free 1-800-MILLIPORE
(1-800-645-5476)
In the U.S., Canada and Puerto Rico,
fax orders to 1-800-MILLIFX
(1-800-645-5439)
Outside of North America contact your
local office. To find the office nearest
you visit www.millipore.com/offices.
Internet: www.millipore.com
Technical Service:
www.millipore.com/techservice
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Process-scale Pellicon Holder
The Pellicon Process-scale Holder is a
unique innovation for production scale
Pellicon systems. This holder, vertically
mounted, can hold up to 80 m2/880 ft2
of membrane area.
Benefits
• Extremely compact footprint
• Easy to change cassettes
• Easy to vent and fully drain
• Simple connections
• Up to 4 levels. Can be easily
extended in levels for simple
membrane area expansion
• Each level up to 20 m2/220 ft2

• Uses standard and Maxi Cassettes
• Can be adapted for series or
parallel configurations
• Simplifies pipework connection
• Hydraulic closure systems are
available for the stainless-steel
Pellicon holder and the
process-scale Pellicon holder. These
systems are convenient, reliable and
easy to use to enable rapid and
repeatable loading operation and
storage of Pellicon 2 cassettes.
Materials of Construction
Manifold segment, fitting blocks and
end plate 316 L stainless steel; tie
rods 304 and 304 L stainless steel.

Ordering Information
Pellicon 2 Filter Holders
Description

Catalogue No.

Pellicon 2 Mini filter holder

XX42 PMI NI

Pressure gauges
One diaphragm-protected digital pressure gauge,
0 – 7 bar, º-inch fittings

XX42 PSG 01L

Pressure gauge adapters

XX42 PM0 01

Fitting kit
Contains all tees, clamps, gaskets and a valve to connect
tubing and pressure gauges to the Pellicon 2 Mini holder

XX42 PFK 01

Pellicon filter holder (for cassettes and Maxi filters)

XX42 P00 80

Pellicon 2 double thick gasket

PSSP 2XC 10

Pellicon Process-scale holder support and plate

XX42 SSP LT

Pellicon Process-scale holder

On request

A Typical Pellicon Production
Processing System
Millipore supplies a range of standard
and custom engineered systems. These
systems can contain from 1 m2/11 ft2 to
several hunded m2 of membrane area,
with Clean-in-Place (CIP) or Steam-inPlace (SIP) integrated as appropriate.
Systems can also be supplied with
integrated process vessels in manual
or fully automatic versions.
All systems are designed,
engineered and manufactured in
ISO® 9001 registered facilities, and
are supplied with extensive validation
data support packages.
Please contact us to discuss your
specific application and process
requirements.

Pellicon XL Devices for Process
Development
For process development of volumes
from 50 mL to 1 liter, Millipore offers
Pellicon XL devices. This small volume
TFF filter is designed for true scalability
by providing the same flow path,
channel length, and channel height as
the Pellicon 2 cassettes. Based on
proven TFF membrane technology,
Pellicon XL devices ensure reliable,
consistent and predictable
performance.
Millipore, Biomax, Durapore, Pellicon and Ultracel are
registered trademarks of Millipore Corporation.
ISO is a registered trademark of the International
Organization of Standardization.
Lit. No. DS1210EN00 Rev. A 10/04
Printed in U.S.A. 04-324
Copyright 2003, 2004 Millipore Corporation
Billerica, MA 01821 U.S.A. All rights reserved.
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Data file 11-0025-76 AG

Ion exchange chromatography

Capto™ S, Capto Q, and Capto DEAE
Capto S, Capto Q and Capto DEAE are, respectively, strong cation,
strong anion and weak anion exchange media for packed
bed chromatography that increase speed and throughput
in capture and intermediate purification. They combine high
capacity with high flow velocity and low backpressure to
reduce process cycle times and increase productivity. As
BioProcess™ media, the Capto range meets the demands of
large-scale biopharmaceutical manufacturers by:
• Raising productivity with high dynamic binding capacity
at high flow
• Reducing process time with high volume throughput
• Cost-effective processing with smaller unit operations

Chromatography media characteristics
High throughput in downstream purification requires separation
media that combine mechanical strength of the matrix with
a pore structure that allows fast mass transfer and high
capacity for target molecules. Capto media are based on
a highly rigid agarose base matrix that offers outstanding
pressure/flow properties, optimized pore structure, and very
high chemical stability to support CIP procedures. Capto
media are intended for general use in large-scale bioprocess
operations. The basic characteristics of Capto S, Capto Q, and
Capto DEAE are summarized in Table 1.

High flow and low backpressure in
large-scale columns
High flow velocities allow increased productivity of large-scale
bioprocessing operations and processing of larger volumes
in one working shift. Shorter cycle times also reduce exposure
of the target protein to proteases. Typical flow velocities for
Capto media in a 1 m diameter column with 20 cm bed height
are over 700 cm/h, with a backpressure below 3 bar.
Figure 1 compares the pressure/flow performance of Capto
with Sepharose 6 Fast Flow in a representative large-scale
situation with a 1 m column that gives negligible wall support.

imagination at work

Velocity (cm/h)
1000
800
600
400
200
0

Capto S
Q Sepharose Fast Flow
0

0.5

1.0

1.5

2.0

2.5
3.0
Pressure (bar)

Fig 1. Pressure/flow curve for Capto S compared to Q Sepharose™ Fast Flow.
Running conditions: AxiChrom™ 1000 for Capto S, Chromaflow™ 1000 for
Q Sepharose Fast Flow, 20 cm packed bed, with water at 20ºC. The pressure
includes pressure drop from the bed and the column. System/tubing pressure
is excluded.

Although the bead and pore sizes are similar between
the two matrices, the pressure/flow properties of Capto
are significantly better. This is a result of the exceptional
mechanical stability of the Capto base matrix.

Anion and cation exchangers with
fast mass transfer and high dynamic
binding capacities
For ion exchange, Capto S uses a sulfonate group, Capto Q
uses a quartenary amine group and Capto DEAE uses a
diethylaminoethyl group. The groups are linked to a high flow
agarose base matrix modified with a dextran surface extender
which further increases capacities and mass transfer
properties. Fast mass transfer ensures high dynamic binding
capacity over a wide range of residence times. High binding
capacity also contributes to shortening the overall processing
time as the total number of cycles may be reduced. The
dynamic binding capacities of Capto S, Capto Q and Capto
DEAE at different residence times are shown in Figure 2.
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Fig 2. Dynamic binding capacity as a function of residence time for: A) Capto Q and bovine serum albumin (BSA), B) Capto S and α-chymotrypsin,
C) Capto DEAE and amyloglucosidase. For Sepharose Fast Flow media, residence times below 2 min are not possible in large-scale columns.

Table 1. Characteristics of Capto S, Capto Q, and Capto DEAE

Capto S
Matrix
Ion exchange type

Capto Q

Capto DEAE

highly cross-linked agarose with dextran surface extender
strong cation, S
-

strong anion, Q

weak anion, DEAE
-N+H(CH2CH3)2

Charged group

-SO3

-N (CH3)3

Total ionic capacity

0.11 to 0.14 mmol Na+/mL medium

0.16 to 0.22 mmol Cl-/mL medium 0.29 to 0.35 mmol Cl-/mL medium

Particle size1

90 µm (d50v)

90 µm (d50v)

Flow velocity

at least 700 cm/h in a 1 m diameter column with 20 cm bed height at 20 °C using process buffers with the
same viscosity as water at < 3 bar (0.3 MPa)

Dynamic binding capacity

> 120 mg lysozyme/mL medium2

> 100 mg BSA/mL medium3

> 90 mg ovalbumin/mL medium3

pH stability4
short term
working
long term

3 to 14
4 to 12
4 to 12

2 to 14
2 to 12
2 to 12

2 to 14
2 to 9
2 to 12

Working temperature5

4°C to 30°C

4°C to 30°C

Chemical stability

all commonly used aqueous buffers, 1 M acetic acid, 1 M NaOH , 8 M urea, 6 M guanidine hydrochloride,
30% isopropanol and 70% ethanol

Storage

20% ethanol + 0.2 M NaAc

20% ethanol

20% ethanol

Avoid

oxidizing agents,
cationic detergents

oxidizing agents,
anionic detergents

oxidizing agents,
anionic detergents

1
2

+

90 µm (d50v)

4°C to 30°C
6

d50v is the median particle size of the cumulative volume distribution.
Dynamic binding capacity at 10% breakthrough as measured at a residence time of 1 min, 600 cm/h in a Tricorn™ 5/100 column with 10 cm bed height, in a 30 mM sodium phosphate buffer, pH 6.8.

3

Dynamic binding capacity at 10% breakthrough as measured at a residence time of 1 minute, 600 cm/h in a Tricorn 5/100 column with 10 cm bed height in a 50 mM Tris-HCl buffer, pH 8.0.

4

Short term pH: pH interval that the medium can be subjected to, for cleaning- or sanitization-in-place (accumulated 90–300 h at room temperature) without significant change in function.
Working pH: pH interval where the medium binds protein as intended or is needed for elution, without adverse long-term effect.
Long term pH: pH interval where the medium can be operated without significant change in function.

5

Low temperatures can decrease capacity of Capto S and Capto DEAE.

6

No significant change in ionic capacity and carbon content after 1 week storage in 1 M NaOH at 40°C.

2
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Rigid media for cost-effective purification
The rigidity of Capto products allows improved process
economics. Capto media characteristics allow a wider working
range of flow velocities, bed heights and sample viscosities,
all of which affect processing costs in a positive way. High
flow velocities increase volume throughput and reduce
process time, longer bed heights means smaller equipment
and reduced footprint, and high flow processing of viscous
samples means less dilution and shorter cycle times.
The available degree of freedom in process design for a medium
can be illustrated as its “window of operation”. Figure 3 shows
schematically the ranges for key operating variables for
Capto IEX and Sepharose 6 Fast Flow. Given a maximum allowed
pressure, it predicts the allowable combinations of column
bed heights and operating velocities. The pressure limits,
shown as blue and red curves, are based on a 1 m diameter
column and calculated from 20 cm bed height and maximum
operating velocities of 700 and 250 cm/h, respectively. At
this point, the pressure is 3 bar for Capto and 1.3 bar for
Sepharose 6 Fast Flow. For Sepharose 6 Fast Flow, 1.3 bar
represents the highest recommended operating pressure
for this medium at this scale. For Capto, 3 bar corresponds
to the maximum pressure for many low-pressure systems;
the medium as such can normally be run to the maximum
pressure rating of low and medium pressure columns.
The size of the area below the pressure limit curves represents
the window of operation, or the available operating range
for the respective medium. As shown in Figure 3, this is
significantly larger for Capto than for Sepharose 6 Fast Flow
based media, especially when bed heights increase to
20-30 cm or more. At these bed heights, Capto can still be
run at flow velocities of 300-400 cm/h or more. Thus, the high
mechanical stability of Capto allows practical and
cost-effective use of smaller diameter columns.

A large window of operation also allows flexibility even if the
viscosity of the feed is high. Doubling viscosity halves the
operational velocity. For a feedstock with a viscosity of 2 cP
at a bed height of 30 cm, the flow velocity of Capto is 235 cm/h
compared to 80 cm/h for Sepharose 6 Fast Flow.
Figure 3 also shows contours of the residence time in the
column. A long residence time allows for better utilization of the
full equilibrium capacity. It is possible to increase the residence
time by either decreasing the flow velocity, or increasing the
column bed height. For Capto, increasing bed heights assures
longer residence times even under high flow conditions.

Selectivity
The charged groups of the S, Q and DEAE ligands used in
Capto media are identical to the charged groups used in
many other ion exchange media. However, minor differences
in selectivity can occur between media having the same
ligand as illustrated in Figures 4 and 5. This is due to differences
in base matrix, ligand density and surface extenders.
Columns:

HiTrap™ Capto Q, 1 mL
HiTrap Q XL, 1 mL
HiTrap Q FF, 1 mL
Columns:
HiTrap™ Capto Q, 1 mL
Sample:
GFP in E. coli homogenate
Start buffer:
50 mM Tris-HCl, pH 8.2
Elution buffer: 50 mM Tris-HCl, 1 M NaCl, pH 8.2
Flow:
1 mL/min (156 cm/h)
Gradient:
0%-100% elution buffer, 15 column volumes (CV)
System:
ÄKTAexplorer™ 100
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Fig 4. The separation ability of Capto Q for GFP compared to Q Sepharose
Fast Flow and Q Sepharose XL media in 1 ml prepacked HiTrap columns.

Fig 3. The highly rigid Capto base matrix allows a much larger window of
operation (area below the curves) at large-scale than Sepharose 6 Fast
Flow. This is particularly true at bed heights of 20-30 cm and above. Data
correspond to a 1 m diameter column, at 20oC and viscosity of water. Red and
blue curves correspond to pressure limits of 1.3 and 3 bar, respectively. Green
contours give the residence time in the column in minutes.
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Capto Q vs Capto DEAE

Columns:

HiTrap Capto S, 1 mL
HiTrap SP XL, 1 mL
HiTrap SP FF, 1 mL
Sample:
α-chymotrypsin in E. coli homogenate
Start buffer:
50 mM Sodium acetate, pH 4.8
Elution buffer: 50 mM Sodium acetate, 1 M NaCl, pH 4.8
Flow:
1 mL/min (156 cm/h)
Gradient:
0% to 100% elution buffer, 10 CV
System:
ÄKTAexplorer 100

In addition to the difference in working pH range, the anion
exchangers Capto Q and Capto DEAE also differ in selectivity.
This difference, which is mainly pH dependent, is illustrated
in Figures 7 and 8. Which product to chose depends on the
individual application and what should be achieved during
the separation. However the general recommendation is to
start by evaluating the strong ion exchanger (Capto Q) since
its function is less dependent on pH.

A280
3500
2500
Capto S
1500

Column:
Media:

500

Sample :

0
3500

Start buffer:
Elution buffer:
Flow rate:
Gradient:

2500
1500

SP Sepharose XL

Capto DEAE
Capto Q
Cond

A280

500

Tricorn 5/50, CV: 1 mL
Capto Q
Capto DEAE
Apo-transferrin (1.3 mg/mL)
β-lactoglobulin (2.7 mg/mL)
Pepsin (2 mg/mL)
20 mM piperazine, pH 6.0
20 mM piperazine, 1 M NaCl, pH 6.0
150 cm/h
0% to 80% elution buffer, 32 CV

0
3500
2500

SP Sepharose Fast Flow

1500
500
0
0

5

10

15

20

25

30

mL

Fig 5. The separation ability of Capto S for α-chymotrypsin compared to
SP Sepharose Fast Flow and SP Sepharose XL media in 1 mL prepacked
HiTrap columns.

Strong ion exchangers like Capto S and Capto Q maintain
their charge (and thus their function) over a wide pH range
whereas with weak ion exchangers the degree of dissociation
and thus ion exchange capacity varies with pH. Capto DEAE,
although predominantly a weak anion exchanger, can not be
fully discharged by raising the pH due to a minor content of
quaternarized amine groups (Fig 6). It is therefore, possible to
use DEAE media at higher pH values for separations of highly
charged species as nucleotides, for example.
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Fig 6. Titration curve of Capto DEAE.
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Fig 7. The selectivity difference between Capto Q and Capto DEAE at pH 6
exemplified by separation of a mixture containing three proteins and some
breakdown products.
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Fig 8. Elution conductivity as a function of pH for a set of model proteins on A)
Capto Q, where only the change in surface charge of the proteins influences the
elution position B) Capto DEAE, where both the change in surface charge of the
proteins and the changed charge of the ligand determine the elution behavior.

Scale-up modelling and productivity calculations based on
experimental data at small and pilot scale indicate that it is
possible to capture and recover >100 kg of green fluorescent
protein (GFP) from an Escherichia coli homogenate in 24 h
using Capto Q in a 1.6 m i.d. column at 20 cm bed height
(equivalent to 400 L of medium). Assuming the same process
conditions, using Q Sepharose Fast Flow would require a 3 m
i.d. column or 1400 L medium (in practice, this means three
separate columns would be needed). This example supports
the argument that Capto Q is being particularly suitable for
high throughput and high productivity capture purification.
For further details see Application note 11-0026-20.
Similar calculations indicate that it is possible to capture and
recover >100 kg of α-chymotrypsin from E. coli homogenate
in 24 hours with Capto S in a 0.8 m i.d. column at 20 cm bed
height (equivalent to 100 L of medium). Assuming the same
process cycle conditions, using SP Sepharose Fast Flow would
require a 1.2 m i.d. column at 20 cm bed height (equivalent
to 250 L medium). This example also indicates that Capto S
is suitable for high throughput and high productivity capture
purification. For further details see Application note 28-4078-15.
Process cycle times and productivity data for both examples
are summarized in Table 3. Similar improvement in
productivity is obtained with Capto DEAE compared to DEAE
Sepharose Fast Flow.

GFP
Capto Q
Q Sepharose Fast Flow
α-chymotrypsin
Capto S
SP Sepharose Fast Flow
amyloglucosidase
Capto DEAE†
DEAE Sepharose Fast Flow†
†

Productivity
(kg/h, m3)

Media volume for
100 kg/24 h (L)

91
190

11
3

400
1400

131
229

53
17

80
250

197
306

37
12

114
353

Productivity calculations based on pure protein

Operation
Fast method development
In order to find the most suitable chromatography media
and/or process conditions, screening and optimization
should be performed. Time and sample can be saved in
the early stages of development by using small-scale
formats. PreDictor™ 96-well filter plates and Assist software
may be used for initial screening of process conditions
such as, pH and conductivity (Fig 9). ÄKTA™ avant – with
Design of Experiment (DoE) functionality - or ÄKTAexplorer
chromatography systems together with prepacked columns,
such as HiScreen™ and HiTrap columns, can be used for
further optimization and verification of the operating conditions.
pH 6

pH 7
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Improved productivity based on high flow features
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(min)
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200 mg/ml

100

250 mg/ml

80

60

40

0

10

20

30

40

50

60

70

20

80

0

10

20

Incubation time (min)

30

pH 8

50

60

70

80

60

70

80

pH 9

140

140

120

120

100

80

60

40

20

40

Incubation time (min)

Ionic Strength (mM)

Note that the DEAE ligand has buffering properties. Therefore,
a greater volume or concentration of equilibration buffer may
be reqired for titration of the DEAE ligand in comparison to
the non-titrateable Q ligand.

Target protein
and medium

Ionic Strength (mM)

Recent developments in upstream processing have resulted
in larger feed volumes and increased protein expression
levels. The combination of high volume throughput and high
capacity makes Capto media the optimal choice for processing
large amounts of protein in a fast and efficient way. As ion
exchangers, their behavior can be easily controlled and
application areas predicted by buffer choice and pI of the
target proteins. Note that to reach the full potential of media
where the design includes dextran, close attention must be
paid to pH, conductivity, and other loading conditions. If this is
done, very high capacities can be reached.

Table 3. Results from scale-up modelling and productivity calculations for
Capto Q, Capto S, and Capto DEAE as described in the text

Ionic Strength (mM)

Applications
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Fig 9. Screening for optimal binding conditions (pH, ionic strength and
incubation time) for amyloglucosidase on Capto DEAE by batch uptake
methodology using 96-well filter plates. Note that incubation time using
this methodology is not equivalent to residence time in the column; typical
residence times can be seen in Fig 2c.

11-0025-76 AG

5

Column:
Medium:
Sample:

A)

For more information about method development and
optimization, consult the handbooks, “High-throughput process
development with PreDictor plates“ and ”Ion Exchange
Chromatography & Chromatofocusing: Principles and Methods”.
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Sample:

B)

Start buffer:
Elution buffer:
Flow rate:
Gradient:
System:
Residence time:

40
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100

min

XK 16/40 (bed height 20.7 cm, CV= 41.5 mL)
Capto S
α-chymotrypsin in E. coli homogenate,
4 mg/mL–1040 mL
50 mM NaAc, pH 4.8
50 mM NaAc, 1 M NaCl, pH 4.8
624 cm/h
0%–100% 0 CV, 100% 5 CV
ÄKTAexplorer 100
2 min

mS/cm

A280
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200

150

100

Inlet

CIP

Elution

1000

Re-equilibration

2000

0

50

0
0

Cleaning and sanitization

50

0
0

A scale-up experiment was conducted for Capto S (Fig 10)
using an optimized process for α-chymotrypsin with a
constant residence time of 2 min. From Tricorn 5/100 the bed
height was doubled to 20 cm in a XK 16/40 column
(CV 40 mL). From the XK 16/40 column further scale up was
conducted on an AxiChrom™ 50 (CV 400 mL) by increasing
bed diameter to give a 200-fold scale up.

20
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80

100 min

Column:
Medium:
Sample:

AxiChrom 50 (bed height 22 cm, CV= 431 mL)
Capto S
α-chymotrypsin in E. coli homogenate,
4 mg/mL–10.8 L
Start buffer:
50 mM NaAc, pH 4.8
Elution buffer:
50 mM NaAc, 1 M NaCl, pH 4.8
Flow rate:
645 cm/h
Gradient:
0%–100% 0 CV, 100% 5 CV
System:
ÄKTApilot™
Residence time: 2 min

C)

mS/cm

A280

4000

150

3000
100

Re-equilibration

1000

CIP

2000

Elution

All Capto media withstand all standard CIP solutions (e.g.
1 M NaOH, 2 M NaCl or 70% ethanol) or combinations thereof.

CI P

500

Elution

1000

4000

A specific CIP protocol should be designed for each process
according to the type of contaminants present. The frequency
of CIP depends of the nature and the condition of the starting
material, but one CIP cycle is generally recommended every
1 to 5 separation cycles. For some contaminants a more
rigorous CIP procedure can be required for Capto DEAE than
for Capto S and Capto Q, see instruction manual.

100

1500

To utilize the full potential of Capto media, we recommend
bed heights of 20 cm and higher at large scale.

Cleaning-in-place (CIP) is a cleaning procedure that removes
contaminants such as lipids, precipitates, or denatured
proteins that may remain in the packed column after
regeneration. Regular CIP also prevents the build-up of these
contaminants in the media bed and helps to maintain the
capacity, flow properties and general performance of the media.

150

Wash

Scale-up is typically done by keeping bed height and flow
velocity constant, while increasing column bed diameter and
flow rate. However, since optimization is preferentially done
with small column volumes (to save sample and buffer), some
parameters such as the dynamic binding capacity may be
optimized using shorter bed heights than those being used in
the final scale. As long as the residence time is constant, the
binding capacity for the target molecule remains the same.
Other factors, like clearance of critical impurities, may change
when column bed height is changed and should be validated
using the final bed height.

3000

Wash

Capto media belong to the BioProcess range of media
that are developed and supported for production-scale
chromatography. This includes validated manufacturing
methods, secure supply and Regulatory Support Files (RSF)
to assist process validation and submission to regulatory
authorities.

A280

Wash

Fully scalable

Start buffer:
Elution buffer:
Flow rate:
Gradient:
System:
Residence time:

Tricorn 5/100 (bed height 9.7 cm, CV=1.9 mL)
Capto S
α-chymotrypsin in E. coli homogenate,
4 mg/mL–50 mL
50 mM NaAc, pH 4.8
50 mM NaAc, 1 M NaCl, pH 4.8
285 cm/h
0%–100% 0 CV, 100% 5 CV
ÄKTAexplorer 100
2 min
mS/cm

Inlet

UNICORN™ software on ÄKTA systems makes it simple to transfer
the optimized method to a production scale process system.

0

50

0
0

20

40

60

80

100 min

Fig 10. A 200-fold scale up using (A) Tricorn 5/100, (B) XK 16/40 and,
(C) AxiChrom columns.
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Equipment

Ordering information

Capto media can be used together with most equipment
available for chromatography from lab scale to production
scale. Due to the high rigidity of the medium, packing
procedures are slightly different compared to Sepharose 6
Fast Flow based media. In process-scale, the preferred
packing technique for Capto media is axial compression.
Using AxiChrom columns, with Intelligent Packing and pre-set
packing methods for all Capto media, is the most optimal and
fastest approach. Appropriate columns from GE Healthcare
are shown in Table 4. For details on packing lab-scale
columns, see Instruction manuals, and for packing processscale columns see Application notes.

All Capto media are available as bulk media and in
several pre-packed formats, including PreDictor 96-well
filter plates, PreDictor RoboColumn™, HiTrap, HiScreen,
and ReadyToProcess columns. Please contact your local
GE Healthcare representative for additional information.

All Capto media is also available in the ReadyToProcess™
platform, with pre-packed, pre-qualified and pre-sanitized
ReadyToProcess columns ranging in size from 1-20 L.

Product

Pack size

Capto S

25 mL

17-5441-10

Capto S

100 mL

17-5441-01

Capto S

1L

17-5441-03

Capto S

5L

17-5441-04

Capto S

10 L

17-5441-05

Capto S

60 L

17-5441-60

Capto Q

25 mL

17-5316-10

Capto Q

100 mL

17-5316-02

Capto Q

1L

17-5316-03

Capto Q

5L

17-5316-04

Capto Q

10 L

17-5316-05

Capto Q

60 L

17-5316-60

Capto DEAE

25 mL

17-5443-10

5, 10

Capto DEAE

100 mL

17-5443-01

16, 26, 50

Capto DEAE

1L

17-5443-03

Capto DEAE

5L

17-5443-04

Table 4. Appropriate columns

Column family range

Inner diameter (mm)

Lab scale:
Tricorn
HiScale™
Pilot and production scale:

Code no.

Capto DEAE

10 L

17-5443-05

AxiChrom

50 – 1000

Capto DEAE

60 L

17-5443-60

BPG

100 – 300†

Prepacked formats

Chromaflow

400 – 800‡

HiTrap Capto S

5 × 1 mL

17-5441-22

HiTrap Capto S

5 × 5 mL

17-5441-23

HiTrap Capto Q

5 × 1 mL

11-0013-02

HiTrap Capto Q

5 × 5 mL

11-0013-03

HiTrap Capto DEAE

5 × 1 mL

28-9165-37

HiTrap Capto DEAE

5 × 5 mL

28-9165-40

Store unused media and prepacked columns at 4°C to 30°C in
20% in ethanol and 0.2 M sodium acetate.

PreDictor AIEX screening, 20 µL

4 × 96-well filter plates

28-9432-89

Capto Q and Capto DEAE

PreDictor CIEX screening 20 µL

†
‡

The pressure rating of BPG 450 is too low to use it with Capto media.
Larger pack stations might be required at larger diameters.

Storage
Capto S

Store unused media and prepacked columns at 4°C to 30°C in
20% in ethanol.

PreDictor AIEX screening, 2 µL/6 µL 4 × 96-well filter plates

28-9432-88

4 × 96-well filter plates

28-9432-91

PreDictor CIEX screening 2 µL/6 µL 4 × 96-well filter plates

28-9432-90

PreDictor Capto DEAE, 2 µL

4 × 96-well filter plates

28-9258-11

PreDictor Capto DEAE, 20 µL

4 × 96-well filter plates

28-9258-12

PreDictor Capto DEAE, 50 µL

4 × 96-well filter plates

28-9258-13

PreDictor Capto DEAE Isotherm

4 × 96-well filter plates

28-9432-80

PreDictor Capto Q, 2 µL

4 × 96-well filter plates

28-9257-73

PreDictor Capto Q, 20 µL

4 × 96-well filter plates

28-9258-06

PreDictor Capto Q, 50 µL

4 × 96-well filter plates

28-9258-07

PreDictor Capto Q Isotherm

4 × 96-well filter plates

28-9432-78

PreDictor Capto S, 2 µL

4 × 96-well filter plates

28-9258-08

PreDictor Capto S, 20 µL

4 × 96-well filter plates

28-9258-09

PreDictor Capto S, 50 µL

4 × 96-well filter plates

28-9258-10

PreDictor Capto S Isotherm

4 × 96-well filter plates

28-9432-79

11-0025-76 AG
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Product

Pack size

PreDictor RoboColumn
Capto Q, 200 µl

One row of eight
columns

28-9860-72

Code no.

PreDictor RoboColumn
Capto Q, 600 µl

One row of eight
columns

28-9861-75

PreDictor RoboColumn
Capto S, 200 µl

One row of eight
columns

28-9860-81

PreDictor RoboColumn
Capto S, 600 µl

One row of eight
columns

28-9861-76

PreDictor RoboColumn
Capto DEAE, 200 µl

One row of eight
columns

28-9860-82

PreDictor RoboColumn
Capto DEAE, 600 µl

One row of eight
columns

28-9861-77

HiScreen Capto DEAE

1 × 4.7 mL

28-9269-82

HiScreen Capto Q

1 × 4.7 mL

28-9269-78

HiScreen Capto S

1 × 4.7 mL

28-9269-79

ReadyToProcess Capto Q

2.5 L

28-9017-23

ReadyToProcess Capto Q

10 L

28-9017-24

ReadyToProcess Capto Q

1L

28-9510-90

ReadyToProcess Capto Q

20 L

28-9017-25

ReadyToProcess Capto S

20 L

28-9017-31

ReadyToProcess Capto S

2.5 L

28-9017-29

ReadyToProcess Capto S

10 L

28-9017-30

ReadyToProcess Capto S

1L

28-9510-93

Related literature

Code no.

Data files
PreDictor 96-well filter plates and Assist software

28-9258-39

PreDictor RoboColumn

28-9886-34

HiScreen prepacked columns

28-9305-81

ReadyToProcess columns

28-9159-87

BPG columns

18-1115-23

Chromaflow columns

18-1138-92

AxiChrom columns

28-9290-41

Application notes
Capture of Green Fluorescent Protein on Capto Q

11-0026-20

Methods for packing Capto S and Capto Q in
production scale columns

28-9259-32

High productivity capture of α-chymotrypsin
on Capto S cation exchanger

28-4078-15

Screening and optimization of loading
conditions on Capto S

28-4078-16

Screening of loading conditions on Capto S using
a new high-throughput format, PreDictor plates

28-9258-40

Capto S cation exchanger for post-Protein A
purification of monoclonal antibodies

28-4078-17

Process-scale purification of monoclonal
antibodies – polishing using Capto Q

28-9037-16

Purification of a monoclonal antibody using
ReadyToProcess columns

28-9198-56

Use of Capto ViralQ for the removal of genomic
DNA from influenza virus produced in MDCK cells

28-9769-69

Two-step purification of monoclonal IgG1 from
CHO cell culture supernatant

28-9078-92

Handbooks
High-throughput process development with
PreDictor plates, principles and methods

28-9403-58

Ion Exchange Chromatography & Chromatofocusing:
Principles and Methods

11-0004-21

For local office contact information, visit
www.gelifesciences.com/contact

GE, imagination at work, and GE monogram are trademarks of General Electric Company.

www.gelifesciences.com/bioprocess
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Sartopore® 2 0.2 µm
Sterilizing Grade Filter Elements

Product Information
– Industry standard of high-performance
liquid sterile filters
– Unique hydrophilic heterogeneous double layer
Polyethersulfone membrane
– Exceptional high throughput and excellent
flowrates at low pressure drops
– High thermal resistance and broad chemical
compatibility

High-Performance and broad compatibility
Sartopore® 2 filter elements feature a unique hydrophilic heterogeneous double layer design of a 0.45 µm pre-filter and 0.2 µm
final filter membrane with an exceptionally high throughput and
flow-rate. In addition to its outstanding performance, the Polyethersulfone membrane gives Sartopore® 2 0.2 µm broad chemical
compatibility, including a pH-range from pH 1 to pH 14, and
a high thermal resistance.

Scalability
Sartopore® 2 0.2 µm filter elements are available in a broad range
of sizes and formats to provide linear scale-up from R&D to
process scale. The wide range of membrane areas from 150 cm2
to 1.8 m2 per filter element guarantees greatest flexibility and
most economic filter sizing.
Applications

Industry standard for sterile-grade liquid filters
Sartopore® 2 0.2 µm filters are fully validated as sterilizing grade
filter elements according to current ASTM F-838 guidelines.
Each individual element is integrity tested by diffusion and
bubble point test prior to release, assuring absolute reliability.
Sartopore® 2 filter elements are designed, developed and
manufactured in accordance with an ISO 9001 certified Quality
Management System. The Validation and Extractables Guide are
available for compliance with regulatory requirements.

– Therapeutics
– Biological Fluids
– Ophthalmic solutions
– Injectables
– Media
– SVPs, LVPs
– Antibiotics
– WFI
– Buffers
– Chemicals
– Cleaning and sanitizing agents
– Bulk pharmaceutical products

Sartopore® 2 0.2 µm

Technical Data
Available Sizes

Filtration Area

Cartridges, T-Style MaxiCaps® | MaxiCaps® | Gamma MaxiCaps®
Size 0.5 (Only Cartridge)
0.3 m2 | 3.2 ft2
Size 1
0.6 m2 | 6.5 ft2
Size 2
1.2 m2 | 12.9 ft2
Size 3
1.8 m2 | 19.4 ft2
Mini Cartridges | MidiCaps® | Gamma MidiCaps®
Size 7
0.05 m2 | 0.5 ft2
Size 8
0.1 m2 | 1.1 ft2
Size 9
0.2 m2 | 2.2 ft2
0.45 m2 | 4.8 ft2
Size 0 (Only MidiCaps®
& Gamma MidiCaps®)
Capsules | Gamma Capsules
Size 4
Size 5

0.015 m2 | 0.16 ft2
0.03 m2 | 0.32 ft2

Max. Diffusion at 2.5 bar | 36 psi
[ml/min]

Min. Bubble Point
[bar | psi]

10
18
36
54

3.2 | 46
3.2 | 46
3.2 | 46
3.2 | 46

4
5
7
14

3.2 | 46
3.2 | 46
3.2 | 46
3.2 | 46

1
2

3.2 | 46
3.2 | 46

Max. Allowable Differential Pressure

Max. Allowable Back Pressure

Mini Cartridges |Cartridges
5 bar | 72.5 psi at 20°C
2 bar | 29 psi at 80°C

2 bar | 29 psi at 20°C
(for all elements)

T-Style MaxiCaps® | MaxiCaps® | Gamma MaxiCaps® | MidiCaps® | Gamma MidiCaps®
5 bar | 72.5 psi at 20°C
3 bar | 43.5 psi at 50°C
Capsules | Gamma Capsules
4 bar | 58 psi at 20°C
2 bar | 29 psi at 50°C

Materials

Pore Size Combination

Prefilter Membrane
Polyethersulfone, asymmetric

End Caps
Polypropylene

Endfilter Membrane
Polyethersulfone, asymmetric

Capsule Housing
Polypropylene

Support Fleece
Polypropylene
(In-Line Steam sterilizable & autoclavable)
Polyester
(γ-irradiatable or γ-irradiatable | autoclavable)

O-Ring
Silicone
(other materials on request)

Core
Polypropylene

Filling Bell
Polycarbonate

0.45 µm + 0.2 µm

Regulatory Compliance
– Each individual element is tested for integrity by Bubble Point and Diffusion test
– Fully validated as sterilizing grade filters according to ASTM current F-838 guidelines
– Designed, developed and manufactured in accordance with an ISO 9001 certified Quality Management System
– Meet or exceed the requirements for WFI quality standards set by the current USP
– Non pyrogenic according to USP Bacterial Endotoxins
– USP Plastic Class VI Test
– Non fiber releasing according to 21 CFR

Sterilization

Performance

Mini Cartridges, Cartridges
In-Line Steam Sterilization
134 °C, 0.3 bar, 20 min.
Min. 25 Sterilization Cycles

Total Throughput Comparison
Total Throughput at 95 % blockage [kg]

100

or

80

Autoclaving
134°C, 2 bar, 30 min
Min. 25 Sterilization Cycles

60
40

MaxiCaps®, MidiCaps® & Capsules
Autoclaving
134°C, 2 bar, 30 min
Min. 25 Sterilization Cycles (MidiCaps® & MaxiCaps®)
Min. 5 Sterilization Cycles (Capsules)
Gamma MaxiCaps®, Gamma MidiCaps® & Gamma Capsules
Gamma Irradiation
< 50 kGy
1 Sterilization Cycle
T-Style MaxiCaps®
Autoclaving
134°C, 2 bar, 30 min
Min. 5 Sterilization Cycles

20
0

Sartopore® 2 PESU
0.45 | 0.2 µm 0.8 | 0.2 µm

PVDF
0.2 µm

PVDF
0.22 µm

Nylon
0.2 | 0.2 µm

10″ Cartridge format

Water Flow Rates for Standard Cartridges
[psi]
15

Differential pressure [bar]

1

10″

0.75

20″

30″

0.5

7.5

0.25

or
Gamma Irradiation
< 50 kGy
1 Sterilization Cycle

0

0
0

2,000

4,000

6,000

8,000

10,000

12,000

14,000

Flow [l/h]

Standardized at 20 °C

Water Flow Rates for T-Style MaxiCaps®

Technical References
Validation Guide
Extractables Guide

SPK5802-e
SPK5731-e

Differential Pressure [bar]
1

[psi]
14.5

10” OO, SO
20” OO, SO

0.75

10” SS, SY, YY

30” OO, SO

20” SS, SY, YY
0.5

7.25

30” SS, SY, YY

0.25

0

0
0

1000

2000

3000
4000
Flow Rate [l/h]

5000

6000

Sartopore® 2 0.2 µm
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Ordering Information
Mini Cartridge
544

15

07

H

Adapter
15: Bayonet adapter with o-ring
18: Plug Adapter with double o-ring

Sales and Service Contacts

For further contacts, visit www.sartorius-stedim.com

--

-

-

--

--

B

Filter Size
7: 0.05 m2 | 0.5 ft2
8: 0.1 m2 | 1.1 ft2
9: 0.2 m2 | 2.2 ft2

Packing Size
B: box of 5

Sales and Service Contacts
(Standard with silicone o-ring optional with EPDM o-ring. Example: 5441507H7---E--B)
For further contacts, visit www.sartorius-stedim.com
Europe Cartridge
Americas

Germany
Netherlands
USA
China
544 GmbH25
07 Sartorius
H Stedim Netherlands B.V.
Sartorius Stedim Biotech (Beijing) Co. Ltd.
Sartorius Stedim Biotech
Sartorius Stedim North America Inc.
No. 33 Yu’an Road
August-Spindler-Strasse 11
5 Orville Drive, Suite 200
Phone +31.30.60.25.080
Germany
Netherlands
USA
China
Airport Industrial Park Zone B
37079 Goettingen
Bohemia, NY 11716
Fax +31.30.60.25.099
Adapter
Sartorius Stedim Biotech
(Beijing)
Co. Ltd.
Sartorius Stedim Biotech GmbH
Sartorius Stedim Netherlands
B.V.
Sartorius Stedim North America Inc.
Shunyi
District,
Beijing 101300
Phone
Toll-Free
+1.800.368.7178
Filter Size
No. 33 Yu’an Road
August-Spindler-Strasse
11 +49.551.308.0
5 Orville Drive, Suite 200
21:Phone
double
open
end
with
flat
gaskets
filtratie.nederland@sartorius-stedim.com
+31.30.60.25.080
2
2
Phone
+86.10.80426516
Fax
+49.551.308.3289
Fax
+1.631.254.4253
Airport Industrial Park Zone B
37079 Goettingen
Bohemia,
NY 11716
0: 0.3 m | 3.2 ft (5“)
25:Fax
2 Flange
Bayonet adapter with 226 double
o-ring
+31.30.60.25.099
+86.10.80426580
Shunyi District, BeijingFax
101300
1: 0.6 m2 | 6.5 ft2 (10“)
Phone +49.551.308.0
Toll-Free +1.800.368.7178
Poland
27:filtratie.nederland@sartorius-stedim.com
Bayonet
adapter with
222 double o-ring
Sartorius
Stedim
Systems
GmbH
Argentina
2
2
Phone
+86.10.80426516
Fax +49.551.308.3289
FaxSp.+1.631.254.4253
Sartorius
Stedim
Poland
z
o.o.
2:
1.2
m
|
12.9
ft
(20“)
28:5 3– 7Flange Bayonet adapter with 222 double o-ring
Robert-Bosch-Strasse
Sartorius Argentina
S.A. +86.10.80426580 Sartorius Stedim (Shanghai)
ul. Wrzesinska 70
3:A.1.8
m2 |4251
19.4 ft2Fax
(30“)
Trading Co., Ltd.
34302 Guxhagen
Int.
Ávalos
Poland
62-025 Kostrzyn
Sartorius Stedim Systems GmbH
Argentina
3rd Floor, North Wing, Tower 1
B1605ECS
Munro
Sartorius
Stedim
Polando-ring
Sp. z o.o.
Phone
+49.5665.407.0
(Standard
with
silicone
optional
with
EPDM
o-ring.
Example:
5442507H1---E)
Sartorius Stedim (Shanghai)
Robert-Bosch-Strasse 5 – 7
Sartorius Argentina S.A.
Phone
+48.61.647.38.40
No. 4560 Jinke Road
Buenos
Aires
Fax +49.5665.407.2200ul. Wrzesinska 70
Trading
Co.,
Ltd.
34302 Guxhagen
Int.
A.
Ávalos
4251
Fax +48.61.879.25.04
Zhangjiang Hi-Tech Park
62-025 Kostrzyn
Phone +54.11.4721.0505
3rd Floor, North Wing,Pudong
Tower 1District
B1605ECS Munro
®
Phone +49.5665.407.0
Fax +54.11.4762.2333 No. 4560 Jinke Road
T-Style
MaxiCaps
Phone +48.61.647.38.40
Buenos Aires
France
Shanghai 201210, P.R. China
Fax +49.5665.407.2200
Russian
Federation
Fax +48.61.879.25.04
Zhangjiang Hi-Tech Park
Sartorius Stedim FMT S.A.S.
Phone +54.11.4721.0505
Stedim RUS”
Phone +86.21.6878.2300
Pudong District
544
83
07 LLC “Sartorius
H
GZI des Paluds
Fax +54.11.4762.2333Brazil
Vasilyevsky Island
+86.21.6878.2882
France
Shanghai 201210, P.R.Fax
China
Avenue de Jouques – CS
91051
Sartorius
do
Brasil
Ltda
th
Russian Federation 5 line 70, Lit. A
Sartorius Stedim FMT 13781
S.A.S. Aubagne Cedex
Avenida Senador Vergueiro
LLC “Sartorius Stedim 199178
RUS” St. Petersburg
Phone2962
+86.21.6878.2300
ZI des Paluds
Sartorius
Stedim Biotech (Beijing) Co. Ltd.
São Bernardo
Filter
Size Island
Sterilization Brazil
Connector
Inlet do Campo
Connector
Outlet
Vasilyevsky
Fax +86.21.6878.2882
Phone
+33.442.845600
Avenue de Jouques – CS
91051
Sartorius do Brasil LtdaCEP 09600-000 - SP- Brasil
Guangzhou Representative Office
Phone +7.812.327.53.27
2 70, Lit. 2A
5th line
Fax
+33.442.845619
1:
0.6
m
|
6.5
ft
(10“)
G-: γ-irradiatable
S: 1½“
Tri-Clamp
S: 1½“ Tri-Clamp
50 mm
13781 Aubagne Cedex
Avenida Senador
Vergueiro
2962 50 mm
Unit
K,
Building
23
Fax
+7.812.327.53.23
199178 St. Petersburg
Phone +55.11.4362.8900
Sartorius Stedim
Biotech
(Beijing)
Co. Ltd.
São BernardoO:do½“
Campo
Huihua
Commerce
& Trade
2: 1.2 m2 | 12.9 ft2 (20“)
and autoclavable
single
stepped
hose
barb
O:
½“
single
stepped
hose
barbBuilding
Phone +33.442.845600
Fax +55.11.4362.8901 Guangzhou Representative Office
Phone
CEP
09600-000
SPBrasil
2 +7.812.327.53.27
2
No.
80
Xianlie
Middle
Road
Sartorius
Stedim
France
SAS
3: 1.8
m | 19.4 ft (30“)
Y: 1“ single stepped hose barb
Y: 1“ single stepped hose barb
Fax +33.442.845619
Unit K, Building 23 Guangzhou 510070
Fax +7.812.327.53.23 Spain
ZI des Paluds
Sartorius Stedim Spain,Phone
S.A.U.+55.11.4362.8900
Huihua Commerce & Trade Building
Avenue de Jouques – CS 71058
Fax +55.11.4362.8901Mexico
Avda. de la Industria, 32
No.de80C.V.
Xianlie Middle Phone
Road +86.20.37618687 | 37618651
Sartorius Stedim France
SAS Aubagne Cedex
13781
Sartorius de México, S.A.
Spain
Edificio
PAYMA
Guangzhou s/n,
510070 Fax +86.20.37619051
ZI des Paluds
Libramiento
Norte
de
Tepotzotlan
®
®
Sartorius Stedim
Spain,
S.A.U.
28108
Alcobendas
(Madrid)
Phone
+33.442.845600
MaxiCaps
|
Gamma
MaxiCaps
Avenue de Jouques – CS 71058
Mexico
Colonia Barrio Tlacateco,
Phone +86.20.37618687 | 37618651
Avda. de la Industria, 32
13781 Aubagne CedexFax +33.442.846545
Sartorius de México, S.A.
de C.V. de Tepotzotlan,
Phone +34.913.586.098
Municipio
Fax +86.20.37619051 India
Edificio PAYMA
Libramiento Norte de Tepotzotlan
s/n,
Sartorius Stedim India Pvt. Ltd.
Fax
+34.913.589.623
Estado
de
México,
544
73
07
H
28108 Alcobendas (Madrid)
Phone +33.442.845600
Colonia Barrio Tlacateco,
#69/2-69/3, NH 48, Jakkasandra
Austria
C.P.
54605
Fax +33.442.846545
India
Phone
+34.913.586.098
Municipio
de
Tepotzotlan,
Nelamangala Tq
Sartorius Stedim Austria GmbH
Phone +52.55.5562.1102
Sartorius Stedim India562
Pvt.123
Ltd. Bangalore, India
+34.913.589.623 Switzerland
Estado de México,
ModecenterstrasseFilter
22 Fax Size
Connector
Outlet
Sterilization
Inlet
Sartorius
Stedim Switzerland
AG Connector
Fax +52.55.5562.2942
#69/2-69/3,
NH
48,
Jakkasandra
Austria
C.P.
54605
1030 Vienna
2
2
Phone
+91.80.4350.5250
Ringstrasse
24
a
S:
1½“
Tri-Clamp
50 mm
1:
0.6
m
|
6.5
ft
(10“)
G-:
γ-irradiatable
S:
1½“
Tri-Clamp
50
mm
Nelamangala Tq
Sartorius Stedim Austria GmbH
leadsmex@sartorius.com
Switzerland
Fax +91.80.4350.5253
8317 Tagelswangen Phone +52.55.5562.1102
562 123 Bangalore,
India
Modecenterstrasse 22Phone +43.1.7965763.18
O: ½“ single
stepped hose barb
2: 1.2
m2 | 12.9
ft2 Switzerland
(20“)
--:
O: ½“ single stepped hose barb
Sartorius
Stedim
AG autoclavable
Fax +52.55.5562.2942
Fax
+43.1.796576344
1030 Vienna
Phone +41.52.354.36.36
Ringstrasse
24fta2 (30“)
F: ¾“ Tri-Clamp 25 mm
3: 1.8
m2 | 19.4
F: ¾“ Tri-Clamp
25 mm Phone +91.80.4350.5250
Peru
leadsmex@sartorius.com
Japan
8317 Tagelswangen Fax +41.52.354.36.46
Phone +43.1.7965763.18
Sartorius Peru S.A.C. Fax +91.80.4350.5253
Sartorius Stedim Japan K.K.
Fax +43.1.796576344 Belgium
Avenue
Alberto
del
Campo
411
Phone
+41.52.354.36.36
(Optional
vent valve
design
for
connection
of
integrity
tester.
Example:
5447307H1--SSIT)
4th Fl., Daiwa Shinagawa North Bldg.
Sartorius Stedim Belgium
N.V.with
Peru
U.K.
Floor 12 – The Office Japan
8-11, Kita-Shinagawa 1-chome
Rue Colonel Bourg 105Fax +41.52.354.36.46
Sartorius Peru S.A.C. 15076 – San Isidro, Lima
Sartorius Stedim UK Ltd.
Sartorius
Stedim
Japan
K.K.
Belgium
Shinagawa-ku,
Tokyo, 140-0001 Japan
1030 Bruxelles
®
® Centre
Avenue Alberto del Campo 411
Longmead
Business
4th Fl., Daiwa Shinagawa North Bldg.
Sartorius Stedim Belgium N.V.
MidiCaps
|
Gamma
MidiCaps
Phone
+51.1.441
0158
U.K.
Floor 12 – The Office
Phone
+81.3.4331.4300
Blenheim
Road,
Epsom
Phone
+32.2.756.06.80
8-11, Kita-Shinagawa 1-chome
Rue Colonel Bourg 105
Fax
+51.1.422
6100
15076 – San Isidro, Lima
+81.3.4331.4301
Surrey KT19 9 QQ
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USER GUIDE

POROS™ HIC Resins: Ethyl, Benzyl, and Benzyl Ultra
Pub. No. 100063752 Rev. A
WARNING! Read the Safety Data Sheets (SDSs) and follow the
handling instructions. Wear appropriate protective eyewear,
clothing, and gloves. Safety Data Sheets (SDSs) are available
from thermofisher.com/support.
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Specifications
Table 1 Ligands, hydrophobicity, and applications
Resin

Ligand

Relative
hydrophobicity

Application

Ethyl

Novel ethyl

Low

Benzyl

Low-density
benzyl/
aromatic

Moderate

Benzyl
Ultra

High-density
benzyl/
aromatic

High

Bind/elute mode to bind
moderately to strongly
hydrophobic molecules.
Bind/elute or flow‑through
mode depending on the
hydrophobicity of the
molecule.
Flow-through mode in lower
salt concentration to bind
impurities such as
aggregates.

[1]
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Hydrophobicity results are based on lysozyme gradient elution. Column size:
0.66 cmD × 20 cmL; 1.7-M ammonium sulfate, 50-mM sodium phosphate pH 7.0;
Gradient elution: 1.7-M ammonium sulfate/50 mM sodium phosphate pH 7.0 to
50‑mM sodium phosphate pH 7.0 over 10 column volumes; Flow rate: 100 cm/hr.

Product information

Table 2 Characteristics and stability

Product description

Characteristic
Support matrix
Shipping solution
Average particle size
Mechanical
resistance
pH range
Ionic strength range
Buffer additives

™

POROS Hydrophobic Interaction Chromatography (HIC) resins are
rigid, 50-µL polymeric resins with a range of hydrophobic
functionalities for the purification of antibody fragments, antibody
drug conjugates (ADCs), recombinant proteins, viruses, and other
biomolecules. The resin backbone consists of crosslinked poly(styrenedivinylbenzene) with a unique pore structure that provides rapid
mass transport and enables enhanced productivity. The particle
surface is coated with a novel polymer coating, which is then further
derivatized with a range of hydrophobic ligands for flexible
purification process design.
™

POROS HIC resins are suitable for bind/elute and flow‑through
applications at lower salt concentrations. These resins have superior
resolution capability, high capacity, and differentiating selectivity for a
range of biomolecules, and this performance is independent of flow
rate.

Salts

Storage
Store resins at 2– 30°C. Do not freeze.
Solvents

Shrinkage/swelling
Operating
temperature
™

Description
Crosslinked poly(styrene-divinylbenzene)
18% ethanol
50 µm
100 bar (1450 psi, 10 MPa)
1–14
0 to 5 M, all common salts
All common agents, including 1 M sodium
hydroxide, 8 M urea, 6 M guanidine hydrochloride,
ethylene glycol, and detergents
Ammonium sulfate, sodium sulfate, sodium
chloride, sodium acetate, sodium citrate and other
common salts
IMPORTANT! POROS™ Benzyl and POROS™ Benzyl
Ultra are designed for use with lower salt
concentration than traditional HIC resins. With
some molecules, high salt concentration can cause
poor recovery due to a strong interaction between
the target and the ligand.
Water, 0–100% alcohol, acetonitrile, 1 to 2 M acids
(for example, acetic, hydrochloric, phosphoric),
other common organic solvents
Do not expose to strong oxidizers (such as
hypochlorite), oxidizing acids (such as nitric), strong
reducing agents (such as sulfite), acetone, or benzyl
alcohol.
<1% from 1–100% solvent
2– 30°C
Do not freeze

POROS HIC resins can be operated at high linear flow rates with a
pressure drop that allows use with conventional low-pressure
™
chromatography columns and systems. POROS HIC resins have
linear and predictable pressure flow responses as column diameter
increases (Figure 1 and Figure 2).

Product usage: See "Ordering information" on page 5.

Prepare slurry: lab-scale columns (£ 100 mL)
Buffer‑exchange using a 0.2–0.45 µm bottle‑top filter or sintered-glass
filter:
1. Transfer the required volume of resin slurry to the top of a
bottle‑top filter.
2. Apply vacuum to remove the shipping solution.
3. Resuspend the resin cake to the starting resin slurry volume with
water. Mix with a plastic or rubber spatula. Do not grind the resin
bed or tear the filter membrane.
4. Repeat the vacuum and resuspension steps for a total of three
exchanges.
5. Resuspend the exchanged resin to the original slurry
concentration, then proceed with column packing.
6. Verify that the slurry concentration is 50–70% (see “Determine the
slurry concentration“ on page 2).
7. If needed, adjust the slurry concentration to 50–70%.
Fig. 1 Pressure-flow properties of POROS™ Ethyl resin—20-cm bed
height

Prepare slurry: lab-scale and larger scale columns
(> 100 mL)
Buffer‑exchange using repeated gravity settling:
1. Allow the resin to settle in the shipping container. Settling
requires > 8 hours because the density of the resin is
approximately that of water.
2. Carefully decant the supernatant. Do not disturb the bed.

3.
4.
5.
6.
7.
8.

Some particles/turbidity may be present in the decant as beads
slough off the settled bed or come loose from the carboy side
walls. This is not problematic.
Replace the supernatant with the same volume of the desired
packing solution.
Replace the supernatant with the same volume of water.
Resuspend the resin by gentle agitation, then allow the resin to
settle by gravity.
Repeat steps 1 to 4 two to three times to thoroughly exchange into
water.
Verify that the slurry concentration is 50–70% (see “Determine the
slurry concentration“ on page 2).
If needed, adjust the slurry concentration to 50–70%.

Determine the slurry concentration
Fig. 2 Pressure-flow properties of POROS™ Benzyl Ultra resin—20-cm
bed height

Pack and qualify the column
Packing guidelines
• Resins are supplied in 18% ethanol. For column packing, exchange
the shipping solution with water to remove the ethanol.
• Resins are mechanically rigid and incompressible and can be
packed effectively in low-pressure glass columns and in
high-pressure stainless steel columns. The lack of wall support
with increasing column diameter has minimal impact on
chromatography performance because the beads support
themselves, allowing for flexible column packing approaches and
consistent and robust results. Columns can be packed with
traditional flow pack, axial compression, or pack-in-place/stall
pack packing methods.
• Standard 10–23 µm screens (frits) can be used.

2

1. Separate the slurry using either of the following methods.
• Gravity settling—Add 100 mL of slurry in water to a 100-mL
graduated cylinder, then allow to settle for >72 hours.
Note: The time that POROS™ HIC resins take to gravity settle
can be inconsistent due to hydrophobicity. We recommend
using the centrifugation method for faster, more consistent
results.
• Centrifugation—Add 10 mL of slurry in water to three (3)
15-mL conical tubes. Centrifuge at 3,000 rpm for 10 minutes at
20°C with the brake off. Remove the tubes from the centrifuge
and allow the tubes to sit for 5 minutes before determining the
concentration.
2. Calculate the concentration: Volume of resin/total volume in the
graduated cylinder or conical tube.
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Pack the column

Qualify the column

When you adjust the flow rate to form the bed, you may observe some
turbidity in the eluent as packing starts. Turbidity will clear as packing
proceeds and 1–2 bed volumes of packing buffer pass through the
column.
1. Determine the required slurry volume:

To qualify the integrity of a packed column, determine HETP (height
equivalent to a theoretical plate) and asymmetry using a non-binding
analyte (a “plug”).

Example for a POROS™ Ethyl 40 cmD × 20 cmL 25-L column using
slurry with a 50% slurry ratio:
25 L / 0.56 × 1.06 = 47.3 L slurry required
The 1.06 packing factor above accounts for the difference in bed
volume between a centrifuged bed in water and a 3-bar pressurepacked bed. Use a 1.12 packing factor for POROS™ Benzyl and
POROS™ Benzyl Ultra.
2. Ensure that the column outlet is closed and plumbed directly to
waste. Do not connect the column outlet to the chromatography
system. Plumbing into the system creates backpressure that fights
against the inlet pressure trying to settle the bed and pack the
column.
3. Ensure that the column is level and locked in place before starting
the pack.
4. Deliver the required slurry volume to the column by hand or with
a diaphragm pump, as dictated by your equipment and the
intended packing procedure. Use a squirt bottle containing
packing solution to remove any residual resin from the column
wall.
™

5.

6.
7.
8.

POROS resin beads have a skeletal density similar to the density
of water and do not settle rapidly. Do not allow the resin to
gravity‑settle in the column before packing.
With the column inlet line connected to the system and the
bottom outlet closed, bring the primed top flow adapter to 1–2 cm
from the slurry level, then tighten the O-ring. Do not push up the
resin and over the O-ring. Change the top valve to force the air
and liquid out the top of the adapter and to waste using the
bypass line. Continue to lower the adapter slowly to remove the
bubbles from the top of the column. Do not allow large air
bubbles between the top adaptor and the top of the resin slurry.
Change the valve back to flow through the system on the top,
then open the column bottom.
Increase the flow rate to the maximum or desired flow rate and
pressure obtainable with the equipment used.
After the bed is formed, bring the adapter into contact with the
top of the bed without pushing the resin over the O-ring by
closing the column outlet and displacing liquid through the top of
the adapter to waste through the bypass line.

Recommended column qualification conditions
Condition
Flow rate
Equilibration buffer
Plug solution
Plug volume

Recommendation
50 cm/hour
Water
0.5 M sodium chloride
1% of column volume

Guidelines for qualification
• Ensure uniform column plumbing:
– Avoid using reducers to connect different tubing sizes.
– Minimize and keep consistent the column tubing lengths
between the plug solution to the column inlet and the column
outlet to the detector(s).
• Equilibrate with at least 4 CVs of equilibration buffer before
injection.

Setting specifications
Qualification results depend on several factors, including the:
• Solutions and method used
• Scale
• Column hardware
• Chromatography system
After you define a column qualification procedure for a specific
system (column plus chromatography system), base the qualification
acceptance criteria on historical values and ranges instead of
theoretical qualification results. Performing the column qualification
method consistently and reproducibly is critical to obtaining
meaningful results.

POROS™ resin does not shrink or swell, so an open headspace is
not recommended.
9. Flow at the packing flow rate again for 1–2 CVs, taking note of
the bed height at the desired pressure. Adjust the adapter again
to the noted bed height by displacing the liquid through the top
of the adapter and to waste.
10. After the column is packed, flow 2–3 CVs of packing solution
through the packed bed at the operating flow rate to stabilize the
bed.
The flow rate used should generate no more than 80% of the final
packing pressure.
11. If you will reverse the flow of the column during operation,
condition the column in upflow:
• Flow 2–3 CVs in upflow at the operating flow rate.
• Flow 2–3 CVs in downflow at the operating flow rate, then
adjust the adapter if needed.
• Flow 2 CVs after you adjust the adapter.

POROS™ HIC Resins: Ethyl, Benzyl, and Benzyl Ultra User Guide
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Chromatography condition optimization
General guidelines
Standardized conditions or platform-type evaluations are not
recommended. Different HIC resins that are operated with the same
process conditions can yield variable results.
When optimizing conditions:
• Test different loading and elution conditions to evaluate static
binding capacity and yield based on the target molecule
characteristics and process challenges.
• Limit static binding load incubation time to 15 minutes.
• Optimize the chromatography step for peak separation: Use
conditions that remove some of the bound impurities during the
flow‑through/wash phase and that retain other bound impurities
until elution during the strip and cleaning-in-place (CIP) steps.
• Use buffer salts and reagents of the highest purity.
• Filter (0.22 or 0.45 µm) all buffers, solutions, and load before use.

Resin selection guidelines
• If the hydrophobicity of the target molecule is unknown:
– Run a small-scale bind/elute gradient separation on POROS™
Benzyl resin to determine the elution conductivity of the target
molecule, contaminants, and impurities.
– Optimize conditions on POROS™ Benzyl Ultra resin (higher
hydrophobicity) or POROS™ Ethyl resin (lower
hydrophobicity).
– If needed, continue to optimize conditions on POROS™ Benzyl
resin (mid-range hydrophobicity).
• If the target molecule is hydrophobic, optimize conditions on
POROS™ Ethyl resin or on POROS™ Benzyl with lower salt
concentration.
• For flow‑through applications where the target molecule is less
hydrophobic, optimize conditions on POROS™ Benzyl or POROS™
Benzyl Ultra with lower salt concentration.
After you select the resin, continue to optimize other process
conditions.

Binding capacity and loading condition screening guidelines
Perform high-throughput static binding capacity testing in spin
columns or in a 96-well plate to screen POROS™ HIC resin. Optimize
loading conditions as needed.
Note: A 96-well high-throughput protocol is available on request. This
protocol can be used to evaluate static binding capacity and to screen
several resins and loading conditions per resin in a single 96-well
plate.

Bind/elute chromatography optimization guidelines
Binding conditions guidelines
™

• Salt and salt concentration — POROS HIC resins are designed to
use less lyotropic salts and to bind at lower concentrations than
traditional HIC resins with similar functional groups (Table 3).
Table 3 Typical salts used in hydrophobic interaction
chromatography in order of decreasing lyotropic ("salting out")
effect and increasing chaotropic ("salting in") effect
Effect
Most lyotropic

Most chaotropic

4

Anionic salts
C6H5O7 3–
PO4 3–
SO4 2–
CH3COO–
ClBr–
NO3 –
CIO4 –
I–

Cationic salts
NH4 +
Rb+
K+
Na+
Cs+
Li+
Mg2+
Ca2+
Ba2+

Note the following:
– You can perform initial binding experiments with lower salt
concentrations than are typically used for HIC chromatography.
For example, you can start with 25%, 50% and 75% of the
salting out concentration, instead of the typical 10–15% lower
than the salting out concentration.
– The optimized ionic salt concentration for the salts listed above
can differ from ammonium sulfate, which has been traditionally
used for HIC chromatography.
– Different salts can provide different selectivity.
Optimize the salt concentration for the target molecule by using a
"salting out" experiment: increase the ionic strength of the loading
buffer until the sample precipitates. Alternatively, you can
measure increasing optical density of the loading buffer to detect
aggregation (~350 nm, but this value may differ with each salt).
Salts that are commonly used to perform salting out experiments
are ammonium sulfate, sodium chloride, sodium citrate, sodium
sulfate, and sodium acetate.
• Buffer system—Buffer systems are not as critical for HIC processes
as they are for ion-exchange chromatography steps. Citrate,
acetate, Bis-Tris propane, HEPES, MES, sodium phosphate,
succinate, and Tris are commonly used.
The buffer system is typically dictated by the upstream
purification step. When selecting the upstream buffer system,
consider molecule stability in the buffer, binding optimization, and
buffering capacity.
• pH—pH is not typically critical for HIC processes, but it can affect
the binding strength and selectivity. Because pH effects are
unpredictable on HIC, test a few pH values over the stability range
of the target molecule.
• Flow rate—The target operating flow rate is flexible. Start
optimization at 4-minute residence time (300 cm/hr in a 20-cmL
column).
• Temperature—Temperature can significantly impact HIC
performance. Perform all optimization at the final intended
process temperature.

Elution conditions guidelines
Start elution optimization with a gradient elution. Most often, after
elution performance is determined, you can implement a step elution.
• Salt gradient—To determine where the target molecule and
contaminants/ impurities elute, start with a 20-CV gradient from
high salt to buffer only. To do so, assay fractions across the peaks
(~1/10 CV). Based on this information, the process can be further
optimized.
• Dynamic binding capacity (DBC)—Assess separation as a
function of DBC. The maximum DBC depends on several factors,
including sample solubility, column selectivity, buffer pH, and
loading buffer conductivity.
• Bed height—Initial screening can be run with shorter bed heights
and a constant residence time. Use the final desired bed height for
scale up development (typically 15 cm to 30 cm).

Flow-through chromatography optimization guidelines
An optional flow‑through step can be used remove trace product and
process-related impurities such as aggregates from the target
molecule. You can add the flow‑through step as the second or third
chromatography step for polishing in a downstream process. Different
target molecules have different degrees of hydrophobicity and other
biophysical characteristics. Therefore, it is essential to optimize the
process conditions to achieve the desired aggregate clearance and
recovery of the target molecule.
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Resin cleaning and storage

Loading conditions guidelines
• Initial study —Perform an initial study using a decreasing salt
gradient in bind/elute mode:
– Load approximately 1 mg of protein per 1 ml of resin at 0.5–
1.0 M sodium chloride (or other preferred salt), then elute using
a gradient over 10 column volumes (CVs) in a buffered solution
to determine aggregates, impurities, and target molecule
elution profiles.
– Use the elution conductivity at peak maximum to determine the
highest approximate salt concentration that is required to
remove impurities, but that allows the target molecule to flow
through (Figure 3).

Resin cleaning guidelines
™

• POROS resins can tolerate harsh cleaning conditions that allow
acceptable column life.
• Clean the resin with 3 to 5 CVs of water followed by 3 to 5 CVs of
1 M NaOH.
• For more stringent cleaning, use 20% ethanol/1 M acetic acid.
• Other solutions may be required for column cleaning if the resin is
used for capture chromatography.
• Degas more viscous solutions such as 1 M acetic acid or
20% ethanol before use on the column to avoid gassing out during
operation.
Note: Low-level gassing out does not impact column performance.

Store the resin
Store the resin in 20% ethanol or 0.1 M NaOH at 2–30°C.
Start flow-through
optimization at
~7 mS/cm

Ordering information
Table 4 POROS™ HIC bulk resins
Resin
Ethyl

Fig. 3 Example screening chromatogram to obtain the ideal low
salt condition for flow-through conditions. Process screening
for a monoclonal antibody using POROS™ Benzyl Ultra resin in
flow-through mode. Gradient: High conductivity to low
conductivity using sodium citrate. Based on this chromatogram,
the resin was further optimized in flow-through mode at low
salt conditions starting at 7 mS/cm.
• Buffer system—Buffer systems are not as critical for HIC processes
as they are for ion-exchange chromatography steps. Citrate,
acetate, Bis-Tris propane, HEPES, MES, sodium phosphate,
succinate, and Tris are commonly used.

•

•

•

•

•

The buffer system is typically dictated by the upstream
purification step. When selecting the upstream buffer system,
consider molecule stability in the buffer, binding optimization, and
buffering capacity.
pH—pH is not typically critical for HIC processes, but it can affect
the binding strength and selectivity. Because pH effects are
unpredictable on HIC, test a few pH values over the stability range
of the target molecule.
Flow rate—The target operating flow rate is flexible. Good
impurity binding has been demonstrated at flow rates up to
600 cm/hour on a 20 cmL column (1.6-minute residence time).
Temperature—Temperature can significantly impact HIC
performance. Perform all optimization at the final intended
process temperature.
Dynamic binding capacity (DBC)—A conservative starting point
for DBC determination is 100–250 mg of the target molecule per
mL of resin. Determine the DBC for each impurity by using
breakthrough analysis under the desired load pH and conductivity
conditions.
Bed height—A bed height of 15 cm to 30 cm can be used for this
step.
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Benzyl

Benzyl
Ultra

Cat. No.
A32552
A32553
A32554
A32555
A32556
A32557
A32558
A32559
A32560
A32561
A32562
A32563
A32564
A32565
A32566
A32567
A32568
A32569

Amount
10,000 mL
5,000 mL
1,000 mL
250 mL
50 mL
25 mL
10,000 mL
5,000 mL
1,000 mL
250 mL
50 mL
25 mL
10,000 mL
5,000 mL
1,000 mL
250 mL
50 mL
25 mL

Product usage
Pharmaceutical Grade Reagent. For
Manufacturing and Laboratory Use
Only.
For Research Use Only. Not for use
in diagnostic procedures.
Pharmaceutical Grade Reagent. For
Manufacturing and Laboratory Use
Only.
For Research Use Only. Not for use
in diagnostic procedures.
Pharmaceutical Grade Reagent. For
Manufacturing and Laboratory Use
Only.
For Research Use Only. Not for use
in diagnostic procedures.

Support
For service and technical support, go to thermofisher.com/poros or
call toll-free in US: 1.800.831.6844.
For the latest service and support information at all locations, or to
obtain Certificates of Analysis or Safety Data Sheets (SDSs; also known
as MSDSs), go to thermofisher.com/support, or contact you local
Thermo Fisher Scientific representative.

Limited product warranty
Life Technologies Corporation and/or its affiliate(s) warrant their
products as set forth in the Life Technologies' General Terms and
Conditions of Sale found on Life Technologies' website at
www.thermofisher.com/us/en/home/global/terms-andconditions.html. If you have any questions, please contact Life
Technologies at www.thermofisher.com/support.

5

This page is intentionally blank.

6

POROS™ HIC Resins: Ethyl, Benzyl, and Benzyl Ultra User Guide

This page is intentionally blank.

POROS™ HIC Resins: Ethyl, Benzyl, and Benzyl Ultra User Guide

7

This page is intentionally blank.

Manufacturer: Life Technologies Corporation | 35 Wiggins Avenue | Bedford, MA 01730

The information in this guide is subject to change without notice.
DISCLAIMER: TO THE EXTENT ALLOWED BY LAW, LIFE TECHNOLOGIES AND/OR ITS AFFILIATE(S) WILL NOT BE LIABLE FOR SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE,
MULTIPLE, OR CONSEQUENTIAL DAMAGES IN CONNECTION WITH OR ARISING FROM THIS DOCUMENT, INCLUDING YOUR USE OF IT.
Revision history: Pub. No. 100063752
Revision
A

Date
10 July 2017

Description
New document.

Important Licensing Information: These products may be covered by one or more Limited Use Label Licenses. By use of these products, you accept the terms and conditions of all
applicable Limited Use Label Licenses.
©2017 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.

thermofisher.com/support | thermofisher.com/askaquestion
thermofisher.com
10 July 2017

Virosart® CPV MaxiCaps® and Cartridges
The virus filter for the robust and
efficient removal of all viruses
Product Information
Virosart® CPV is a well established virus retentive filter
within the monoclonal antibody market. The unique
assymmetric PES membrane structure provides highest
virus retention under all circumstances independent
from operation pressure or pressure pauses.

Description
Virus filtration with Virosart® is an integral part of the orthogonal
virus clearance technology platform of Sartorius Stedim Biotech.
This orthogonal technology platform features virus filtration, virus
inactivation and virus adsorption. The Virosart® product ranges
includes three different virus retentive membranes, in order to
provide the best solution for every application.
Virosart® CPV targets the removal of both small non-enveloped
viruses (20 nm) e.g. PPV, MVM and larger enveloped viruses
(> 50 nm) e.g. MuLV from a biopharmaceutical feed stream.
Application & Positioning of Virosart® CPV
The main applications for Virosart® CPV for virus filtration are
monoclonal antibodies (Mab), antibody fragments (Fab) or small
recombinant proteins (<150kD). Virosart® CPV is used at the end
of the purification process for virus filtration of the biopharmaceutical product. At this stage the purity of the biopharmaceutical
product is the highest and virus filter blockage due to contaminants
(DNA, CHOP, aggregates & lipoproteins) is the lowest.
Even if these contaminants should be removed during the polishing
process of the target molecule, small amounts might be sufficient
to cause premature blockage of the final virus filter. To prevent this,
an efficient pre-filtration step, such as the Virosart® Max, might be

required as protection for the Virosart® CPV membrane. The optimum
pre - filter - final filter ratio has to be identified during development
of the process step.
Product Benefits
Virosart® CPV provides highest virus safety to the biopharmaceutical
product. Based on the unique double layer 20 nm PES membrane,
Virosart® CPV provides excellent flow rates and superior capacity.
This filter retains more than 4 log10 of small non-enveloped viruses
(e.g. PPV, MVM) and more than 6 log10 of large enveloped viruses
(e.g. MuLV). This filter offers highest virus safety over the entire flow
decay profile independent of operating pressure or pressure pauses.
Scalability
Scale down work is realised using the Virosart® CPV Minisart (5 cm2
capsule) to enable filtration work for flow and capacity studies as
well as for optimizing the final pre - filter - final filter ration. These
elements, available as IT tested devices are also used for reliable
scale-down work within GLP virus spiking studies. Scale up studies
as well as small scale production are performed using Virosart® CPV
capsule and|or MidiCaps® (180 cm2 | 2.000 cm2) to reliably scale up
into larger scale manufacturing. Large scale manufacturing is operated with Virosart® CPV MaxiCaps® or cartridges. Typical batch sizes
of products subject to virus filtration with Virosart® CPV MaxiCaps®
and cartridges are > 50 liter.

Virus Clearance

Integrity Testing
Virosart® CPV filters are tested for integrity using a water based
integrity test, e.g. based on the Sartocheck® technology of Sartorius
Stedim Biotech. Virosart® CPV filters have been validated for 4 log10
removal of small non-enveloped viruses using bacteriophage PP7
as the model virus. Validation data is shown in the validation guide
of Virosart® CPV.

Quality Control
Each individual Virosart® CPV filter is autoclaved and integrity
tested during manufacture assuring highest product reliability.
Documentation
Virosart® CPV filters are designed, developed and manufactured
in accordance with a ISO 9001 certified Quality Management
System. A Validation Guide is available for compliance with
regulatory requirements.

Technical Data
Specifications
Materials
Membrane
Support Fleece
Core
End Caps
Capsule Housing

Extractables
Virosart® CPV filters meet, or exceed the requirements for
WFI quality standards set by the USP 26
Double layer polyethersulfone
Polypropylene
Polypropylene
Polypropylene
Polypropylene

Available Sizes | Filtration Area
MaxiCaps®
Size 1
Size 2
Size 3

0.7 m2 | 7 ft2
1.4 m2 | 14 ft2
2.1 m2 | 21 ft2

Standard Filter Cartridges
Size 1
Size 2
Size 3

0.7 m2 | 7 ft2
1.4 m2 | 14 ft2
2.1 m2 | 21 ft2

Available Connectors
Sanitary for MaxiCaps® & code 7 for cartridges

In the reversed direction
of filtration

Passes USP Plastics Class VI Test
Non-fiber releasing according to 21 CFR
Sterilization
Steaming (Virosart® CPV cartridges only!):
121°C @ 1 bar | 14.5 psi for 30 min
up to 2 cycles

Pore Size
CPV (20 nm nominal)

Operating Parameters
In the direction of filtration

Non-pyrogenic according to USP Bacterial Endotoxins

At 20°C max. 5.0 bar | 72.5 psi
At 121°C max. 0.2 bar | 2.9 psi
At 20°C max. 0.2 bar | 2.9 psi

Autoclaving:
121°C @ 1 bar | 14.5 psi for 30 min
up to 2 cycles
No In-Line Steam Sterilization of MaxiCaps®!
Technical References
Validation Guide:

SPK5754-e | 85030-522-02

Extractable Guide:

SPK5773-e | 85034-536-47

Virus Information Guide:

SPK5752-e | 85030-521-91

Characteristic Water Flow Rates for Virosart® CPV
10“ Standard Filter Cartridges & 10” MaxiCaps®
Pressure [psi]
14.6

0

Characteristic Water Flow Rates for Virosart® CPV
20” Standard Filter Cartridges & 20” MaxiCaps®
Pressure [psi]

29.2

0

14.6

29.2

3000

Flow [mL/min]

Flow [mL/min]

1500

1000
800 - 1,400 mL/min
500

0

2000
1,600 - 2,800 mL/min
1000

0
0

1
Pressure [bar]

2

0

1
Pressure [bar]
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Characteristic Water Flow Rates for Virosart® CPV
30” Standard Filter Cartridges & 30” MaxiCaps®
Pressure [psi]

0

14.6

29.2

Flow [mL/min]

4500

3000
2,400 - 4,200 mL/min
1500

0
0

1
Pressure [bar]

2

Ordering Information
®

®

Ordering Information Virosart CPV Standard Filter Cartridges

Ordering Information Virosart CPV MaxiCaps

545 25

545 73

28

V1

Explanation
®

28

V1

--

SS

®

Explanation
®

Virosart CPV, double layer

Virosart CPV, double layer

Adapter
25: S-adapter top,
locking bayonet adapter
with double O-ring bottom

Capsule Design
13: Old MaxiCaps® design
73: New MaxiCaps® desgin

Pore Size
28: PPV retentive,
20 nm filter membrane
Height Filtration Area
V1: 10“ 0.7 m2 |7 ft2
V2: 20“ 1.4 m2 |14 ft2
V3: 30“ 2.1 m2 |21 ft2

Pore Size
28: PPV retentive,
20 nm filter membrane
Height Filtration Area
V1: 10“ 0.7 m2 | 7 ft2
V2: 20“ 1.4 m2 | 14 ft2
V3: 30“ 2.1 m2 | 21 ft2
Adapter
SS Sanitary inlet – and outlet
adapter

Virus Clearance
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Sales and Service Contacts
For further contacts, visit www.sartorius-stedim.com

Americas

Germany
Sartorius Stedim Biotech GmbH
August-Spindler-Strasse 11
37079 Goettingen
Phone +49.551.308.0
Fax +49.551.308.3289
Sartorius Stedim Systems GmbH
Robert-Bosch-Strasse 5 – 7
34302 Guxhagen
Phone +49.5665.407.0
Fax +49.5665.407.2200
France
Sartorius Stedim FMT S.A.S.
ZI des Paluds
Avenue de Jouques – CS 91051
13781 Aubagne Cedex
Phone +33.442.845600
Fax +33.442.845619
Sartorius Stedim France SAS
ZI des Paluds
Avenue de Jouques – CS 71058
13781 Aubagne Cedex
Phone +33.442.845600
Fax +33.442.846545
Austria
Sartorius Stedim Austria GmbH
Modecenterstrasse 22
1030 Vienna
Phone +43.1.7965763.18
Fax +43.1.796576344
Belgium
Sartorius Stedim Belgium N.V.
Rue Colonel Bourg 105
1030 Bruxelles
Phone +32.2.756.06.80
Fax +32.2.756.06.81
Hungary
Sartorius Stedim Hungária Kft.
Kagyló u. 5
2092 Budakeszi
Phone +36.23.457.227
Fax +36.23.457.147
Italy
Sartorius Stedim Italy S.p.A.
Via dell’Antella, 76/A
50012 Antella-Bagno a Ripoli (FI)

Netherlands
Sartorius Stedim Netherlands B.V.
Phone +31.30.60.25.080
Fax +31.30.60.25.099
filtratie.nederland@sartorius-stedim.com
Poland
Sartorius Stedim Poland Sp. z o.o.
ul. Wrzesinska 70
62-025 Kostrzyn
Phone +48.61.647.38.40
Fax +48.61.879.25.04
Russian Federation
LLC “Sartorius Stedim RUS”
Uralskaya str. 4, Lit. B
199155 St. Petersburg
Phone +7.812.327.53.27
Fax +7.812.327.53.23
Spain
Sartorius Stedim Spain, S.A.U.
Avda. de la Industria, 32
Edificio PAYMA
28108 Alcobendas (Madrid)
Phone +34.902.110.935
Fax +34.91.358.96.23
Switzerland
Sartorius Stedim Switzerland AG
Ringstrasse 24 a
8317 Tagelswangen
Phone +41.52.354.36.36
Fax +41.52.354.36.46
U.K.
Sartorius Stedim UK Ltd.
Longmead Business Centre
Blenheim Road, Epsom
Surrey KT19 9 QQ

USA
Sartorius Stedim North America Inc.
5 Orville Drive, Suite 200
Bohemia, NY 11716
Toll-Free +1.800.368.7178
Fax +1.631.254.4253
Argentina
Sartorius Argentina S.A.
Int. A. Ávalos 4251
B1605ECS Munro
Buenos Aires
Phone +54.11.4721.0505
Fax +54.11.4762.2333
Brazil
Sartorius do Brasil Ltda
Avenida Senador Vergueiro 2962
São Bernardo do Campo
CEP 09600-000 - SP- Brasil
Phone +55.11.4362.8900
Fax +55.11.4362.8901
Mexico
Sartorius de México S.A. de C.V.
Circuito Circunvalación Poniente
No. 149
Ciudad Satélite
53100, Estado de México
México
Phone +52.5555.62.1102
Fax +52.5555.62.2942

Asia | Pacific
Australia
Sartorius Stedim Australia Pty. Ltd.
Unit 5, 7-11 Rodeo Drive
Dandenong South Vic 3175

Phone +44.1372.737159
Fax +44.1372.726171

Phone +61.3.8762.1800
Fax +61.3.8762.1828

Ukraine
LLC “Biohit”
Post Box 440 “B”
01001 Kiev, Ukraine

China
Sartorius Stedim Biotech (Beijing) Co. Ltd.
No. 33 Yu’an Road
Airport Industrial Park Zone B
Shunyi District, Beijing 101300

Phone +380.44.411.4918
Fax +380.50.623.3162

Phone +39.055.63.40.41
Fax +39.055.63.40.526

Phone +86.10.80426516
Fax +86.10.80426580
Sartorius Stedim (Shanghai)
Trading Co., Ltd.
3rd Floor, North Wing, Tower 1
No. 4560 Jinke Road
Zhangjiang Hi-Tech Park
Pudong District
Shanghai 201210, P.R. China
Phone +86.21.6878.2300
Fax +86.21.6878.2882
Sartorius Stedim Biotech (Beijing) Co. Ltd.
Guangzhou Representative Office
Unit K, Building 23
Huihua Commerce & Trade Building
No. 80 Xianlie Middle Road
Guangzhou 510070
Phone +86.20.37618687 | 37618651
Fax +86.20.37619051

www.sartorius-stedim.com

India
Sartorius Stedim India Pvt. Ltd.
#69/2-69/3, NH 48, Jakkasandra
Nelamangala Tq
562 123 Bangalore, India
Phone +91.80.4350.5250
Fax +91.80.4350.5253
Japan
Sartorius Stedim Japan K.K.
4th Fl., Daiwa Shinagawa North Bldg.
8-11, Kita-Shinagawa 1-chome
Shinagawa-ku, Tokyo, 140-0001 Japan
Phone +81.3.4331.4300
Fax +81.3.4331.4301
Malaysia
Sartorius Stedim Malaysia Sdn. Bhd.
Lot L3-E-3B, Enterprise 4
Technology Park Malaysia
Bukit Jalil
57000 Kuala Lumpur, Malaysia
Phone +60.3.8996.0622
Fax +60.3.8996.0755
Singapore
Sartorius Stedim Singapore Pte. Ltd.
1 Science Park Road,
The Capricorn, #05-08A,
Singapore Science Park II
Singapore 117528
Phone +65.6872.3966
Fax +65.6778.2494
South Korea
Sartorius Korea Biotech Co., Ltd.
8th Floor, Solid Space B/D,
PanGyoYeok-Ro 220, BunDang-Gu
SeongNam-Si, GyeongGi-Do, 463-400
Phone +82.31.622.5700
Fax +82.31.622.5799

Specifications subject to change without notice. Copyright Sartorius Stedim Biotech GmbH. Printed in the EU on paper bleached without chlorine.
Publication No.: SPK2065-e151110 · Order No.: 85030-522-03 · Ver. 11 | 2015
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Material Safety Data Sheet
Sodium hydroxide, Pellets, Reagent ACS MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium hydroxide, Pellets, Reagent ACS

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLS4090
CAS#: 1310-73-2

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: WB4900000
TSCA: TSCA 8(b) inventory: Sodium hydroxide

Order Online: ScienceLab.com

CI#: Not available.
Synonym: Caustic Soda

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Sodium Hydroxide

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: NaOH

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium hydroxide

1310-73-2

100

Toxicological Data on Ingredients: Sodium hydroxide LD50: Not available. LC50: Not available.

Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of ingestion,
of inhalation. The amount of tissue damage depends on length of contact. Eye contact can result in corneal damage or
blindness. Skin contact can produce inflammation and blistering. Inhalation of dust will produce irritation to gastro-intestinal or
respiratory tract, characterized by burning, sneezing and coughing. Severe over-exposure can produce lung damage, choking,
unconsciousness or death. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is
characterized by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. The substance is toxic to lungs. Repeated or prolonged exposure to the
substance can produce target organs damage. Repeated exposure of the eyes to a low level of dust can produce eye irritation.
Repeated skin exposure can produce local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying
degree of respiratory irritation or lung damage.

p. 1

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. WARNING: It may
be hazardous to the person providing aid to give mouth-to-mouth resuscitation when the inhaled material is toxic, infectious or
corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar,
tie, belt or waistband.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: of metals
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available. Slightly explosive in presence of heat.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards:
sodium hydroxide + zinc metal dust causes ignition of the latter. Under proper conditions of temperature, pressure and state
of division, it can ignite or react violently with acetaldehyde, ally alcohol, allyl chloride, benzene-1,4-diol, chlorine trifluoride,
1,2 dichlorethylene, nitroethane, nitromethane, nitroparaffins, nitropropane, cinnamaldehyde, 2,2-dichloro-3,3-dimethylbutane.
Sodium hydroxide in contact with water may generate enough heat to ignite adjacent combustible materials. Phosphorous
boiled with NaOH yields mixed phosphines which may ignite spontanously in air. sodium hydroxide and cinnamaldehyde +
heat may cause ignition. Reaction with certain metals releases flammable and explosive hydrogen gas.
Special Remarks on Explosion Hazards:
Sodium hydroxide reacts to form explosive products with ammonia + silver nitrate. Benzene extract of allyl benzenesulfonate
prepared from allyl alcohol, and benzene sulfonyl chloride in presence of aquesous sodium hydroxide, under vacuum
distillation, residue darkened and exploded. Sodium Hydroxde + impure tetrahydrofuran, which can contain peroxides, can
p. 2

cause serious explosions. Dry mixtures of sodium hydroxide and sodium tetrahydroborate liberate hydrogen explosively at
230-270 deg. C. Sodium Hydroxide reacts with sodium salt of trichlorophenol + methyl alcohol + trichlorobenzene + heat to
cause an explosion.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the residue with
a dilute solution of acetic acid.
Large Spill:
Corrosive solid. Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of acetic acid. Be careful that the product is not present at a concentration level
above TLV. Check TLV on the MSDS and with local authorities.

Section 7: Handling and Storage
Precautions:
Keep container dry. Do not breathe dust. Never add water to this product. In case of insufficient ventilation, wear suitable
respiratory equipment. If you feel unwell, seek medical attention and show the label when possible. Avoid contact with skin
and eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals, acids, alkalis, moisture.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 23°C (73.4°F).

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor and dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to
avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure Limits:
CEIL: 2 from ACGIH (TLV) [United States] [1995] Consult local authorities for acceptable exposure limits.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Odorless.
Taste: Not available.
Molecular Weight: 40 g/mole
Color: White.
pH (1% soln/water): 13.5 [Basic.]
p. 3

Boiling Point: 1388°C (2530.4°F)
Melting Point: 323°C (613.4°F)
Critical Temperature: Not available.
Specific Gravity: 2.13 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances:
Highly reactive with metals. Reactive with oxidizing agents, reducing agents, acids, alkalis, moisture.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic. Much heat is evolved when solid material is dissolved in water. Therefore cold water and caution must be
used for this process. Sodium hydroxide solution and octanol + diborane during a work-up of a reaction mixture of oxime
and diborane in tetrahyrofuran is very exothermic, a mild explosion being noted on one occassion. Reactive with water,
acids, acid chlorides, strong bases, strong oxidizing agents, strong reducing agents, flammable liquids, organic halogens,
metals (i.e aluminum, tin, zinc), nitromethane, glacial acetic acid, acetic anhydride, acrolein, chlorohydrin, chlorosulfonic acid,
ethylene cyanohydrin, glyoxal, hydrochloric acid, sulfuric acid, hydrosulfuric acid, nitric acid, oleum, propiolactone, acylonitrile,
phorosous pentoxide, chloroethanol, chloroform-methanol, tetrahydroborate, cyanogen azide, 1,2,4,5 tetrachlorobenzene,
cinnamaldehyde. Reacts with formaldehyde hydroxide to yield formic acid, and hydrogen.
Special Remarks on Corrosivity: Very caustic to aluminum and other metals in presence of moisture.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: Causes damage to the following organs: lungs.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive). Very hazardous in case of skin contact (corrosive, irritant,
permeator), of eye contact (corrosive), of ingestion, .
Special Remarks on Toxicity to Animals:
p. 4

Lowest Published Lethal Dose: LDL [Rabbit] - Route: Oral; Dose: 500 mg/kg
Special Remarks on Chronic Effects on Humans: May affect genetic material (mutagenic). Investigation as a mutagen
(cytogenetic analysis), but no data available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May be harmful if absorbed through skin. Causes severe skin irritation and burns. May
cause deep penetrating ulcers of the skin. Eyes: Causes severe eye irritation and burns. May cause chemical conjunctivitis
and corneal damage. Inhalation: Harmful if inhaled. Causes severe irritation of the respiratory tract and mucous membranes
with coughing, burns, breathing difficulty, and possible coma. Irritation may lead the chemical pneumonitis and pulmonary
edema. Causes chemical burns to the respiratory tract and mucous membranes. Ingestion: May be fatal if swallowed. May
cause severe and permanent damage to the digestive tract. Causes severe gastrointestinal tract irritation and burns. May
cause perforation of the digestive tract. Causes severe pain, nausea, vomiting, diarrhea, and shock. May cause corrosion and
permanent destruction of the esophagus and digestive tract.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Sodium hydroxide, solid UNNA: 1823 PG: II
Special Provisions for Transport: Not available.

Section 15: Other Regulatory Information
Federal and State Regulations:
Illinois toxic substances disclosure to employee act: Sodium hydroxide Illinois chemical safety act: Sodium hydroxide New
York release reporting list: Sodium hydroxide Rhode Island RTK hazardous substances: Sodium hydroxide Pennsylvania
RTK: Sodium hydroxide Minnesota: Sodium hydroxide Massachusetts RTK: Sodium hydroxide New Jersey: Sodium hydroxide
Louisiana spill reporting: Sodium hydroxide California Director's List of Hazardous Substances: Sodium hydroxide TSCA 8(b)
inventory: Sodium hydroxide CERCLA: Hazardous substances.: Sodium hydroxide: 1000 lbs. (453.6 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): CLASS E: Corrosive solid.
p. 5

DSCL (EEC):
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 2
Personal Protection: j
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear
appropriate respirator when ventilation is inadequate. Splash goggles.

Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:32 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium Hydroxide, 50% MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium Hydroxide, 50%

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLS3127, SLS4549
CAS#: Mixture.
RTECS: Not applicable.
TSCA: TSCA 8(b) inventory: Sodium hydroxide; Water
CI#: Not applicable.

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com

Synonym: Sodium Hydroxide, 50% Solution

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Not applicable.

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: Not applicable.

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium hydroxide

1310-73-2

50

Water

7732-18-5

50

Toxicological Data on Ingredients: Sodium hydroxide LD50: Not available. LC50: Not available.

Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of ingestion, . Slightly
hazardous in case of inhalation (lung sensitizer). Liquid or spray mist may produce tissue damage particularly on mucous
membranes of eyes, mouth and respiratory tract. Skin contact may produce burns. Inhalation of the spray mist may produce
severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath. Severe over-exposure can
result in death. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized
by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. The substance is toxic to lungs. Repeated or prolonged exposure to the
substance can produce target organs damage. Repeated or prolonged contact with spray mist may produce chronic eye
irritation and severe skin irritation. Repeated or prolonged exposure to spray mist may produce respiratory tract irritation
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leading to frequent attacks of bronchial infection. Repeated exposure to a highly toxic material may produce general
deterioration of health by an accumulation in one or many human organs.

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids
open. Cold water may be used. Get medical attention immediately. Finish by rinsing thoroughly with running water to avoid a
possible infection.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. Seek medical
attention.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention immediately.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards:
Sodium hydroxide reacts to form explosive products with ammonia + silver nitrate. Benzene extract of allyl benzenesulfonate
prepared from allyl alcohol, and benzene sulfonyl chloride in presence of aquesous sodium hydroxide, under vacuum
distillation, residue darkened and exploded. Sodium Hydroxde + impure tetrahydrofuran, which can contain peroxides, can
cause serious explosions. Dry mixtures of sodium hydroxide and sodium tetrahydroborate liberate hydrogen explosively at
230-270 deg. C. Sodium Hydroxide reacts with sodium salt of trichlorophenol + methyl alcohol + trichlorobenzene + heat to
cause an explosion. (Sodium hydroxide)
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Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container. If
necessary: Neutralize the residue with a dilute solution of acetic acid.
Large Spill:
Corrosive liquid. Poisonous liquid. Stop leak if without risk. Absorb with DRY earth, sand or other non-combustible material.
Do not get water inside container. Do not touch spilled material. Use water spray curtain to divert vapor drift. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of acetic acid. Be careful that the product is not present at a concentration level
above TLV. Check TLV on the MSDS and with local authorities.

Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product. In case of insufficient ventilation,
wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Avoid
contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals, acids, alkalis,
moisture.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value.
Personal Protection:
Face shield. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Boots.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
Sodium hydroxide STEL: 2 (mg/m3) from ACGIH (TLV) [United States] TWA: 2 CEIL: 2 (mg/m3) from OSHA (PEL) [United
States] CEIL: 2 (mg/m3) from NIOSHConsult local authorities for acceptable exposure limits.

Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
Odor: Odorless.
Taste: Alkaline. Bitter. (Strong.)
Molecular Weight: Not applicable.
Color: Clear Colorless.
pH (1% soln/water): Basic.
Boiling Point: 140°C (284°F)
Melting Point: 12°C (53.6°F)
Critical Temperature: Not available.
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Specific Gravity: 1.53 (Water = 1)
Vapor Pressure: The highest known value is 2.3 kPa (@ 20°C) (Water).
Vapor Density: The highest known value is 0.62 (Air = 1) (Water).
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials, water/moisture
Incompatibility with various substances:
Reactive with oxidizing agents, reducing agents, metals, acids, alkalis. Slightly reactive with water
Corrosivity:
Extremely corrosive in presence of aluminum, brass. Corrosive in presence of copper, of stainless steel(304), of stainless
steel(316). Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic. Much heat is evolved when solid material is dissolved in water. Therefore cold water and caution must be
used for this process. Generates considerable heat when a sodium hydroxide solution is mixed with an acid Sodium
hydroxide solution and octanol + diborane during a work-up of a reaction mixture of oxime and diborane in tetrahyrofuran
is very exothermic, a mild explosion being noted on one occassion. Reactive with water, acids (mineral, non-oxidizing, e.g.
hydrochloric, hydrofluoric acid, muriatic acid, phosphoric), acids (mineral, oxidizing e.g. chromic acid, hypochlorous acid, nitric
acid, sulfuric acid), acids (organic e.g. acetic acid, benzoic acid, formic acid, methanoic acid, oxalic acid), aldehydes (e.g.
acetaldehyde, acrolein, chloral hydrate, foraldehyde), carbamates (e.g. carbanolate, carbofuran), esters (e.g. butyl acetate,
ethyl acetate, propyl formate), halogenated organics (dibromoethane, hexachlorobenzene, methyl chloride, trichloroethylene),
isocyanates (e.g. methyl isocyanate), ketones (acetone, acetophenone, MEK, MIBK), acid chlorides, strong bases, strong
oxidizing agents, strong reducing agents, flammable liquids, powdered metals and metals (i.e aluminum, tin, zinc, hafnium,
raney nickel), metals (alkali and alkaline e.g. cesium, potassium, sodium), metal compounds (toxic e.g. berylium, lead
acetate, nickel carbonyl, tetraethyl lead), mitrides (e.g. potassium nitride, sodium nitride), nitriles (e.g. acetonitrile, methyl
cyanide), nitro compounds (organic e.g. nitrobenzene, nitromethane), acetic anhydride, hydroquinone, chlorohydrin,
chlorosulfonic acid, ethylene cyanohydrin, glyoxal, hydrosulfuric acid, oleum, propiolactone, acylonitrile, phorosous pentoxide,
chloroethanol, chloroform-methanol, tetrahydroborate, cyanogen azide, 1,2,4,5 tetrachlorobenzene, cinnamaldehyde. Reacts
with formaldehyde hydroxide to yield formic acid, and hydrogen. (Sodium hydroxide)
Special Remarks on Corrosivity: Very caustic to aluminum and other metals in presence of moisture.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: Not available.
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Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive). Very hazardous in case of skin contact (corrosive, irritant,
permeator), of eye contact (corrosive), of ingestion, .
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Investigation as a mutagen (cytogenetic analysis), but no data available.
(Sodium hydroxide)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May be harmful if absorbed through skin. Causes severe skin irritation and burns. May
cause deep penetrating ulcers of the skin. Eyes: Causes severe eye irritation and burns. May cause chemical conjunctivitis
and corneal damage. Inhalation: Harmful if inhaled. Causes severe irritation of the respiratory tract and mucous membranes
with coughing, burns, breathing difficulty, and possible coma. Irritation may lead the chemical pneumonitis and pulmonary
edema. Causes chemical burns to the respiratory tract and mucous membranes. Ingestion: May be fatal if swallowed. May
cause severe and permanent damage to the digestive tract. Causes

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Sodium hydroxide, solution (Sodium hydroxide) UNNA: UN1824 PG: II
Special Provisions for Transport: Not available.

Section 15: Other Regulatory Information
Federal and State Regulations:
Illinois toxic substances disclosure to employee act: Sodium hydroxide Illinois chemical safety act: Sodium hydroxide New
York release reporting list: Sodium hydroxide Rhode Island RTK hazardous substances: Sodium hydroxide Pennsylvania
RTK: Sodium hydroxide Minnesota: Sodium hydroxide Massachusetts RTK: Sodium hydroxide New Jersey: Sodium hydroxide
Louisiana spill reporting: Sodium hydroxide TSCA 8(b) inventory: Sodium hydroxide; Water CERCLA: Hazardous substances.:
Sodium hydroxide: 1000 lbs. (453.6 kg);
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada):
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CLASS D-2A: Material causing other toxic effects (VERY TOXIC). CLASS E: Corrosive liquid.
DSCL (EEC):
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 1
Personal Protection:
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Face shield.

Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:32 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium chloride MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium chloride

Contact Information:

Catalog Codes: SLS3262, SLS1045, SLS3889, SLS1669,
SLS3091
CAS#: 7647-14-5

Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

RTECS: VZ4725000

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

TSCA: TSCA 8(b) inventory: Sodium chloride

Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

CI#: Not applicable.
Synonym: Salt; Sea Salt

International CHEMTREC, call: 1-703-527-3887

Chemical Name: Sodium chloride

For non-emergency assistance, call: 1-281-441-4400

Chemical Formula: NaCl

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium chloride

7647-14-5

100

Toxicological Data on Ingredients: Sodium chloride: ORAL (LD50): Acute: 3000 mg/kg [Rat.]. 4000 mg/kg [Mouse].
DERMAL (LD50): Acute: &gt;10000 mg/kg [Rabbit]. DUST (LC50): Acute: &gt;42000 mg/m 1 hours [Rat].

Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for
bacteria and/or yeast. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. Repeated or
prolonged exposure is not known to aggravate medical condition.

Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits toxic fumes.
Special Remarks on Explosion Hazards:
Electrolysis of sodium chloride in presence of nitrogenous compounds to produce chlorine may lead to formation of explosive
nitrogen trichloride. Potentially explosive reaction with dichloromaleic anhydride + urea.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.

Section 7: Handling and Storage
Precautions:
Keep locked up.. Do not ingest. Do not breathe dust. Avoid contact with eyes. Wear suitable protective clothing. If ingested,
seek medical advice immediately and show the container or the label. Keep away from incompatibles such as oxidizing
agents, acids.
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Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Slight.
Taste: Saline.
Molecular Weight: 58.44 g/mole
Color: White.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 1413°C (2575.4°F)
Melting Point: 801°C (1473.8°F)
Critical Temperature: Not available.
Specific Gravity: 2.165 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in cold water, hot water. Soluble in glycerol, and ammonia. Very slightly soluble in alcohol. Insoluble in
Hydrochloric Acid.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
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Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, high temperatures.
Incompatibility with various substances: Reactive with oxidizing agents, metals, acids.
Corrosivity: Not considered to be corrosive for metals and glass.
Special Remarks on Reactivity:
Hygroscopic. Reacts with most nonnoble metals such as iron or steel, building materials (such as cement) Sodium chloride is
rapidly attacked by bromine trifluoride. Violent reaction with lithium.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3000 mg/kg [Rat.]. Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit]. Acute toxicity of the dust (LC50):
>42000 mg/m3 1 hours [Rat].
Chronic Effects on Humans: MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/
or yeast.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Lowest Published Lethal Dose (LDL) [Man] - Route: Oral; Dose: 1000 mg/kg
Special Remarks on Chronic Effects on Humans:
Causes adverse reproductive effects in humans (fetotoxicity, abortion, ) by intraplacental route. High intake of sodium chloride,
whether from occupational exposure or in the diet, may increase risk of TOXEMIA OF PREGNANCY in susceptible women
(Bishop, 1978). Hypertonic sodium chloride solutions have been used to induce abortion in late pregnancy by direct infusion
into the uterus (Brown et al, 1972), but this route of administration is not relevant to occupational exposures. May cause
adverse reproductive effects and birth defects in animals, particularly rats and mice (fetotoxicity, abortion, musculoskeletal
abnormalities, and maternal effects (effects on ovaries, fallopian tubes) by oral, intraperitoneal, intraplacental, intrauterine,
parenteral, and subcutaneous routes. While sodium chloride has been used as a negative control n some reproductive
studies, it has also been used as an example that almost any chemical can cause birth defects in experimental animals
if studied under the right conditions (Nishimura & Miyamoto, 1969). In experimental animals, sodium chloride has caused
delayed effects on newborns, has been fetotoxic, and has caused birth defects and abortions in rats and mice (RTECS, 1997).
May affect genetic material (mutagenic)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause skin irritation. Eyes: Causes eye irritation. Ingestion: Ingestion of large
quantities can irritate the stomach (as in overuse of salt tablets) with nausea and vomiting. May affect behavior (muscle
spasicity/contraction, somnolence), sense organs, metabolism, and cardiovascular system. Continued exposure may
produce dehydration, internal organ congestion, and coma. Inhalation: Material is irritating to mucous membranes and upper
respiratory tract.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
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Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium chloride
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R40- Possible risks of irreversible effects. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.

Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II.
Other Special Considerations: Not available.
Created: 10/11/2005 12:33 PM
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Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979

Revision date: 10/21/2016

Supersedes: 10/03/2014

SECTION: 1. Product and company identification
1.1.

Product identifier

Product form

: Substance

Name

: Nitrogen, refrigerated liquid

CAS No

: 7727-37-9

Formula

: N2

Other means of identification

: Nitrogen (cryogenic liquid), Nitrogen, Medipure Liquid Nitrogen

1.2.

Relevant identified uses of the substance or mixture and uses advised against

Use of the substance/mixture

1.3.

: Medical applications
Industrial use
Food applications

Details of the supplier of the safety data sheet
Praxair, Inc.
10 Riverview Drive
Danbury, CT 06810-6268 - USA
T 1-800-772-9247 (1-800-PRAXAIR) - F 1-716-879-2146
www.praxair.com

1.4.

Emergency telephone number

Emergency number

: Onsite Emergency: 1-800-645-4633

CHEMTREC, 24hr/day 7days/week
— Within USA: 1-800-424-9300, Outside USA: 001-703-527-3887
(collect calls accepted, Contract 17729)

SECTION 2: Hazard identification
2.1.

Classification of the substance or mixture

GHS-US classification
Refrigerated liquefied gas H281

2.2.

Label elements

GHS-US labeling
Hazard pictograms (GHS-US)

:

Signal word (GHS-US)

: WARNING

Hazard statements (GHS-US)

: H281 - CONTAINS REFRIGERATED GAS; MAY CAUSE CRYOGENIC BURNS OR INJURY
OSHA-H01 - MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION

Precautionary statements (GHS-US)

: P202 - Do not handle until all safety precautions have been read and understood
P271+P403 - Use and store only outdoors or in a well-ventilated place
P282 - Wear cold insulating gloves/face shield/eye protection. cold insulating gloves, face
shield, eye protection
CGA-PG05 - Use a back flow preventive device in the piping
CGA-PG24 - DO NOT change or force fit connections
CGA-PG06 - Close valve after each use and when empty
CGA-PG23 - Always keep container in upright position

GHS04

2.3.

Other hazards

Other hazards not contributing to the
EN (English US)

: Asphyxiant in high concentrations
SDS ID: P-4630
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This document is only controlled while on the Praxair, Inc. website and a copy of this controlled version is available for download. Praxair cannot assure the integrity or
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979
classification
2.4.

Revision date: 10/21/2016

Supersedes: 10/03/2014

Contact with liquid may cause cold burns/frostbite.

Unknown acute toxicity (GHS US)
No data available

SECTION 3: Composition/Information on ingredients
3.1.

Substance

Name

Product identifier

%

Nitrogen, refrigerated liquid

(CAS No) 7727-37-9

100

(Main constituent)

3.2.

Mixture

Not applicable

SECTION 4: First aid measures
4.1.

Description of first aid measures

First-aid measures after inhalation

: Remove victim to uncontaminated area wearing self contained breathing apparatus. Keep
victim warm and rested. Call a doctor. Apply artificial respiration if breathing stopped.

First-aid measures after skin contact

: The liquid may cause frostbite. For exposure to liquid, immediately warm frostbite area with
warm water not to exceed 105°F (41°C). Water temperature should be tolerable to normal
skin. Maintain skin warming for at least 15 minutes or until normal coloring and sensation have
returned to the affected area. In case of massive exposure, remove clothing while showering
with warm water. Seek medical evaluation and treatment as soon as possible.

First-aid measures after eye contact

: Immediately flush eyes thoroughly with water for at least 15 minutes. Hold the eyelids open and
away from the eyeballs to ensure that all surfaces are flushed thoroughly. Contact an
ophthalmologist immediately.. Get immediate medical attention.

First-aid measures after ingestion

: Ingestion is not considered a potential route of exposure.

4.2.

Most important symptoms and effects, both acute and delayed
No additional information available

4.3.

Indication of any immediate medical attention and special treatment needed

None.

SECTION 5: Firefighting measures
5.1.

Extinguishing media

Suitable extinguishing media
5.2.

Special hazards arising from the substance or mixture

Reactivity
5.3.

: Use extinguishing media appropriate for surrounding fire.

: No reactivity hazard other than the effects described in sub-sections below.
Advice for firefighters

Firefighting instructions

: DANGER! Extremely cold liquid and gas under pressure. Take care not to direct spray onto
vents on top of container. Do not discharge sprays directly into liquid; cryogenic liquid can
freeze water rapidly
Evacuate all personnel from the danger area. Use self-contained breathing apparatus (SCBA)
and protective clothing. Immediately cool containers with water from maximum distance. Stop
flow of gas if safe to do so, while continuing cooling water spray. Remove ignition sources if
safe to do so. Remove containers from area of fire if safe to do so. On-site fire brigades must
comply with OSHA 29 CFR 1910.156 and applicable standards under 29 CFR 1910 Subpart
L—Fire Protection.

Protection during firefighting

: Compressed gas: asphyxiant. Suffocation hazard by lack of oxygen.

Special protective equipment for fire fighters

: Use self-contained breathing apparatus. Standard protective clothing and equipment (Self
Contained Breathing Apparatus) for fire fighters.
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979
Specific methods

Revision date: 10/21/2016

Supersedes: 10/03/2014

: Use fire control measures appropriate for the surrounding fire. Exposure to fire and heat
radiation may cause gas containers to rupture. Cool endangered containers with water spray jet
from a protected position. Prevent water used in emergency cases from entering sewers and
drainage systems
Exposure to fire may cause containers to rupture/explode
Stop flow of product if safe to do so
Use water spray or fog to knock down fire fumes if possible
If leaking do not spray water onto container. Water surrounding area (from protected position)
to contain fire.

Other information

: Cryogenic liquid causes severe frostbite, a burn-like injury. Heat of fire can build pressure in a
closed container and cause it to rupture. Venting vapors may obscure visibility. Air will
condense on surfaces such as vaporizers or piping exposed to liquid or cold gas. Nitrogen,
which has a lower boiling point than oxygen, evaporates first, leaving an oxygen-enriched
condensate
Containers are equipped with a pressure relief device. (Exceptions may exist where authorized
by DOT.).

SECTION 6: Accidental release measures
6.1.

Personal precautions, protective equipment and emergency procedures

General measures

6.1.1.

: Evacuate area. Ensure adequate air ventilation. Wear self-contained breathing apparatus when
entering area unless atmosphere is proven to be safe. Prevent from entering sewers,
basements and workpits, or any place where its accumulation can be dangerous. Stop leak if
safe to do so.

For non-emergency personnel
No additional information available

6.1.2.

For emergency responders
No additional information available

6.2.

Environmental precautions
Try to stop release.

6.3.

Methods and material for containment and cleaning up
No additional information available

6.4.

Reference to other sections
See also sections 8 and 13.

SECTION 7: Handling and storage
7.1.

Precautions for safe handling

Precautions for safe handling

EN (English US)

: Wear leather safety gloves and safety shoes when handling cylinders. Protect cylinders from
physical damage; do not drag, roll, slide or drop. While moving cylinder, always keep in place
removable valve cover. Never attempt to lift a cylinder by its cap; the cap is intended solely to
protect the valve. When moving cylinders, even for short distances, use a cart (trolley, hand
truck, etc.) designed to transport cylinders. Never insert an object (e.g, wrench, screwdriver,
pry bar) into cap openings; doing so may damage the valve and cause a leak. Use an
adjustable strap wrench to remove over-tight or rusted caps. Slowly open the valve. If the
valve is hard to open, discontinue use and contact your supplier. Close the container valve
after each use; keep closed even when empty. Never apply flame or localized heat directly to
any part of the container. High temperatures may damage the container and could cause the
pressure relief device to fail prematurely, venting the container contents. For other precautions
in using this product, see section 16.

SDS ID: P-4630

This document is only controlled while on the Praxair, Inc. website and a copy of this controlled version is available for download. Praxair cannot assure the integrity or
accuracy of any version of this document after it has been downloaded or removed from our website.

3/9

Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979
7.2.

Revision date: 10/21/2016

Supersedes: 10/03/2014

Conditions for safe storage, including any incompatibilities

Storage conditions

: Store in a cool, well-ventilated place. Store and use with adequate ventilation. Store only where
temperature will not exceed 125°F (52°C). Firmly secure containers upright to keep them from
falling or being knocked over. Install valve protection cap, if provided, firmly in place by hand.
Store full and empty containers separately. Use a first-in, first-out inventory system to prevent
storing full containers for long periods
OTHER PRECAUTIONS FOR HANDLING, STORAGE, AND USE: When handling product
under pressure, use piping and equipment adequately designed to withstand the pressures to
be encountered. Never work on a pressurized system. Use a back flow preventive device in the
piping. Gases can cause rapid suffocation because of oxygen deficiency; store and use with
adequate ventilation. If a leak occurs, close the container valve and blow down the system in a
safe and environmentally correct manner in compliance with all international, federal/national,
state/provincial, and local laws; then repair the leak. Never place a container where it may
become part of an electrical circuit.

7.3.

Specific end use(s)
None.

SECTION 8: Exposure controls/personal protection
8.1.

Control parameters

Nitrogen, refrigerated liquid (7727-37-9)
ACGIH
Not established
USA OSHA
8.2.

Not established

Exposure controls

Appropriate engineering controls

: Oxygen detectors should be used when asphyxiating gases may be released. Systems under
pressure should be regularly checked for leakages. Provide adequate general and local
exhaust ventilation. Consider work permit system e.g. for maintenance activities.

Hand protection

: Wear working gloves when handling gas containers.

Eye protection

: Wear safety glasses with side shields. Wear goggles and a face shield when transfilling or
breaking transfer connections.

Respiratory protection

: Self contained breathing apparatus (SCBA) or positive pressure airline with mask are to be
used in oxygen-deficient atmospheres.

Thermal hazard protection

: Wear cold insulating gloves. Wear cold insulating gloves when transfilling or breaking transfer
connections.

Environmental exposure controls

: None necessary.

Other information

: Wear safety shoes while handling containers.

SECTION 9: Physical and chemical properties
9.1.

Information on basic physical and chemical properties

Physical state

: Gas

Appearance

: Colorless liquid.

Molecular mass

: 28 g/mol

Color

: Colorless liquid.

Odor

: No odor warning properties.

Odor threshold

: No data available

pH

: Not applicable.

Relative evaporation rate (butyl acetate=1)

: No data available

Relative evaporation rate (ether=1)

: Not applicable.

Melting point

: -210 °C

Freezing point

: No data available

Boiling point

: -195.8 °C

Flash point

: No data available

Critical temperature

: -149.9 °C
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979

Revision date: 10/21/2016

Supersedes: 10/03/2014

Auto-ignition temperature

: Not applicable.

Decomposition temperature

: No data available

Flammability (solid, gas)

: No data available

Vapor pressure

: Not applicable.

Critical pressure

: 3390 kPa

Relative vapor density at 20 °C

: No data available

Relative density

: 0.8

Density

: 808.5 kg/m³ Liquid density at boiling point and 1 atm

Relative gas density

: 0.97

Solubility

: Water: 20 mg/l

Log Pow

: Not applicable.

Log Kow

: Not applicable.

Viscosity, kinematic

: Not applicable.

Viscosity, dynamic

: Not applicable.

Explosive properties

: Not applicable.

Oxidizing properties

: None.

Explosion limits

: No data available

9.2.

Other information

Gas group

: Refrigerated liquefied gas

Additional information

: Gas/vapor heavier than air. May accumulate in confined spaces, particularly at or below ground
level

SECTION 10: Stability and reactivity
10.1.

Reactivity
No reactivity hazard other than the effects described in sub-sections below.

10.2.

Chemical stability

10.3.

Possibility of hazardous reactions

10.4.

Conditions to avoid

10.5.

Incompatible materials

Stable under normal conditions.

None.

Avoid high temperatures, exposure to Lithium (Li), Neodymium (Nd), Titanium (Ti), Magnesium.

None.
10.6.

Hazardous decomposition products
Under certain conditions, nitrogen can react violently with lithium, neodymium, titanium (above
1472°F/800°C), and magnesium to form nitrides. At high temperature, it can also combine with
oxygen and hydrogen.

SECTION 11: Toxicological information
11.1.

Information on toxicological effects

Acute toxicity

: Not classified

Skin corrosion/irritation

: Not classified

Serious eye damage/irritation

: Not classified

Respiratory or skin sensitization

: Not classified

Germ cell mutagenicity

: Not classified

Carcinogenicity

: Not classified

pH: Not applicable.
pH: Not applicable.
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979
Reproductive toxicity

: Not classified

Specific target organ toxicity (single exposure)

: Not classified

Specific target organ toxicity (repeated
exposure)

: Not classified

Aspiration hazard

: Not classified

Revision date: 10/21/2016

Supersedes: 10/03/2014

SECTION 12: Ecological information
12.1.

Toxicity

Ecology - general
12.2.

: No ecological damage caused by this product.

Persistence and degradability

Nitrogen, refrigerated liquid (7727-37-9)
Persistence and degradability
12.3.

No ecological damage caused by this product.

Bioaccumulative potential

Nitrogen, refrigerated liquid (7727-37-9)
Log Pow
Log Kow
Bioaccumulative potential
12.4.

Not applicable.
Not applicable.
No ecological damage caused by this product.

Mobility in soil

Nitrogen, refrigerated liquid (7727-37-9)
Mobility in soil
Ecology - soil
12.5.

No data available.
No ecological damage caused by this product.

Other adverse effects

Other adverse effects

: Can cause frost damage to vegetation.

Effect on ozone layer

: None

Effect on the global warming

: No known effects from this product

SECTION 13: Disposal considerations
13.1.

Waste treatment methods

Waste disposal recommendations

: Dispose of contents/container in accordance with local/regional/national/international
regulations. Contact supplier for any special requirements.

SECTION 14: Transport information
In accordance with DOT
Transport document description

: UN1977 Nitrogen, refrigerated liquid (cryogenic liquid), 2.2

UN-No.(DOT)

: UN1977

Proper Shipping Name (DOT)

: Nitrogen, refrigerated liquid

Class (DOT)

: 2.2 - Class 2.2 - Non-flammable compressed gas 49 CFR 173.115

Hazard labels (DOT)

: 2.2 - Non-flammable gas

cryogenic liquid
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979
DOT Special Provisions (49 CFR 172.102)

Revision date: 10/21/2016

Supersedes: 10/03/2014

: 345 - “Nitrogen, refrigerated liquid (cryogenic liquid), UN1977” transported in open cryogenic
receptacles with a maximum capacity of 1 L are not subject to the requirements of this
subchapter. The receptacles must be constructed with glass double walls having the space
between the walls vacuum insulated and each receptacle must be transported in an outer
packaging with sufficient cushioning and absorbent materials to protect the receptacle from
damage
346 - “Nitrogen, refrigerated liquid (cryogenic liquid), UN1977” transported in accordance with
the requirements for open cryogenic receptacles in §173.320 and this special provision are not
subject to any other requirements of this subchapter. The receptacle must contain no
hazardous materials other than the liquid nitrogen which must be fully absorbed in a porous
material in the receptacle
T75 - When portable tank instruction T75 is referenced in Column (7) of the 172.101 Table, the
applicable refrigerated liquefied gases are authorized to be transported in portable tanks in
accordance with the requirements of 178.277 of this subchapter
TP5 - For a portable tank used for the transport of flammable refrigerated liquefied gases or
refrigerated liquefied oxygen, the maximum rate at which the portable tank may be filled must
not exceed the liquid flow capacity of the primary pressure relief system rated at a pressure not
exceeding 120 percent of the portable tank's design pressure. For portable tanks used for the
transport of refrigerated liquefied helium and refrigerated liquefied atmospheric gas (except
oxygen), the maximum rate at which the tank is filled must not exceed the liquid flow capacity of
the pressure relief device rated at 130 percent of the portable tank's design pressure. Except
for a portable tank containing refrigerated liquefied helium, a portable tank shall have an outage
of at least two percent below the inlet of the pressure relief device or pressure control valve,
under conditions of incipient opening, with the portable tank in a level attitude. No outage is
required for helium

Additional information
Emergency Response Guide (ERG) Number

: 121 (UN1066);120 (UN1977)

Other information

: No supplementary information available.

Special transport precautions

: Avoid transport on vehicles where the load space is not separated from the driver's
compartment. Ensure vehicle driver is aware of the potential hazards of the load and knows
what to do in the event of an accident or an emergency. Before transporting product containers:
- Ensure there is adequate ventilation. - Ensure that containers are firmly secured. - Ensure
cylinder valve is closed and not leaking. - Ensure valve outlet cap nut or plug (where provided)
is correctly fitted. - Ensure valve protection device (where provided) is correctly fitted.

Transport by sea
UN-No. (IMDG)

: 1977

Proper Shipping Name (IMDG)

: NITROGEN, REFRIGERATED LIQUID

Class (IMDG)

: 2.2 - Non-flammable, non-toxic gases

MFAG-No

: 120

Air transport
UN-No. (IATA)

: 1977

Proper Shipping Name (IATA)

: NITROGEN, REFRIGERATED LIQUID

Class (IATA)

: 2

Civil Aeronautics Law

: Gases under pressure/Gases nonflammable nontoxic under pressure

SECTION 15: Regulatory information
15.1. US Federal regulations
Nitrogen, refrigerated liquid (7727-37-9)
Listed on the United States TSCA (Toxic Substances Control Act) inventory
SARA Section 311/312 Hazard Classes
Immediate (acute) health hazard
Sudden release of pressure hazard
All components of this product are listed on the Toxic Substances Control Act (TSCA)
inventory.
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Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979

Revision date: 10/21/2016

Supersedes: 10/03/2014

This product or mixture does not contain a toxic chemical or chemicals in excess
of the applicable de minimis concentration as specified in 40 CFR §372.38(a)
subject to the reporting requirements of section 313 of Title III of the Superfund
Amendments and Reauthorization Act of 1986 and 40 CFR Part 372.
15.2. International regulations
CANADA
Nitrogen, refrigerated liquid (7727-37-9)
Listed on the Canadian DSL (Domestic Substances List)

EU-Regulations
Nitrogen, refrigerated liquid (7727-37-9)
Listed on the EEC inventory EINECS (European Inventory of Existing Commercial Chemical Substances)
15.2.2. National regulations
Nitrogen, refrigerated liquid (7727-37-9)
Listed on the AICS (Australian Inventory of Chemical Substances)
Listed on IECSC (Inventory of Existing Chemical Substances Produced or Imported in China)
Listed on the Korean ECL (Existing Chemicals List)
Listed on NZIoC (New Zealand Inventory of Chemicals)
Listed on PICCS (Philippines Inventory of Chemicals and Chemical Substances)
Listed on INSQ (Mexican National Inventory of Chemical Substances)
15.3. US State regulations
Nitrogen, refrigerated liquid(7727-37-9)
U.S. - California - Proposition 65 - Carcinogens List

No

U.S. - California - Proposition 65 - Developmental
Toxicity

No

U.S. - California - Proposition 65 - Reproductive
Toxicity - Female

No

U.S. - California - Proposition 65 - Reproductive
Toxicity - Male

No

State or local regulations

U.S. - Massachusetts - Right To Know List
U.S. - New Jersey - Right to Know Hazardous Substance List
U.S. - Pennsylvania - RTK (Right to Know) List

California Proposition 65 - This product does not contain any substances known to the state of California to cause cancer,
developmental and/or reproductive harm

EN (English US)

SDS ID: P-4630

This document is only controlled while on the Praxair, Inc. website and a copy of this controlled version is available for download. Praxair cannot assure the integrity or
accuracy of any version of this document after it has been downloaded or removed from our website.

8/9

Nitrogen, refrigerated liquid
Safety Data Sheet P-4630
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication.
Date of issue: 01/01/1979

Revision date: 10/21/2016

Supersedes: 10/03/2014

SECTION 16: Other information
Other information

: When you mix two or more chemicals, you can create additional, unexpected hazards. Obtain
and evaluate the safety information for each component before you produce the mixture.
Consult an industrial hygienist or other trained person when you evaluate the end product.
Before using any plastics, confirm their compatibility with this product
Praxair asks users of this product to study this SDS and become aware of the product hazards
and safety information. To promote safe use of this product, a user should (1) notify
employees, agents, and contractors of the information in this SDS and of any other known
product hazards and safety information, (2) furnish this information to each purchaser of the
product, and (3) ask each purchaser to notify its employees and customers of the product
hazards and safety information
The opinions expressed herein are those of qualified experts within Praxair, Inc. We believe
that the information contained herein is current as of the date of this Safety Data Sheet. Since
the use of this information and the conditions of use are not within the control of Praxair, Inc, it
is the user's obligation to determine the conditions of safe use of the product
Praxair SDSs are furnished on sale or delivery by Praxair or the independent distributors and
suppliers who package and sell our products. To obtain current SDSs for these products,
contact your Praxair sales representative, local distributor, or supplier, or download from
www.praxair.com. If you have questions regarding Praxair SDSs, would like the document
number and date of the latest SDS, or would like the names of the Praxair suppliers in your
area, phone or write the Praxair Call Center (Phone: 1-800-PRAXAIR/1-800-772-9247;
Address: Praxair Call Center, Praxair, Inc, P.O. Box 44, Tonawanda, NY 14151-0044)
PRAXAIR and the Flowing Airstream design are trademarks or registered trademarks of Praxair
Technology, Inc. in the United States and/or other countries.

NFPA health hazard

: 3 - Short exposure could cause serious temporary or
residual injury even though prompt medical attention was
given.

NFPA fire hazard

: 0 - Materials that will not burn.

NFPA reactivity

: 0 - Normally stable, even under fire exposure conditions,
and are not reactive with water.

NFPA specific hazard

: SA - This denotes gases which are simple asphyxiants.

HMIS III Rating
Health

: 3 Serious Hazard - Major injury likely unless prompt action is taken and medical treatment is
given

Flammability

: 0 Minimal Hazard

Physical

: 2 Moderate Hazard

SDS US (GHS HazCom 2012) - Praxair
This information is based on our current knowledge and is intended to describe the product for the purposes of health, safety and environmental requirements only. It should not therefore be construed as
guaranteeing any specific property of the product.
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Material Safety Data Sheet
Hydrochloric acid MSDS
Section 1: Chemical Product and Company Identification
Product Name: Hydrochloric acid

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLH1462, SLH3154
CAS#: Mixture.

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: MW4025000
TSCA: TSCA 8(b) inventory: Hydrochloric acid

Order Online: ScienceLab.com

CI#: Not applicable.
Synonym: Hydrochloric Acid; Muriatic Acid

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Not applicable.

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: Not applicable.

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Hydrogen chloride

7647-01-0

20-38

Water

7732-18-5

62-80

Toxicological Data on Ingredients: Hydrogen chloride: GAS (LC50): Acute: 4701 ppm 0.5 hours [Rat].

Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of ingestion, . Slightly
hazardous in case of inhalation (lung sensitizer). Non-corrosive for lungs. Liquid or spray mist may produce tissue damage
particularly on mucous membranes of eyes, mouth and respiratory tract. Skin contact may produce burns. Inhalation of the
spray mist may produce severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath.
Severe over-exposure can result in death. Inflammation of the eye is characterized by redness, watering, and itching. Skin
inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (sensitizer). CARCINOGENIC EFFECTS: Classified 3 (Not classifiable for
human.) by IARC [Hydrochloric acid]. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to kidneys, liver, mucous membranes, upper
respiratory tract, skin, eyes, Circulatory System, teeth. Repeated or prolonged exposure to the substance can produce target
p. 1

organs damage. Repeated or prolonged contact with spray mist may produce chronic eye irritation and severe skin irritation.
Repeated or prolonged exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial
infection. Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in one
or many human organs.

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. WARNING: It may
be hazardous to the person providing aid to give mouth-to-mouth resuscitation when the inhaled material is toxic, infectious or
corrosive. Seek immediate medical attention.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention immediately.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: of metals
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards:
Non combustible. Calcium carbide reacts with hydrogen chloride gas with incandescence. Uranium phosphide reacts with
hydrochloric acid to release spontaneously flammable phosphine. Rubidium acetylene carbides burns with slightly warm
hydrochloric acid. Lithium silicide in contact with hydrogen chloride becomes incandescent. When dilute hydrochloric acid is
used, gas spontaneously flammable in air is evolved. Magnesium boride treated with concentrated hydrochloric acid produces
spontaneously flammble gas. Cesium acetylene carbide burns hydrogen chloride gas. Cesium carbide ignites in contact with
hydrochloric acid unless acid is dilute. Reacts with most metals to produce flammable Hydrodgen gas.
Special Remarks on Explosion Hazards:
p. 2

Hydrogen chloride in contact with the following can cause an explosion, ignition on contact, or other violent/vigorous reaction:
Acetic anhydride AgClO + CCl4 Alcohols + hydrogen cyanide, Aluminum Aluminum-titanium alloys (with HCl vapor), 2-Amino
ethanol, Ammonium hydroxide, Calcium carbide Ca3P2 Chlorine + dinitroanilines (evolves gas), Chlorosulfonic acid Cesium
carbide Cesium acetylene carbide, 1,1-Difluoroethylene Ethylene diamine Ethylene imine, Fluorine, HClO4 Hexalithium
disilicide H2SO4 Metal acetylides or carbides, Magnesium boride, Mercuric sulfate, Oleum, Potassium permanganate,
beta-Propiolactone Propylene oxide Rubidium carbide, Rubidium, acetylene carbide Sodium (with aqueous HCl), Sodium
hydroxide Sodium tetraselenium, Sulfonic acid, Tetraselenium tetranitride, U3P4 , Vinyl acetate. Silver perchlorate with carbon
tetrachloride in the presence of hydrochloric acid produces trichloromethyl perchlorate which detonates at 40 deg. C.

Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container. If
necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Corrosive liquid. Poisonous liquid. Stop leak if without risk. Absorb with DRY earth, sand or other non-combustible material.
Do not get water inside container. Do not touch spilled material. Use water spray curtain to divert vapor drift. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of sodium carbonate. Be careful that the product is not present at a concentration
level above TLV. Check TLV on the MSDS and with local authorities.

Section 7: Handling and Storage
Precautions:
Keep locked up.. Keep container dry. Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product.
In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show
the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, organic
materials, metals, alkalis, moisture. May corrode metallic surfaces. Store in a metallic or coated fiberboard drum using a strong
polyethylene inner package.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Face shield. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Boots.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
CEIL: 5 (ppm) from OSHA (PEL) [United States] CEIL: 7 (mg/m3) from OSHA (PEL) [United States] CEIL: 5 from NIOSH
CEIL: 7 (mg/m3) from NIOSH TWA: 1 STEL: 5 (ppm) [United Kingdom (UK)] TWA: 2 STEL: 8 (mg/m3) [United Kingdom
(UK)]Consult local authorities for acceptable exposure limits.

Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
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Odor: Pungent. Irritating (Strong.)
Taste: Not available.
Molecular Weight: Not applicable.
Color: Colorless to light yellow.
pH (1% soln/water): Acidic.
Boiling Point:
108.58 C @ 760 mm Hg (for 20.22% HCl in water) 83 C @ 760 mm Hg (for 31% HCl in water) 50.5 C (for 37% HCl in water)
Melting Point:
-62.25°C (-80°F) (20.69% HCl in water) -46.2 C (31.24% HCl in water) -25.4 C (39.17% HCl in water)
Critical Temperature: Not available.
Specific Gravity:
1.1- 1.19 (Water = 1) 1.10 (20%and 22% HCl solutions) 1.12 (24% HCl solution) 1.15 (29.57% HCl solution) 1.16 (32% HCl
solution) 1.19 (37% and 38%HCl solutions)
Vapor Pressure: 16 kPa (@ 20°C) average
Vapor Density: 1.267 (Air = 1)
Volatility: Not available.
Odor Threshold: 0.25 to 10 ppm
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, diethyl ether.
Solubility: Soluble in cold water, hot water, diethyl ether.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, water
Incompatibility with various substances:
Highly reactive with metals. Reactive with oxidizing agents, organic materials, alkalis, water.
Corrosivity:
Extremely corrosive in presence of aluminum, of copper, of stainless steel(304), of stainless steel(316). Non-corrosive in
presence of glass.
Special Remarks on Reactivity:
Reacts with water especially when water is added to the product. Absorption of gaseous hydrogen chloride on mercuric
sulfate becomes violent @ 125 deg. C. Sodium reacts very violently with gaseous hydrogen chloride. Calcium phosphide
and hydrochloric acid undergo very energetic reaction. It reacts with oxidizers releasing chlorine gas. Incompatible with,
alkali metals, carbides, borides, metal oxides, vinyl acetate, acetylides, sulphides, phosphides, cyanides, carbonates. Reacts
with most metals to produce flammable Hydrogen gas. Reacts violently (moderate reaction with heat of evolution) with
water especially when water is added to the product. Isolate hydrogen chloride from heat, direct sunlight, alkalies (reacts
vigorously), organic materials, and oxidizers (especially nitric acid and chlorates), amines, metals, copper and alloys (e.g.
brass), hydroxides, zinc (galvanized materials), lithium silicide (incandescence), sulfuric acid(increase in temperature and
pressure) Hydrogen chloride gas is emitted when this product is in contact with sulfuric acid. Adsorption of Hydrochloric Acid
onto silicon dioxide results in exothmeric reaction. Hydrogen chloride causes aldehydes and epoxides to violently polymerize.
Hydrogen chloride or Hydrochloric Acid in contact with the folloiwng can cause explosion or ignition on contact or
Special Remarks on Corrosivity:
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Highly corrosive. Incompatible with copper and copper alloys. It attacks nearly all metals (mercury, gold, platinium, tantalum,
silver, and certain alloys are exceptions). It is one of the most corrosive of the nonoxidizing acids in contact with copper alloys.
No corrosivity data on zinc, steel. Severe Corrosive effect on brass and bronze
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation.
Toxicity to Animals:
Acute oral toxicity (LD50): 900 mg/kg [Rabbit]. Acute toxicity of the vapor (LC50): 1108 ppm, 1 hours [Mouse]. Acute toxicity of
the vapor (LC50): 3124 ppm, 1 hours [Rat].
Chronic Effects on Humans:
CARCINOGENIC EFFECTS: Classified 3 (Not classifiable for human.) by IARC [Hydrochloric acid]. May cause damage to the
following organs: kidneys, liver, mucous membranes, upper respiratory tract, skin, eyes, Circulatory System, teeth.
Other Toxic Effects on Humans:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of ingestion, . Hazardous in case of eye contact
(corrosive), of inhalation (lung corrosive).
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Doses (LDL/LCL) LDL [Man] -Route: Oral; 2857 ug/kg LCL [Human] - Route: Inhalation; Dose: 1300
ppm/30M LCL [Rabbit] - Route: Inhalation; Dose: 4413 ppm/30M
Special Remarks on Chronic Effects on Humans:
May cause adverse reproductive effects (fetoxicity). May affect genetic material.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Corrosive. Causes severe skin irritation and burns. Eyes: Corrosive. Causes severe
eye irritation/conjuntivitis, burns, corneal necrosis. Inhalation: May be fatal if inhaled. Material is extremely destructive to
tissue of the mucous membranes and upper respiratory tract. Inhalation of hydrochloric acid fumes produces nose, throat,
and larryngeal burning, and irritation, pain and inflammation, coughing, sneezing, choking sensation, hoarseness, laryngeal
spasms, upper respiratory tract edema, chest pains, as well has headache, and palpitations. Inhalation of high concentrations
can result in corrosive burns, necrosis of bronchial epithelium, constriction of the larynx and bronchi, nasospetal perforation,
glottal closure, occur, particularly if exposure is prolonged. May affect the liver. Ingestion: May be fatal if swallowed. Causes
irritation and burning, ulceration, or perforation of the gastrointestinal tract and resultant peritonitis, gastric hemorrhage and
infection. Can also cause nausea, vomitting (with "coffee ground" emesis), diarrhea, thirst, difficulty swallowing, salivation,
chills, fever, uneasiness, shock, strictures and stenosis (esophogeal, gastric, pyloric). May affect behavior (excitement), the
cardiovascular system (weak rapid pulse, tachycardia), respiration (shallow respiration), and urinary system (kidneys- renal
failure, nephritis). Acute exposure via inhalation or ingestion can also cause erosion of tooth enamel. Chronic Potential Health
Effects: dyspnea, bronchitis. Chemical pneumonitis and pulmonary edema can also

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
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Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Hydrochloric acid, solution UNNA: 1789 PG: II
Special Provisions for Transport: Not available.

Section 15: Other Regulatory Information
Federal and State Regulations:
Connecticut hazardous material survey.: Hydrochloric acid Illinois toxic substances disclosure to employee act: Hydrochloric
acid Illinois chemical safety act: Hydrochloric acid New York release reporting list: Hydrochloric acid Rhode Island RTK
hazardous substances: Hydrochloric acid Pennsylvania RTK: Hydrochloric acid Minnesota: Hydrochloric acid Massachusetts
RTK: Hydrochloric acid Massachusetts spill list: Hydrochloric acid New Jersey: Hydrochloric acid New Jersey spill list:
Hydrochloric acid Louisiana RTK reporting list: Hydrochloric acid Louisiana spill reporting: Hydrochloric acid California
Director's List of Hazardous Substances: Hydrochloric acid TSCA 8(b) inventory: Hydrochloric acid TSCA 4(a) proposed test
rules: Hydrochloric acid SARA 302/304/311/312 extremely hazardous substances: Hydrochloric acid SARA 313 toxic chemical
notification and release reporting: Hydrochloric acid CERCLA: Hazardous substances.: Hydrochloric acid: 5000 lbs. (2268 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS D-2A: Material causing other toxic effects (VERY TOXIC). CLASS E: Corrosive liquid.
DSCL (EEC):
R34- Causes burns. R37- Irritating to respiratory system. S26- In case of contact with eyes, rinse immediately with plenty of
water and seek medical advice. S45- In case of accident or if you feel unwell, seek medical advice immediately (show the label
where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 1
Personal Protection:
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Face shield.

Section 16: Other Information
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References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II. -Guide de la loi et du règlement sur le transport des marchandises dangeureuses au canada.
Centre de conformité internatinal Ltée. 1986.
Other Special Considerations: Not available.
Created: 10/09/2005 05:45 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet: CHO / ID 603479

Material Safety Data Sheet for Cell Cultures
(Biosafety Level 1)
1. Product Identification
Name of cell line: CHO (CLS order no. 603479)
Designation: Chinese Hamster Ovary cell line, permanent cell line

2. Company Identification
CLS Cell Lines Service GmbH
Dr. Eckener-Str. 8
D-69214 Eppelheim
Germany
Emergency phone number:

+49 (0)6221 700799

3. Composition / Ingredients
Unit: cryovial; frozen liquid
Hazardous Ingredient(s)
Dimethyl Sulfoxide

CAS no.
67-68-5

Non-Hazardous Ingredient(s)
DMEM, supplemented for freezing
FBS (Fetal Bovine Serum)
Cells

Percentage
10

EC no.
200-664-3

Percentage
60-80
10-20
1

4. Hazards Identification
Hamster source cell line
Categorized as non-infectious and non-toxic

5. First Aid Measures
Skin contact:
Wash off immediately with plenty of water and soap.
Eye contact:
Flush eyes immediately with water for 10-15 minutes.
Ingestion:
If the material was swallowed, rinse the mouth with water.

6. Accidental Release Measures
Use personal protective equipment
Do not flush into surface water.
Clean contaminated surface thoroughly. Autoclave before disposal into appropriated containers.

CLS Cell Lines Service GmbH, Dr. Eckener-Straße 8, 69214 Eppelheim, Germany
TEL: +49(0)6221 700799
FAX +49(0)6221 700717
info@clsgmbh.de www.clsgmbh.de
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7. Handling and storage
Handling:
Open only under a sterile workbench. Wear protective equipment. Handle as if containing infectious
material.
Storage:
Keep the cryovial at -150°C (freezer) or at -196°C (liquid nitrogen vapour phase).

8. Personal Protection
Hygienic measures
Avoid the contact with skin, eyes and clothing. Keep away from food and drinks. Wash hands
immediately after handling the product.
Normally, no respiratory protective equipment is required.
Use protective gloves and safety goggles and wear a lab coat while handling the product.

9. Physical and Chemical Properties / Reactivity
Form:
Liquid
DMSO is stable. It is incompatible with a very wide range of materials, including acid chlorides,
strong acids, strong oxidizing agents, strong reducing agents, phosphorus halides, moisture, copper
wool + trichloroacetic acid, hygroscopic.

10. Toxicological Information
Not hazardous according to Directive 67/548/EC.
Toxicity data for DMSO:
ORL-RAT LD50 14500 mg kg-1
IVN-MAN TDLO 686 mg kg-1
IVN-MUS LD50 3100 mg kg-1
IVN-DOG LD50 2500 mg kg

ORL-MAM LD50 21400 mg kg-1
IPR-RAT LD50 8200 mg kg-1
ORL-BWD LD50 100 mg kg-1

11. Transportation Information
Non-hazardous for air, sea and road freight.

12. General Information
Recommended use:
For in vitro research use only.

\\192.168.2.50\daten\A_BetriebsHandbuch_CLS\Produktinformation\ProduktInfo Zelllinien\CHO\MSDS_CHO.docx

Disclaimer:
The information provided in the present Material Safety Data Sheet is believed to be correct at the
date of publication. No guarantee is given for its accuracy or completeness, but is intended as
guidance only. Biological material may be hazardous and should be used with caution.
CLS Cell Lines Service GmbH shall not be held liable for any damage resulting from handling or from
contact with the product.

CLS Cell Lines Service GmbH, Dr. Eckener-Straße 8, 69214 Eppelheim, Germany
TEL: +49(0)6221 700799
FAX +49(0)6221 700717
info@clsgmbh.de www.clsgmbh.de
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SAFETY DATA SHEET
Creation Date 30-Apr-2010

Revision Date 17-Jan-2018

Revision Number 4

1. Identification
Product Name

Sodium hypochlorite

Cat No. :

SS290-1; SS290-4; SS290-4LC

Synonyms

No information available

Recommended Use
Uses advised against

Laboratory chemicals.
Not for food, drug, pesticide or biocidal product use

Details of the supplier of the safety data sheet
Company
Fisher Scientific
One Reagent Lane
Fair Lawn, NJ 07410
Tel: (201) 796-7100

Emergency Telephone Number
CHEMTRECÒ, Inside the USA: 800-424-9300
CHEMTRECÒ, Outside the USA: 001-703-527-3887

2. Hazard(s) identification
Classification
This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200)

Corrosive to metals
Skin Corrosion/irritation
Serious Eye Damage/Eye Irritation
Specific target organ toxicity (single exposure)
Target Organs - Respiratory system.

Category 1
Category 2
Category 1
Category 3

Label Elements
Signal Word
Danger
Hazard Statements
May be corrosive to metals
Causes severe skin burns and eye damage
May cause respiratory irritation

______________________________________________________________________________________________
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Precautionary Statements
Prevention
Wash face, hands and any exposed skin thoroughly after handling
Wear protective gloves/protective clothing/eye protection/face protection
Avoid breathing dust/fume/gas/mist/vapors/spray
Use only outdoors or in a well-ventilated area
Keep only in original container
Inhalation
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
Call a POISON CENTER or doctor/physician if you feel unwell
Skin
IF ON SKIN: Wash with plenty of soap and water
If skin irritation occurs: Get medical advice/attention
Take off contaminated clothing and wash before reuse
Eyes
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing
Immediately call a POISON CENTER or doctor/physician
Spills
Absorb spillage to prevent material damage
Storage
Store in a well-ventilated place. Keep container tightly closed
Store locked up
Store in corrosive resistant polypropylene container with a resistant inliner
Store in a dry place
Disposal
Dispose of contents/container to an approved waste disposal plant
Hazards not otherwise classified (HNOC)
Toxic to aquatic life with long lasting effects
Contact with acids liberates toxic gas

3. Composition/Information on Ingredients
Component
Water
Sodium hypochlorite

CAS-No
7732-18-5
7681-52-9

Weight %
94-96
4-6

4. First-aid measures
General Advice

Immediate medical attention is required. Show this safety data sheet to the doctor in
attendance.

Eye Contact

Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes.
Immediate medical attention is required. Keep eye wide open while rinsing.

Skin Contact

Wash off immediately with plenty of water for at least 15 minutes. Remove and wash
contaminated clothing before re-use. Call a physician immediately.

Inhalation

If breathing is difficult, give oxygen. Do not use mouth-to-mouth method if victim ingested or
inhaled the substance; give artificial respiration with the aid of a pocket mask equipped with
a one-way valve or other proper respiratory medical device. Remove from exposure, lie
down. Call a physician immediately.

Ingestion

Do not induce vomiting. Never give anything by mouth to an unconscious person. Clean
mouth with water. Call a physician immediately.

Most important symptoms and

Causes eye burns. Causes burns by all exposure routes. . Product is a corrosive material.

______________________________________________________________________________________________
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Notes to Physician

Use of gastric lavage or emesis is contraindicated. Possible perforation of stomach or
esophagus should be investigated: Ingestion causes severe swelling, severe damage to the
delicate tissue and danger of perforation
Treat symptomatically

Suitable Extinguishing Media

CO 2, dry chemical, dry sand, alcohol-resistant foam.

Unsuitable Extinguishing Media

No information available

effects

5. Fire-fighting measures

Flash Point
Method -

Not applicable
No information available

No information available
Autoignition Temperature
Explosion Limits
No data available
Upper
No data available
Lower
Sensitivity to Mechanical Impact No information available
Sensitivity to Static Discharge No information available
Specific Hazards Arising from the Chemical
Thermal decomposition can lead to release of irritating gases and vapors. The product causes burns of eyes, skin and mucous
membranes. Do not allow run-off from fire fighting to enter drains or water courses.
Hazardous Combustion Products
Hydrogen chloride gas Sodium oxides Thermal decomposition can lead to release of irritating gases and vapors
Protective Equipment and Precautions for Firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full
protective gear. Thermal decomposition can lead to release of irritating gases and vapors.
NFPA
Health
3

Flammability
0

Instability
1

Physical hazards
N/A

6. Accidental release measures
Personal Precautions
Environmental Precautions

Ensure adequate ventilation. Use personal protective equipment. Keep people away from
and upwind of spill/leak. Evacuate personnel to safe areas.
Do not flush into surface water or sanitary sewer system. Do not allow material to
contaminate ground water system. Prevent product from entering drains. Local authorities
should be advised if significant spillages cannot be contained. See Section 12 for additional
ecological information. Avoid release to the environment. Collect spillage.

Methods for Containment and Clean Soak up with inert absorbent material. Keep in suitable, closed containers for disposal.
Up

7. Handling and storage
Handling

Use only under a chemical fume hood. Wear personal protective equipment. Do not get in
eyes, on skin, or on clothing. Do not ingest. Do not breathe vapors or spray mist.

Storage

Keep containers tightly closed in a dry, cool and well-ventilated place. Corrosives area.

8. Exposure controls / personal protection
Exposure Guidelines

This product does not contain any hazardous materials with occupational exposure
limitsestablished by the region specific regulatory bodies.

______________________________________________________________________________________________
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Use only under a chemical fume hood. Ensure that eyewash stations and safety showers
are close to the workstation location.

Engineering Measures
Personal Protective Equipment
Eye/face Protection

Wear appropriate protective eyeglasses or chemical safety goggles as described by
OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard
EN166. Tightly fitting safety goggles. Face-shield.

Skin and body protection

Long sleeved clothing.

Respiratory Protection

Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or other symptoms are experienced.

Hygiene Measures

Handle in accordance with good industrial hygiene and safety practice.

9. Physical and chemical properties
Liquid
Light yellow
Chlorine
No information available
No information available
0 °C / 32 °F
No information available
Not applicable
> 1 (Ether = 1.0)
Not applicable

Physical State
Appearance
Odor
Odor Threshold
pH
Melting Point/Range
Boiling Point/Range
Flash Point
Evaporation Rate
Flammability (solid,gas)
Flammability or explosive limits
Upper
Lower
Vapor Pressure
Vapor Density
Specific Gravity
Solubility
Partition coefficient; n-octanol/water
Autoignition Temperature
Decomposition Temperature
Viscosity
Molecular Formula
Molecular Weight

No data available
No data available
14 mmHg
No information available
1.1
Soluble in water
No data available
No information available
No information available
No information available
NaOCl
75.4492

10. Stability and reactivity
Reactive Hazard

Yes

Stability

Stable under normal conditions.

Conditions to Avoid

Incompatible products. Excess heat.

Incompatible Materials

Strong oxidizing agents, Strong acids, Strong bases, Strong reducing agents

Hazardous Decomposition Products Hydrogen chloride gas, Sodium oxides, Thermal decomposition can lead to release of
irritating gases and vapors
Hazardous Polymerization

Hazardous polymerization does not occur.

Hazardous Reactions

None under normal processing.
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11. Toxicological information
Acute Toxicity
Product Information
Oral LD50
Dermal LD50
Vapor LC50
Component Information

Based on ATE data, the classification criteria are not met. ATE > 2000 mg/kg.
Based on ATE data, the classification criteria are not met. ATE > 2000 mg/kg.
Based on ATE data, the classification criteria are not met. ATE > 20 mg/l.

Component
Water
Sodium hypochlorite

LD50 Oral
LD50 = 8200 mg/kg ( Rat )

LD50 Dermal
Not listed
LD50 > 10000 mg/kg ( Rabbit )

LC50 Inhalation
Not listed
> 10500 mg/l (Rat) 1h

No information available
Toxicologically Synergistic
Products
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Irritation

Causes burns by all exposure routes

Sensitization

No information available

Carcinogenicity

The table below indicates whether each agency has listed any ingredient as a carcinogen.

Component
Water
Sodium hypochlorite

CAS-No
7732-18-5
7681-52-9

IARC
Not listed
Not listed

NTP
Not listed
Not listed

Mutagenic Effects

No information available

Reproductive Effects

No information available.

Developmental Effects

No information available.

Teratogenicity

No information available.

STOT - single exposure
STOT - repeated exposure

Respiratory system
None known

Aspiration hazard

No information available

ACGIH
Not listed
Not listed

OSHA
Not listed
Not listed

Mexico
Not listed
Not listed

Symptoms / effects,both acute and Product is a corrosive material. Use of gastric lavage or emesis is contraindicated.
Possible perforation of stomach or esophagus should be investigated: Ingestion causes
delayed
severe swelling, severe damage to the delicate tissue and danger of perforation
Endocrine Disruptor Information

No information available

Other Adverse Effects

The toxicological properties have not been fully investigated.

12. Ecological information
Ecotoxicity
The product contains following substances which are hazardous for the environment. Very toxic to aquatic organisms.
Component
Sodium hypochlorite

Freshwater Algae
EC50: = 0.095 mg/L, 24h
(Skeletonema costatum)

Freshwater Fish
Pimephales promelas:
LC50=0.82-0.98 mg/L 96h

Persistence and Degradability

No information available

Bioaccumulation/ Accumulation

No information available.

Mobility

.

Microtox
-

Water Flea
2.1 mg/L EC50 = 96 h
0.033-0.044 mg/L EC50 48
h
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13. Disposal considerations
Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste. Chemical waste generators must also consult local, regional, and
national hazardous waste regulations to ensure complete and accurate classification.

Waste Disposal Methods

14. Transport information
DOT
UN-No
Proper Shipping Name
Hazard Class
Packing Group
TDG
UN-No
Proper Shipping Name
Hazard Class
Packing Group
IATA
UN-No
Proper Shipping Name
Hazard Class
Packing Group
IMDG/IMO
UN-No
Proper Shipping Name
Hazard Class
Packing Group

UN1791
HYPOCHLORITE SOLUTIONS
8
III
UN1791
HYPOCHLORITE SOLUTION
8
III
UN1791
HYPOCHLORITE SOLUTION
8
III
UN1791
HYPOCHLORITE SOLUTION
8
III

15. Regulatory information
All of the components in the product are on the following Inventory lists: X = listed
International Inventories
Component
Water
Sodium hypochlorite

TSCA
X
X

DSL
X
X

NDSL EINECS ELINCS
231-791-2
231-668-3
-

NLP

PICCS
X
X

ENCS
X

AICS
X
X

IECSC
X
X

KECL
X
X

Legend:
X - Listed
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA.
F - Indicates a substance that is the subject of a Section 5(f) Rule under TSCA.
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated
polymer made with any free-radical initiator regardless of the amount used.
P - Indicates a commenced PMN substance
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule
T - Indicates a substance that is the subject of a Section 4 test rule under TSCA.
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base
Production and Site Reports (40 CFR 710(B).
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants
that comprises one of the eligibility criteria for the exemption rule.

U.S. Federal Regulations
TSCA 12(b)

Not applicable

SARA 313

Not applicable

SARA 311/312 Hazard Categories

See section 2 for more information

CWA (Clean Water Act)

______________________________________________________________________________________________
Page 6 / 7

Revision Date 17-Jan-2018
Sodium hypochlorite
______________________________________________________________________________________________
CWA - Hazardous
Substances
X

Component
Sodium hypochlorite

CWA - Reportable
Quantities
100 lb

CWA - Toxic Pollutants CWA - Priority Pollutants
-

-

Not applicable

Clean Air Act

OSHA Occupational Safety and Health Administration
Not applicable
Not applicable

CERCLA
Component
Sodium hypochlorite
California Proposition 65
U.S. State Right-to-Know
Regulations
Component
Water
Sodium hypochlorite

Hazardous Substances RQs
100 lb

CERCLA EHS RQs
-

This product does not contain any Proposition 65 chemicals

Massachusetts
X

New Jersey
X

Pennsylvania
X
X

Illinois
-

Rhode Island
-

U.S. Department of Transportation
Reportable Quantity (RQ):
DOT Marine Pollutant
DOT Severe Marine Pollutant

N
N
N

U.S. Department of Homeland Security
This product does not contain any DHS chemicals.
Other International Regulations
Mexico - Grade

No information available

Prepared By

Regulatory Affairs
Thermo Fisher Scientific
Email: EMSDS.RA@thermofisher.com

Creation Date
Revision Date
Print Date
Revision Summary

30-Apr-2010
17-Jan-2018
17-Jan-2018
This document has been updated to comply with the US OSHA HazCom 2012 Standard
replacing the current legislation under 29 CFR 1910.1200 to align with the Globally
Harmonized System of Classification and Labeling of Chemicals (GHS).

16. Other information

Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the
date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other
materials or in any process, unless specified in the text

End of SDS
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Material Safety Data Sheet
Ammonium sulfate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Ammonium sulfate

Contact Information:

Catalog Codes: SLA2851, SLA2011, SLA1168, SLA2674
CAS#: 7783-20-2
RTECS: BS4500000
TSCA: TSCA 8(b) inventory: Ammonium sulfate
CI#: Not available.

Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com

Synonym: Sulfluric Acid, Diammonium Salt

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Ammonium Sulfate

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: (NH4)2SO4

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Ammonium sulfate

7783-20-2

100

Toxicological Data on Ingredients: Ammonium sulfate: ORAL (LD50): Acute: 2840 mg/kg [Rat]. 640 mg/kg [Mouse].

Section 3: Hazards Identification
Potential Acute Health Effects: Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
p. 1

Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: CLOSED CUP: Higher than 93.3°C (200°F).
Flammable Limits: Not available.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances:
Flammable in presence of oxidizing materials. Slightly flammable to flammable in presence of heat.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available. Explosive in presence of oxidizing materials.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards:
A mixture of ammonium sulfate and potassium chlorate decomposes with incandescence when heated. When a little
ammonium sulfate is added to fused potassium nitrite, a vigorous reaction occurs attended by flame. Non combustible. This
substance itself does not burn, but may decompose upon heating to produce corrosive and/or toxic fumes.
Special Remarks on Explosion Hazards:
If accidently mixed with oxidizers like potassium chlorate, potassium nitrate or potassium nitrite, there is an explosion hazard
during fire. A mixture of ammonium sulfate and ammonium nitrate can easily be exploded by potassium or sodium-potassium
alloy.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.

Section 7: Handling and Storage
Precautions:
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Keep away from heat. Keep away from sources of ignition. Do not ingest. Do not breathe dust. Wear suitable protective
clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately
and show the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing
agents.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Crystals solid.)
Odor: Odorless.
Taste: Not available.
Molecular Weight: 132.14 g/mole
Color: brownish gray to white
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: 280°C (536°F)
Critical Temperature: Not available.
Specific Gravity: 1.77 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Soluble in cold water. Insoluble in acetone.

Section 10: Stability and Reactivity Data
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Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials.
Incompatibility with various substances:
Highly reactive with oxidizing agents. Reactive with alkalis.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Incompatible with the following: Potassium + ammonium nitrate, potassium chlorate, potassium nitrate, potassium nitrite,
sodium hypochlorite, sodium/potassium alloy + ammonium nitrate. Substance should not contact either zinc or copper bearing
materials. Reacts with alkali to release ammonia.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 640 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Dose/Conc: LDL [Domestic animal - Goat, Sheep) - Route: Oral; Dose: 3500 mg/kg
Special Remarks on Chronic Effects on Humans:
It may be a possible mutagen. It has been tested for mutagenicity, but so far tests have been inconclusive or test information
has not been made available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes skin irritation. Eyes: Causes eye irritation. Inhalation: May cause respiratory tract
irritation. Ingestion: When ingested, its osmolarity can draw water from the body into the bowel, acting as a laxative. However,
if enough is absorbed systemically it may produce Ammonia poisoning. Symptoms may include gastrointestinal (digestive)
tract irritation with nausea, vomiting, hypermotility, diarrhea. May also affect eyes (Mydriasis), behavior/central nervous system
(somnolence, tremor, convulsions, muscle contraction or spasticity), and respiratory system (respiratory stimulation, dyspnea).
Also, with ingestion of large doses of Ammonium Sulfate arises the possibility of sufficient absorption to produce diuresis, an
excessive discharge of urine, and kidney damage (renal tubular disorder, abnormal renal function). Chronic Potential Health
Effects: One Russian occupational standard study discussed chronic exposure effects which may include cardiac contraction,
neurotoxicity, and hypertension. This has not been confirmed in other ammonium sulfate exposed workers.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
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Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations:
Rhode Island RTK hazardous substances: Ammonium sulfate Pennsylvania RTK: Ammonium sulfate Florida: Ammonium
sulfate Massachusetts RTK: Ammonium sulfate New Jersey: Ammonium sulfate TSCA 8(b) inventory: Ammonium sulfate
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R16- Explosive when mixed with oxidizing substances. R36/38- Irritating to eyes and skin. S24/25- Avoid contact with skin and
eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.

Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:14 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
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no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Acetic acid MSDS
Section 1: Chemical Product and Company Identification
Product Name: Acetic acid

Contact Information:

Catalog Codes: SLA3784, SLA1438, SLA2101, SLA3604,
SLA1258
CAS#: 64-19-7

Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

RTECS: AF1225000

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

TSCA: TSCA 8(b) inventory: Acetic acid

Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

CI#: Not applicable.
Synonym: Acetic acid; glacial acetic acid

International CHEMTREC, call: 1-703-527-3887

Chemical Name: Acetic Acid, Glacial

For non-emergency assistance, call: 1-281-441-4400

Chemical Formula: C2-H4-O2

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Acetic acid

64-19-7

100

Toxicological Data on Ingredients: Acetic acid: ORAL (LD50): Acute: 3310 mg/kg [Rat]. 4960 mg/kg [Mouse]. 3530 mg/kg
[Rat]. DERMAL (LD50): Acute: 1060 mg/kg [Rabbit]. VAPOR (LC50): Acute: 5620 ppm 1 hours [Mouse].

Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Hazardous in case of skin
contact (corrosive, permeator), of eye contact (corrosive). Liquid or spray mist may produce tissue damage particularly on
mucous membranes of eyes, mouth and respiratory tract. Skin contact may produce burns. Inhalation of the spray mist may
produce severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath. Inflammation of the
eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching, scaling, reddening, or,
occasionally, blistering.
Potential Chronic Health Effects:
Hazardous in case of skin contact (irritant), of ingestion, of inhalation. CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast. TERATOGENIC
EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to kidneys, mucous
membranes, skin, teeth. Repeated or prolonged exposure to the substance can produce target organs damage. Repeated
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or prolonged contact with spray mist may produce chronic eye irritation and severe skin irritation. Repeated or prolonged
exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial infection.

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. WARNING: It may
be hazardous to the person providing aid to give mouth-to-mouth resuscitation when the inhaled material is toxic, infectious or
corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Flammable.
Auto-Ignition Temperature: 463°C (865.4°F)
Flash Points: CLOSED CUP: 39°C (102.2°F). OPEN CUP: 43°C (109.4°F).
Flammable Limits: LOWER: 4% UPPER: 19.9%
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Flammable in presence of open flames and sparks, of heat. Slightly flammable to flammable in presence of oxidizing
materials, of metals.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available. Slightly explosive in presence of oxidizing materials.
Fire Fighting Media and Instructions:
Flammable liquid, soluble or dispersed in water. SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use alcohol foam,
water spray or fog. Cool containing vessels with water jet in order to prevent pressure build-up, autoignition or explosion.
Special Remarks on Fire Hazards:
Reacts with metals to produces flammable hydrogen gas. It will ignite on contact with potassium-tert-butoxide. A mixture of
ammonium nitrate and acetic acid ignites when warmed, especially if warmed.
Special Remarks on Explosion Hazards:
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Acetic acid vapors may form explosive mixtures with air. Reactions between acetic acid and the following materials
are potentially explosive: 5-azidotetrazole, bromine pentafluoride, chromium trioxide, hydrogen peroxide, potassium
permanganate, sodium peroxide, and phorphorus trichloride. Dilute acetic acid and dilute hydrogen can undergo an
exothermic reaction if heated, forming peracetic acid which is explosive at 110 degrees C. Reaction between chlorine
trifluoride and acetic acid is very violent, sometimes explosive.

Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container. If
necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Flammable liquid. Corrosive liquid. Keep away from heat. Keep away from sources of ignition. Stop leak if without risk. If the
product is in its solid form: Use a shovel to put the material into a convenient waste disposal container. If the product is in
its liquid form: Absorb with DRY earth, sand or other non-combustible material. Do not get water inside container. Absorb
with an inert material and put the spilled material in an appropriate waste disposal. Do not touch spilled material. Use water
spray curtain to divert vapor drift. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance
on disposal. Neutralize the residue with a dilute solution of sodium carbonate. Be careful that the product is not present at a
concentration level above TLV. Check TLV on the MSDS and with local authorities.

Section 7: Handling and Storage
Precautions:
\Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do not ingest. Do not
breathe gas/fumes/ vapor/spray. Never add water to this product. In case of insufficient ventilation, wear suitable respiratory
equipment. If ingested, seek medical advice immediately and show the container or the label. Avoid contact with skin and
eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals, acids, alkalis.
Storage:
Store in a segregated and approved area. Keep container in a cool, well-ventilated area. Keep container tightly closed and
sealed until ready for use. Avoid all possible sources of ignition (spark or flame).

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Splash goggles. Synthetic apron. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves
(impervious).
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
TWA: 10 STEL: 15 (ppm) [Australia] TWA: 25 STEL: 27 (mg/m3) [Australia] TWA: 10 STEL: 15 (ppm) from NIOSH TWA: 25
STEL: 37 (mg/m3) from NIOSH TWA: 10 STEL: 15 (ppm) [Canada] TWA: 26 STEL: 39 (mg/m3) [Canada] TWA: 25 STEL: 37
(mg/m3) TWA: 10 STEL: 15 (ppm) from ACGIH (TLV) [United States] [1999] TWA: 10 (ppm) from OSHA (PEL) [United States]
TWA: 25 (mg/m3) from OSHA (PEL) [United States]Consult local authorities for acceptable exposure limits.

Section 9: Physical and Chemical Properties
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Physical state and appearance: Liquid.
Odor: Pungent, vinegar-like, sour (Strong.)
Taste: Vinegar, sour (Strong.)
Molecular Weight: 60.05 g/mole
Color: Colorless. Clear (Light.)
pH (1% soln/water): 2 [Acidic.]
Boiling Point: 118.1°C (244.6°F)
Melting Point: 16.6°C (61.9°F)
Critical Temperature: 321.67°C (611°F)
Specific Gravity: 1.049 (Water = 1)
Vapor Pressure: 1.5 kPa (@ 20°C)
Vapor Density: 2.07 (Air = 1)
Volatility: Not available.
Odor Threshold: 0.48 ppm
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.2
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, diethyl ether, acetone.
Solubility:
Easily soluble in cold water, hot water. Soluble in diethyl ether, acetone. Miscible with Glycerol, alcohol, Benzene, Carbon
Tetrachloride. Practically insoluble in Carbon Disulfide.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Heat, ignition sources, incompatible materials
Incompatibility with various substances: Reactive with oxidizing agents, reducing agents, metals, acids, alkalis.
Corrosivity:
Highly corrosive in presence of stainless steel(304). Slightly corrosive in presence of aluminum, of copper. Non-corrosive in
presence of stainless steel(316).
Special Remarks on Reactivity:
Reacts violently with strong oxidizing agents, acetaldehyde, and acetic anhydride. Material can react with metals, strong
bases, amines, carbonates, hydroxides, phosphates, many oxides,cyanides, sulfides, chromic acid, nitric acid, hydrogen
peroxide, carbonates. ammonium nitrate, ammonium thiosulfate, chlorine trifluoride, chlorosulfonic acid, perchloric acid,
permanganates, xylene, oleum, potassium hydroxide, sodium hydroxide, phosphorus isocyanate, ethylenediamine, ethylene
imine.
Special Remarks on Corrosivity: Moderate corrosive effect on bronze. No corrosion data on brass
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
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Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3310 mg/kg [Rat]. Acute dermal toxicity (LD50): 1060 mg/kg [Rabbit]. Acute toxicity of the vapor (LC50): 5620
1 hours [Mouse].
Chronic Effects on Humans:
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast. May cause damage to
the following organs: kidneys, mucous membranes, skin, teeth.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive). Very hazardous in case of skin contact (irritant), of ingestion, .
Hazardous in case of skin contact (corrosive, permeator), of eye contact (corrosive).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: May affect genetic material and may cause reproductive effects based on
animal data. No human data found.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Extremely irritating and corrosive. Causes skin irritation (reddening and itching,
inflammation). May cause blistering , tissue damage and burns. Eyes: Extremely irritating and corrosive. Causes eye irritation,
lacrimation, redness, and pain. May cause burns, blurred vision, conjunctivitis, conjunctival and corneal destruction and
permanent injury. Inhalation: Causes severe respiratory tract irritation. Affects the sense organs (nose, ear, eye, taste),
and blood. May cause chemical pneumonitis, bronchitis, and pulmonary edema. Severe exposure may result in lung tissue
damage and corrosion (ulceration) of the mucous membranes. Inhalation may also cause rhinitis, sneezing, coughing,
oppressive feeling in the chest or chest pain, dyspnea, wheezing, tachypnea, cyanosis, salivation, nausea, giddiness,
muscular weakness. Ingestion: Moderately toxic. Corrosive. Causes gastrointestinal tract irritation (burning and pain of the
mouth, throat, and abdomen, coughing, ulceration, bleeding, nausea, abdomial spasms, vomiting, hematemesis, diarrhea.
May Also affect the liver (impaired liver function), behavior (convulsions, giddines, muscular weakness), and the urinary
system - kidneys (Hematuria, Albuminuria, Nephrosis, acute renal failure, acute tubular necrosis). May also cause dyspnea
or asphyxia. May also lead to shock, coma and death. Chronic Potential Health Effects: Chronic exposure via ingestion may
cause blackening or erosion of the teeth and jaw necrosis, pharyngitis, and gastritis. It may also behavior (similar to acute
ingestion), and metabolism (weight loss). Chronic exposure via inhalation may cause asthma and/or bronchitis with cough,
phlegm, and/or shortness of breath . It may also affect the blood (decreased leukocyte count), and urinary system (kidneys).
Repeated or prolonged skin contact may cause thickening, blackening, and cracking of the skin.

Section 12: Ecological Information
Ecotoxicity:
Ecotoxicity in water (LC50): 423 mg/l 24 hours [Fish (Goldfish)]. 88 ppm 96 hours [Fish (fathead minnow)]. 75 ppm 96 hours
[Fish (bluegill sunfish)]. >100 ppm 96 hours [Daphnia].
BOD5 and COD: BOD-5: 0.34-0.88 g oxygen/g
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification:
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CLASS 3: Flammable liquid. Class 8: Corrosive material
Identification: : Acetic Acid, Glacial UNNA: 2789 PG: II
Special Provisions for Transport: Not available.

Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Acetic acid Rhode Island RTK hazardous substances: Acetic acid Pennsylvania RTK: Acetic
acid Florida: Acetic acid Minnesota: Acetic acid Massachusetts RTK: Acetic acid New Jersey: Acetic acid California Director's
List of Hazardous Subtances (8 CCR 339): Acetic acid TSCA 8(b) inventory: Acetic acid CERCLA: Hazardous substances.:
Acetic acid: 5000 lbs. (2268 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS B-3: Combustible liquid with a flash point between 37.8°C (100°F) and 93.3°C (200°F). CLASS E: Corrosive liquid.
DSCL (EEC):
R10- Flammable. R35- Causes severe burns. S23- Do not breathe gas/fumes/vapour/spray [***] S26- In case of contact with
eyes, rinse immediately with plenty of water and seek medical advice. S45- In case of accident or if you feel unwell, seek
medical advice immediately (show the label where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 2
Reactivity: 0
Personal Protection: H
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 2
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves (impervious). Synthetic apron. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear
appropriate respirator when ventilation is inadequate. Splash goggles.

Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 03:35 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
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no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium acetate anhydrous MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium acetate anhydrous

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLS2710, SLS1918, SLS1123
CAS#: 127-09-3
RTECS: AJ4300010
TSCA: TSCA 8(b) inventory: Sodium acetate anhydrous
CI#: Not applicable.

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com

Synonym: Acetic acid, sodium salt

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Sodium acetate

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: CH3COONa

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium acetate anhydrous

127-09-3

100

Toxicological Data on Ingredients: Not applicable.

Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of ingestion, of inhalation. Slightly hazardous in case of skin contact (irritant), of eye contact (irritant).
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
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Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Slightly flammable to flammable in presence of open flames and sparks, of heat. Non-flammable in presence of shocks.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Combustible when exposed to heat or flame.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the residue with
a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and dispose of according to
local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Neutralize the residue with a dilute solution
of acetic acid. Finish cleaning by spreading water on the contaminated surface and allow to evacuate through the sanitary
system.

Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. Wear suitable protective clothing. In
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case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the
container or the label. Keep away from incompatibles such as oxidizing agents, acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Granular, crystalline powder.)
Odor: Odorless to acetic (Slight.)
Taste: Not available.
Molecular Weight: 82.03 g/mole
Color: Colorless. White.
pH (1% soln/water): 11 [Basic.]
Boiling Point: Not available.
Melting Point: 324°C (615.2°F)
Critical Temperature: Not available.
Specific Gravity: 1.528 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water, hot water.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
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Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials, moisture.
Incompatibility with various substances: Reactive with oxidizing agents, acids.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible (violent reaction) with fluorine diketene, potassium nitrate. Also
incompatible wth nitric acid. Emits fumes of acetic acid upon heating and on contact with strong acids.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3530 mg/kg [Rat]. Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit]. Acute toxicity of the dust (LC50):
>30000 mg/m 1 hours [Rat]. 3
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans:
Hazardous in case of ingestion, of inhalation. Slightly hazardous in case of skin contact (irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause skin irritation. Eyes: May cause eye irritation. Ingestion: May cause digestive
tract irritation with abdominal pain, nausea, and vomiting. May affect behavior, and urinary system. Inhalation: May cause
respiratory tract irritation. Symptoms may include coughing, sore throat, labored breathing, and chest pain.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
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Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium acetate anhydrous
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. Not applicable.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.

Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II. Registery of Toxic Effects of Chemical Substances. Hazardous Substance Data Bank.
Other Special Considerations: Not available.
Created: 10/09/2005 06:28 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Water MSDS
Section 1: Chemical Product and Company Identification
Product Name: Water

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLW1063
CAS#: 7732-18-5

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: ZC0110000
TSCA: TSCA 8(b) inventory: Water

Order Online: ScienceLab.com

CI#: Not available.
Synonym: Dihydrogen oxide

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Water

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: H2O

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Water

7732-18-5

100

Toxicological Data on Ingredients: Not applicable.

Section 3: Hazards Identification
Potential Acute Health Effects:
Non-corrosive for skin. Non-irritant for skin. Non-sensitizer for skin. Non-permeator by skin. Non-irritating to the eyes. Nonhazardous in case of ingestion. Non-hazardous in case of inhalation. Non-irritant for lungs. Non-sensitizer for lungs. Noncorrosive to the eyes. Non-corrosive for lungs.
Potential Chronic Health Effects:
Non-corrosive for skin. Non-irritant for skin. Non-sensitizer for skin. Non-permeator by skin. Non-irritating to the eyes.
Non-hazardous in case of ingestion. Non-hazardous in case of inhalation. Non-irritant for lungs. Non-sensitizer for lungs.
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.

Section 4: First Aid Measures
Eye Contact: Not applicable.
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Skin Contact: Not applicable.
Serious Skin Contact: Not available.
Inhalation: Not applicable.
Serious Inhalation: Not available.
Ingestion: Not Applicable
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances: Not Applicable
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill: Mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.
Large Spill: Absorb with an inert material and put the spilled material in an appropriate waste disposal.

Section 7: Handling and Storage
Precautions: No specific safety phrase has been found applicable for this product.
Storage: Not applicable.

Section 8: Exposure Controls/Personal Protection
Engineering Controls: Not Applicable
Personal Protection: Safety glasses. Lab coat.
Personal Protection in Case of a Large Spill: Not Applicable
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
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Odor: Odorless.
Taste: Not available.
Molecular Weight: 18.02 g/mole
Color: Colorless.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 100°C (212°F)
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: 1 (Water = 1)
Vapor Pressure: 2.3 kPa (@ 20°C)
Vapor Density: 0.62 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: Not applicable
Solubility: Not Applicable

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Not available.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Eye contact.
Toxicity to Animals:
LD50: [Rat] - Route: oral; Dose: > 90 ml/kg LC50: Not available.
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans:
Non-corrosive for skin. Non-irritant for skin. Non-sensitizer for skin. Non-permeator by skin. Non-hazardous in case of
ingestion. Non-hazardous in case of inhalation. Non-irritant for lungs. Non-sensitizer for lungs. Non-corrosive to the eyes. Noncorrosive for lungs.
Special Remarks on Toxicity to Animals: Not available.
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Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Water
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. Not applicable.
HMIS (U.S.A.):
Health Hazard: 0
Fire Hazard: 0
Reactivity: 0
Personal Protection: a
National Fire Protection Association (U.S.A.):
Health: 0
Flammability: 0
Reactivity: 0
Specific hazard:
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Protective Equipment:
Not applicable. Lab coat. Not applicable. Safety glasses.

Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:33 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Conforms to 93/112/EC and ISO 11014-1

SAFETY DATA SHEET
Order
Number

Customer
Number
Identification of the substance/preparation and of the company/undertaking

1.

Product name

:

Tris Base, Molecular Biology Grade

Chemical formula

:

C4H11NO3

Synonym

:

tris(Hydroxymethyl)aminomethane; 1,3-Propanediol,
2-amino-2-(hydroxymethyl)-

Catalog #

: 648310

Supplier

: Manufactured by EMD Biosciences, Inc.
10394 Pacific Center Court
San Diego, CA 92121
(858)450-5558/(800)854-3417
FAX: (858)453-3552

Emergency
telephone number

2.

Composition / information on ingredients

Substance/Preparation

: Substance

Chemical name*

CAS No.

1) tris(Hydroxymethyl)aminomethane; 1,3-Propanediol,
2-amino-2-(hydroxymethyl)-

3.

77-86-1

EC Number
201-064-4

Symbol
Xi

R-Phrases
R36/38

Hazards identification

Physical/chemical hazards

: Not applicable.

Human health hazards

: CAUTION!
MAY CAUSE EYE AND SKIN IRRITATION.

4.

: Call Chemtrec®
(800)424-9300 (within U.S.A.)
(703)527-3887 (outside U.S.A.)

First-aid measures

First-Aid measures
: If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Get medical attention.
: Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if
symptoms appear.
: In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient.
Remove contaminated clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly
clean shoes before reuse. Get medical attention.
: Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes. Cold water may be used. Get medical attention.

Inhalation
Ingestion

Skin Contact

Eye Contact
Effects and symptoms

: Hazardous in case of skin contact (irritant). Skin inflammation is characterized by itching, scaling, reddening,
or, occasionally, blistering.
: Hazardous in case of eye contact (irritant).

Skin Contact
Eye Contact
Aggravating conditions

5.

: Repeated or prolonged exposure is not known to aggravate medical condition.

Fire-fighting measures

Flammability of the Product

: May be combustible at high temperature.

Extinguishing Media
: SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Hazardous thermal (de)composition : These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
products
Suitable

Catalog #

648310
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Special fire-fighting procedures

: Fire fighters should wear positive pressure self-contained breathing apparatus (SCBA) and full turnout gear.

Protection of fire-fighters

: Be sure to use an approved/certified respirator or equivalent.

6.

Accidental release measures
: Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self-contained breathing apparatus should be
used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
: Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
: Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading
water on the contaminated surface and allow to evacuate through the sanitary system

Personal precautions

Small Spill and Leak
Large Spill and Leak

7.

Handling and storage

Handling

: Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the
residue under a fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust.
Wear suitable protective clothing. If ingested, seek medical advice immediately and show the container or the
label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, alkalis.

Storage

: Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 20°C (68°F).

Packaging materials
: Use original container.

Recommended use

8.

Exposure controls/personal protection
: Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure
to airborne contaminants below the exposure limit.
: Wash hands after handling compounds and before eating, smoking, using lavatory, and at the end of day.

Engineering measures

Hygiene measures

Ingredient Name
1) Tris Base, Molecular Biology Grade

Occupational Exposure Limits
Not available.

Personal protective equipment
Respiratory system

: Dust respirator. Be sure to use an approved/certified respirator or equivalent.

Skin and body

: Lab coat.

Hands

: Gloves.

Eyes

: Splash goggles.

Protective Clothing
(Pictograms)

:

9.

Physical and chemical properties

Physical state

: Solid. (Solid crystalline powder.)

Color

: White.

Molecular Weight

: 121.1 g/mole

Melting Point

: 171.2 to 172.3°C (340.2 to 342.1°F)

Solubility

: Easily soluble in cold water.

Flash point

: Not available.

Explosive properties

: Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.

10. Stability and reactivity
: The product is stable.

Stability
Conditions to avoid

: Not available.

Materials to avoid

: Reactive with oxidizing agents, alkalis.

Hazardous Decomposition Products

: These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).

Catalog #

648310
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11. Toxicological information
:

RTECS #

TY2900000

Local effects
Skin irritation

: Hazardous in case of skin contact (irritant).

Acute toxicity

: LD50: Not available.
LC50: Not available.

Chronic toxicity

: Repeated or prolonged exposure is not known to aggravate medical condition.

Other Toxic Effects on
Humans

: Not available.
Hazardous in case of skin contact (irritant).

Not available.
Not available.

Carcinogenic effects

: Not available.

Mutagenic effects

: Not available.

Reproduction toxicity

: Not available.

Teratogenic effects

: Not available.

12. Ecological information
Ecotoxicity

: Not available.

Toxicity of the Products of
Biodegradation

: The product itself and its products of degradation are not toxic.

13. Disposal considerations
Methods of disposal; Waste of
residues; Contaminated packaging

: Waste must be disposed of in accordance with federal, state and local environmental control regulations.

14. Transport information
International transport regulations
Land - Road/Railway
: Not controlled under ADR (Europe).

ADR/RID Class
Sea

: Not controlled under IMDG.

IMDG Class
Air

: Not controlled under IATA.

IATA-DGR Class

Not applicable.

Special Provisions for
Transport

15. Regulatory information
EU Regulations
Hazard symbol(s)

:

Classification

: Irritant

Risk Phrases

: R36/38- Irritating to eyes and skin.

Safety Phrases

: S26- In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

U.S. Federal Regulations

Catalog #

648310

: TSCA 8(b) inventory: Tris Base, Molecular Biology Grade
SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found.
SARA 302/304/311/312 hazardous chemicals: No products were found.
SARA 311/312 MSDS distribution - chemical inventory - hazard identification: No products were found.
SARA 313 toxic chemical notification and release reporting: No products were found.
Clean Water Act (CWA) 307: No products were found.
Clean Water Act (CWA) 311: No products were found.
Clean air act (CAA) 112 accidental release prevention: No products were found.
Clean air act (CAA) 112 regulated flammable substances: No products were found.
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HCS Classification

Clean air act (CAA) 112 regulated toxic substances: No products were found.
: CLASS: Irritating substance.

State Regulations

:

: Not controlled under WHMIS (Canada).

WHMIS (Canada)

CEPA DSL: Tris Base, Molecular Biology Grade

16. Other information
Hazardous Material
Information System
(U.S.A.)

Health
Fire Hazard
Reactivity
Personal Protection

2 National Fire
1 Protection
Association (U.S.A.)
0
E

Fire Hazard

1
Health

2

0

Reactivity
Specific Hazard

Notice to Reader

To the best of our knowledge, the information contained herein is accurate. However, neither the above named supplier nor any of its
subsidiaries assumes any liability whatsoever for the accuracy or completeness of the information contained herein
Final determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should be
used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazards that exist.
Date of issue

Catalog #

648310

3/26/2003.
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Material Safety Data Sheet
Sodium phosphate, dibasic MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium phosphate, dibasic

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLS2365, SLS2986, SLS4408
CAS#: 7558-79-4

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: WC4500000
TSCA: TSCA 8(b) inventory: Sodium phosphate, dibasic
CI#: Not available.
Synonym: Dibasic Sodium Phosphate; Disodium
hydrogen phosphate; Disodium monohydrogen phosphate;
Disodium orthophosphate; Disodium phosphoric acid;
Phosphoric acid, disodium salt; Soda phosphate; Sodium
hydrogen phosphate

Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400

Chemical Name: Sodium Monohydrogen Phosphate(2:1:1)
Chemical Formula: Na2HPO4

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium phosphate, dibasic

7558-79-4

100

Toxicological Data on Ingredients: Not applicable.

Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.

Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill: Use a shovel to put the material into a convenient waste disposal container.

Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe dust. Wear suitable protective clothing. In case of insufficient ventilation, wear suitable
respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Keep away from
incompatibles such as acids, alkalis.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic
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Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid powder.)
Odor: Odorless.
Taste: Saline.
Molecular Weight: 141.96 g/mole
Color: White.
pH (1% soln/water): 9.1 [Basic.]
Boiling Point: Not available.
Melting Point:
Decomposition temperature: 240°C (464°F) Converted to Sodium Pyrophosphate @ about 240 deg. C
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: 4.9 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in hot water. Soluble in cold water. Insoluble in methanol, n-octanol.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability:
p. 3

Exposure to moisture and to incompatible materials. When heated to decompostition, it emits toxic fumes of phosphoxides and
sodium oxide.
Incompatibility with various substances: Reactive with acids, alkalis.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with magnesium, alkaloids, antipyrine, chloral hydrate, lead acetate,
pyrogallol, resorcinol, strong mineral acids, strong organic acids.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 17000 mg/kg [Rat].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes mild skin irritation. May cause dermatitis. Eyes: Causes mild eye irritation.
Ingestion: May cause irritation of the digestive tract and may cause purging. It is slowly aborbed. Expected to be a low
ingestion hazard for usual industrial handling. Ingestion of large doses may affect behavior/central nervous system (tetany).
However, if a significant amount of phosphate is absorbed, hypophosphatemia will occur. Severe hypophosphatemia may
result in hypocalcemia and tetany. Cardiovasular, respiratory, neurologic, and musculoskeletal effects may occur secondary
to hypernatremia, hypophosphatemia, and hypocalcemia Inhalation: May cause respiratory tract and mucous membrane
irritation. Low hazard for usual industrial handling. Chronic Potential Health Effects: Skin: High and repeated exposure may
cause dermatitis.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
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Identification: : Not available. UNNA: 9147 PG: III
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Sodium phosphate, dibasic Pennsylvania RTK: Sodium phosphate, dibasic Massachusetts
RTK: Sodium phosphate, dibasic New Jersey: Sodium phosphate, dibasic California Director's List of Hazardous Sustances:
Sodium phosphate, dibasic TSCA 8(b) inventory: Sodium phosphate, dibasic CERCLA: Hazardous substances.: Sodium
phosphate, dibasic: 5000 lbs. (2268 kg)
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.

Section 16: Other Information
References: -Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987.
Other Special Considerations: Not available.
Created: 10/09/2005 06:34 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium carbonate monohydrate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium carbonate monohydrate

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLS1099, SLS2521, SLS3943
CAS#: 5968-11-6

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: Not available.
TSCA: TSCA 8(b) inventory: No products were found.
CI#: Not available.

Order Online: ScienceLab.com

Synonym: Disodium Carbonate monohydrate

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Carbonic Acid, disodium salt,
monohydrate

International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400

Chemical Formula: Na2CO3.H20

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium carbonate monohydrate

5968-11-6

100

Toxicological Data on Ingredients: Sodium carbonate monohydrate: DUST (LC50): Acute: 468 mg/m 4 hours [Guinea pig].

Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation (lung irritant). Corrosive to
eyes and skin. The amount of tissue damage depends on length of contact. Eye contact can result in corneal damage or
blindness. Skin contact can produce inflammation and blistering. Severe over-exposure can produce lung damage, choking,
unconsciousness or death.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (irritant). CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS:
Not available. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance
may be toxic to upper respiratory tract, skin, eyes. Repeated or prolonged exposure to the substance can produce target
organs damage. Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can
produce local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or
lung damage.
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Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar,
tie, belt or waistband.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the residue with
a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and dispose of according to
local and regional authority requirements.
Large Spill:
Corrosive solid. Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
p. 2

Neutralize the residue with a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and
allow to evacuate through the sanitary system.

Section 7: Handling and Storage
Precautions:
Keep container dry. Do not ingest. Do not breathe dust. Never add water to this product. Wear suitable protective clothing. In
case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the
container or the label. Avoid contact with skin and eyes.
Storage: Hygroscopic. Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor and dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to
avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Granular solid.)
Odor: Odorless.
Taste: Not available.
Molecular Weight: 124 g/mole
Color: White.
pH (1% soln/water): 11.6 [Basic.]
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Density: 2.25 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
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Dispersion Properties: See solubility in water.
Solubility:
Soluble in hot water. Partially soluble in cold water. Soluble in 3 parts of cold water. Soluble in 1.8 parts of boiling water.
Insoluble in alcohol. Soluble in 7 parts of glycero

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, moisture
Incompatibility with various substances:
Reactive with acids. Slightly reactive to reactive with moisture.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with aluminum and fluorine. Dries out somewhat in warm, dry air or
above 50 C and becomes anhydrous at 100 C.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Dermal contact. Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute toxicity
of the dust (LC50): 468 mg/m 4 hours [Guinea pig]. 3
Chronic Effects on Humans: May cause damage to the following organs: upper respiratory tract, skin, eyes.
Other Toxic Effects on Humans: Hazardous in case of skin contact (irritant), of ingestion, of inhalation (lung irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: May cause adverse reproductive effects based on animal test data
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes skin irritation with possible burns depending on the concentration, site (abraded
or intact skin), and duration of exposure. Eyes: Causes eye irritation and possible burns. May cause chemical conjunctivitis.
Concentrated solutions may cause permanent corneal injury (permanent corneal opacity). Ingestion: Sodium carbonate
ingestion may cause irritation of the digestive tract resulting in nausea, vomiting, diarrhea, thrist, abdominal pain depending
on concentration and amount ingested. May also affect the cardiovascular system . Inhalation: Dust may cause respiratory
tract and mucous membrane irritation with coughing and shortness of breath (dyspnea), pulmonary edema. Chronic Potential
Health Effects: Chronic inhalation may result in decreased pulmonary function, nasal congestion, nosebleeds, perforation
of the nasal septum. Other effects of chronic exposure are skin (dermatitis and ulceration), and gastrointestinal complaints.
However, the effects of chronic exposure seem to be reversible if exposure is decreased.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
p. 4

Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations: No products were found.
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada):
CLASS D-1A: Material causing immediate and serious toxic effects (VERY TOXIC). CLASS E: Corrosive solid.
DSCL (EEC):
R36/37/38- Irritating to eyes, respiratory system and skin. S22- Do not breathe dust. S26- In case of contact with eyes, rinse
immediately with plenty of water and seek medical advice.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 0
Reactivity: 1
Personal Protection: j
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear
appropriate respirator when ventilation is inadequate. Splash goggles.

Section 16: Other Information
References: Not available.
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Other Special Considerations: Not available.
Created: 10/11/2005 12:33 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium bicarbonate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium bicarbonate

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLS3241, SLS2446, SLS3868
CAS#: 144-55-8

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: VZ0950000
TSCA: TSCA 8(b) inventory: Sodium bicarbonate
CI#: Not available.
Synonym: Baking Soda; Bicarbonate of soda; Sodium
acid carbonate; Monosodium carbonate; Sodium hydrogen
carbonate; Carbonic acid monosodium salt

Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400

Chemical Name: Sodium Bicarbonate
Chemical Formula: NaHCO3

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Sodium bicarbonate

144-55-8

100

Toxicological Data on Ingredients: Not applicable.

Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.

Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
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Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits acrid smoke and irritating fumes.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.

Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe dust. If ingested, seek medical advice immediately and show the container or the label. Keep
away from incompatibles such as acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.

Section 8: Exposure Controls/Personal Protection
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Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.

Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Odorless.
Taste: Saline. Alkaline.
Molecular Weight: 84.01g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Density: 2.159 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Soluble in cold water. Slightly soluble in alcohol. Solubility in Water: 6.4, 7.6, 8.7, 10.0, 11.3, 12.7, 14.2, 16.5, 19.1 g/100
solution at 0, 10, 20, 30, 40, 50, 60, 80, adn 100 deg. C, respectively. Solubility in Water: 6.9, 8,2, 9.6, 11.1, 12.7, 14.5, 16.5,
19.7, and 23.6 g/100g water at 0, 10, 20, 30, 40, 50, 60, 80, 100 deg. C, respectively.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, Moisture. Stable in dry air, but slowly decomposes in moist air.
Incompatibility with various substances: Reactive with acids.
p. 3

Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Reacts with acids to form carbon dioxide. Dangerous reaction with monoammonium phosphate or a sodium-potassium alloy.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 3360 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans:
Sodium Bicarbonate as produced genetic effects in rats (unscheduled DNA synthesis). However, no affects have been found
in humans.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause mild skin irritation. Eyes: May cause mild eye irritation. Inhalation: May
cause respiratory tract irritation. Symptoms may include coughing and sneezing. Ingestion: Symptoms of overexposure to
Sodium Bicarbonate include thirst, abdominal pain, gastroenteritis, and inflammation of the digestive tract. Chronic Potential
Health Effects: Skin: Repeated or prolonged skin contact may cause irritation, drying or cracking of the skin. Ingestion and
Inhalation: Chronic toxicity usually occurs within 4 to 10 days following ingestion of very large amounts. Repeated or prolonged
ingestion or inhalation of large amounts may cause metabolic abnormalities, and sodium retention. Metabolic abnormalities
such as acidosis, hypernatremia, hypochloremia, alkalosis, hypocalcemia, or sodium retention may affect the blood, kidneys,
respiration (cyanosis, apnea secondary to metabolic acidosis or pulmonary edema), and cardiovascular system (tachycardia,
hypotension). Severe toxicity may also affect behavior/central nervous system/nervous system. Neurological changes may
result from metabolic abnormalities. These may include fatigue, irritability, dizziness, mental confusion, paresthesia, seizures,
tetany, cerebral edema Medical Conditions Aggravated by Exposure: Persons with pre-existing skin conditions might have
increased sensitivity. Predisposing conditions that contribute to a mild alkali syndrome include, renal disease, dehydration, adn
electrolyte imbalance, hypertension, sarcoidosis, congestive heart failure, edema, or other sodium retaining conditions.

Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.

Section 14: Transport Information
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DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium bicarbonate
Other Regulations: Not available.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. Not applicable.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.

Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:26 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Propylene glycol MSDS
Section 1: Chemical Product and Company Identification
Product Name: Propylene glycol

Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396

Catalog Codes: SLP1162, SLP2974
CAS#: 57-55-6

US Sales: 1-800-901-7247
International Sales: 1-281-441-4400

RTECS: TY2000000
TSCA: TSCA 8(b) inventory: Propylene glycol

Order Online: ScienceLab.com

CI#: Not applicable.
Synonym: 1,2,-propanediol, 1,2-dihydroxypropane

CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300

Chemical Name: Propylene Glycol

International CHEMTREC, call: 1-703-527-3887

Chemical Formula: CH3CHOHCH2OH

For non-emergency assistance, call: 1-281-441-4400

Section 2: Composition and Information on Ingredients
Composition:
Name

CAS #

% by Weight

Propylene glycol

57-55-6

100

Toxicological Data on Ingredients: Propylene glycol: ORAL (LD50): Acute: 20000 mg/kg [Rat]. 22000 mg/kg [Mouse].
DERMAL (LD50): Acute: 20800 mg/kg [Rabbit].

Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of ingestion. Slightly hazardous in case of skin contact (irritant, permeator), of eye contact (irritant), of
inhalation.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (sensitizer). CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS:
Not available. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be
toxic to central nervous system (CNS). Repeated or prolonged exposure to the substance can produce target organs damage.

Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids
open. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar,
tie, belt or waistband.
Serious Ingestion: Not available.

Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: 371°C (699.8°F)
Flash Points: CLOSED CUP: 99°C (210.2°F). OPEN CUP: 107°C (224.6°F) (Cleveland).
Flammable Limits: LOWER: 2.6% UPPER: 12.5%
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances: Slightly flammable to flammable in presence of heat.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: When heated to decomposition it emits acrid smoke and irritating fumes.
Special Remarks on Explosion Hazards: Not available.

Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.
Finish cleaning by spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Absorb with an inert material and put the spilled material in an appropriate waste disposal. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system. Be careful that the product is not present at a
concentration level above TLV. Check TLV on the MSDS and with local authorities.

Section 7: Handling and Storage
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Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not ingest. Do not breathe gas/fumes/ vapor/spray. Wear suitable
protective clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice
immediately and show the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as
oxidizing agents, reducing agents, acids, alkalis, moisture.
Storage:
Hygroscopic. Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 23°C (73.4°F).

Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Splash goggles. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
TWA: 10 (mg/m3) from AIHA Consult local authorities for acceptable exposure limits.

Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid. (Oily liquid.)
Odor: Practically Odorless.
Taste: Practically Tasteless.
Molecular Weight: 76.1g/mole
Color: Colorless. Clear
pH (1% soln/water): Not available.
Boiling Point: 188°C (370.4°F)
Melting Point: -59°C (-74.2°F)
Critical Temperature: Not available.
Specific Gravity: 1.036 (Water = 1)
Vapor Pressure:
0 kPa (@ 20°C) 0.08 mmHg at 20 C 0.129 mmHg at 25 C
Vapor Density: 2.62 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.9
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, acetone.
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Solubility: Soluble in cold water, hot water, acetone.

Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, excess heat, exposure to moist air or water
Incompatibility with various substances: Reactive with oxidizing agents, reducing agents, acids, alkalis.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with chloroformates, strong acids (nitric acid, hydrofluloric acid),
caustics, aliphatic amines, isocyanates, strong oxidizers, acid anhydrides, silver nitrate, reducing agents.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.

Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Eye contact.
Toxicity to Animals:
Acute oral toxicity (LD50): 18500 mg/kg [Rabbit]. Acute dermal toxicity (LD50): 20800 mg/kg [Rabbit].
Chronic Effects on Humans: May cause damage to the following organs: central nervous system (CNS).
Other Toxic Effects on Humans:
Hazardous in case of ingestion. Slightly hazardous in case of skin contact (irritant, permeator), of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans:
May affect genetic material (mutagenic). May cause adverse reproductive effects and birth defects (teratogenic) based on
animal test data.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause mild skin irritation. It may be absorbed through the skin and cause systemic
effects similar to those of ingestion. Eyes: May cause mild eye irritation with some immediate, transitory stinging, lacrimation,
blepharospasm, and mild transient conjunctival hyperemia. There is no residual discomfort or injury once it is washed
away. Inhalation: May cause respiratory tract irritation. Ingestion: It may cause gastrointestinal tract irritation. It may affect
behavior/central nervous system(CNS depression, general anesthetic, convulsions, seizures, somnolence, stupor, muscle
contraction or spasticity, coma), brain (changes in surface EEG), metabolism, blood (intravascular hemolysis, white blood
cells - decreased neutrophil function), respiration (respiratory stimulation, chronic pulmonary edema, cyanosis), cardiovascular
system(hypotension, bradycardia, arrhythmias, cardiac arrest), endocrine system (hypoglycemia), urinary system (kidneys),
and liver. Chronic Potential Health Effects: Skin: Prolonged or repeated skin contact may cause allergic contact dermatitis.
Ingestion: Prolonged or repeated ingestion may cause hyperglycemia and may affect behavior/CNS (symptoms similar to that
of acute ingestion). Inhalation: Prolonged or repeated inhalation may affect behavior/CNS (with symptoms similar to ingestion),
and spleen

Section 12: Ecological Information
Ecotoxicity:
Ecotoxicity in water (LC50): >5000 mg/l 24 hours [Goldfish]. >10000 mg/l 48 hours [guppy]. >10000 mg/l 48 hours [water flea].
BOD5 and COD: Not available.
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Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.

Section 13: Disposal Considerations
Waste Disposal:

Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.

Section 15: Other Regulatory Information
Federal and State Regulations:
Pennsylvania RTK: Propylene glycol Minnesota: Propylene glycol TSCA 8(b) inventory: Propylene glycol
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R21/22- Harmful in contact with skin and if swallowed. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: h
National Fire Protection Association (U.S.A.):
Health: 0
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.

Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II. -Supplier MSDS -LOLI -RTECS -HSDB
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Other Special Considerations: Not available.
Created: 10/10/2005 08:24 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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SAFETY DATA SHEET
Oxygen

Section 1. Identification
GHS product identifier

: Oxygen

Chemical name

: oxygen

Other means of
identification

: Molecular oxygen; Oxygen molecule; Pure oxygen; O2; UN 1072; Dioxygen; Oxygen
USP, Aviator’s Breathing Oxygen (ABO)

Product type

: Gas.

Product use

: Synthetic/Analytical chemistry.

Synonym

: Molecular oxygen; Oxygen molecule; Pure oxygen; O2; UN 1072; Dioxygen; Oxygen
USP, Aviator’s Breathing Oxygen (ABO)
: 001043
: Airgas USA, LLC and its affiliates
259 North Radnor-Chester Road
Suite 100
Radnor, PA 19087-5283
1-610-687-5253

SDS #
Supplier's details

24-hour telephone

: 1-866-734-3438

Section 2. Hazards identification
OSHA/HCS status
Classification of the
substance or mixture

: This material is considered hazardous by the OSHA Hazard Communication Standard
(29 CFR 1910.1200).
: OXIDIZING GASES - Category 1
GASES UNDER PRESSURE - Compressed gas

GHS label elements
Hazard pictograms

:

Signal word

: Danger

Hazard statements

: May cause or intensify fire; oxidizer.
Contains gas under pressure; may explode if heated.

Precautionary statements
General

Response

: Read and follow all Safety Data Sheets (SDS’S) before use. Read label before use.
Keep out of reach of children. If medical advice is needed, have product container or
label at hand. Close valve after each use and when empty. Use equipment rated for
cylinder pressure. Do not open valve until connected to equipment prepared for use.
Use a back flow preventative device in the piping. Use only equipment of compatible
materials of construction. Open valve slowly. Use only with equipment cleaned for
Oxygen service.
: Keep away from clothing, incompatible materials and combustible materials. Keep
reduction valves, valves and fittings free from oil and grease.
: In case of fire: Stop leak if safe to do so.

Storage

: Protect from sunlight. Store in a well-ventilated place.

Disposal

: Not applicable.

Prevention

Hazards not otherwise
classified

Date of issue/Date of revision

: None known.

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 3. Composition/information on ingredients
Substance/mixture

: Substance

Chemical name

: oxygen

Other means of
identification

: Molecular oxygen; Oxygen molecule; Pure oxygen; O2; UN 1072; Dioxygen; Oxygen
USP, Aviator’s Breathing Oxygen (ABO)

Product code

: 001043

CAS number/other identifiers
CAS number

: 7782-44-7

Ingredient name

%

CAS number

oxygen

100

7782-44-7

Any concentration shown as a range is to protect confidentiality or is due to batch variation.
There are no additional ingredients present which, within the current knowledge of the supplier and in the
concentrations applicable, are classified as hazardous to health or the environment and hence require reporting
in this section.
Occupational exposure limits, if available, are listed in Section 8.

Section 4. First aid measures
Description of necessary first aid measures
Eye contact

Inhalation

Skin contact

Ingestion

: Immediately flush eyes with plenty of water, occasionally lifting the upper and lower
eyelids. Check for and remove any contact lenses. Continue to rinse for at least 10
minutes. Get medical attention.
: Remove victim to fresh air and keep at rest in a position comfortable for breathing. If
not breathing, if breathing is irregular or if respiratory arrest occurs, provide artificial
respiration or oxygen by trained personnel. It may be dangerous to the person providing
aid to give mouth-to-mouth resuscitation. Get medical attention if adverse health effects
persist or are severe. If unconscious, place in recovery position and get medical
attention immediately. Maintain an open airway. Loosen tight clothing such as a collar,
tie, belt or waistband.
: Flush contaminated skin with plenty of water. Remove contaminated clothing and
shoes. Get medical attention if symptoms occur. Wash clothing before reuse. Clean
shoes thoroughly before reuse.
: As this product is a gas, refer to the inhalation section.

Most important symptoms/effects, acute and delayed
Potential acute health effects
Eye contact

: Contact with rapidly expanding gas may cause burns or frostbite.

Inhalation

: No known significant effects or critical hazards.

Skin contact

: Contact with rapidly expanding gas may cause burns or frostbite.

Frostbite
Ingestion

: Try to warm up the frozen tissues and seek medical attention.
: As this product is a gas, refer to the inhalation section.

Over-exposure signs/symptoms
Eye contact

: No specific data.

Inhalation

: No specific data.

Skin contact

: No specific data.

Ingestion

: No specific data.

Indication of immediate medical attention and special treatment needed, if necessary
Notes to physician
Specific treatments

Date of issue/Date of revision

: Treat symptomatically. Contact poison treatment specialist immediately if large
quantities have been ingested or inhaled.
: No specific treatment.

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 4. First aid measures
Protection of first-aiders

: No action shall be taken involving any personal risk or without suitable training. It may
be dangerous to the person providing aid to give mouth-to-mouth resuscitation.

See toxicological information (Section 11)

Section 5. Fire-fighting measures
Extinguishing media
Suitable extinguishing
media
Unsuitable extinguishing
media

: Use an extinguishing agent suitable for the surrounding fire.
: None known.

Specific hazards arising
from the chemical

: Contains gas under pressure. Oxidizing material. This material increases the risk of
fire and may aid combustion. Contact with combustible material may cause fire. In a
fire or if heated, a pressure increase will occur and the container may burst or explode.
: No specific data.

Hazardous thermal
decomposition products
Special protective actions
for fire-fighters

: Promptly isolate the scene by removing all persons from the vicinity of the incident if
there is a fire. No action shall be taken involving any personal risk or without suitable
training. Contact supplier immediately for specialist advice. Move containers from fire
area if this can be done without risk. Use water spray to keep fire-exposed containers
cool. If involved in fire, shut off flow immediately if it can be done without risk.
: Fire-fighters should wear appropriate protective equipment and self-contained breathing
apparatus (SCBA) with a full face-piece operated in positive pressure mode.

Special protective
equipment for fire-fighters

Section 6. Accidental release measures
Personal precautions, protective equipment and emergency procedures
For non-emergency
personnel

: No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas. Keep unnecessary and unprotected personnel from
entering. Shut off all ignition sources. No flares, smoking or flames in hazard area.
Avoid breathing gas. Provide adequate ventilation. Wear appropriate respirator when
ventilation is inadequate. Put on appropriate personal protective equipment.
For emergency responders : If specialized clothing is required to deal with the spillage, take note of any information in
Section 8 on suitable and unsuitable materials. See also the information in "For nonemergency personnel".
Environmental precautions

: Ensure emergency procedures to deal with accidental gas releases are in place to avoid
contamination of the environment. Inform the relevant authorities if the product has
caused environmental pollution (sewers, waterways, soil or air).

Methods and materials for containment and cleaning up
Small spill

: Immediately contact emergency personnel. Stop leak if without risk. Use spark-proof
tools and explosion-proof equipment.
: Immediately contact emergency personnel. Stop leak if without risk. Use spark-proof
tools and explosion-proof equipment. Note: see Section 1 for emergency contact
information and Section 13 for waste disposal.

Large spill

Section 7. Handling and storage
Precautions for safe handling

Date of issue/Date of revision

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 7. Handling and storage
Protective measures

Advice on general
occupational hygiene

Conditions for safe storage,
including any
incompatibilities

: Put on appropriate personal protective equipment (see Section 8). Contains gas under
pressure. Avoid breathing gas. Do not puncture or incinerate container. Use
equipment rated for cylinder pressure. Close valve after each use and when empty.
Protect cylinders from physical damage; do not drag, roll, slide, or drop. Use a suitable
hand truck for cylinder movement.
Avoid contact with eyes, skin and clothing. Empty containers retain product residue
and can be hazardous. Keep away from clothing, incompatible materials and
combustible materials. Keep reduction valves free from grease and oil.
: Eating, drinking and smoking should be prohibited in areas where this material is
handled, stored and processed. Workers should wash hands and face before eating,
drinking and smoking. Remove contaminated clothing and protective equipment before
entering eating areas. See also Section 8 for additional information on hygiene
measures.
: Store in accordance with local regulations. Store in a segregated and approved area.
Store away from direct sunlight in a dry, cool and well-ventilated area, away from
incompatible materials (see Section 10). Cylinders should be stored upright, with valve
protection cap in place, and firmly secured to prevent falling or being knocked over.
Cylinder temperatures should not exceed 52 °C (125 °F). Separate from reducing
agents and combustible materials. Store away from grease and oil. Keep container
tightly closed and sealed until ready for use. See Section 10 for incompatible materials
before handling or use.

Section 8. Exposure controls/personal protection
Control parameters
Occupational exposure limits
Ingredient name

Exposure limits

oxygen

None.

Appropriate engineering
controls

: Good general ventilation should be sufficient to control worker exposure to airborne
contaminants.

Environmental exposure
controls

: Emissions from ventilation or work process equipment should be checked to ensure
they comply with the requirements of environmental protection legislation. In some
cases, fume scrubbers, filters or engineering modifications to the process equipment
will be necessary to reduce emissions to acceptable levels.

Individual protection measures
Hygiene measures
: Wash hands, forearms and face thoroughly after handling chemical products, before
eating, smoking and using the lavatory and at the end of the working period.
Appropriate techniques should be used to remove potentially contaminated clothing.
Wash contaminated clothing before reusing. Ensure that eyewash stations and safety
showers are close to the workstation location.
Eye/face protection
: Safety eyewear complying with an approved standard should be used when a risk
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts. If contact is possible, the following protection should be worn, unless
the assessment indicates a higher degree of protection: safety glasses with sideshields.
Skin protection
Hand protection

Date of issue/Date of revision

: Chemical-resistant, impervious gloves complying with an approved standard should be
worn at all times when handling chemical products if a risk assessment indicates this is
necessary. Considering the parameters specified by the glove manufacturer, check
during use that the gloves are still retaining their protective properties. It should be
noted that the time to breakthrough for any glove material may be different for different
glove manufacturers. In the case of mixtures, consisting of several substances, the
protection time of the gloves cannot be accurately estimated.

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 8. Exposure controls/personal protection
Body protection

Other skin protection

Respiratory protection

: Personal protective equipment for the body should be selected based on the task being
performed and the risks involved and should be approved by a specialist before
handling this product.
: Appropriate footwear and any additional skin protection measures should be selected
based on the task being performed and the risks involved and should be approved by a
specialist before handling this product.
: Based on the hazard and potential for exposure, select a respirator that meets the
appropriate standard or certification. Respirators must be used according to a
respiratory protection program to ensure proper fitting, training, and other important
aspects of use. Respirator selection must be based on known or anticipated exposure
levels, the hazards of the product and the safe working limits of the selected respirator.

Section 9. Physical and chemical properties
Appearance
Physical state

: Gas. [Compressed gas.]

Color

: Colorless. Blue.

Odor

: Odorless.
: Not available.

Odor threshold
pH
Melting point

: Not available.
: -218.4°C (-361.1°F)

Boiling point
Critical temperature

: -183°C (-297.4°F)
: -118.15°C (-180.7°F)

Flash point

: [Product does not sustain combustion.]

Evaporation rate

: Not available.

Flammability (solid, gas)

: Extremely flammable in the presence of the following materials or conditions: reducing
materials, combustible materials and organic materials.
: Not available.

Lower and upper explosive
(flammable) limits
Vapor pressure
Vapor density
Specific Volume (ft 3/lb)
3

: Not available.
: 1.1 (Air = 1)
: 12.0482

Gas Density (lb/ft )

: 0.083

Relative density

: Not applicable.

Solubility

: Not available.

Solubility in water

: Not available.

Partition coefficient: noctanol/water
Auto-ignition temperature

: 0.65

Decomposition temperature

: Not available.

Viscosity

: Not applicable.

Flow time (ISO 2431)
Molecular weight

: Not available.
: 32 g/mole

: Not available.

Section 10. Stability and reactivity
Reactivity

: No specific test data related to reactivity available for this product or its ingredients.

Chemical stability

: The product is stable.

Possibility of hazardous
reactions

: Hazardous reactions or instability may occur under certain conditions of storage or use.
Conditions may include the following:
contact with combustible materials
Reactions may include the following:
risk of causing fire

Date of issue/Date of revision

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 10. Stability and reactivity
Conditions to avoid

: No specific data.

Incompatible materials

: Highly reactive or incompatible with the following materials:
combustible materials
reducing materials
grease
oil

Hazardous decomposition
products

: Under normal conditions of storage and use, hazardous decomposition products should
not be produced.

Hazardous polymerization

: Under normal conditions of storage and use, hazardous polymerization will not occur.

Section 11. Toxicological information
Information on toxicological effects
Acute toxicity
Not available.
Irritation/Corrosion
Not available.
Sensitization
Not available.
Mutagenicity
Not available.
Carcinogenicity
Not available.
Reproductive toxicity
Not available.
Teratogenicity
Not available.
Specific target organ toxicity (single exposure)
Not available.
Specific target organ toxicity (repeated exposure)
Not available.
Aspiration hazard
Not available.
Information on the likely
routes of exposure

: Not available.

Potential acute health effects
Eye contact
: Contact with rapidly expanding gas may cause burns or frostbite.
Inhalation

: No known significant effects or critical hazards.

Skin contact

: Contact with rapidly expanding gas may cause burns or frostbite.

Ingestion

: As this product is a gas, refer to the inhalation section.

Symptoms related to the physical, chemical and toxicological characteristics
Date of issue/Date of revision

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 11. Toxicological information
Eye contact

: No specific data.

Inhalation

: No specific data.

Skin contact

: No specific data.

Ingestion

: No specific data.

Delayed and immediate effects and also chronic effects from short and long term exposure
Short term exposure
Potential immediate
: Not available.
effects
Potential delayed effects

: Not available.

Long term exposure
Potential immediate
effects

: Not available.

Potential delayed effects

: Not available.

Potential chronic health effects
Not available.
General

: No known significant effects or critical hazards.

Carcinogenicity

: No known significant effects or critical hazards.

Mutagenicity

: No known significant effects or critical hazards.

Teratogenicity

: No known significant effects or critical hazards.

Developmental effects

: No known significant effects or critical hazards.

Fertility effects

: No known significant effects or critical hazards.

Numerical measures of toxicity
Acute toxicity estimates
Not available.

Section 12. Ecological information
Toxicity
Not available.
Persistence and degradability
Not available.
Bioaccumulative potential
Product/ingredient name

LogPow

BCF

Potential

oxygen

0.65

-

low

Mobility in soil
Soil/water partition
coefficient (KOC)
Other adverse effects

Date of issue/Date of revision

: Not available.

: No known significant effects or critical hazards.

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 13. Disposal considerations
Disposal methods

: The generation of waste should be avoided or minimized wherever possible. Disposal
of this product, solutions and any by-products should at all times comply with the
requirements of environmental protection and waste disposal legislation and any
regional local authority requirements. Dispose of surplus and non-recyclable products
via a licensed waste disposal contractor. Waste should not be disposed of untreated to
the sewer unless fully compliant with the requirements of all authorities with jurisdiction.
Empty Airgas-owned pressure vessels should be returned to Airgas. Waste packaging
should be recycled. Incineration or landfill should only be considered when recycling is
not feasible. This material and its container must be disposed of in a safe way. Empty
containers or liners may retain some product residues. Do not puncture or incinerate
container.

Section 14. Transport information
DOT

TDG

Mexico

IMDG

IATA

UN number

UN1072

UN1072

UN1072

UN1072

UN1072

UN proper
shipping name

OXYGEN,
COMPRESSED

OXYGEN,
COMPRESSED

OXYGEN,
COMPRESSED

OXYGEN,
COMPRESSED

OXYGEN,
COMPRESSED

Transport
2.2 (5.1)
hazard class(es)

2.2

2.2 (5.1)

2.2 (5.1)

2.2 (5.1)

Packing group

-

-

-

-

-

Environmental
hazards

No.

No.

No.

No.

No.

“Refer to CFR 49 (or authority having jurisdiction) to determine the information required for shipment of the
product.”
Additional information
DOT Classification

TDG Classification

IATA

: Limited quantity Yes.
Quantity limitation Passenger aircraft/rail: 75 kg. Cargo aircraft: 150 kg.
Special provisions A52
: Product classified as per the following sections of the Transportation of Dangerous
Goods Regulations: 2.13-2.17 (Class 2), 2.23-2.25 (Class 5).
Explosive Limit and Limited Quantity Index 0.125
ERAP Index 3000
Passenger Carrying Ship Index 50
Passenger Carrying Road or Rail Index 75
Special provisions 42
: Quantity limitation Passenger and Cargo Aircraft: 75 kg. Cargo Aircraft Only: 150 kg.

Special precautions for user : Transport within user’s premises: always transport in closed containers that are
upright and secure. Ensure that persons transporting the product know what to do in the
event of an accident or spillage.
Transport in bulk according
to Annex II of MARPOL and
the IBC Code

Date of issue/Date of revision

: Not available.

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 15. Regulatory information
U.S. Federal regulations

: TSCA 8(a) CDR Exempt/Partial exemption: This material is listed or exempted.

Clean Air Act Section 112
(b) Hazardous Air
Pollutants (HAPs)

: Not listed

Clean Air Act Section 602
Class I Substances

: Not listed

Clean Air Act Section 602
Class II Substances

: Not listed

DEA List I Chemicals
(Precursor Chemicals)

: Not listed

DEA List II Chemicals
(Essential Chemicals)

: Not listed

SARA 302/304
Composition/information on ingredients
No products were found.
SARA 304 RQ

: Not applicable.

SARA 311/312
Classification

: Refer to Section 2: Hazards Identification of this SDS for classification of substance.

State regulations
Massachusetts

: This material is listed.

New York

: This material is not listed.

New Jersey

: This material is listed.

Pennsylvania

: This material is listed.

International regulations
Chemical Weapon Convention List Schedules I, II & III Chemicals
Not listed.
Montreal Protocol (Annexes A, B, C, E)
Not listed.
Stockholm Convention on Persistent Organic Pollutants
Not listed.
Rotterdam Convention on Prior Informed Consent (PIC)
Not listed.
UNECE Aarhus Protocol on POPs and Heavy Metals
Not listed.
Inventory list
Australia

: This material is listed or exempted.

Canada

: This material is listed or exempted.

China

: This material is listed or exempted.

Europe

: This material is listed or exempted.

Japan

: Japan inventory (ENCS): Not determined.
Japan inventory (ISHL): Not determined.

Malaysia

: Not determined.

New Zealand

: This material is listed or exempted.

Philippines

: This material is listed or exempted.

Republic of Korea

: This material is listed or exempted.

Date of issue/Date of revision

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 15. Regulatory information
Taiwan

: This material is listed or exempted.

Thailand

: Not determined.

Turkey

: Not determined.

United States

: This material is listed or exempted.

Viet Nam

: Not determined.

Section 16. Other information
Hazardous Material Information System (U.S.A.)
/

Health

0

Flammability

0

Physical hazards

3

Caution: HMIS® ratings are based on a 0-4 rating scale, with 0 representing minimal hazards or risks, and 4
representing significant hazards or risks. Although HMIS® ratings and the associated label are not required on
SDSs or products leaving a facility under 29 CFR 1910.1200, the preparer may choose to provide them. HMIS®
ratings are to be used with a fully implemented HMIS® program. HMIS® is a registered trademark and service
mark of the American Coatings Association, Inc.
The customer is responsible for determining the PPE code for this material. For more information on HMIS®
Personal Protective Equipment (PPE) codes, consult the HMIS® Implementation Manual.
National Fire Protection Association (U.S.A.)
Flammability

0
Health

0

0
OX

Instability/Reactivity
Special

Reprinted with permission from NFPA 704-2001, Identification of the Hazards of Materials for Emergency
Response Copyright ©1997, National Fire Protection Association, Quincy, MA 02269. This reprinted material is
not the complete and official position of the National Fire Protection Association, on the referenced subject
which is represented only by the standard in its entirety.
Copyright ©2001, National Fire Protection Association, Quincy, MA 02269. This warning system is intended to
be interpreted and applied only by properly trained individuals to identify fire, health and reactivity hazards of
chemicals. The user is referred to certain limited number of chemicals with recommended classifications in
NFPA 49 and NFPA 325, which would be used as a guideline only. Whether the chemicals are classified by NFPA
or not, anyone using the 704 systems to classify chemicals does so at their own risk.
Procedure used to derive the classification
Classification

Justification

OXIDIZING GASES - Category 1
GASES UNDER PRESSURE - Compressed gas

Expert judgment
According to package

History
Date of printing

: 2/3/2018

Date of issue/Date of
revision
Date of previous issue

: 2/3/2018

Version

: 0.03

Key to abbreviations

Date of issue/Date of revision

: 1/27/2017
: ATE = Acute Toxicity Estimate
BCF = Bioconcentration Factor
GHS = Globally Harmonized System of Classification and Labelling of Chemicals
IATA = International Air Transport Association
IBC = Intermediate Bulk Container
IMDG = International Maritime Dangerous Goods
LogPow = logarithm of the octanol/water partition coefficient
MARPOL = International Convention for the Prevention of Pollution From Ships, 1973
: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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Section 16. Other information
References

as modified by the Protocol of 1978. ("Marpol" = marine pollution)
UN = United Nations
: Not available.

Indicates information that has changed from previously issued version.
Notice to reader
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot
guarantee that these are the only hazards that exist.

Date of issue/Date of revision

: 2/3/2018

Date of previous issue

: 1/27/2017

Version

: 0.03
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